data_2kcm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.873 0.844 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.24 -172.16 39.18 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.47 141.11 51.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.757 -0.849 . . . . 0.0 109.691 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.8 p -86.19 118.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.526 0.679 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.02 -28.75 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.657 -0.652 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.425 ' HG ' ' N ' ' A' ' 8' ' ' TYR . 46.2 t -155.96 153.07 28.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.425 ' N ' ' HG ' ' A' ' 7' ' ' SER . 80.0 t80 -157.02 112.72 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.598 0.713 . . . . 0.0 109.21 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.24 116.05 27.69 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.757 0.789 . . . . 0.0 109.434 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.09 76.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -37.98 85.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.596 -0.69 . . . . 0.0 109.844 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 14' ' ' TYR . 55.5 mtpt -95.88 11.07 35.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.877 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' LYS . 64.2 pttt 34.95 27.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.521 0.676 . . . . 0.0 110.341 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 12' ' ' LYS . 35.7 t80 -141.7 123.08 14.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.59 0.71 . . . . 0.0 109.347 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -114.4 -164.11 14.83 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -146.78 134.32 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.658 -0.907 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.8 132.4 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.487 0.661 . . . . 0.0 109.271 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -100.51 116.96 33.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.84 161.56 53.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -65.08 -35.77 82.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.961 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -87.48 9.03 22.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.542 -0.724 . . . . 0.0 109.175 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.65 58.66 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -91.97 118.13 30.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -1.028 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.8 p -80.59 163.97 23.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.718 0.771 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -144.82 150.96 38.04 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.61 0.719 . . . . 0.0 109.69 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.56 143.44 28.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.567 0.698 . . . . 0.0 109.998 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.495 ' C ' ' HD1' ' A' ' 28' ' ' HIS . 66.7 mt -110.75 127.26 55.28 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.749 0.785 . . . . 0.0 109.892 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.495 ' HD1' ' C ' ' A' ' 27' ' ' LEU . 10.0 m80 -140.73 159.42 42.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.765 0.793 . . . . 0.0 109.9 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -65.67 -35.17 80.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.1 t -62.33 -17.77 59.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -93.88 -18.56 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.507 -0.745 . . . . 0.0 109.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.0 141.04 32.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.594 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.76 152.82 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.686 0.755 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 70.7 mmtt -66.68 -39.42 88.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 38' ' ' GLU . 98.7 mttt -63.96 -39.38 94.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.481 0.658 . . . . 0.0 109.264 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -51.1 -9.46 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.547 -0.721 . . . . 0.0 109.405 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 36' ' ' LYS . 11.8 pt-20 -70.34 -36.57 74.32 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . -83.2 -8.87 84.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -94.29 0.29 55.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.966 . . . . 0.0 108.995 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.91 153.25 42.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.452 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -113.91 120.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.045 0.926 . . . . 0.0 110.104 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -91.0 136.4 33.1 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.684 0.754 . . . . 0.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.08 26.44 40.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -149.22 -164.63 2.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 111.143 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 95.8 mtp -87.48 145.66 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.902 0.858 . . . . 0.0 110.871 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.41 161.1 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -118.91 124.76 47.88 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.864 0.84 . . . . 0.0 110.152 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -149.4 157.03 42.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.503 0.668 . . . . 0.0 109.326 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.26 150.58 38.55 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.72 -0.612 . . . . 0.0 109.365 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.86 152.81 76.86 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.701 2.267 . . . . 0.0 112.813 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.812 0.815 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.56 151.63 15.22 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.809 0.814 . . . . 0.0 109.876 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.37 159.98 14.81 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.471 0.653 . . . . 0.0 109.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -149.79 138.66 21.01 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.645 0.736 . . . . 0.0 110.273 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 58.05 68.6 0.82 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.584 0.707 . . . . 0.0 109.941 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mm -66.24 138.25 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.322 0.582 . . . . 0.0 109.507 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -132.37 141.97 49.12 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.095 0.95 . . . . 0.0 110.307 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.43 93.0 25.09 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.494 1.548 0 C-N-CA 122.686 2.257 . . . . 0.0 111.951 -179.311 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.5 pttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.788 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.46 -168.11 36.09 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -130.58 133.8 46.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.735 -0.862 . . . . 0.0 109.816 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.68 111.83 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.752 0.786 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -73.71 -33.5 38.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.637 -0.664 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -161.63 153.91 19.8 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.014 0.911 . . . . 0.0 110.738 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -153.16 102.4 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -96.56 112.09 23.97 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.058 0.932 . . . . 0.0 109.505 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.97 79.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.619 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.49 85.53 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.7 mtmt -94.05 3.09 55.81 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mttp 47.08 15.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.218 0.533 . . . . 0.0 110.322 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 33.6 t80 -144.96 159.35 43.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.004 0.907 . . . . 0.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -161.58 -152.55 6.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.83 154.1 48.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.89 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 150.03 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.56 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -112.4 116.38 30.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.792 0.806 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.62 160.99 47.76 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.01 -36.2 83.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.919 -0.754 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.76 9.32 19.31 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.61 7.44 81.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -87.41 119.31 27.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.682 -0.893 . . . . 0.0 109.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.5 m -75.47 153.1 37.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.533 0.682 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -135.29 132.56 37.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.807 0.813 . . . . 0.0 109.804 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.15 140.81 40.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.646 0.736 . . . . 0.0 110.426 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 4.3 tt -115.51 117.46 30.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.162 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.645 ' HD1' ' H ' ' A' ' 30' ' ' SER . 53.8 t-80 -139.46 166.6 24.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.995 0.902 . . . . 0.0 110.156 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 10.1 m-85 -62.36 -40.86 97.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.86 -0.525 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.645 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 38.6 t -60.25 -17.75 44.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.821 -0.549 . . . . 0.0 109.945 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.79 -7.24 47.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 109.045 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.2 mt -88.0 125.3 34.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.768 0.794 . . . . 0.0 110.037 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.13 -41.8 97.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -126.65 131.15 51.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.81 0.814 . . . . 0.0 109.038 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -35.75 81.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.784 -0.572 . . . . 0.0 109.545 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -60.47 -36.46 78.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.538 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.58 -10.13 16.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.753 -0.592 . . . . 0.0 109.42 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -67.27 -38.61 85.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.0 -8.97 85.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -98.73 5.11 47.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.408 -1.054 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 156.1 26.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.32 130.3 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.175 0.988 . . . . 0.0 110.088 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -98.02 135.94 38.99 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.802 0.81 . . . . 0.0 110.907 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.1 59.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -135.52 173.76 11.37 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.264 -1.139 . . . . 0.0 111.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.41 142.16 37.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.739 0.78 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.73 163.5 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -121.0 135.32 55.24 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.867 0.841 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.26 156.51 39.84 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.729 0.776 . . . . 0.0 110.016 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.82 156.63 37.07 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.802 -0.561 . . . . 0.0 109.551 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.94 148.99 64.25 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.43 2.087 . . . . 0.0 112.948 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 2.5 m . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.815 0.817 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -165.47 157.26 14.73 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.761 0.791 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.29 133.66 46.84 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.87 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -114.64 135.55 54.03 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.907 0.861 . . . . 0.0 110.146 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.24 66.74 1.12 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.583 0.706 . . . . 0.0 110.383 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 63' ' ' ILE . 96.7 mt -73.06 137.27 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.561 0.696 . . . . 0.0 109.784 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 p -132.04 150.28 52.2 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.743 0.782 . . . . 0.0 110.122 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 82.86 36.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 C-N-CA 122.701 2.267 . . . . 0.0 111.348 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.394 0.616 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.56 4.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.77 146.38 52.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.583 -0.951 . . . . 0.0 110.123 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 44' ' ' GLY . 10.0 p -75.71 113.39 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.54 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.81 -34.33 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -148.94 146.13 27.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.976 -1.077 . . . . 0.0 110.241 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -162.76 102.08 1.02 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.8 mt -115.65 114.14 24.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 109.17 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.27 66.4 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.67 54.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 60.3 pttt -97.14 1.17 49.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.22 -0.925 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 57.71 38.69 27.59 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.296 0.569 . . . . 0.0 109.997 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 59.0 m-85 -149.14 159.45 44.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.18 33.92 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.99 157.61 45.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.458 -1.025 . . . . 0.0 109.627 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.94 135.0 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.689 -0.632 . . . . 0.0 109.565 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -94.07 99.07 11.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.05 170.68 28.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.6 -35.42 80.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.601 -0.94 . . . . 0.0 109.012 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.9 1.21 40.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.011 -1.055 . . . . 0.0 108.887 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.29 24.15 57.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 98.0 mt-10 -89.13 114.14 25.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.14 -1.212 . . . . 0.0 109.718 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -74.4 147.61 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.176 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 23' ' ' GLU . 96.3 m-85 -122.36 144.71 48.85 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.469 0.652 . . . . 0.0 109.533 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.9 -43.65 98.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 tt 70.4 96.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.773 ' HD1' ' H ' ' A' ' 30' ' ' SER . 3.9 t-80 -116.47 119.04 34.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.461 0.648 . . . . 0.0 109.637 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -57.09 -21.37 31.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.773 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 77.9 p -66.94 -19.29 65.7 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -88.3 3.83 48.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 mt -77.84 133.67 38.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.89 -42.59 99.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -121.32 120.4 34.99 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.4 0.619 . . . . 0.0 109.557 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.14 -36.24 82.95 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.77 -39.17 90.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.737 . . . . 0.0 109.596 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.63 -6.56 26.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.94 -37.36 84.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.177 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.39 88.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -91.93 -3.1 56.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -1.159 . . . . 0.0 109.175 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 169.22 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.516 -0.74 . . . . 0.0 110.348 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.26 143.42 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -110.0 130.0 55.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.532 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' H ' ' CG1' ' A' ' 5' ' ' VAL . . . 93.13 -15.42 62.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -97.39 -175.05 3.1 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.216 -1.167 . . . . 0.0 110.799 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 96.2 mtp -80.05 148.33 31.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.57 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.69 151.13 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.252 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.82 125.57 45.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.725 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.85 147.74 37.67 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.06 152.5 42.52 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.689 -0.632 . . . . 0.0 109.311 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.89 139.5 62.44 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.334 2.023 . . . . 0.0 112.201 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.486 ' CG2' ' HZ1' ' A' ' 61' ' ' LYS . 43.4 m . . . . . 0 N--CA 1.488 1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.095 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 121.514 0.674 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.44 153.95 39.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.23 144.83 43.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.686 -0.633 . . . . 0.0 109.494 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HZ1' ' CG2' ' A' ' 52' ' ' THR . 2.7 ttmp? -128.59 143.98 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.48 0.657 . . . . 0.0 109.617 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.33 71.09 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.452 0.644 . . . . 0.0 110.127 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.46 129.49 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.43 -0.794 . . . . 0.0 108.886 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 m -131.06 155.52 46.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.507 -0.746 . . . . 0.0 110.011 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.86 112.41 58.03 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.255 1.97 . . . . 0.0 111.69 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.61 -167.77 33.14 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.164 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -130.99 137.21 49.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.714 -0.874 . . . . 0.0 109.417 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.87 105.95 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.038 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.02 -38.82 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.492 0.663 . . . . 0.0 109.448 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.8 p -154.49 158.73 40.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -158.4 114.89 2.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.545 -0.722 . . . . 0.0 109.148 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 100.43 8.82 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.68 72.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.759 0.79 . . . . 0.0 109.339 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.81 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.69 . . . . 0.0 109.939 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.8 mtpt -94.29 4.23 54.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 108.969 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mttp 56.29 4.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.293 0.568 . . . . 0.0 109.555 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 59.1 m-85 -130.8 154.2 48.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.659 0.742 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.02 -169.0 22.76 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.41 151.19 51.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.487 -1.008 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.19 159.35 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.43 0.633 . . . . 0.0 109.378 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -113.05 107.87 16.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.675 0.75 . . . . 0.0 109.661 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.5 161.9 53.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 47.3 p-10 -65.01 -33.9 77.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.955 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 93.3 m-20 -90.13 7.2 39.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 108.751 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.7 14.83 64.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 98.2 mt-10 -92.23 119.27 31.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -1.108 . . . . 0.0 109.686 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -78.41 152.67 32.09 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.696 0.76 . . . . 0.0 110.657 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.4 m-85 -138.76 135.35 34.6 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.552 0.691 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.82 144.29 35.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.662 -0.649 . . . . 0.0 110.245 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 tt -113.76 120.16 39.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 29' ' ' PHE . 80.8 t60 -136.1 171.72 14.06 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.685 0.755 . . . . 0.0 109.724 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 5.3 m-85 -61.4 -39.53 91.04 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.665 0.745 . . . . 0.0 109.551 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.412 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 79.2 p -59.62 -20.29 54.89 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.712 -0.617 . . . . 0.0 110.023 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.02 -9.52 36.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 0.0 109.426 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.83 124.02 38.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 109.79 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.37 -41.67 96.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 109.438 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -130.09 114.06 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.578 -0.702 . . . . 0.0 109.243 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -49.67 -27.53 4.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.01 -37.01 85.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.28 -7.0 20.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.118 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -65.96 -33.44 75.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.748 . . . . 0.0 109.068 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 -7.82 85.24 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' CD ' ' N ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -93.8 0.65 56.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -1.128 . . . . 0.0 108.738 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.12 150.27 47.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.584 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.57 126.81 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.885 0.85 . . . . 0.0 109.893 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.91 139.33 30.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.725 0.774 . . . . 0.0 110.835 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.37 51.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -146.1 -164.85 2.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.909 -1.348 . . . . 0.0 110.949 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtm -86.35 142.73 28.27 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.724 0.773 . . . . 0.0 110.543 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.8 135.88 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.551 0.691 . . . . 0.0 109.284 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -94.98 126.94 40.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -0.76 . . . . 0.0 109.855 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -150.08 149.42 30.27 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.47 150.71 36.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 179.83 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.459 179.711 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.924 0.869 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 143.69 29.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.03 167.08 12.65 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.759 0.79 . . . . 0.0 110.017 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -149.53 142.83 25.16 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.795 0.807 . . . . 0.0 110.053 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.56 74.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.838 0.828 . . . . 0.0 110.566 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 63' ' ' ILE . 16.1 mm -69.76 133.43 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 109.249 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.3 t -138.12 138.8 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.023 0.916 . . . . 0.0 110.05 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.434 ' CD2' ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.82 127.1 55.39 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.312 -1.381 0 C-N-CA 122.005 1.803 . . . . 0.0 110.825 179.269 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.834 0.826 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.88 -174.38 36.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -133.12 142.05 48.49 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.693 -0.886 . . . . 0.0 110.049 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.13 113.83 22.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.846 0.831 . . . . 0.0 108.98 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.22 -38.38 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.425 -0.797 . . . . 0.0 109.418 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -161.45 162.57 30.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.858 0.837 . . . . 0.0 110.217 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -153.08 109.82 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.0 mm? -99.87 106.59 18.45 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.024 0.916 . . . . 0.0 109.655 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.52 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.389 0.614 . . . . 0.0 109.567 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.11 79.2 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' TYR . 98.9 mttt -89.33 -4.31 58.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.391 -0.818 . . . . 0.0 109.003 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.33 -17.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 23.2 p90 -132.52 158.19 42.75 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.49 -138.73 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -148.91 151.43 34.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.669 -0.901 . . . . 0.0 110.193 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 17' ' ' ILE . 96.7 mt -133.1 133.44 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.545 0.688 . . . . 0.0 109.257 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -103.44 116.97 33.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.947 0.88 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.94 160.45 52.76 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -68.62 -24.87 64.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.82 -0.812 . . . . 0.0 109.898 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -91.29 6.86 43.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.4 -0.813 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.1 72.3 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -92.37 115.89 28.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.392 -1.063 . . . . 0.0 110.132 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.9 p -81.14 148.25 29.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.609 0.719 . . . . 0.0 110.006 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.53 136.98 43.46 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.806 0.813 . . . . 0.0 110.015 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -73.43 139.61 45.97 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.549 0.69 . . . . 0.0 109.963 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.2 tt -113.99 120.59 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.812 0.815 . . . . 0.0 109.663 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -138.2 163.1 32.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.852 0.834 . . . . 0.0 109.107 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.862 -0.524 . . . . 0.0 109.773 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -57.54 -17.93 16.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 109.366 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.29 -9.87 34.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.464 -0.773 . . . . 0.0 108.986 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.96 112.03 22.12 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.922 0.868 . . . . 0.0 109.593 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -63.26 -41.57 99.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.869 -0.52 . . . . 0.0 109.655 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 36' ' ' LYS . 91.1 m-20 -128.53 106.76 9.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -54.91 -6.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.565 -0.71 . . . . 0.0 109.129 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 34' ' ' ASP . 68.6 mttm -64.54 -37.88 89.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.584 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.16 -7.55 49.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.484 -0.76 . . . . 0.0 109.512 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -56.79 -44.93 82.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.637 -0.664 . . . . 0.0 109.622 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.39 -9.57 86.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 41' ' ' LEU . 33.8 mtmm -116.13 16.65 15.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.418 -1.048 . . . . 0.0 109.121 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 40' ' ' LYS . 5.3 mt -55.14 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 109.935 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.0 162.15 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.256 1.027 . . . . 0.0 110.636 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -145.53 95.07 2.6 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.75 0.786 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.55 -15.72 62.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -84.95 165.37 17.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -1.216 . . . . 0.0 110.54 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.9 mtm -66.75 143.6 56.84 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.962 0.887 . . . . 0.0 111.052 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.95 161.62 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 109.259 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -130.32 129.08 42.74 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.791 0.805 . . . . 0.0 110.009 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -144.01 160.57 40.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.503 0.668 . . . . 0.0 109.617 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.81 154.29 38.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.836 -0.54 . . . . 0.0 109.589 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -49.73 142.89 24.01 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.652 2.235 . . . . 0.0 112.745 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.714 0.769 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.38 155.07 14.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.698 0.761 . . . . 0.0 109.903 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.48 137.08 47.03 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.856 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -133.39 142.55 48.42 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.878 0.847 . . . . 0.0 109.898 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.51 48.81 9.26 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.627 0.727 . . . . 0.0 109.773 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.61 139.23 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.546 0.688 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -133.74 149.78 51.48 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.691 0.758 . . . . 0.0 110.028 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.92 103.31 43.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 C--N 1.313 -1.318 0 C-N-CA 122.788 2.326 . . . . 0.0 111.316 -179.831 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.26 -163.85 20.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -141.76 144.17 33.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.572 -0.958 . . . . 0.0 110.117 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.452 HG11 ' H ' ' A' ' 44' ' ' GLY . 4.4 p -77.48 126.08 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.741 -0.599 . . . . 0.0 109.759 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.34 -35.32 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.741 . . . . 0.0 109.588 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 m -151.28 135.4 16.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.996 -1.065 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -157.01 114.99 3.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -119.45 124.87 47.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.691 0.758 . . . . 0.0 109.287 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -24.14 67.75 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.476 0.655 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.891 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.6 mtmt -97.03 -3.69 40.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 109.163 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 65.61 -8.46 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.527 0.68 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.6 p90 -150.9 161.37 42.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.754 . . . . 0.0 109.254 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.51 -119.36 0.97 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.3 153.16 40.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.655 -0.909 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.42 HG22 HD12 ' A' ' 17' ' ' ILE . 96.6 mt -134.81 145.58 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.532 0.682 . . . . 0.0 109.739 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -107.92 108.71 19.98 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.764 0.793 . . . . 0.0 109.379 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.24 158.48 53.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.4 p-10 -66.09 -34.3 77.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.828 -0.807 . . . . 0.0 109.89 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 52.0 t0 -89.23 10.55 21.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.213 -0.929 . . . . 0.0 109.544 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.37 14.98 69.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -97.31 121.5 39.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.158 -1.201 . . . . 0.0 109.8 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.2 p -78.16 153.56 31.95 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.736 0.779 . . . . 0.0 110.714 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -141.81 136.52 30.71 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.716 0.77 . . . . 0.0 109.656 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.73 144.19 39.46 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.617 0.722 . . . . 0.0 110.167 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.6 tt -111.54 120.82 43.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.572 0.701 . . . . 0.0 109.318 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -128.82 138.85 52.29 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.757 0.789 . . . . 0.0 109.511 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 30' ' ' SER . 20.8 p90 -66.88 -35.1 79.26 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.068 0.937 . . . . 0.0 109.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 37.4 m -63.66 -33.12 74.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.49 0.662 . . . . 0.0 109.791 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.25 -0.7 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.91 139.54 37.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.294 -0.879 . . . . 0.0 109.659 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.77 -41.52 97.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -128.22 121.13 28.64 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -45.83 -27.72 0.92 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.568 0.699 . . . . 0.0 109.674 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -64.83 -32.57 74.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.01 -14.41 22.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.515 -0.741 . . . . 0.0 109.175 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.08 -31.48 69.08 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.73 0.776 . . . . 0.0 109.473 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.2 -3.72 75.39 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.6 7.73 32.91 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.324 -1.104 . . . . 0.0 108.852 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.7 151.1 48.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.436 0.636 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.55 137.93 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.807 0.813 . . . . 0.0 109.938 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -107.28 130.84 54.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.769 0.795 . . . . 0.0 110.453 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.452 ' H ' HG11 ' A' ' 5' ' ' VAL . . . 92.53 -23.0 30.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -91.46 179.19 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -1.132 . . . . 0.0 111.15 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtm -82.62 153.38 25.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.507 0.67 . . . . 0.0 110.493 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.4 m -133.97 161.58 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.746 -0.596 . . . . 0.0 109.542 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -120.94 131.99 54.67 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.551 0.691 . . . . 0.0 109.436 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -150.74 159.94 44.18 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.569 0.699 . . . . 0.0 109.816 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.65 153.19 37.9 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.43 133.9 39.32 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.885 2.39 . . . . 0.0 112.966 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.303 -1.445 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.857 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.45 0.643 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.93 146.15 35.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.716 0.769 . . . . 0.0 109.658 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.93 155.72 18.52 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.551 0.691 . . . . 0.0 109.863 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.21 147.29 34.64 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.728 0.775 . . . . 0.0 109.932 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.93 51.04 14.26 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.732 0.777 . . . . 0.0 109.87 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.53 139.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.0 109.547 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -129.72 149.66 51.37 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.891 0.853 . . . . 0.0 109.917 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.612 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.1 mm? -111.63 81.42 3.27 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.118 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.492 1.44 0 C-N-CA 122.472 2.114 . . . . 0.0 111.589 -179.397 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.04 -159.03 9.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -133.93 149.87 51.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 109.645 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 44' ' ' GLY . 6.1 p -80.74 123.35 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p -93.18 -31.16 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -157.18 149.28 22.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 110.071 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -158.77 106.14 1.84 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.21 110.87 22.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.829 . . . . 0.0 109.025 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.28 84.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.655 -0.653 . . . . 0.0 109.865 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.23 92.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 14' ' ' TYR . 9.9 mtpm? -98.93 7.57 45.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.355 -0.84 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' LYS . 56.1 pttt 35.06 30.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.551 0.691 . . . . 0.0 110.381 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 12' ' ' LYS . 88.5 t80 -139.58 140.84 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.34 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.35 -161.75 14.02 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.3 157.85 45.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.497 -1.002 . . . . 0.0 109.494 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 17' ' ' ILE . 96.3 mt -128.85 132.61 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.63 104.11 15.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.353 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.24 158.43 52.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 39.4 p-10 -64.66 -34.03 77.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.442 -1.034 . . . . 0.0 109.106 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.8 t70 -86.88 6.46 31.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 108.991 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.11 16.89 70.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -93.6 117.94 30.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.962 -1.317 . . . . 0.0 109.636 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -74.36 149.8 40.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.475 -0.766 . . . . 0.0 109.367 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -129.21 139.45 51.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.024 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -74.44 144.05 44.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.68 . . . . 0.0 109.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.51 116.83 23.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.472 -0.768 . . . . 0.0 109.211 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.47 ' CG ' ' N ' ' A' ' 29' ' ' PHE . 84.7 t60 -140.54 170.27 16.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.827 . . . . 0.0 109.411 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.47 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 2.7 m-85 -62.19 -44.11 97.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.106 -0.996 . . . . 0.0 109.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.411 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 16.3 m -55.6 -20.2 12.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.859 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.24 -6.48 53.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.107 -0.995 . . . . 0.0 109.973 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.63 130.87 36.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.78 -41.71 99.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.494 -0.754 . . . . 0.0 109.091 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -142.11 131.39 23.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.403 -0.811 . . . . 0.0 109.125 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -61.93 -31.19 71.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.211 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -59.18 -36.35 75.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 108.851 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.88 -8.29 35.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.35 -42.07 94.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.02 -20.93 71.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -84.75 -0.21 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.125 -1.221 . . . . 0.0 109.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.32 147.94 52.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -127.12 136.69 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.49 -0.756 . . . . 0.0 109.563 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -101.27 138.37 38.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 0.0 110.297 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 88.24 -23.66 14.26 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 m -88.45 178.33 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.94 -1.329 . . . . 0.0 110.513 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -85.4 149.9 25.1 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.586 -0.696 . . . . 0.0 109.906 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.62 164.77 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 109.144 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -124.25 136.15 53.93 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.498 -0.751 . . . . 0.0 109.455 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.1 157.32 43.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -93.93 153.26 40.93 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.162 -0.961 . . . . 0.0 109.295 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 142.17 60.2 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.638 2.225 . . . . 0.0 112.384 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.199 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.386 0.612 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -153.48 153.93 33.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -99.87 -83.04 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.312 -0.867 . . . . 0.0 109.466 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' ALA . 56.3 tttm 60.31 144.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.496 -0.752 . . . . 0.0 110.548 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.11 43.1 32.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 0.0 110.002 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.17 140.29 18.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.149 -0.969 . . . . 0.0 109.03 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 m -121.27 153.21 37.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.738 . . . . 0.0 109.208 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -133.16 82.82 52.83 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 C-N-CA 121.956 1.771 . . . . 0.0 111.152 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.742 0.782 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.58 -174.32 41.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -135.89 134.54 38.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.846 -0.796 . . . . 0.0 109.618 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.84 120.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.797 0.808 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.27 -38.96 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.668 -0.645 . . . . 0.0 109.494 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.8 m -134.31 147.66 50.63 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.689 0.757 . . . . 0.0 110.324 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.607 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 66.5 t80 -161.06 117.63 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.71 110.19 16.99 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.834 0.826 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.16 85.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 109.832 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.01 90.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.849 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.95 2.19 40.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 43.0 39.21 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.504 0.669 . . . . 0.0 110.09 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 93.3 t80 -147.64 158.0 43.81 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.68 0.753 . . . . 0.0 109.955 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -176.73 -162.84 28.02 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -133.71 155.88 48.96 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.575 0.703 . . . . 0.0 109.26 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 17' ' ' ILE . 96.8 mt -133.4 137.5 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.5 0.667 . . . . 0.0 109.447 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -95.16 109.16 21.28 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.11 149.39 49.01 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -68.76 -22.64 64.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.684 -0.892 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 58.7 t0 -76.16 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.0 56.05 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.16 130.54 35.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -1.0 . . . . 0.0 110.356 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -76.23 145.9 39.43 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.56 0.695 . . . . 0.0 110.037 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.34 139.89 50.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.905 0.86 . . . . 0.0 110.117 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.13 143.72 47.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.701 0.762 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.5 tt -108.2 119.35 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.0 109.689 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -129.09 128.26 43.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.157 0.979 . . . . 0.0 109.395 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CG ' ' N ' ' A' ' 30' ' ' SER . 22.7 p90 -64.47 -34.75 78.93 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.964 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 29.7 m -63.29 -33.15 74.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.718 -0.613 . . . . 0.0 110.672 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 60' ' ' ALA . 98.7 mt-10 -73.07 2.77 6.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.38 143.35 33.58 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.634 0.731 . . . . 0.0 109.865 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.33 -40.17 96.56 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' A' ' 36' ' ' LYS . 9.5 p30 -137.46 101.85 4.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.904 0.859 . . . . 0.0 108.775 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -52.23 -7.27 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.788 -0.57 . . . . 0.0 109.621 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 34' ' ' ASP . 43.8 pttt -68.57 -30.1 68.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.225 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 39.7 p30 -79.4 -2.68 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -49.58 -42.59 44.85 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.7 -6.99 82.32 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -95.09 1.27 54.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -1.077 . . . . 0.0 109.517 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.64 152.88 44.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 109.868 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.45 126.4 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 122.118 0.961 . . . . 0.0 109.816 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.607 ' NZ ' ' H ' ' A' ' 8' ' ' TYR . 50.0 tttp -99.34 139.01 35.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.747 0.784 . . . . 0.0 110.817 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 25.19 51.49 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.9 t -143.82 -179.6 6.57 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.137 -1.213 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.12 146.84 34.91 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.745 0.783 . . . . 0.0 110.461 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.0 161.54 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.495 0.665 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -118.16 126.06 51.46 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.863 0.84 . . . . 0.0 109.731 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.49 155.79 39.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.441 0.639 . . . . 0.0 109.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -106.61 163.2 17.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.03 147.4 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.538 2.158 . . . . 0.0 112.718 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.674 -0.641 . . . . 0.0 109.71 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.582 0.705 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.86 155.39 34.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.677 0.751 . . . . 0.0 110.015 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 31' ' ' GLU . . . -116.01 129.92 56.58 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.591 0.71 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 160.48 26.98 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.901 0.858 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.2 48.4 19.54 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.507 0.67 . . . . 0.0 109.571 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -72.31 132.1 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -135.95 154.62 51.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.764 0.792 . . . . 0.0 110.734 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.08 98.25 33.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.489 1.233 0 C-N-CA 122.792 2.328 . . . . 0.0 111.074 -179.594 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.57 0.7 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.33 -172.5 38.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -135.55 134.17 39.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.691 -0.888 . . . . 0.0 109.895 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 13.6 p -78.03 106.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.766 0.793 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.18 -39.01 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.275 0.56 . . . . 0.0 109.662 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -159.07 156.79 29.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 110.469 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' OH ' ' CZ ' ' A' ' 29' ' ' PHE . 68.3 t80 -155.03 109.59 2.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.14 116.59 30.07 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.766 0.793 . . . . 0.0 109.294 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 -25.45 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.651 . . . . 0.0 109.336 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.2 -35.85 81.67 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.626 0.727 . . . . 0.0 109.443 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' TYR . 1.8 mptm? -90.89 7.09 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 61.47 -7.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.387 0.613 . . . . 0.0 109.705 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.5 p90 -161.48 163.8 30.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.462 -0.774 . . . . 0.0 109.635 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.29 -131.98 2.66 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -143.34 152.27 41.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.924 . . . . 0.0 110.036 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.94 133.15 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -95.66 106.71 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.81 0.814 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.36 163.86 54.54 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.71 -39.38 94.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.757 -0.849 . . . . 0.0 109.672 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -82.31 0.91 39.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.53 -0.731 . . . . 0.0 109.386 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.52 62.22 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 80.1 mm-40 -88.55 119.46 29.02 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.085 -1.244 . . . . 0.0 110.109 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -76.37 147.71 37.89 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.662 0.744 . . . . 0.0 110.279 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.6 m-85 -136.34 137.56 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.625 0.726 . . . . 0.0 109.616 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.15 141.11 32.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.4 tt -112.83 116.82 30.65 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.809 0.814 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.86 146.78 45.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 26.3 m-85 -63.56 -39.23 93.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.34 0.59 . . . . 0.0 109.918 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -57.59 -18.54 20.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.442 -0.786 . . . . 0.0 110.024 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.02 -7.46 51.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.141 -0.974 . . . . 0.0 110.304 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.25 138.03 38.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 0.0 109.784 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.75 -41.37 98.02 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.454 0.645 . . . . 0.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -135.94 125.54 25.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.9 -11.43 27.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.499 0.666 . . . . 0.0 109.509 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.42 -14.92 56.56 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -76.79 -4.84 45.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 109.384 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -55.41 -46.07 76.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.748 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.33 -4.44 84.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -94.92 -3.8 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 108.961 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.21 149.14 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.714 -0.616 . . . . 0.0 110.136 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.2 134.56 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.871 0.843 . . . . 0.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.39 133.92 41.34 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.942 0.877 . . . . 0.0 111.29 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.13 61.77 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -96.86 177.11 5.74 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.985 -1.303 . . . . 0.0 110.947 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.6 mtp -81.09 147.63 30.02 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.766 0.793 . . . . 0.0 110.396 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.14 157.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -113.81 132.61 55.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.41 157.67 38.85 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.63 150.78 37.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.42 163.66 38.32 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.35 2.7 . . . . 0.0 113.249 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.61 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.892 0.853 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.29 158.63 30.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.3 130.5 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.941 0.877 . . . . 0.0 110.344 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.62 55.71 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.815 0.817 . . . . 0.0 109.388 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 63' ' ' ILE . 96.7 mt -75.49 136.23 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.56 0.695 . . . . 0.0 110.636 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 m -127.43 151.87 48.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.032 0.92 . . . . 0.0 109.865 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.25 85.65 38.29 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 122.649 2.232 . . . . 0.0 111.902 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.696 0.76 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.08 -150.28 5.65 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.98 141.24 49.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.589 -0.948 . . . . 0.0 109.579 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 8.9 p -81.71 118.33 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.06 -31.14 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.024 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.7 m -157.06 153.95 28.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.805 -1.184 . . . . 0.0 110.839 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' LEU . 38.8 t80 -160.28 -74.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.716 0.77 . . . . 0.0 108.953 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' TYR . 9.6 mt 57.8 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.782 0.801 . . . . 0.0 110.079 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.9 68.51 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.697 0.76 . . . . 0.0 109.152 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.87 -35.18 79.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.7 mtpt -93.6 -7.46 43.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 108.792 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 57.86 -4.09 0.05 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.313 0.578 . . . . 0.0 110.112 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.0 p90 -161.04 164.18 31.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.99 -129.48 1.03 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -143.15 154.76 44.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.54 133.77 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.549 0.69 . . . . 0.0 109.23 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -90.39 97.15 11.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.759 0.79 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.11 163.04 42.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 40.5 p-10 -66.13 -34.8 78.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.789 -0.83 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 54.6 t0 -83.6 2.7 36.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.088 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.58 14.9 72.33 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 97.4 mt-10 -91.85 123.16 35.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.484 -1.009 . . . . 0.0 109.728 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -76.78 150.37 36.19 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.585 0.707 . . . . 0.0 110.339 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.7 m-85 -138.12 137.6 37.86 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.352 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -77.81 139.94 39.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.666 -0.646 . . . . 0.0 110.019 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 tt -114.97 118.53 33.69 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.54 0.686 . . . . 0.0 109.475 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.716 ' HD1' ' H ' ' A' ' 30' ' ' SER . 31.0 t-80 -126.05 137.89 53.67 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 6.2 p90 -59.76 -28.51 67.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.586 0.707 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.716 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 78.9 p -63.73 -26.27 68.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 109.397 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -79.34 -0.43 32.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.5 131.22 35.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.071 -1.018 . . . . 0.0 109.573 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LYS . 96.9 m-20 -131.41 98.85 4.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -46.3 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.673 0.749 . . . . 0.0 109.649 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 34' ' ' ASP . 25.8 mtpp -64.5 -35.79 82.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 109.833 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -73.43 -2.35 22.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.0 109.55 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.17 -32.25 73.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.501 -0.75 . . . . 0.0 109.388 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.02 -8.7 81.86 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -103.39 14.44 31.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.302 -1.117 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.05 151.71 44.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 110.082 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.43 133.26 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.779 0.8 . . . . 0.0 109.792 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -101.07 130.81 47.15 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.931 0.872 . . . . 0.0 111.075 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 5' ' ' VAL . . . 91.71 -18.12 54.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -93.91 -177.25 4.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.023 -1.281 . . . . 0.0 111.816 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.74 140.53 40.83 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.715 0.769 . . . . 0.0 110.367 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.25 131.04 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -90.09 127.0 35.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.492 -0.755 . . . . 0.0 109.742 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.66 152.72 42.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.672 -0.643 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.72 152.89 38.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.41 143.42 93.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.323 2.015 . . . . 0.0 112.281 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.448 -0.782 . . . . 0.0 109.23 179.733 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.9 mt . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.569 0.7 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.51 30.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.477 -0.764 . . . . 0.0 109.2 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.71 138.3 46.28 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 110.01 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.85 138.61 47.1 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.476 0.655 . . . . 0.0 109.358 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.2 61.15 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.687 0.756 . . . . 0.0 109.697 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.18 133.08 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.528 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 p -139.1 153.09 47.97 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.834 0.826 . . . . 0.0 109.828 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.419 ' H ' ' CD2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -87.67 135.91 33.47 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.747 -0.596 . . . . 0.0 109.472 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.356 2.037 . . . . 0.0 111.44 179.141 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.261 0.553 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.6 -149.19 5.6 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.67 142.31 50.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.922 . . . . 0.0 109.687 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -82.15 107.03 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -37.28 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 109.867 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.5 m -148.23 146.93 28.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.041 -1.037 . . . . 0.0 110.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -158.27 105.34 1.9 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.9 111.97 23.96 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.51 -29.56 70.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.549 -0.72 . . . . 0.0 109.581 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.76 84.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' TYR . 55.5 mtpt -92.67 -3.7 54.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt 55.19 6.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.742 -0.599 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 12' ' ' LYS . 45.2 m-85 -130.16 154.14 47.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.639 -0.663 . . . . 0.0 109.736 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.73 -170.15 26.05 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.97 149.87 47.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.412 -1.052 . . . . 0.0 109.761 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.01 133.92 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -85.48 108.05 17.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.846 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.21 158.7 53.17 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 45.8 p-10 -65.84 -33.0 74.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.553 -0.969 . . . . 0.0 109.573 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 24.3 p30 -90.11 8.36 33.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 17.07 63.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.8 123.09 40.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -1.211 . . . . 0.0 109.753 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 p -79.41 149.17 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 110.39 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.15 132.94 45.11 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -82.77 144.47 30.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 0.0 109.707 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' A' ' 27' ' ' LEU . 6.2 tt -113.18 122.96 49.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.552 ' HD1' ' H ' ' A' ' 30' ' ' SER . 49.4 t-80 -138.81 168.04 20.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.717 . . . . 0.0 109.387 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 14.1 m-85 -65.36 -39.67 92.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.781 . . . . 0.0 109.523 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.552 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 37.7 t -61.4 -18.17 57.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.325 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.4 -9.3 48.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.305 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.65 107.12 19.15 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.35 -0.844 . . . . 0.0 109.504 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.9 mm? -64.76 -41.94 95.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.482 -0.761 . . . . 0.0 109.165 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -101.28 109.34 21.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.597 -0.689 . . . . 0.0 109.29 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -63.75 -32.64 74.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.184 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.1 -34.57 76.55 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.02 -7.03 31.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 0.0 108.865 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.18 -42.23 90.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.695 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.85 84.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -95.99 -1.04 49.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.271 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.58 144.68 56.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.623 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.44 121.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.647 0.737 . . . . 0.0 109.623 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -95.2 143.04 26.94 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.934 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 25.35 50.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 t -152.83 -167.0 2.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.725 -1.456 . . . . 0.0 110.981 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.63 144.13 30.5 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.424 0.63 . . . . 0.0 110.768 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.57 161.26 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.437 ' CD2' ' CG ' ' A' ' 66' ' ' PRO . 42.3 m-70 -124.38 136.22 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.457 -0.777 . . . . 0.0 109.837 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.34 155.23 42.47 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.772 . . . . 0.0 109.007 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.12 155.02 71.76 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.922 2.415 . . . . 0.0 112.108 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.456 -0.778 . . . . 0.0 108.924 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.42 0.628 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.416 ' O ' ' CG2' ' A' ' 52' ' ' THR . . . -149.87 141.99 24.03 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.34 149.05 30.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.671 -0.643 . . . . 0.0 109.85 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -145.06 128.5 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.837 . . . . 0.0 109.167 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 56.24 61.16 2.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.42 -0.8 . . . . 0.0 109.239 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.68 139.49 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.632 -0.667 . . . . 0.0 109.596 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 p -136.22 162.19 33.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.722 . . . . 0.0 109.852 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 80.49 47.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' CG ' ' CD2' ' A' ' 48' ' ' HIS . 67.1 Cg_endo . . . . . 0 N--CA 1.494 1.501 0 C-N-CA 123.178 2.585 . . . . 0.0 111.493 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.519 0.676 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.66 6.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -132.82 139.56 47.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.552 -0.97 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.93 121.32 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.18 -32.98 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 t -154.38 144.88 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.916 -1.115 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -158.73 96.53 1.38 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -100.77 124.55 46.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.167 -0.958 . . . . 0.0 109.378 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.61 -35.79 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.696 0.76 . . . . 0.0 109.268 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.13 -30.06 70.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' TYR . 58.1 mttp -94.35 -7.03 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.015 . . . . 0.0 108.926 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 58.83 -3.94 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.565 -0.71 . . . . 0.0 109.846 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 28.0 p90 -151.64 161.23 43.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.042 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 -133.59 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -141.25 157.83 44.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 109.775 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -136.26 154.91 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.415 -0.803 . . . . 0.0 109.241 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -109.79 106.56 16.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.764 0.792 . . . . 0.0 109.146 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.43 161.4 50.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -1.01 . . . . 0.0 109.338 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.3 p-10 -89.9 9.99 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.448 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 16.62 65.08 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.49 114.6 26.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -1.164 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -74.86 146.73 41.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 110.363 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -122.81 139.55 53.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.55 -0.718 . . . . 0.0 109.248 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.24 131.08 36.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.554 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 6.5 tt -104.9 123.41 47.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.088 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.36 153.12 52.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.698 . . . . 0.0 109.412 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.29 -35.57 81.28 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.783 0.801 . . . . 0.0 108.894 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.5 p -61.28 -21.09 63.61 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.446 -0.784 . . . . 0.0 109.62 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.66 -3.89 59.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.068 -1.02 . . . . 0.0 109.645 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.5 126.0 39.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 0.0 109.891 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -63.14 -41.31 99.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' LYS . 93.9 m-20 -127.17 89.72 3.02 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.84 -15.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 109.555 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' ASP . 44.0 mmtm -66.2 -34.96 79.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.163 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 36.3 p30 -73.66 -3.0 25.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.42 -36.09 82.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.39 -12.56 81.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -95.38 6.12 49.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -1.179 . . . . 0.0 109.304 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.8 mt -68.94 156.44 38.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.083 -1.01 . . . . 0.0 109.953 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.89 128.76 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.669 0.747 . . . . 0.0 109.663 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -98.76 138.16 36.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.421 -0.8 . . . . 0.0 110.874 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.6 24.91 61.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -141.63 -174.4 4.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 110.744 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtp -79.55 149.36 31.45 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.665 0.745 . . . . 0.0 110.557 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.86 164.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -127.62 133.09 49.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.54 163.51 38.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.367 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.75 152.05 38.84 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.241 -0.912 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.04 150.18 88.91 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.623 2.215 . . . . 0.0 112.734 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.817 0.818 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.21 170.72 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.948 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -101.98 -46.22 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.408 -0.808 . . . . 0.0 108.891 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ALA . 88.3 tttt 59.12 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.944 0.878 . . . . 0.0 110.903 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.14 87.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 0.0 109.833 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.2 mt -103.36 137.37 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.505 -0.747 . . . . 0.0 109.697 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 p -134.64 160.16 38.98 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.859 0.838 . . . . 0.0 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.23 81.79 22.1 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 122.755 2.303 . . . . 0.0 111.277 -179.635 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.435 0.636 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.29 -145.86 4.3 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.61 142.13 49.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -1.004 . . . . 0.0 109.751 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -81.52 112.04 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -70.35 -37.39 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.391 -0.818 . . . . 0.0 109.781 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 t -165.8 156.61 13.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -153.87 107.47 2.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.32 124.57 52.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.508 -0.745 . . . . 0.0 109.639 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.47 77.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.348 0.594 . . . . 0.0 109.9 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.4 73.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 109.96 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' TYR . 13.7 mptt -87.68 6.67 33.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt 64.22 -17.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.2 p90 -160.72 165.21 30.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.043 -1.035 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.32 -136.15 3.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.9 152.53 51.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.993 . . . . 0.0 109.93 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 17' ' ' ILE . 96.6 mt -134.01 137.57 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -92.55 100.73 13.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.09 174.08 44.4 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -63.52 -39.6 94.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.45 -1.029 . . . . 0.0 109.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -80.94 -0.61 40.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.65 11.75 79.15 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 128.22 34.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.239 . . . . 0.0 109.683 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.4 p -74.22 148.54 41.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.807 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.35 136.81 43.68 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -79.64 137.72 37.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.719 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.71 89.37 2.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.706 ' HD1' ' H ' ' A' ' 30' ' ' SER . 43.1 t-80 -96.04 165.11 12.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 0.0 110.264 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.0 -40.59 96.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.706 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 12.3 t -61.77 -18.37 59.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.178 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.29 -5.34 59.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.4 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.66 125.41 47.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.57 -41.37 98.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -130.75 114.47 15.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.644 -0.66 . . . . 0.0 109.246 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -64.19 -11.68 33.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.351 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.07 -38.65 91.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.52 -5.4 23.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.29 -39.72 76.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.4 -9.19 87.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -96.35 -0.64 49.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.197 -1.178 . . . . 0.0 109.087 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.9 146.79 54.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.06 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.835 0.826 . . . . 0.0 109.555 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.35 140.73 29.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 110.661 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.21 50.18 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.698 ' HG ' ' H ' ' A' ' 46' ' ' MET . 6.9 t -147.46 -164.99 2.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.939 -1.33 . . . . 0.0 110.588 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.698 ' H ' ' HG ' ' A' ' 45' ' ' SER . 97.2 mtp -82.33 140.28 33.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.724 -0.61 . . . . 0.0 110.372 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.59 135.72 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.706 . . . . 0.0 109.256 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -94.31 128.95 41.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.669 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -144.23 155.85 44.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.73 110.64 59.32 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.531 -0.731 . . . . 0.0 109.258 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.49 146.9 24.21 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.334 2.023 . . . . 0.0 112.559 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.672 -0.643 . . . . 0.0 109.304 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.593 0.711 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.18 150.55 28.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.212 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 151.31 22.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 109.898 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -141.43 133.96 28.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.21 66.84 1.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.682 0.753 . . . . 0.0 109.886 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.81 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.2 p -131.13 148.74 52.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.453 -0.779 . . . . 0.0 109.816 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.85 145.13 29.02 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.496 1.622 0 C-N-CA 122.421 2.08 . . . . 0.0 112.041 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 121.639 0.733 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.61 -167.1 22.53 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -132.05 137.36 47.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.696 0.76 . . . . 0.0 110.018 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.48 122.11 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.652 0.739 . . . . 0.0 110.1 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.46 -34.83 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -156.32 160.58 39.84 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.92 0.867 . . . . 0.0 110.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -162.99 93.9 0.82 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.401 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.01 113.57 26.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.905 0.86 . . . . 0.0 108.822 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.0 -13.97 59.89 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.25 -65.94 0.45 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 109.824 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.18 17.13 14.79 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 56.7 57.83 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.688 0.756 . . . . 0.0 109.782 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.99 166.11 32.56 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.85 0.833 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.96 174.08 45.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -133.6 150.7 51.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.765 -0.844 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.98 133.07 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.801 0.81 . . . . 0.0 109.842 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -92.58 115.09 27.79 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.867 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.66 158.33 50.05 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.3 p-10 -66.88 -23.56 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.939 -0.742 . . . . 0.0 110.119 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 82.7 m-20 -89.95 5.27 47.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 109.243 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.68 15.58 65.47 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.74 120.26 39.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.714 -0.874 . . . . 0.0 109.922 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -78.37 155.03 30.25 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 109.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.16 135.26 35.51 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.896 0.855 . . . . 0.0 110.136 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -75.59 142.84 42.62 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.728 0.775 . . . . 0.0 109.849 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.98 132.06 53.91 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.746 0.784 . . . . 0.0 109.749 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.479 ' HD1' ' H ' ' A' ' 29' ' ' PHE . 2.4 t60 -134.3 146.04 49.64 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.984 0.897 . . . . 0.0 110.102 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.479 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 4.1 m-85 -62.16 -42.16 98.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 t -62.87 -18.52 63.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 2.7 mp0 -88.99 -0.52 57.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.0 109.218 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 34' ' ' ASP . 75.5 mt -90.22 -3.08 58.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.4 mt 59.27 -70.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 32' ' ' LEU . 43.2 t0 -110.05 105.71 14.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -56.69 -12.22 1.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.821 -0.549 . . . . 0.0 109.533 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.61 -36.55 84.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.0 109.979 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -77.08 -5.54 49.32 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.421 -0.799 . . . . 0.0 109.072 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 79.0 tt0 -57.37 -38.29 73.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.778 -0.576 . . . . 0.0 109.575 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.07 -8.42 86.55 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.11 0.05 50.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.284 -1.127 . . . . 0.0 109.003 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.85 152.01 46.43 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.615 0.721 . . . . 0.0 110.108 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.94 129.92 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.114 0.959 . . . . 0.0 109.722 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -95.78 138.34 33.57 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.713 0.768 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.21 25.29 55.41 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 t -140.01 172.59 12.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.154 -1.204 . . . . 0.0 110.707 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.1 mtt -76.3 141.56 41.58 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.938 0.875 . . . . 0.0 109.999 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.19 161.79 39.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.499 0.666 . . . . 0.0 109.682 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -122.07 129.5 52.45 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.921 0.867 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -151.39 158.98 44.44 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.827 0.822 . . . . 0.0 109.797 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.49 143.76 26.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.1 141.78 58.9 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.412 2.074 . . . . 0.0 112.123 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.756 -0.59 . . . . 0.0 109.708 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 121.777 0.799 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.39 148.68 29.77 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.739 0.78 . . . . 0.0 109.983 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.41 133.8 49.58 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.643 0.735 . . . . 0.0 109.706 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -118.29 143.84 46.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.96 0.886 . . . . 0.0 110.409 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.59 62.42 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.739 0.781 . . . . 0.0 109.884 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 63' ' ' ILE . 96.8 mt -75.79 137.09 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.576 0.703 . . . . 0.0 109.8 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.9 p -133.05 160.23 37.77 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.999 0.904 . . . . 0.0 110.107 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.11 98.33 38.7 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 C-N-CA 122.612 2.208 . . . . 0.0 111.604 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.295 0.569 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.68 -172.98 32.81 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' NZ ' ' O ' ' A' ' 44' ' ' GLY . 62.3 tttm -142.99 128.31 18.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -1.088 . . . . 0.0 109.224 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.68 130.52 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.937 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.31 -36.4 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 p -158.48 161.97 37.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.961 -1.087 . . . . 0.0 110.556 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -165.75 93.98 0.57 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.21 122.0 42.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -77.07 -14.31 59.83 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.661 -0.65 . . . . 0.0 109.382 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.17 -67.99 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.739 -0.601 . . . . 0.0 110.593 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.93 19.26 15.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.441 -0.787 . . . . 0.0 109.072 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 56.3 66.19 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.83 170.66 21.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.229 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.64 166.79 38.78 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.65 150.89 52.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.619 -0.93 . . . . 0.0 109.282 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 17' ' ' ILE . 96.6 mt -133.96 147.81 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -94.95 117.15 29.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.463 -0.773 . . . . 0.0 109.576 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 159.46 52.69 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.72 -35.53 81.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.387 -1.066 . . . . 0.0 109.603 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -80.64 -0.75 39.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.212 -0.93 . . . . 0.0 109.485 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -5.22 63.13 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE2' ' OH ' ' A' ' 25' ' ' TYR . 20.0 pt-20 -80.24 133.81 36.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.124 -1.221 . . . . 0.0 110.364 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.6 p -83.41 162.77 20.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.431 ' OH ' ' OE2' ' A' ' 23' ' ' GLU . 62.4 m-85 -134.87 146.57 49.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.79 125.41 34.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.253 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -103.39 122.23 44.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.815 . . . . 0.0 108.927 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.641 ' HD1' ' H ' ' A' ' 30' ' ' SER . 53.6 t-80 -135.82 166.79 22.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 11.3 m-85 -62.13 -40.04 94.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.641 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 1.1 m -60.99 -21.5 63.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.453 -0.78 . . . . 0.0 109.991 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.17 -6.76 54.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.26 107.13 18.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.04 -41.38 97.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -113.69 97.47 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.59 -27.01 68.65 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.831 . . . . 0.0 109.234 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.86 -27.79 66.97 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.0 -9.35 58.64 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.456 -0.777 . . . . 0.0 109.264 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -64.61 -35.42 80.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 110.01 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.42 0.97 38.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -149.92 58.08 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -1.205 . . . . 0.0 108.982 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mt -81.49 -165.95 1.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.84 159.84 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.749 0.785 . . . . 0.0 109.714 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.4 93.65 2.18 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . . . 98.63 -13.85 62.3 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -86.49 -177.66 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.409 . . . . 0.0 111.021 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.06 145.95 29.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.568 -0.708 . . . . 0.0 110.434 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 m -133.29 164.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -135.17 135.33 40.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.374 -0.829 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.41 163.7 38.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.56 153.06 38.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.96 139.36 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.953 1.769 . . . . 0.0 112.874 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.276 0.56 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.73 151.38 21.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.32 119.43 39.46 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.79 147.81 40.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.568 -0.708 . . . . 0.0 110.062 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.52 48.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.392 0.615 . . . . 0.0 109.432 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.43 135.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.808 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.9 m -126.92 149.56 49.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 109.275 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.59 97.35 36.41 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 N--CA 1.49 1.307 0 C-N-CA 122.606 2.204 . . . . 0.0 112.483 -179.606 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.212 0.53 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.34 175.64 20.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.5 145.61 47.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.87 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.43 112.46 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 7.5 p -70.77 -41.59 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.535 -0.728 . . . . 0.0 109.745 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 p -160.33 160.62 32.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.573 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -156.84 111.27 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.68 0.752 . . . . 0.0 109.61 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mp -106.83 102.4 11.77 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.2 -23.86 65.79 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.09 96.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.026 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.4 mtmt -97.23 4.24 51.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 59.1 2.95 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.308 0.575 . . . . 0.0 110.12 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 12' ' ' LYS . 62.0 m-85 -118.89 152.3 36.54 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.0 109.895 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.97 -168.9 21.67 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -137.51 149.71 46.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.754 -0.851 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.1 138.49 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.487 0.66 . . . . 0.0 109.527 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -99.46 105.25 17.16 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.761 0.791 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.44 160.66 51.22 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 43.0 p-10 -66.59 -33.37 75.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.649 -0.912 . . . . 0.0 109.712 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 84.7 m-20 -87.99 6.46 35.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.774 -0.579 . . . . 0.0 109.496 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.84 16.95 64.39 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.5 mt-10 -93.68 118.54 31.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.99 . . . . 0.0 109.673 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 p -77.29 153.22 34.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.798 0.809 . . . . 0.0 110.06 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 98.0 m-85 -141.47 134.97 29.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.603 0.716 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -79.35 140.56 37.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.699 0.761 . . . . 0.0 110.108 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.422 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 4.4 tt -112.61 115.0 27.9 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.756 0.788 . . . . 0.0 109.254 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.604 ' HD1' ' H ' ' A' ' 30' ' ' SER . 52.3 t-80 -141.25 167.32 22.45 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.841 0.829 . . . . 0.0 110.303 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 13.5 m-85 -61.65 -35.41 77.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.844 -0.535 . . . . 0.0 110.146 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.604 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 77.8 p -62.99 -20.27 65.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.619 -0.675 . . . . 0.0 109.863 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -93.61 -11.02 32.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.11 116.03 28.35 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.372 -0.83 . . . . 0.0 109.569 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.52 -42.14 95.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.537 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -117.65 134.76 54.55 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.738 0.78 . . . . 0.0 109.589 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 mptm? -77.45 -12.42 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 19.2 ptmt -65.4 -41.96 93.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.717 -0.615 . . . . 0.0 110.313 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 98.0 m-20 -78.33 -8.31 58.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 109.606 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.36 -36.81 79.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 109.108 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.6 -9.75 80.76 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 68.3 mttm -98.46 -0.76 42.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.175 -1.191 . . . . 0.0 109.296 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.9 145.74 15.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.739 . . . . 0.0 110.184 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -124.18 125.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 122.018 0.913 . . . . 0.0 109.47 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 6' ' ' VAL . 7.4 tmtm? -95.69 137.24 35.04 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.908 0.861 . . . . 0.0 110.854 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 25.93 38.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 46' ' ' MET . 8.9 t -142.06 -164.95 1.91 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.026 -1.279 . . . . 0.0 111.343 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.672 ' H ' ' HG ' ' A' ' 45' ' ' SER . 82.6 mtp -88.49 139.94 29.97 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.965 0.888 . . . . 0.0 110.961 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.24 159.8 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.368 0.604 . . . . 0.0 109.503 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -124.05 132.32 53.66 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 110.07 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -154.99 161.16 41.46 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.617 0.722 . . . . 0.0 109.801 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -102.73 150.69 37.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.47 159.8 50.38 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.487 2.125 . . . . 0.0 112.542 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.689 -0.632 . . . . 0.0 109.474 179.826 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.753 0.787 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.3 156.38 35.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.703 0.763 . . . . 0.0 109.728 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.31 87.86 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -89.75 148.4 23.27 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.833 0.825 . . . . 0.0 110.294 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.86 58.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.617 0.723 . . . . 0.0 109.616 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.45 129.37 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.917 0.865 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.1 m -135.79 126.38 27.05 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.645 0.735 . . . . 0.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -89.26 132.35 37.84 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo . . . . . 0 N--CA 1.49 1.265 0 C-N-CA 122.412 2.075 . . . . 0.0 111.319 179.431 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.28 -166.42 28.28 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -135.13 138.25 43.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.876 -0.779 . . . . 0.0 110.313 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.434 HG11 ' H ' ' A' ' 44' ' ' GLY . 8.0 p -74.12 126.19 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.359 0.599 . . . . 0.0 109.409 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -94.37 -42.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.1 m -152.85 153.75 33.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.992 0.901 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -161.02 117.18 2.23 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.681 0.753 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.87 110.34 17.07 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 109.231 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.64 -34.49 77.07 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.529 0.681 . . . . 0.0 109.401 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -34.33 75.53 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' TYR . 28.6 mmtp -95.7 -1.58 49.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? 57.67 6.54 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.452 0.644 . . . . 0.0 109.57 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' LYS . 47.6 m-85 -123.02 160.13 26.95 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.911 0.863 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.91 -170.16 28.43 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.03 148.34 33.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.791 -0.829 . . . . 0.0 109.604 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 17' ' ' ILE . 96.6 mt -133.69 132.89 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.74 0.781 . . . . 0.0 109.903 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -97.07 113.63 25.2 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.921 0.867 . . . . 0.0 110.078 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.88 161.47 52.3 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -64.59 -35.8 82.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.062 -0.669 . . . . 0.0 109.643 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -83.52 9.5 11.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.74 65.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 75.6 mm-40 -95.95 115.22 27.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.703 -0.881 . . . . 0.0 110.049 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.0 t -77.16 146.95 36.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.681 0.753 . . . . 0.0 110.04 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 99.0 m-85 -136.0 136.55 40.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.782 0.801 . . . . 0.0 109.529 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 63.7 m-85 -81.35 143.07 32.46 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.829 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.62 121.87 46.31 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.154 0.978 . . . . 0.0 109.548 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -139.0 167.78 21.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.959 0.885 . . . . 0.0 109.602 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 6.2 m-85 -62.05 -38.08 87.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.405 0.621 . . . . 0.0 109.413 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.8 m -61.59 -20.85 63.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 26' ' ' PHE . 94.7 mt-10 -90.84 -11.68 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.842 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.6 mt -96.12 106.08 18.22 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -64.88 -42.22 94.99 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.61 0.719 . . . . 0.0 109.515 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -110.82 90.1 3.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -49.0 -19.5 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -66.16 -35.9 81.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.48 -12.36 61.59 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.341 0.591 . . . . 0.0 109.496 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 78.4 tt0 -66.23 -34.89 79.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.414 0.626 . . . . 0.0 109.591 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.09 -7.76 84.84 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -108.18 15.45 24.16 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.944 . . . . 0.0 109.604 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.59 151.36 46.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.815 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.56 133.3 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.122 0.963 . . . . 0.0 109.607 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -100.23 133.51 44.53 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.434 ' H ' HG11 ' A' ' 5' ' ' VAL . . . 93.33 -24.16 26.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -90.7 -178.87 5.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.979 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.81 148.39 27.81 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.793 0.806 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 160.07 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.474 0.654 . . . . 0.0 109.286 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -121.23 125.28 46.72 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.005 0.907 . . . . 0.0 110.312 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -138.36 150.96 47.09 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.333 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.49 131.12 22.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -48.45 141.68 18.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.739 2.292 . . . . 0.0 113.047 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.619 0.723 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.71 153.7 21.38 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.76 0.79 . . . . 0.0 109.834 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.6 151.09 21.05 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.683 0.754 . . . . 0.0 109.866 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.33 138.71 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.857 0.837 . . . . 0.0 110.039 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.69 66.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.53 0.681 . . . . 0.0 110.173 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.9 130.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.618 0.723 . . . . 0.0 109.654 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -131.36 164.81 24.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.803 0.811 . . . . 0.0 109.78 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.73 79.63 23.45 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 C-N-CA 122.574 2.183 . . . . 0.0 111.416 -179.856 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.219 0.533 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.3 -167.56 31.74 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -127.33 143.2 51.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.662 -0.905 . . . . 0.0 109.524 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.53 108.42 6.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.505 -0.747 . . . . 0.0 109.677 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.38 -39.26 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.635 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 p -159.85 165.2 32.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.707 -1.246 . . . . 0.0 110.873 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -156.7 114.23 3.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 mp -114.16 111.41 21.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.542 -0.724 . . . . 0.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.5 78.18 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.738 -0.601 . . . . 0.0 109.757 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.0 mttt -92.54 -4.44 53.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? 54.21 6.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.9 m-85 -132.89 123.52 26.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.62 -164.94 22.58 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -141.73 145.15 34.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -1.036 . . . . 0.0 109.122 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.8 136.83 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.795 -0.566 . . . . 0.0 109.825 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -100.49 110.78 22.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 109.181 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.73 155.38 53.45 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.026 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 49.1 p-10 -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.521 -0.988 . . . . 0.0 109.739 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 86.5 m-20 -86.49 10.63 14.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 108.813 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.21 15.44 71.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.1 mt-10 -94.65 109.53 21.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.968 -1.313 . . . . 0.0 109.489 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.0 t -73.98 142.48 45.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.432 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 83.7 m-85 -125.1 135.27 52.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 109.662 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -78.02 144.69 36.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.36 122.42 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -127.28 149.94 49.79 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.606 0.717 . . . . 0.0 109.867 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.5 -37.97 89.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 p -61.64 -25.84 67.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.35 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.84 -1.08 46.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.7 mt -93.85 120.47 34.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.949 -1.095 . . . . 0.0 110.347 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.5 mm? -64.43 -42.44 96.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.597 -0.689 . . . . 0.0 109.768 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -117.01 109.66 17.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -65.99 -15.14 62.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.118 -0.989 . . . . 0.0 108.771 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -65.22 -38.79 91.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.388 -0.82 . . . . 0.0 109.255 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.89 -10.83 60.38 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.54 -33.75 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.001 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.9 -20.69 72.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 4.8 mptp? -90.87 -88.92 0.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.297 -1.12 . . . . 0.0 109.415 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' LYS . 53.2 mt 44.81 -175.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 0.0 109.53 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.78 159.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -122.21 124.85 44.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 110.5 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.12 -15.47 27.63 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.477 -0.765 . . . . 0.0 111.536 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -86.55 178.75 6.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.589 . . . . 0.0 110.868 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.1 mtm -79.97 145.74 32.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -0.751 . . . . 0.0 110.838 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.56 161.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -126.76 131.15 51.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.501 -0.749 . . . . 0.0 109.598 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -146.81 154.02 40.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.307 -0.871 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -97.12 164.29 18.14 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.079 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.62 143.26 95.29 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.998 1.798 . . . . 0.0 112.589 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.198 0.523 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.23 156.22 36.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.577 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.61 141.56 38.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.641 -0.662 . . . . 0.0 109.522 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.95 152.07 49.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.468 -0.77 . . . . 0.0 109.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.16 49.16 14.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.459 -0.776 . . . . 0.0 109.217 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.71 135.72 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.123 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -134.63 150.98 50.73 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.645 0.736 . . . . 0.0 110.139 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.95 95.14 32.92 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 C-N-CA 121.975 1.783 . . . . 0.0 111.459 -179.577 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.457 0.646 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.31 20.47 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -131.39 143.75 50.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.857 . . . . 0.0 109.953 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.33 113.53 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.668 0.747 . . . . 0.0 110.338 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.06 -35.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.37 0.605 . . . . 0.0 109.465 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.617 ' HG ' ' CD2' ' A' ' 9' ' ' LEU . 45.8 t -171.78 151.15 2.78 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.235 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -105.66 -33.73 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.9 0.857 . . . . 0.0 109.032 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.617 ' CD2' ' HG ' ' A' ' 7' ' ' SER . 37.0 mt 45.93 75.22 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.62 0.724 . . . . 0.0 109.444 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.76 68.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.837 0.827 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.74 80.99 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.633 0.73 . . . . 0.0 109.606 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 14' ' ' TYR . 64.4 mttp -94.07 0.48 55.94 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 55.44 5.66 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.204 0.526 . . . . 0.0 109.945 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' LYS . 49.5 m-85 -123.14 125.07 44.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.14 164.77 19.41 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -132.2 142.16 49.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.748 -0.854 . . . . 0.0 109.89 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 17' ' ' ILE . 96.1 mt -133.15 136.51 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.51 0.672 . . . . 0.0 109.463 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -93.6 104.0 16.15 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.761 0.791 . . . . 0.0 109.674 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.82 162.86 53.82 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.19 -38.31 90.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.884 . . . . 0.0 109.691 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.25 3.98 25.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.322 -0.861 . . . . 0.0 109.084 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.26 19.72 61.97 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.19 118.44 27.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -1.17 . . . . 0.0 109.927 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.2 p -78.85 157.14 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.532 0.682 . . . . 0.0 110.196 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.57 139.77 42.41 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.568 0.699 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.73 124.96 40.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.771 -0.581 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.5 tt -103.69 117.39 34.27 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.566 0.698 . . . . 0.0 109.194 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.457 ' CD2' ' HG ' ' A' ' 30' ' ' SER . 4.6 t60 -117.49 163.08 16.94 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.732 . . . . 0.0 109.374 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.498 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 17.3 m-85 -62.86 -36.83 84.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.743 0.782 . . . . 0.0 108.979 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.457 ' HG ' ' CD2' ' A' ' 28' ' ' HIS . 82.6 p -63.03 -18.33 63.21 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.406 0.622 . . . . 0.0 109.525 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.87 -6.89 53.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.963 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.54 117.51 30.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.114 -0.991 . . . . 0.0 109.547 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.6 mm? -63.66 -41.23 98.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -118.86 114.52 22.74 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.417 0.627 . . . . 0.0 109.397 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.32 -36.12 81.2 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.733 . . . . 0.0 109.155 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.05 -33.8 75.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 109.862 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -68.97 -4.34 16.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 109.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 81.6 tt0 -63.3 -37.56 87.72 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.95 89.84 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -96.65 3.75 52.31 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.33 -1.1 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 147.79 50.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -108.67 113.39 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.96 0.886 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -95.38 141.59 28.77 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.491 0.662 . . . . 0.0 110.567 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 24.95 51.46 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -148.1 -165.03 2.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.95 -1.324 . . . . 0.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.88 146.86 28.63 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.502 0.668 . . . . 0.0 110.638 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.18 158.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.688 -0.632 . . . . 0.0 109.33 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.53 132.53 54.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.582 0.706 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.17 158.26 40.08 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.681 0.753 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.27 150.38 37.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.66 156.98 59.91 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.474 2.116 . . . . 0.0 111.898 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 13.8 p . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.632 -0.667 . . . . 0.0 109.308 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 mt . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 121.763 0.792 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -159.73 174.27 14.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 110.016 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.34 41.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.875 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.58 148.35 50.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.88 55.49 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.86 0.838 . . . . 0.0 109.213 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -78.52 132.03 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.384 0.612 . . . . 0.0 110.122 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 m -107.26 124.57 49.96 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.802 0.811 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.57 113.28 59.85 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.317 2.011 . . . . 0.0 112.468 -179.872 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.604 0.716 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.82 -159.87 19.09 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -132.67 134.86 45.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.538 -0.978 . . . . 0.0 109.682 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.55 105.48 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.458 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.93 -36.42 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -150.36 144.57 25.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.936 -1.102 . . . . 0.0 109.857 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -125.14 -68.53 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.178 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt 57.93 109.46 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.975 0.893 . . . . 0.0 109.662 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.79 -23.3 27.27 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.904 0.859 . . . . 0.0 108.76 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.43 90.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 109.681 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.5 mttt -97.77 -3.27 39.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.095 -1.003 . . . . 0.0 108.549 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? 52.19 9.35 0.09 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.464 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' LYS . 58.1 m-85 -132.25 148.17 52.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.3 -159.83 10.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.09 155.53 47.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.3 -1.118 . . . . 0.0 109.547 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.69 135.07 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -101.11 118.57 37.25 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.861 0.838 . . . . 0.0 109.768 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.75 156.66 53.36 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 48.1 p-10 -67.27 -27.62 67.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.99 . . . . 0.0 109.549 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 33.1 p-10 -89.41 9.01 27.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.518 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.34 12.51 67.34 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.66 114.69 26.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.006 -1.291 . . . . 0.0 109.917 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 t -78.75 147.75 33.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.605 -0.684 . . . . 0.0 109.672 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.99 141.68 49.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.425 -0.797 . . . . 0.0 109.835 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.41 144.15 40.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -114.16 122.28 46.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.792 0.806 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -139.16 160.51 39.62 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.96 -10.82 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.869 0.842 . . . . 0.0 109.082 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.3 m -67.19 -11.72 58.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 109.37 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -108.38 -23.29 11.95 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.63 128.33 36.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.871 -1.143 . . . . 0.0 109.884 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 64.3 t0 -132.03 129.57 40.24 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.909 0.861 . . . . 0.0 109.563 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 72.9 mmtt -63.92 -36.29 83.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.804 0.812 . . . . 0.0 109.28 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.61 -35.95 81.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.46 -0.775 . . . . 0.0 110.168 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.48 -6.16 2.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.948 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.41 -36.54 84.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.973 -1.079 . . . . 0.0 109.621 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.08 -7.1 81.37 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.59 0.05 52.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -1.189 . . . . 0.0 108.723 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.39 158.68 34.63 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.4 -0.812 . . . . 0.0 109.795 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.89 138.29 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.735 0.779 . . . . 0.0 109.745 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -107.29 129.98 54.82 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.94 25.21 46.08 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -140.29 173.29 11.66 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.03 -1.277 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.3 144.68 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.879 0.847 . . . . 0.0 111.157 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.74 164.93 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -116.65 129.56 56.22 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.51 163.08 38.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 109.391 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -104.59 111.37 65.2 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.39 -0.819 . . . . 0.0 109.469 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.35 137.93 30.7 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.309 2.006 . . . . 0.0 112.597 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.4 m . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.004 . . . . 0.0 109.449 179.642 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.626 0.727 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.21 144.93 43.09 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.091 -1.006 . . . . 0.0 110.237 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.83 99.1 8.87 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 124.994 2.331 . . . . 0.0 111.264 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.304 43.2 tptt -82.24 143.36 31.41 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.555 -2.566 . . . . 0.0 113.1 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 42.14 66.79 0.67 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 122.369 1.08 . . . . 0.0 110.005 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -75.05 137.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -123.8 147.91 47.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.48 -0.763 . . . . 0.0 110.071 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.99 79.72 64.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 N--CA 1.494 1.532 0 C-N-CA 122.763 2.309 . . . . 0.0 111.579 -179.73 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.37 154.5 19.34 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.873 0.844 . . . . 0.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.24 -172.16 39.18 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.47 141.11 51.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.757 -0.849 . . . . 0.0 109.691 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.8 p -86.19 118.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.526 0.679 . . . . 0.0 109.341 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.02 -28.75 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.657 -0.652 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.425 ' HG ' ' N ' ' A' ' 8' ' ' TYR . 46.2 t -155.96 153.07 28.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.425 ' N ' ' HG ' ' A' ' 7' ' ' SER . 80.0 t80 -157.02 112.72 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.598 0.713 . . . . 0.0 109.21 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.24 116.05 27.69 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.757 0.789 . . . . 0.0 109.434 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.09 76.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -37.98 85.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.596 -0.69 . . . . 0.0 109.844 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 14' ' ' TYR . 55.5 mtpt -95.88 11.07 35.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.877 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' LYS . 64.2 pttt 34.95 27.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.521 0.676 . . . . 0.0 110.341 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 12' ' ' LYS . 35.7 t80 -141.7 123.08 14.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.59 0.71 . . . . 0.0 109.347 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -114.4 -164.11 14.83 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -146.78 134.32 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.658 -0.907 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.8 132.4 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.487 0.661 . . . . 0.0 109.271 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -100.51 116.96 33.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.84 161.56 53.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -65.08 -35.77 82.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.961 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -87.48 9.03 22.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.542 -0.724 . . . . 0.0 109.175 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.65 58.66 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -91.97 118.13 30.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -1.028 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.8 p -80.59 163.97 23.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.718 0.771 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -144.82 150.96 38.04 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.61 0.719 . . . . 0.0 109.69 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.56 143.44 28.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.567 0.698 . . . . 0.0 109.998 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.495 ' C ' ' HD1' ' A' ' 28' ' ' HIS . 66.7 mt -110.75 127.26 55.28 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.749 0.785 . . . . 0.0 109.892 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.495 ' HD1' ' C ' ' A' ' 27' ' ' LEU . 10.0 m80 -140.73 159.42 42.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.765 0.793 . . . . 0.0 109.9 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -65.67 -35.17 80.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.1 t -62.33 -17.77 59.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -93.88 -18.56 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.507 -0.745 . . . . 0.0 109.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.0 141.04 32.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.594 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.76 152.82 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.686 0.755 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 70.7 mmtt -66.68 -39.42 88.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 38' ' ' GLU . 98.7 mttt -63.96 -39.38 94.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.481 0.658 . . . . 0.0 109.264 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -51.1 -9.46 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.547 -0.721 . . . . 0.0 109.405 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 36' ' ' LYS . 11.8 pt-20 -70.34 -36.57 74.32 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . -83.2 -8.87 84.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -94.29 0.29 55.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.966 . . . . 0.0 108.995 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.91 153.25 42.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.452 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -113.91 120.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.045 0.926 . . . . 0.0 110.104 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -91.0 136.4 33.1 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.684 0.754 . . . . 0.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.08 26.44 40.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -149.22 -164.63 2.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 111.143 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 95.8 mtp -87.48 145.66 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.902 0.858 . . . . 0.0 110.871 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.41 161.1 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -118.91 124.76 47.88 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.864 0.84 . . . . 0.0 110.152 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -149.4 157.03 42.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.503 0.668 . . . . 0.0 109.326 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.26 150.58 38.55 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.72 -0.612 . . . . 0.0 109.365 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.86 152.81 76.86 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.701 2.267 . . . . 0.0 112.813 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.45 132.22 7.11 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 54' ' ' THR . 56.1 Cg_endo -73.09 -71.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.362 2.041 . . . . 0.0 112.07 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 ' H ' ' HG2' ' A' ' 53' ' ' PRO . 6.1 p 58.38 149.29 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.978 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.39 -36.6 18.03 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.378 2.052 . . . . 0.0 111.768 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.43 -41.77 98.69 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 123.28 -75.59 0.37 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 3.9 mm? -95.66 128.03 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.879 . . . . 0.0 110.279 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.56 151.63 15.22 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.809 0.814 . . . . 0.0 109.876 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.37 159.98 14.81 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.471 0.653 . . . . 0.0 109.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -149.79 138.66 21.01 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.645 0.736 . . . . 0.0 110.273 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 58.05 68.6 0.82 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.584 0.707 . . . . 0.0 109.941 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mm -66.24 138.25 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.322 0.582 . . . . 0.0 109.507 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -132.37 141.97 49.12 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.095 0.95 . . . . 0.0 110.307 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.43 93.0 25.09 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.74 3.13 7.18 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.686 2.257 . . . . 0.0 111.951 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -75.07 154.23 38.01 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 58.0 mp0 -41.78 139.1 1.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.684 0.754 . . . . 0.0 110.227 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.95 -43.46 87.89 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.57 101.58 9.0 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.762 0.791 . . . . 0.0 109.187 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -68.69 -40.19 80.18 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -85.49 134.0 34.06 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.704 0.764 . . . . 0.0 110.167 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -113.96 147.23 38.94 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.752 0.787 . . . . 0.0 110.055 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.378 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -168.2 -164.22 0.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.788 . . . . 0.0 110.164 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.46 -168.11 36.09 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -130.58 133.8 46.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.735 -0.862 . . . . 0.0 109.816 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.68 111.83 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.752 0.786 . . . . 0.0 109.089 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -73.71 -33.5 38.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.637 -0.664 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -161.63 153.91 19.8 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.014 0.911 . . . . 0.0 110.738 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -153.16 102.4 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.5 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -96.56 112.09 23.97 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.058 0.932 . . . . 0.0 109.505 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.97 79.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.619 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.49 85.53 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.43 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.7 mtmt -94.05 3.09 55.81 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mttp 47.08 15.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.218 0.533 . . . . 0.0 110.322 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 33.6 t80 -144.96 159.35 43.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.004 0.907 . . . . 0.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -161.58 -152.55 6.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.83 154.1 48.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.89 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 150.03 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.56 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -112.4 116.38 30.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.792 0.806 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.62 160.99 47.76 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.01 -36.2 83.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.919 -0.754 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.76 9.32 19.31 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.61 7.44 81.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -87.41 119.31 27.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.682 -0.893 . . . . 0.0 109.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.5 m -75.47 153.1 37.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.533 0.682 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -135.29 132.56 37.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.807 0.813 . . . . 0.0 109.804 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' CE1' ' O ' ' A' ' 57' ' ' GLY . 16.5 m-85 -77.15 140.81 40.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.646 0.736 . . . . 0.0 110.426 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.412 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 4.3 tt -115.51 117.46 30.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.162 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.645 ' HD1' ' H ' ' A' ' 30' ' ' SER . 53.8 t-80 -139.46 166.6 24.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.995 0.902 . . . . 0.0 110.156 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 10.1 m-85 -62.36 -40.86 97.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.86 -0.525 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.645 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 38.6 t -60.25 -17.75 44.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.821 -0.549 . . . . 0.0 109.945 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.79 -7.24 47.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 109.045 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.2 mt -88.0 125.3 34.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.768 0.794 . . . . 0.0 110.037 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.13 -41.8 97.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -126.65 131.15 51.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.81 0.814 . . . . 0.0 109.038 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -35.75 81.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.784 -0.572 . . . . 0.0 109.545 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -60.47 -36.46 78.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.538 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.58 -10.13 16.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.753 -0.592 . . . . 0.0 109.42 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -67.27 -38.61 85.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.0 -8.97 85.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -98.73 5.11 47.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.408 -1.054 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 156.1 26.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.32 130.3 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.175 0.988 . . . . 0.0 110.088 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -98.02 135.94 38.99 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.802 0.81 . . . . 0.0 110.907 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.1 59.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -135.52 173.76 11.37 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.264 -1.139 . . . . 0.0 111.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.41 142.16 37.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.739 0.78 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.73 163.5 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -121.0 135.32 55.24 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.867 0.841 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.26 156.51 39.84 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.729 0.776 . . . . 0.0 110.016 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.82 156.63 37.07 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.802 -0.561 . . . . 0.0 109.551 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.94 148.99 64.25 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.43 2.087 . . . . 0.0 112.948 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 2.5 m -130.54 94.96 28.06 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -52.79 139.11 59.71 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.532 2.155 . . . . 0.0 113.016 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -178.01 145.27 0.53 Allowed Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.64 -33.93 43.33 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.68 2.253 . . . . 0.0 111.471 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -173.24 131.72 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.604 0.716 . . . . 0.0 109.888 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' ' CE1' ' A' ' 26' ' ' PHE . . . 137.94 -32.08 2.4 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 57' ' ' GLY . 2.8 mm? 59.18 146.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.651 -0.911 . . . . 0.0 110.578 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -165.47 157.26 14.73 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.761 0.791 . . . . 0.0 110.379 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.29 133.66 46.84 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.87 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -114.64 135.55 54.03 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.907 0.861 . . . . 0.0 110.146 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.24 66.74 1.12 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.583 0.706 . . . . 0.0 110.383 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 HG22 HD13 ' A' ' 63' ' ' ILE . 96.7 mt -73.06 137.27 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.561 0.696 . . . . 0.0 109.784 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 p -132.04 150.28 52.2 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.743 0.782 . . . . 0.0 110.122 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 82.86 36.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 3.68 7.41 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.701 2.267 . . . . 0.0 111.348 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.77 -3.04 58.42 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -72.35 -151.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.557 0.694 . . . . 0.0 110.078 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 59.15 73.43 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.682 0.753 . . . . 0.0 109.291 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -164.12 76.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.576 0.703 . . . . 0.0 109.474 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.511 ' HD1' ' C ' ' A' ' 71' ' ' HIS . 1.3 p80 -152.17 166.52 31.46 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.614 0.721 . . . . 0.0 110.01 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -166.1 119.14 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.713 0.768 . . . . 0.0 109.634 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -154.79 140.57 18.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.724 0.773 . . . . 0.0 110.141 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.186 179.684 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 27.4 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -117.23 134.7 54.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.761 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.56 4.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.77 146.38 52.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.583 -0.951 . . . . 0.0 110.123 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG1' ' H ' ' A' ' 44' ' ' GLY . 10.0 p -75.71 113.39 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.54 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.81 -34.33 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -148.94 146.13 27.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.976 -1.077 . . . . 0.0 110.241 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -162.76 102.08 1.02 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.8 mt -115.65 114.14 24.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 109.17 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.27 66.4 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.67 54.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 60.3 pttt -97.14 1.17 49.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.22 -0.925 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 57.71 38.69 27.59 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.296 0.569 . . . . 0.0 109.997 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 59.0 m-85 -149.14 159.45 44.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.18 33.92 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.99 157.61 45.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.458 -1.025 . . . . 0.0 109.627 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.94 135.0 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.689 -0.632 . . . . 0.0 109.565 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -94.07 99.07 11.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.05 170.68 28.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.6 -35.42 80.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.601 -0.94 . . . . 0.0 109.012 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.9 1.21 40.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.011 -1.055 . . . . 0.0 108.887 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.29 24.15 57.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 98.0 mt-10 -89.13 114.14 25.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.14 -1.212 . . . . 0.0 109.718 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 42.6 t -74.4 147.61 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.176 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 23' ' ' GLU . 96.3 m-85 -122.36 144.71 48.85 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.469 0.652 . . . . 0.0 109.533 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.9 -43.65 98.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 tt 70.4 96.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.773 ' HD1' ' H ' ' A' ' 30' ' ' SER . 3.9 t-80 -116.47 119.04 34.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.461 0.648 . . . . 0.0 109.637 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -57.09 -21.37 31.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.773 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 77.9 p -66.94 -19.29 65.7 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -88.3 3.83 48.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 mt -77.84 133.67 38.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.89 -42.59 99.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -121.32 120.4 34.99 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.4 0.619 . . . . 0.0 109.557 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.14 -36.24 82.95 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.77 -39.17 90.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.737 . . . . 0.0 109.596 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.63 -6.56 26.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.94 -37.36 84.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.177 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.39 88.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -91.93 -3.1 56.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -1.159 . . . . 0.0 109.175 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 169.22 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.516 -0.74 . . . . 0.0 110.348 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.26 143.42 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -110.0 130.0 55.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.532 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' H ' ' CG1' ' A' ' 5' ' ' VAL . . . 93.13 -15.42 62.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -97.39 -175.05 3.1 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.216 -1.167 . . . . 0.0 110.799 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 96.2 mtp -80.05 148.33 31.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.57 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.69 151.13 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.252 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.82 125.57 45.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.725 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 1' ' ' MET . 54.3 p90 -141.85 147.74 37.67 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.06 152.5 42.52 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.689 -0.632 . . . . 0.0 109.311 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.89 139.5 62.44 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.334 2.023 . . . . 0.0 112.201 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.486 ' CG2' ' HZ1' ' A' ' 61' ' ' LYS . 43.4 m -154.17 88.54 3.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.095 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.7 139.23 67.94 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.339 2.026 . . . . 0.0 112.454 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.9 156.53 35.7 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -18.5 65.37 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.509 2.14 . . . . 0.0 111.791 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.9 1.77 33.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.32 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.28 -86.6 0.42 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -128.69 146.83 50.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -1.012 . . . . 0.0 110.203 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.44 153.95 39.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.23 144.83 43.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.686 -0.633 . . . . 0.0 109.494 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HZ1' ' CG2' ' A' ' 52' ' ' THR . 2.7 ttmp? -128.59 143.98 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.48 0.657 . . . . 0.0 109.617 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.33 71.09 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.452 0.644 . . . . 0.0 110.127 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.46 129.49 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.43 -0.794 . . . . 0.0 108.886 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 m -131.06 155.52 46.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.507 -0.746 . . . . 0.0 110.011 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.86 112.41 58.03 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.4 1.97 8.74 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.255 1.97 . . . . 0.0 111.69 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 68' ' ' GLU . 10.7 mp -74.68 137.32 42.07 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 67' ' ' LEU . 97.8 mt-10 54.49 166.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.68 0.752 . . . . 0.0 110.866 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -152.35 159.81 43.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.37 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -108.3 119.74 40.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.658 -0.651 . . . . 0.0 109.879 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.674 ' HD1' ' H ' ' A' ' 73' ' ' HIS . 51.1 t-80 -96.25 139.71 31.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.406 -0.809 . . . . 0.0 109.813 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -59.67 -40.51 88.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 110.198 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.674 ' H ' ' HD1' ' A' ' 71' ' ' HIS . 98.8 m-70 -107.61 127.52 53.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.728 -179.856 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' NE2' ' A' ' 48' ' ' HIS . 6.2 ptt? . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.808 0.813 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -90.42 0.75 57.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.61 -167.77 33.14 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.164 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -130.99 137.21 49.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.714 -0.874 . . . . 0.0 109.417 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.87 105.95 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.038 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.02 -38.82 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.492 0.663 . . . . 0.0 109.448 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.8 p -154.49 158.73 40.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -158.4 114.89 2.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.545 -0.722 . . . . 0.0 109.148 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 100.43 8.82 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.68 72.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.759 0.79 . . . . 0.0 109.339 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.81 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.69 . . . . 0.0 109.939 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.8 mtpt -94.29 4.23 54.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 108.969 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mttp 56.29 4.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.293 0.568 . . . . 0.0 109.555 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 59.1 m-85 -130.8 154.2 48.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.659 0.742 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.02 -169.0 22.76 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.41 151.19 51.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.487 -1.008 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -134.19 159.35 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.43 0.633 . . . . 0.0 109.378 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -113.05 107.87 16.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.675 0.75 . . . . 0.0 109.661 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.5 161.9 53.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 47.3 p-10 -65.01 -33.9 77.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.955 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 93.3 m-20 -90.13 7.2 39.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 108.751 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.7 14.83 64.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 98.2 mt-10 -92.23 119.27 31.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -1.108 . . . . 0.0 109.686 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -78.41 152.67 32.09 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.696 0.76 . . . . 0.0 110.657 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.4 m-85 -138.76 135.35 34.6 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.552 0.691 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.82 144.29 35.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.662 -0.649 . . . . 0.0 110.245 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 tt -113.76 120.16 39.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.508 ' CG ' ' N ' ' A' ' 29' ' ' PHE . 80.8 t60 -136.1 171.72 14.06 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.685 0.755 . . . . 0.0 109.724 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 5.3 m-85 -61.4 -39.53 91.04 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.665 0.745 . . . . 0.0 109.551 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.412 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 79.2 p -59.62 -20.29 54.89 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.712 -0.617 . . . . 0.0 110.023 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.02 -9.52 36.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 0.0 109.426 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.83 124.02 38.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 109.79 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.37 -41.67 96.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 109.438 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -130.09 114.06 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.578 -0.702 . . . . 0.0 109.243 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -49.67 -27.53 4.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.01 -37.01 85.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.28 -7.0 20.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.118 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -65.96 -33.44 75.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.748 . . . . 0.0 109.068 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 -7.82 85.24 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' CD ' ' N ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -93.8 0.65 56.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -1.128 . . . . 0.0 108.738 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.12 150.27 47.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.584 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.57 126.81 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.885 0.85 . . . . 0.0 109.893 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.91 139.33 30.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.725 0.774 . . . . 0.0 110.835 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.37 51.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -146.1 -164.85 2.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.909 -1.348 . . . . 0.0 110.949 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtm -86.35 142.73 28.27 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.724 0.773 . . . . 0.0 110.543 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.8 135.88 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.551 0.691 . . . . 0.0 109.284 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.626 ' NE2' ' N ' ' A' ' 1' ' ' MET . 22.8 m170 -94.98 126.94 40.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -0.76 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -150.08 149.42 30.27 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.47 150.71 36.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 179.83 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 p -140.73 151.3 62.72 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.459 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 54' ' ' THR . 51.2 Cg_exo -50.14 -39.91 51.31 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.199 1.933 . . . . 0.0 111.289 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 53' ' ' PRO . 41.7 m -35.37 99.43 0.17 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.62 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.64 -18.15 13.77 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.341 2.027 . . . . 0.0 111.202 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -125.01 118.01 25.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 113.3 -29.55 7.89 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' GLY . 64.1 mt 58.4 128.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.885 . . . . 0.0 110.05 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 143.69 29.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.03 167.08 12.65 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.759 0.79 . . . . 0.0 110.017 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -149.53 142.83 25.16 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.795 0.807 . . . . 0.0 110.053 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.56 74.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.838 0.828 . . . . 0.0 110.566 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 63' ' ' ILE . 16.1 mm -69.76 133.43 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 109.249 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.3 t -138.12 138.8 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.023 0.916 . . . . 0.0 110.05 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.434 ' CD2' ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.82 127.1 55.39 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 -9.47 23.11 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.005 1.803 . . . . 0.0 110.825 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -82.22 137.43 34.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.538 0.685 . . . . 0.0 109.74 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.55 177.75 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.823 0.82 . . . . 0.0 110.722 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -66.7 142.48 57.4 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.869 0.843 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -71.51 128.98 37.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.831 0.824 . . . . 0.0 110.111 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -153.29 -36.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -75.05 139.38 42.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -67.18 -39.36 86.41 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.587 0.708 . . . . 0.0 109.587 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.885 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' ' O ' ' A' ' 49' ' ' PHE . 85.3 mmm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.383 0.611 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -109.7 142.12 41.33 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.834 0.826 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.88 -174.38 36.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -133.12 142.05 48.49 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.693 -0.886 . . . . 0.0 110.049 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.13 113.83 22.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.846 0.831 . . . . 0.0 108.98 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.22 -38.38 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.425 -0.797 . . . . 0.0 109.418 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.3 p -161.45 162.57 30.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.858 0.837 . . . . 0.0 110.217 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -153.08 109.82 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.0 mm? -99.87 106.59 18.45 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.024 0.916 . . . . 0.0 109.655 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.52 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.389 0.614 . . . . 0.0 109.567 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.11 79.2 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' TYR . 98.9 mttt -89.33 -4.31 58.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.391 -0.818 . . . . 0.0 109.003 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.33 -17.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 23.2 p90 -132.52 158.19 42.75 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.49 -138.73 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -148.91 151.43 34.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.669 -0.901 . . . . 0.0 110.193 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 17' ' ' ILE . 96.7 mt -133.1 133.44 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.545 0.688 . . . . 0.0 109.257 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -103.44 116.97 33.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.947 0.88 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.94 160.45 52.76 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -68.62 -24.87 64.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.82 -0.812 . . . . 0.0 109.898 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -91.29 6.86 43.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.4 -0.813 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.1 72.3 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -92.37 115.89 28.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.392 -1.063 . . . . 0.0 110.132 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.9 p -81.14 148.25 29.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.609 0.719 . . . . 0.0 110.006 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.53 136.98 43.46 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.806 0.813 . . . . 0.0 110.015 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -73.43 139.61 45.97 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.549 0.69 . . . . 0.0 109.963 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.2 tt -113.99 120.59 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.812 0.815 . . . . 0.0 109.663 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -138.2 163.1 32.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.852 0.834 . . . . 0.0 109.107 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.862 -0.524 . . . . 0.0 109.773 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -57.54 -17.93 16.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 109.366 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.29 -9.87 34.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.464 -0.773 . . . . 0.0 108.986 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.96 112.03 22.12 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.922 0.868 . . . . 0.0 109.593 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -63.26 -41.57 99.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.869 -0.52 . . . . 0.0 109.655 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 36' ' ' LYS . 91.1 m-20 -128.53 106.76 9.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -54.91 -6.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.565 -0.71 . . . . 0.0 109.129 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 34' ' ' ASP . 68.6 mttm -64.54 -37.88 89.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.584 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.16 -7.55 49.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.484 -0.76 . . . . 0.0 109.512 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -56.79 -44.93 82.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.637 -0.664 . . . . 0.0 109.622 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.39 -9.57 86.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 41' ' ' LEU . 33.8 mtmm -116.13 16.65 15.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.418 -1.048 . . . . 0.0 109.121 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 40' ' ' LYS . 5.3 mt -55.14 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 109.935 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.0 162.15 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.256 1.027 . . . . 0.0 110.636 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -145.53 95.07 2.6 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.75 0.786 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.55 -15.72 62.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.9 m -84.95 165.37 17.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -1.216 . . . . 0.0 110.54 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.9 mtm -66.75 143.6 56.84 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.962 0.887 . . . . 0.0 111.052 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.95 161.62 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 109.259 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -130.32 129.08 42.74 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.791 0.805 . . . . 0.0 110.009 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 1' ' ' MET . 52.6 p90 -144.01 160.57 40.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.503 0.668 . . . . 0.0 109.617 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.81 154.29 38.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.836 -0.54 . . . . 0.0 109.589 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -49.73 142.89 24.01 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.652 2.235 . . . . 0.0 112.745 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' OG1' ' A' ' 54' ' ' THR . 2.5 p -126.77 147.79 62.42 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.24 57.2 2.16 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.741 2.294 . . . . 0.0 111.657 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.496 ' HG1' ' N ' ' A' ' 59' ' ' ALA . 12.9 p -135.3 58.82 28.5 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 109.287 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.96 -17.6 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.494 2.13 . . . . 0.0 110.311 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -110.83 48.42 0.92 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.538 0.685 . . . . 0.0 109.199 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.98 -20.38 0.17 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 54' ' ' THR . 79.6 mt 60.56 145.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.656 -0.908 . . . . 0.0 110.288 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.496 ' N ' ' HG1' ' A' ' 54' ' ' THR . . . -164.38 155.07 14.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.698 0.761 . . . . 0.0 109.903 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.48 137.08 47.03 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.856 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -133.39 142.55 48.42 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.878 0.847 . . . . 0.0 109.898 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.51 48.81 9.26 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.627 0.727 . . . . 0.0 109.773 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.61 139.23 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.546 0.688 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -133.74 149.78 51.48 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.691 0.758 . . . . 0.0 110.028 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.92 103.31 43.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.448 ' O ' ' CE1' ' A' ' 69' ' ' HIS . 95.2 Cg_endo -81.58 -2.69 11.61 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.788 2.326 . . . . 0.0 111.316 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 tp -65.17 139.01 58.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.714 0.769 . . . . 0.0 110.655 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 59.17 87.4 0.08 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.603 0.716 . . . . 0.0 109.612 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.448 ' CE1' ' O ' ' A' ' 66' ' ' PRO . 97.6 m-70 -79.54 148.79 31.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.923 0.868 . . . . 0.0 110.106 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 69' ' ' HIS . 85.5 t60 55.18 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.659 0.742 . . . . 0.0 110.054 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 14.4 p80 -64.43 139.1 58.73 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.613 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -84.07 -12.62 54.82 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -152.08 162.17 41.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.425 ' OXT' ' CG ' ' A' ' 74' ' ' HIS . 54.7 t-80 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.354 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.85 -173.87 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.26 -163.85 20.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -141.76 144.17 33.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.572 -0.958 . . . . 0.0 110.117 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG11 ' H ' ' A' ' 44' ' ' GLY . 4.4 p -77.48 126.08 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.741 -0.599 . . . . 0.0 109.759 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.34 -35.32 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.741 . . . . 0.0 109.588 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 m -151.28 135.4 16.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.996 -1.065 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -157.01 114.99 3.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -119.45 124.87 47.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.691 0.758 . . . . 0.0 109.287 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -24.14 67.75 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.476 0.655 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.891 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.558 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.6 mtmt -97.03 -3.69 40.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 109.163 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 65.61 -8.46 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.527 0.68 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.6 p90 -150.9 161.37 42.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.754 . . . . 0.0 109.254 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.51 -119.36 0.97 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.3 153.16 40.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.655 -0.909 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.42 HG22 HD12 ' A' ' 17' ' ' ILE . 96.6 mt -134.81 145.58 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.532 0.682 . . . . 0.0 109.739 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -107.92 108.71 19.98 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.764 0.793 . . . . 0.0 109.379 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.24 158.48 53.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.4 p-10 -66.09 -34.3 77.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.828 -0.807 . . . . 0.0 109.89 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 52.0 t0 -89.23 10.55 21.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.213 -0.929 . . . . 0.0 109.544 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.37 14.98 69.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -97.31 121.5 39.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.158 -1.201 . . . . 0.0 109.8 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.2 p -78.16 153.56 31.95 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.736 0.779 . . . . 0.0 110.714 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -141.81 136.52 30.71 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.716 0.77 . . . . 0.0 109.656 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.73 144.19 39.46 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.617 0.722 . . . . 0.0 110.167 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.6 tt -111.54 120.82 43.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.572 0.701 . . . . 0.0 109.318 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -128.82 138.85 52.29 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.757 0.789 . . . . 0.0 109.511 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 30' ' ' SER . 20.8 p90 -66.88 -35.1 79.26 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.068 0.937 . . . . 0.0 109.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 37.4 m -63.66 -33.12 74.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.49 0.662 . . . . 0.0 109.791 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.25 -0.7 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.91 139.54 37.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.294 -0.879 . . . . 0.0 109.659 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.77 -41.52 97.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -128.22 121.13 28.64 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -45.83 -27.72 0.92 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.568 0.699 . . . . 0.0 109.674 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -64.83 -32.57 74.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.01 -14.41 22.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.515 -0.741 . . . . 0.0 109.175 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.08 -31.48 69.08 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.73 0.776 . . . . 0.0 109.473 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.2 -3.72 75.39 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.6 7.73 32.91 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.324 -1.104 . . . . 0.0 108.852 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.7 151.1 48.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.436 0.636 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.55 137.93 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.807 0.813 . . . . 0.0 109.938 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -107.28 130.84 54.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.769 0.795 . . . . 0.0 110.453 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.452 ' H ' HG11 ' A' ' 5' ' ' VAL . . . 92.53 -23.0 30.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -91.46 179.19 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -1.132 . . . . 0.0 111.15 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtm -82.62 153.38 25.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.507 0.67 . . . . 0.0 110.493 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.4 m -133.97 161.58 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.746 -0.596 . . . . 0.0 109.542 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -120.94 131.99 54.67 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.551 0.691 . . . . 0.0 109.436 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -150.74 159.94 44.18 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.569 0.699 . . . . 0.0 109.816 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.65 153.19 37.9 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.43 133.9 39.32 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.885 2.39 . . . . 0.0 112.966 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 m -154.03 94.66 2.85 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.98 89.28 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.728 2.285 . . . . 0.0 112.364 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.45 157.28 88.09 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.94 -17.47 60.13 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.58 2.186 . . . . 0.0 111.131 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.85 -3.42 51.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.03 -88.81 0.29 Allowed Glycine 0 N--CA 1.5 2.962 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 mt -139.8 130.94 26.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.483 -1.01 . . . . 0.0 110.235 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.93 146.15 35.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.716 0.769 . . . . 0.0 109.658 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.93 155.72 18.52 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.551 0.691 . . . . 0.0 109.863 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.21 147.29 34.64 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.728 0.775 . . . . 0.0 109.932 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.93 51.04 14.26 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.732 0.777 . . . . 0.0 109.87 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.53 139.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.0 109.547 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.4 t -129.72 149.66 51.37 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.891 0.853 . . . . 0.0 109.917 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.612 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 1.1 mm? -111.63 81.42 3.27 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.118 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.43 41.09 0.57 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.472 2.114 . . . . 0.0 111.589 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 65' ' ' LEU . 11.5 mt -56.7 141.82 42.46 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.649 0.738 . . . . 0.0 110.102 -179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.03 86.14 2.34 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.677 0.751 . . . . 0.0 109.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -82.69 -68.36 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.663 0.744 . . . . 0.0 109.691 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.71 -43.43 80.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 72' ' ' HIS . 78.3 m80 -77.24 146.11 37.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.806 0.813 . . . . 0.0 109.927 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' HIS . 99.1 m-70 48.94 179.53 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.927 0.87 . . . . 0.0 110.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.8 m80 44.43 83.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.896 0.855 . . . . 0.0 109.861 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.803 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -107.19 179.63 4.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.496 -0.753 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.04 -159.03 9.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -133.93 149.87 51.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 109.645 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG13 ' H ' ' A' ' 44' ' ' GLY . 6.1 p -80.74 123.35 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p -93.18 -31.16 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -157.18 149.28 22.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 110.071 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -158.77 106.14 1.84 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.8 mp -101.21 110.87 22.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.829 . . . . 0.0 109.025 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.28 84.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.655 -0.653 . . . . 0.0 109.865 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.23 92.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 14' ' ' TYR . 9.9 mtpm? -98.93 7.57 45.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.355 -0.84 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' LYS . 56.1 pttt 35.06 30.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.551 0.691 . . . . 0.0 110.381 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 12' ' ' LYS . 88.5 t80 -139.58 140.84 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.34 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.35 -161.75 14.02 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.3 157.85 45.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.497 -1.002 . . . . 0.0 109.494 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.417 HD12 HG23 ' A' ' 17' ' ' ILE . 96.3 mt -128.85 132.61 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.63 104.11 15.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.353 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.24 158.43 52.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 39.4 p-10 -64.66 -34.03 77.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.442 -1.034 . . . . 0.0 109.106 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.8 t70 -86.88 6.46 31.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 108.991 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.11 16.89 70.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -93.6 117.94 30.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.962 -1.317 . . . . 0.0 109.636 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -74.36 149.8 40.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.475 -0.766 . . . . 0.0 109.367 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -129.21 139.45 51.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.024 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -74.44 144.05 44.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.68 . . . . 0.0 109.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.9 tt -124.51 116.83 23.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.472 -0.768 . . . . 0.0 109.211 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.47 ' CG ' ' N ' ' A' ' 29' ' ' PHE . 84.7 t60 -140.54 170.27 16.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.827 . . . . 0.0 109.411 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.47 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 2.7 m-85 -62.19 -44.11 97.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.106 -0.996 . . . . 0.0 109.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.411 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 16.3 m -55.6 -20.2 12.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.859 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.24 -6.48 53.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.107 -0.995 . . . . 0.0 109.973 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.63 130.87 36.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.78 -41.71 99.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.494 -0.754 . . . . 0.0 109.091 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -142.11 131.39 23.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.403 -0.811 . . . . 0.0 109.125 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -61.93 -31.19 71.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.211 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -59.18 -36.35 75.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 108.851 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.88 -8.29 35.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.35 -42.07 94.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.02 -20.93 71.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -84.75 -0.21 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.125 -1.221 . . . . 0.0 109.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 40.8 mt -67.32 147.94 52.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.272 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -127.12 136.69 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.49 -0.756 . . . . 0.0 109.563 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -101.27 138.37 38.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 0.0 110.297 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 88.24 -23.66 14.26 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 m -88.45 178.33 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.94 -1.329 . . . . 0.0 110.513 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -85.4 149.9 25.1 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.586 -0.696 . . . . 0.0 109.906 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.62 164.77 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 109.144 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -124.25 136.15 53.93 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.498 -0.751 . . . . 0.0 109.455 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.1 157.32 43.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -93.93 153.26 40.93 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.162 -0.961 . . . . 0.0 109.295 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -67.13 142.17 60.2 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.638 2.225 . . . . 0.0 112.384 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 5.0 p -154.29 88.76 3.39 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.199 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 54' ' ' THR . 51.0 Cg_exo -53.13 -47.3 28.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.996 1.797 . . . . 0.0 111.719 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.512 ' O ' ' O ' ' A' ' 53' ' ' PRO . 1.2 p 52.55 157.18 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.975 0 CA-C-O 121.075 0.464 . . . . 0.0 110.811 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.49 -38.58 74.9 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.551 1.501 . . . . 0.0 111.247 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -63.42 -42.71 98.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.547 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.77 -64.35 0.61 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.46 132.37 53.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.438 -1.036 . . . . 0.0 110.123 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -153.48 153.93 33.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -99.87 -83.04 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.312 -0.867 . . . . 0.0 109.466 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' ALA . 56.3 tttm 60.31 144.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.496 -0.752 . . . . 0.0 110.548 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.11 43.1 32.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 0.0 110.002 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.17 140.29 18.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.149 -0.969 . . . . 0.0 109.03 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 m -121.27 153.21 37.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.738 . . . . 0.0 109.208 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' H ' HD13 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -133.16 82.82 52.83 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 0.88 9.47 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.956 1.771 . . . . 0.0 111.152 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.9 mm? -91.3 122.21 33.72 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.502 -0.749 . . . . 0.0 109.34 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -144.56 10.38 1.42 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -89.84 109.26 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -67.23 -37.86 84.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.476 -0.765 . . . . 0.0 109.92 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -131.28 160.49 34.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -105.44 144.84 31.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.592 -0.693 . . . . 0.0 109.607 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -147.32 137.15 22.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.564 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.19 146.28 50.03 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.742 0.782 . . . . 0.0 110.178 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.58 -174.32 41.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -135.89 134.54 38.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.846 -0.796 . . . . 0.0 109.618 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.84 120.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.797 0.808 . . . . 0.0 109.612 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.3 p -91.27 -38.96 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.668 -0.645 . . . . 0.0 109.494 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.8 m -134.31 147.66 50.63 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.689 0.757 . . . . 0.0 110.324 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.607 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 66.5 t80 -161.06 117.63 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.71 110.19 16.99 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.834 0.826 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.16 85.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 109.832 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.01 90.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.849 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.95 2.19 40.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 43.0 39.21 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.504 0.669 . . . . 0.0 110.09 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 93.3 t80 -147.64 158.0 43.81 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.68 0.753 . . . . 0.0 109.955 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -176.73 -162.84 28.02 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -133.71 155.88 48.96 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.575 0.703 . . . . 0.0 109.26 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 17' ' ' ILE . 96.8 mt -133.4 137.5 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.5 0.667 . . . . 0.0 109.447 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -95.16 109.16 21.28 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.11 149.39 49.01 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -68.76 -22.64 64.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.684 -0.892 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 58.7 t0 -76.16 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.0 56.05 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.16 130.54 35.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -1.0 . . . . 0.0 110.356 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -76.23 145.9 39.43 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.56 0.695 . . . . 0.0 110.037 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.34 139.89 50.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.905 0.86 . . . . 0.0 110.117 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.13 143.72 47.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.701 0.762 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.5 tt -108.2 119.35 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.0 109.689 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -129.09 128.26 43.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.157 0.979 . . . . 0.0 109.395 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CG ' ' N ' ' A' ' 30' ' ' SER . 22.7 p90 -64.47 -34.75 78.93 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.964 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 29.7 m -63.29 -33.15 74.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.718 -0.613 . . . . 0.0 110.672 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 60' ' ' ALA . 98.7 mt-10 -73.07 2.77 6.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.38 143.35 33.58 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.634 0.731 . . . . 0.0 109.865 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.33 -40.17 96.56 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' A' ' 36' ' ' LYS . 9.5 p30 -137.46 101.85 4.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.904 0.859 . . . . 0.0 108.775 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -52.23 -7.27 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.788 -0.57 . . . . 0.0 109.621 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.545 ' H ' ' C ' ' A' ' 34' ' ' ASP . 43.8 pttt -68.57 -30.1 68.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.225 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 39.7 p30 -79.4 -2.68 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -49.58 -42.59 44.85 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.7 -6.99 82.32 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -95.09 1.27 54.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -1.077 . . . . 0.0 109.517 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.64 152.88 44.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 109.868 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.45 126.4 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 122.118 0.961 . . . . 0.0 109.816 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.607 ' NZ ' ' H ' ' A' ' 8' ' ' TYR . 50.0 tttp -99.34 139.01 35.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.747 0.784 . . . . 0.0 110.817 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 25.19 51.49 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.9 t -143.82 -179.6 6.57 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.137 -1.213 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.12 146.84 34.91 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.745 0.783 . . . . 0.0 110.461 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.0 161.54 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.495 0.665 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -118.16 126.06 51.46 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.863 0.84 . . . . 0.0 109.731 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.49 155.79 39.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.441 0.639 . . . . 0.0 109.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -106.61 163.2 17.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.03 147.4 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.538 2.158 . . . . 0.0 112.718 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -150.52 87.96 4.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.674 -0.641 . . . . 0.0 109.71 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.2 131.48 46.57 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.363 2.042 . . . . 0.0 112.237 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -148.72 152.63 37.99 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.813 -0.555 . . . . 0.0 109.712 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 -15.68 40.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -83.31 -2.34 55.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.753 -0.592 . . . . 0.0 109.446 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.59 -87.11 0.4 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.44 154.43 48.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.858 -0.79 . . . . 0.0 110.115 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.86 155.39 34.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.677 0.751 . . . . 0.0 110.015 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 31' ' ' GLU . . . -116.01 129.92 56.58 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.591 0.71 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 160.48 26.98 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.901 0.858 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.2 48.4 19.54 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.507 0.67 . . . . 0.0 109.571 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -72.31 132.1 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -135.95 154.62 51.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.764 0.792 . . . . 0.0 110.734 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.08 98.25 33.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.1 -0.62 10.8 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.792 2.328 . . . . 0.0 111.074 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.17 123.13 32.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -105.21 -161.02 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.508 0.67 . . . . 0.0 109.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -75.16 132.58 41.27 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.893 0.854 . . . . 0.0 110.072 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -66.47 -40.35 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.751 -0.593 . . . . 0.0 109.686 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 73' ' ' HIS . 78.7 m80 -59.03 -40.53 85.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.805 -0.559 . . . . 0.0 109.921 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 t60 42.64 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.571 0.7 . . . . 0.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' HIS . 57.7 t-80 -73.91 130.59 40.2 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.906 0.86 . . . . 0.0 110.322 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.205 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -107.6 151.81 25.13 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.57 0.7 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.33 -172.5 38.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -135.55 134.17 39.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.691 -0.888 . . . . 0.0 109.895 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 13.6 p -78.03 106.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.766 0.793 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.18 -39.01 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.275 0.56 . . . . 0.0 109.662 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -159.07 156.79 29.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 110.469 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' OH ' ' CZ ' ' A' ' 29' ' ' PHE . 68.3 t80 -155.03 109.59 2.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.14 116.59 30.07 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.766 0.793 . . . . 0.0 109.294 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 -25.45 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.651 . . . . 0.0 109.336 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.2 -35.85 81.67 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.626 0.727 . . . . 0.0 109.443 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 14' ' ' TYR . 1.8 mptm? -90.89 7.09 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 61.47 -7.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.387 0.613 . . . . 0.0 109.705 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.611 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.5 p90 -161.48 163.8 30.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.462 -0.774 . . . . 0.0 109.635 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.29 -131.98 2.66 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -143.34 152.27 41.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.924 . . . . 0.0 110.036 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.94 133.15 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -95.66 106.71 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.81 0.814 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.36 163.86 54.54 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.71 -39.38 94.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.757 -0.849 . . . . 0.0 109.672 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -82.31 0.91 39.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.53 -0.731 . . . . 0.0 109.386 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.52 62.22 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 80.1 mm-40 -88.55 119.46 29.02 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.085 -1.244 . . . . 0.0 110.109 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -76.37 147.71 37.89 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.662 0.744 . . . . 0.0 110.279 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.6 m-85 -136.34 137.56 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.625 0.726 . . . . 0.0 109.616 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.15 141.11 32.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' O ' ' CB ' ' A' ' 14' ' ' TYR . 4.4 tt -112.83 116.82 30.65 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.809 0.814 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -119.86 146.78 45.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 26.3 m-85 -63.56 -39.23 93.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.34 0.59 . . . . 0.0 109.918 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -57.59 -18.54 20.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.442 -0.786 . . . . 0.0 110.024 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.02 -7.46 51.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.141 -0.974 . . . . 0.0 110.304 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.25 138.03 38.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 0.0 109.784 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.75 -41.37 98.02 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.454 0.645 . . . . 0.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -135.94 125.54 25.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.9 -11.43 27.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.499 0.666 . . . . 0.0 109.509 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.42 -14.92 56.56 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -76.79 -4.84 45.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 109.384 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -55.41 -46.07 76.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.748 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.33 -4.44 84.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -94.92 -3.8 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 108.961 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.21 149.14 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.714 -0.616 . . . . 0.0 110.136 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.2 134.56 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.871 0.843 . . . . 0.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.39 133.92 41.34 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.942 0.877 . . . . 0.0 111.29 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.47 -12.13 61.77 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -96.86 177.11 5.74 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.985 -1.303 . . . . 0.0 110.947 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.6 mtp -81.09 147.63 30.02 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.766 0.793 . . . . 0.0 110.396 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.14 157.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -113.81 132.61 55.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.41 157.67 38.85 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.63 150.78 37.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.42 163.66 38.32 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.35 2.7 . . . . 0.0 113.249 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.5 p -123.61 149.31 58.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 54' ' ' THR . 50.0 Cg_exo -50.88 -49.58 16.49 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.134 1.889 . . . . 0.0 111.925 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.65 99.55 0.18 Allowed Pre-proline 0 N--CA 1.495 1.82 0 CA-C-O 120.99 0.424 . . . . 0.0 110.512 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.66 -15.88 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.255 1.97 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -122.34 94.7 4.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.516 0.674 . . . . 0.0 110.065 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 134.52 -32.16 2.66 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' GLY . 64.5 mt 58.81 146.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.892 0.853 . . . . 0.0 110.565 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.29 158.63 30.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.3 130.5 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.941 0.877 . . . . 0.0 110.344 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.62 55.71 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.815 0.817 . . . . 0.0 109.388 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 63' ' ' ILE . 96.7 mt -75.49 136.23 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.56 0.695 . . . . 0.0 110.636 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 m -127.43 151.87 48.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.032 0.92 . . . . 0.0 109.865 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.25 85.65 38.29 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.11 0.92 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.649 2.232 . . . . 0.0 111.902 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.06 125.88 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.465 -0.772 . . . . 0.0 109.78 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.89 147.5 23.31 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.851 0.834 . . . . 0.0 110.33 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.96 132.86 44.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.954 0.883 . . . . 0.0 110.401 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.605 ' CG ' ' H ' ' A' ' 71' ' ' HIS . 35.8 t-80 -147.46 -129.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.605 ' H ' ' CG ' ' A' ' 70' ' ' HIS . 86.6 t60 50.11 79.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.797 0.808 . . . . 0.0 109.738 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -80.65 136.85 36.28 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.724 0.774 . . . . 0.0 110.154 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -67.49 -42.19 83.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.409 0.624 . . . . 0.0 109.718 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.652 ' CD2' ' H ' ' A' ' 74' ' ' HIS . 3.8 p80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.645 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -106.82 152.04 24.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.696 0.76 . . . . 0.0 110.238 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.08 -150.28 5.65 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.98 141.24 49.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.589 -0.948 . . . . 0.0 109.579 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 5' ' ' VAL . 8.9 p -81.71 118.33 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.06 -31.14 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.024 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.7 m -157.06 153.95 28.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.805 -1.184 . . . . 0.0 110.839 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' LEU . 38.8 t80 -160.28 -74.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.716 0.77 . . . . 0.0 108.953 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' TYR . 9.6 mt 57.8 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.782 0.801 . . . . 0.0 110.079 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.9 68.51 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.697 0.76 . . . . 0.0 109.152 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.87 -35.18 79.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.608 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.7 mtpt -93.6 -7.46 43.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 108.792 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 57.86 -4.09 0.05 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.313 0.578 . . . . 0.0 110.112 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.608 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.0 p90 -161.04 164.18 31.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.99 -129.48 1.03 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -143.15 154.76 44.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.54 133.77 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.549 0.69 . . . . 0.0 109.23 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -90.39 97.15 11.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.759 0.79 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.11 163.04 42.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 40.5 p-10 -66.13 -34.8 78.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.789 -0.83 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 54.6 t0 -83.6 2.7 36.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.088 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.58 14.9 72.33 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 97.4 mt-10 -91.85 123.16 35.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.484 -1.009 . . . . 0.0 109.728 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -76.78 150.37 36.19 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.585 0.707 . . . . 0.0 110.339 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.7 m-85 -138.12 137.6 37.86 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.352 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -77.81 139.94 39.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.666 -0.646 . . . . 0.0 110.019 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 tt -114.97 118.53 33.69 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.54 0.686 . . . . 0.0 109.475 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.716 ' HD1' ' H ' ' A' ' 30' ' ' SER . 31.0 t-80 -126.05 137.89 53.67 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 6.2 p90 -59.76 -28.51 67.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.586 0.707 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.716 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 78.9 p -63.73 -26.27 68.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 109.397 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -79.34 -0.43 32.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.5 131.22 35.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.071 -1.018 . . . . 0.0 109.573 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LYS . 96.9 m-20 -131.41 98.85 4.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -46.3 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.673 0.749 . . . . 0.0 109.649 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 34' ' ' ASP . 25.8 mtpp -64.5 -35.79 82.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 109.833 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -73.43 -2.35 22.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.0 109.55 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.17 -32.25 73.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.501 -0.75 . . . . 0.0 109.388 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.02 -8.7 81.86 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -103.39 14.44 31.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.302 -1.117 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.05 151.71 44.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 110.082 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.43 133.26 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.779 0.8 . . . . 0.0 109.792 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -101.07 130.81 47.15 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.931 0.872 . . . . 0.0 111.075 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 5' ' ' VAL . . . 91.71 -18.12 54.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -93.91 -177.25 4.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.023 -1.281 . . . . 0.0 111.816 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.74 140.53 40.83 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.715 0.769 . . . . 0.0 110.367 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.25 131.04 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -90.09 127.0 35.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.492 -0.755 . . . . 0.0 109.742 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.66 152.72 42.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.672 -0.643 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.72 152.89 38.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.41 143.42 93.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.323 2.015 . . . . 0.0 112.281 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -152.42 87.84 4.12 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.448 -0.782 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.1 89.24 1.22 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.712 2.274 . . . . 0.0 111.667 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.24 176.54 2.33 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 109.481 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.56 -33.41 78.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.691 2.261 . . . . 0.0 111.647 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.92 -42.37 99.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.87 -86.64 0.23 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.9 mt -105.23 130.97 53.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -1.023 . . . . 0.0 109.96 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.51 30.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.477 -0.764 . . . . 0.0 109.2 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.71 138.3 46.28 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 110.01 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.85 138.61 47.1 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.476 0.655 . . . . 0.0 109.358 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.2 61.15 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.687 0.756 . . . . 0.0 109.697 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.18 133.08 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.528 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 p -139.1 153.09 47.97 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.834 0.826 . . . . 0.0 109.828 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.419 ' CD2' ' H ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -87.67 135.91 33.47 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.747 -0.596 . . . . 0.0 109.472 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.68 -5.33 16.72 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.356 2.037 . . . . 0.0 111.44 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 9.6 mp -70.75 141.14 51.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.721 0.772 . . . . 0.0 110.168 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 48.93 98.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.758 0.79 . . . . 0.0 110.048 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -156.5 -171.07 3.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.1 t60 53.81 75.66 0.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.808 0.813 . . . . 0.0 109.876 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -155.59 152.03 28.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.904 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -155.49 -44.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.66 0.743 . . . . 0.0 109.399 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.84 -43.3 99.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.36 -0.837 . . . . 0.0 110.253 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.504 ' ND1' ' OXT' ' A' ' 74' ' ' HIS . 54.7 t-80 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.755 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.32 154.38 42.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.318 -0.864 . . . . 0.0 109.87 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.6 -149.19 5.6 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.67 142.31 50.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.922 . . . . 0.0 109.687 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -82.15 107.03 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 p -76.48 -37.28 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 109.867 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.5 m -148.23 146.93 28.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.041 -1.037 . . . . 0.0 110.474 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -158.27 105.34 1.9 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -108.9 111.97 23.96 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.51 -29.56 70.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.549 -0.72 . . . . 0.0 109.581 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.76 84.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.499 ' C ' ' H ' ' A' ' 14' ' ' TYR . 55.5 mtpt -92.67 -3.7 54.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt 55.19 6.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.742 -0.599 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.499 ' H ' ' C ' ' A' ' 12' ' ' LYS . 45.2 m-85 -130.16 154.14 47.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.639 -0.663 . . . . 0.0 109.736 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.73 -170.15 26.05 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.97 149.87 47.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.412 -1.052 . . . . 0.0 109.761 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.01 133.92 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -85.48 108.05 17.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.846 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.21 158.7 53.17 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 45.8 p-10 -65.84 -33.0 74.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.553 -0.969 . . . . 0.0 109.573 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 24.3 p30 -90.11 8.36 33.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 17.07 63.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.8 123.09 40.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -1.211 . . . . 0.0 109.753 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 p -79.41 149.17 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 110.39 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.15 132.94 45.11 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -82.77 144.47 30.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 0.0 109.707 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.401 ' CD2' ' C ' ' A' ' 27' ' ' LEU . 6.2 tt -113.18 122.96 49.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.552 ' HD1' ' H ' ' A' ' 30' ' ' SER . 49.4 t-80 -138.81 168.04 20.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.717 . . . . 0.0 109.387 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 14.1 m-85 -65.36 -39.67 92.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.781 . . . . 0.0 109.523 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.552 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 37.7 t -61.4 -18.17 57.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.325 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.4 -9.3 48.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.305 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.65 107.12 19.15 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.35 -0.844 . . . . 0.0 109.504 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.9 mm? -64.76 -41.94 95.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.482 -0.761 . . . . 0.0 109.165 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -101.28 109.34 21.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.597 -0.689 . . . . 0.0 109.29 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -63.75 -32.64 74.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.184 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.1 -34.57 76.55 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.02 -7.03 31.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 0.0 108.865 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.18 -42.23 90.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.695 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.85 84.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -95.99 -1.04 49.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.271 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.58 144.68 56.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.623 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.44 121.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.647 0.737 . . . . 0.0 109.623 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -95.2 143.04 26.94 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.934 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 25.35 50.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 t -152.83 -167.0 2.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.725 -1.456 . . . . 0.0 110.981 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.63 144.13 30.5 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.424 0.63 . . . . 0.0 110.768 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.57 161.26 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.437 ' CD2' ' CG ' ' A' ' 66' ' ' PRO . 42.3 m-70 -124.38 136.22 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.457 -0.777 . . . . 0.0 109.837 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.34 155.23 42.47 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.772 . . . . 0.0 109.007 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.12 155.02 71.76 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.922 2.415 . . . . 0.0 112.108 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.455 ' OG1' ' OG1' ' A' ' 54' ' ' THR . 0.2 OUTLIER -103.02 155.45 36.58 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.456 -0.778 . . . . 0.0 108.924 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.41 -19.14 65.12 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.773 2.315 . . . . 0.0 111.113 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' LYS . 70.2 p -41.98 152.48 0.31 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.769 -0.582 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -38.54 -22.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.341 2.028 . . . . 0.0 111.19 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' THR . 19.6 tptm -145.29 -76.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.572 -0.705 . . . . 0.0 109.333 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . 168.92 -83.08 0.09 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 58' ' ' LEU . 2.1 mm? 41.58 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.865 -0.786 . . . . 0.0 109.782 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' GLY . . . -149.87 141.99 24.03 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.34 149.05 30.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.671 -0.643 . . . . 0.0 109.85 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -145.06 128.5 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.837 . . . . 0.0 109.167 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 56.24 61.16 2.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.42 -0.8 . . . . 0.0 109.239 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.68 139.49 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.632 -0.667 . . . . 0.0 109.596 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 p -136.22 162.19 33.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.722 . . . . 0.0 109.852 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' O ' ' NE2' ' A' ' 69' ' ' HIS . 0.3 OUTLIER -122.59 80.49 47.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' CG ' ' CD2' ' A' ' 48' ' ' HIS . 67.1 Cg_endo -84.93 27.27 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 123.178 2.585 . . . . 0.0 111.493 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -70.5 -106.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.47 -0.769 . . . . 0.0 111.259 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -101.33 126.43 48.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.33 -0.857 . . . . 0.0 110.687 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.513 ' NE2' ' O ' ' A' ' 65' ' ' LEU . 90.4 m-70 -140.56 143.75 35.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.583 -0.698 . . . . 0.0 109.548 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 71' ' ' HIS . 50.6 p-80 -83.26 -13.73 54.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.23 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.621 ' CE1' ' NE2' ' A' ' 70' ' ' HIS . 35.7 m80 -75.04 140.72 43.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 110.035 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -66.49 -38.8 88.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.456 -0.777 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -152.91 155.74 37.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.105 -0.997 . . . . 0.0 110.161 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.462 ' ND1' ' OXT' ' A' ' 74' ' ' HIS . 47.5 t-80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.993 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.613 ' N ' ' CE2' ' A' ' 49' ' ' PHE . 66.2 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -129.9 138.57 51.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.777 . . . . 0.0 109.386 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.66 6.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -132.82 139.56 47.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.552 -0.97 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.93 121.32 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.18 -32.98 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 t -154.38 144.88 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.916 -1.115 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -158.73 96.53 1.38 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.447 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -100.77 124.55 46.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.167 -0.958 . . . . 0.0 109.378 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.61 -35.79 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.696 0.76 . . . . 0.0 109.268 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.13 -30.06 70.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' TYR . 58.1 mttp -94.35 -7.03 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.015 . . . . 0.0 108.926 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 58.83 -3.94 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.565 -0.71 . . . . 0.0 109.846 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' LYS . 28.0 p90 -151.64 161.23 43.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.042 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 -133.59 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -141.25 157.83 44.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 109.775 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -136.26 154.91 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.415 -0.803 . . . . 0.0 109.241 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -109.79 106.56 16.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.764 0.792 . . . . 0.0 109.146 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.43 161.4 50.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -1.01 . . . . 0.0 109.338 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 30.3 p-10 -89.9 9.99 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.448 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 16.62 65.08 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.49 114.6 26.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -1.164 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -74.86 146.73 41.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 110.363 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -122.81 139.55 53.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.55 -0.718 . . . . 0.0 109.248 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.24 131.08 36.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.554 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.406 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 6.5 tt -104.9 123.41 47.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.088 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -134.36 153.12 52.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.698 . . . . 0.0 109.412 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.29 -35.57 81.28 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.783 0.801 . . . . 0.0 108.894 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.5 p -61.28 -21.09 63.61 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.446 -0.784 . . . . 0.0 109.62 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.66 -3.89 59.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.068 -1.02 . . . . 0.0 109.645 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.5 126.0 39.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 0.0 109.891 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -63.14 -41.31 99.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' LYS . 93.9 m-20 -127.17 89.72 3.02 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.84 -15.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 109.555 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' ASP . 44.0 mmtm -66.2 -34.96 79.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.163 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 36.3 p30 -73.66 -3.0 25.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.42 -36.09 82.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.39 -12.56 81.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -95.38 6.12 49.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -1.179 . . . . 0.0 109.304 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.8 mt -68.94 156.44 38.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.083 -1.01 . . . . 0.0 109.953 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.89 128.76 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.669 0.747 . . . . 0.0 109.663 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -98.76 138.16 36.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.421 -0.8 . . . . 0.0 110.874 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.6 24.91 61.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -141.63 -174.4 4.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 110.744 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtp -79.55 149.36 31.45 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.665 0.745 . . . . 0.0 110.557 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.86 164.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -127.62 133.09 49.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.613 ' CE2' ' N ' ' A' ' 1' ' ' MET . 52.3 p90 -150.54 163.51 38.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.367 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.75 152.05 38.84 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.241 -0.912 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.04 150.18 88.91 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.623 2.215 . . . . 0.0 112.734 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -148.94 88.04 5.26 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.95 88.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.403 2.069 . . . . 0.0 111.915 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.531 ' C ' ' H ' ' A' ' 56' ' ' LYS . 7.2 p -137.17 68.3 55.66 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.06 12.43 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.653 2.236 . . . . 0.0 111.305 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 54' ' ' THR . 9.8 ptpp? -105.79 8.75 32.98 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.723 0.773 . . . . 0.0 109.223 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.31 -17.91 0.08 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 54' ' ' THR . 50.1 mt 62.7 147.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.754 -0.851 . . . . 0.0 110.457 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.21 170.72 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.948 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -101.98 -46.22 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.408 -0.808 . . . . 0.0 108.891 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ALA . 88.3 tttt 59.12 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.944 0.878 . . . . 0.0 110.903 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.14 87.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 0.0 109.833 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.2 mt -103.36 137.37 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.505 -0.747 . . . . 0.0 109.697 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 p -134.64 160.16 38.98 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.859 0.838 . . . . 0.0 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.23 81.79 22.1 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.4 -1.95 10.39 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.755 2.303 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 68' ' ' GLU . 37.5 tp -94.97 128.28 41.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.152 -0.967 . . . . 0.0 110.756 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 67' ' ' LEU . 75.1 mm-40 53.89 110.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.974 0.892 . . . . 0.0 109.868 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -97.73 132.92 42.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -74.11 128.8 36.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.724 0.773 . . . . 0.0 109.931 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 71' ' ' HIS . 9.0 p80 -82.99 144.25 30.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.106 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -83.72 -13.0 55.07 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.731 0.776 . . . . 0.0 109.098 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -74.93 154.99 37.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 74' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.994 -1.003 . . . . 0.0 108.851 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -111.08 170.9 7.8 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.435 0.636 . . . . 0.0 109.857 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.29 -145.86 4.3 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.61 142.13 49.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -1.004 . . . . 0.0 109.751 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.4 p -81.52 112.04 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -70.35 -37.39 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.391 -0.818 . . . . 0.0 109.781 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 t -165.8 156.61 13.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -153.87 107.47 2.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.32 124.57 52.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.508 -0.745 . . . . 0.0 109.639 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.47 77.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.348 0.594 . . . . 0.0 109.9 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.4 73.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 109.96 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.62 ' C ' ' H ' ' A' ' 14' ' ' TYR . 13.7 mptt -87.68 6.67 33.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt 64.22 -17.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.62 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.2 p90 -160.72 165.21 30.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.043 -1.035 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.32 -136.15 3.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.9 152.53 51.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.993 . . . . 0.0 109.93 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 17' ' ' ILE . 96.6 mt -134.01 137.57 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -92.55 100.73 13.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.09 174.08 44.4 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -63.52 -39.6 94.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.45 -1.029 . . . . 0.0 109.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -80.94 -0.61 40.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.65 11.75 79.15 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 128.22 34.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.239 . . . . 0.0 109.683 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.4 p -74.22 148.54 41.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.807 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.35 136.81 43.68 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -79.64 137.72 37.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.719 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tt -109.71 89.37 2.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.706 ' HD1' ' H ' ' A' ' 30' ' ' SER . 43.1 t-80 -96.04 165.11 12.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 0.0 110.264 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.0 -40.59 96.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.706 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 12.3 t -61.77 -18.37 59.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.178 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.29 -5.34 59.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.4 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.66 125.41 47.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.57 -41.37 98.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -130.75 114.47 15.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.644 -0.66 . . . . 0.0 109.246 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -64.19 -11.68 33.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.351 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.07 -38.65 91.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.52 -5.4 23.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.29 -39.72 76.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.4 -9.19 87.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -96.35 -0.64 49.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.197 -1.178 . . . . 0.0 109.087 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.9 146.79 54.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -115.06 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.835 0.826 . . . . 0.0 109.555 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.35 140.73 29.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 110.661 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.21 50.18 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.698 ' HG ' ' H ' ' A' ' 46' ' ' MET . 6.9 t -147.46 -164.99 2.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.939 -1.33 . . . . 0.0 110.588 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.698 ' H ' ' HG ' ' A' ' 45' ' ' SER . 97.2 mtp -82.33 140.28 33.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.724 -0.61 . . . . 0.0 110.372 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.59 135.72 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.706 . . . . 0.0 109.256 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -94.31 128.95 41.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.669 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -144.23 155.85 44.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.73 110.64 59.32 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.531 -0.731 . . . . 0.0 109.258 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.49 146.9 24.21 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.334 2.023 . . . . 0.0 112.559 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p -109.39 150.31 40.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.672 -0.643 . . . . 0.0 109.304 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.49 88.62 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.336 2.024 . . . . 0.0 111.822 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 82.3 0.52 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.809 . . . . 0.0 108.965 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -31.58 66.25 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.653 2.235 . . . . 0.0 111.458 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -110.49 105.94 15.07 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.463 0.649 . . . . 0.0 109.379 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 128.72 -45.58 1.14 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 57' ' ' GLY . 54.6 mt 58.43 128.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.804 -0.821 . . . . 0.0 110.123 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.18 150.55 28.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.212 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 151.31 22.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 109.898 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -141.43 133.96 28.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.21 66.84 1.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.682 0.753 . . . . 0.0 109.886 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.81 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.2 p -131.13 148.74 52.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.453 -0.779 . . . . 0.0 109.816 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.85 145.13 29.02 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . 56.0 Cg_endo -71.61 -84.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.421 2.08 . . . . 0.0 112.041 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.402 ' H ' ' HG2' ' A' ' 66' ' ' PRO . 4.7 tp 42.36 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.418 0.628 . . . . 0.0 109.581 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' PRO . 96.2 mt-10 52.92 -110.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.686 -0.634 . . . . 0.0 110.263 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -149.2 146.06 27.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -71.5 148.5 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.461 -0.774 . . . . 0.0 110.566 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -69.78 136.87 51.39 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.678 0.751 . . . . 0.0 110.523 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 46.57 88.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.607 0.717 . . . . 0.0 110.062 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -83.18 135.06 34.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 0.0 110.024 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.683 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.2 156.55 45.33 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.639 0.733 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.61 -167.1 22.53 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -132.05 137.36 47.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.696 0.76 . . . . 0.0 110.018 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -76.48 122.11 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.652 0.739 . . . . 0.0 110.1 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.46 -34.83 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -156.32 160.58 39.84 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.92 0.867 . . . . 0.0 110.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -162.99 93.9 0.82 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.401 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mp -102.01 113.57 26.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.905 0.86 . . . . 0.0 108.822 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.0 -13.97 59.89 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.25 -65.94 0.45 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 109.824 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.18 17.13 14.79 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 56.7 57.83 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.688 0.756 . . . . 0.0 109.782 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.99 166.11 32.56 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.85 0.833 . . . . 0.0 110.144 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.96 174.08 45.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -133.6 150.7 51.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.765 -0.844 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.98 133.07 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.801 0.81 . . . . 0.0 109.842 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -92.58 115.09 27.79 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.867 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.66 158.33 50.05 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.3 p-10 -66.88 -23.56 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.939 -0.742 . . . . 0.0 110.119 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 82.7 m-20 -89.95 5.27 47.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 109.243 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.68 15.58 65.47 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.74 120.26 39.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.714 -0.874 . . . . 0.0 109.922 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -78.37 155.03 30.25 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 109.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.16 135.26 35.51 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.896 0.855 . . . . 0.0 110.136 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -75.59 142.84 42.62 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.728 0.775 . . . . 0.0 109.849 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.2 tt -107.98 132.06 53.91 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.746 0.784 . . . . 0.0 109.749 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.479 ' HD1' ' H ' ' A' ' 29' ' ' PHE . 2.4 t60 -134.3 146.04 49.64 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.984 0.897 . . . . 0.0 110.102 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.479 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 4.1 m-85 -62.16 -42.16 98.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 t -62.87 -18.52 63.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 2.7 mp0 -88.99 -0.52 57.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.0 109.218 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 34' ' ' ASP . 75.5 mt -90.22 -3.08 58.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.4 mt 59.27 -70.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 32' ' ' LEU . 43.2 t0 -110.05 105.71 14.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -56.69 -12.22 1.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.821 -0.549 . . . . 0.0 109.533 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.61 -36.55 84.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.0 109.979 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -77.08 -5.54 49.32 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.421 -0.799 . . . . 0.0 109.072 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 79.0 tt0 -57.37 -38.29 73.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.778 -0.576 . . . . 0.0 109.575 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.07 -8.42 86.55 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.11 0.05 50.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.284 -1.127 . . . . 0.0 109.003 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.85 152.01 46.43 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.615 0.721 . . . . 0.0 110.108 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.94 129.92 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.114 0.959 . . . . 0.0 109.722 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -95.78 138.34 33.57 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.713 0.768 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.21 25.29 55.41 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 t -140.01 172.59 12.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.154 -1.204 . . . . 0.0 110.707 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.1 mtt -76.3 141.56 41.58 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.938 0.875 . . . . 0.0 109.999 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.19 161.79 39.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.499 0.666 . . . . 0.0 109.682 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -122.07 129.5 52.45 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.921 0.867 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -151.39 158.98 44.44 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.827 0.822 . . . . 0.0 109.797 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.49 143.76 26.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.1 141.78 58.9 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.412 2.074 . . . . 0.0 112.123 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 m -153.6 90.46 3.39 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.756 -0.59 . . . . 0.0 109.708 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -55.52 140.34 83.12 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.337 2.025 . . . . 0.0 111.801 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.52 160.35 59.59 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.93 -38.18 18.01 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.894 2.396 . . . . 0.0 112.089 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -64.25 -41.37 96.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.15 -86.89 0.15 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt -113.92 134.98 54.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.644 -0.915 . . . . 0.0 109.96 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.39 148.68 29.77 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.739 0.78 . . . . 0.0 109.983 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.41 133.8 49.58 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.643 0.735 . . . . 0.0 109.706 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -118.29 143.84 46.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.96 0.886 . . . . 0.0 110.409 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.59 62.42 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.739 0.781 . . . . 0.0 109.884 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.424 HG23 HD13 ' A' ' 63' ' ' ILE . 96.8 mt -75.79 137.09 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.576 0.703 . . . . 0.0 109.8 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.9 p -133.05 160.23 37.77 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.999 0.904 . . . . 0.0 110.107 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.11 98.33 38.7 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.63 -35.87 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.612 2.208 . . . . 0.0 111.604 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -77.96 128.09 33.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.727 0.775 . . . . 0.0 109.485 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 57.2 mp0 -97.45 127.1 43.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.81 0.814 . . . . 0.0 110.146 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -93.32 121.09 34.35 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.52 0.676 . . . . 0.0 110.344 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -149.54 164.95 33.66 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.747 0.784 . . . . 0.0 110.209 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -73.62 130.06 39.25 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.731 0.777 . . . . 0.0 110.196 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -84.42 149.17 26.17 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.784 0.802 . . . . 0.0 110.707 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 11.5 p80 -69.11 142.75 54.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.629 0.728 . . . . 0.0 110.152 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 74' ' ' HIS . 55.6 p-80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.431 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 97.8 mmm . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.53 165.54 11.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.416 -0.803 . . . . 0.0 109.993 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.68 -172.98 32.81 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' NZ ' ' O ' ' A' ' 44' ' ' GLY . 62.3 tttm -142.99 128.31 18.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -1.088 . . . . 0.0 109.224 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.68 130.52 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.937 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.31 -36.4 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 p -158.48 161.97 37.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.961 -1.087 . . . . 0.0 110.556 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -165.75 93.98 0.57 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.2 mp -101.21 122.0 42.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -77.07 -14.31 59.83 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.661 -0.65 . . . . 0.0 109.382 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.17 -67.99 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.739 -0.601 . . . . 0.0 110.593 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.93 19.26 15.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.441 -0.787 . . . . 0.0 109.072 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 56.3 66.19 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.83 170.66 21.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.229 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.64 166.79 38.78 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.65 150.89 52.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.619 -0.93 . . . . 0.0 109.282 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 17' ' ' ILE . 96.6 mt -133.96 147.81 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -94.95 117.15 29.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.463 -0.773 . . . . 0.0 109.576 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 159.46 52.69 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.72 -35.53 81.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.387 -1.066 . . . . 0.0 109.603 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -80.64 -0.75 39.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.212 -0.93 . . . . 0.0 109.485 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -5.22 63.13 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' OE2' ' OH ' ' A' ' 25' ' ' TYR . 20.0 pt-20 -80.24 133.81 36.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.124 -1.221 . . . . 0.0 110.364 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.6 p -83.41 162.77 20.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.431 ' OH ' ' OE2' ' A' ' 23' ' ' GLU . 62.4 m-85 -134.87 146.57 49.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.79 125.41 34.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.253 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.4 tt -103.39 122.23 44.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.815 . . . . 0.0 108.927 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.641 ' HD1' ' H ' ' A' ' 30' ' ' SER . 53.6 t-80 -135.82 166.79 22.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 11.3 m-85 -62.13 -40.04 94.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.641 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 1.1 m -60.99 -21.5 63.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.453 -0.78 . . . . 0.0 109.991 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.17 -6.76 54.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.26 107.13 18.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.04 -41.38 97.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -113.69 97.47 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.59 -27.01 68.65 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.831 . . . . 0.0 109.234 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.86 -27.79 66.97 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.0 -9.35 58.64 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.456 -0.777 . . . . 0.0 109.264 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -64.61 -35.42 80.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 110.01 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.42 0.97 38.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -149.92 58.08 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -1.205 . . . . 0.0 108.982 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mt -81.49 -165.95 1.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.84 159.84 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.749 0.785 . . . . 0.0 109.714 -179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.4 93.65 2.18 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.447 ' O ' ' NZ ' ' A' ' 4' ' ' LYS . . . 98.63 -13.85 62.3 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m -86.49 -177.66 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.409 . . . . 0.0 111.021 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.06 145.95 29.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.568 -0.708 . . . . 0.0 110.434 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.5 m -133.29 164.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 1' ' ' MET . 75.1 t60 -135.17 135.33 40.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.374 -0.829 . . . . 0.0 109.456 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.41 163.7 38.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.56 153.06 38.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.96 139.36 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.953 1.769 . . . . 0.0 112.874 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -153.55 87.91 3.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 54' ' ' THR . 54.1 Cg_exo -53.58 -43.17 60.02 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.231 1.954 . . . . 0.0 111.542 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER 53.58 161.02 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 CA-C-O 121.222 0.534 . . . . 0.0 110.472 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -41.33 73.17 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.32 2.013 . . . . 0.0 112.04 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.74 -43.04 97.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.752 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.96 -63.59 0.61 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.6 mt -109.85 125.71 53.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.308 -1.113 . . . . 0.0 110.055 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.73 151.38 21.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.32 119.43 39.46 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -115.79 147.81 40.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.568 -0.708 . . . . 0.0 110.062 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 66.52 48.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.392 0.615 . . . . 0.0 109.432 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.43 135.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.808 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.9 m -126.92 149.56 49.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 109.275 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.59 97.35 36.41 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.2 5.97 6.02 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.606 2.204 . . . . 0.0 112.483 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.7 tp -81.75 -0.56 43.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 108.907 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.6 142.15 45.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' HIS . 99.5 m-70 -107.96 115.14 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.578 -0.701 . . . . 0.0 109.488 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' HIS . 61.5 m170 52.88 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.616 0.722 . . . . 0.0 110.842 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.468 ' CD2' ' H ' ' A' ' 71' ' ' HIS . 7.4 p80 -67.24 -44.43 79.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.631 ' CD2' ' H ' ' A' ' 73' ' ' HIS . 84.0 t60 -139.44 -109.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.726 . . . . 0.0 109.642 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.631 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 96.4 m-70 43.18 87.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.618 -0.676 . . . . 0.0 109.994 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 74' ' ' HIS . 84.0 t60 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.037 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.493 ' H3 ' ' CB ' ' A' ' 20' ' ' ASP . 5.0 mpp? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.455 0.645 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -71.37 -80.98 0.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.678 -0.639 . . . . 0.0 109.755 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.34 175.64 20.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.5 145.61 47.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.87 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -88.43 112.46 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 7.5 p -70.77 -41.59 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.535 -0.728 . . . . 0.0 109.745 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.1 p -160.33 160.62 32.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.573 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -156.84 111.27 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.68 0.752 . . . . 0.0 109.61 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.1 mp -106.83 102.4 11.77 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.2 -23.86 65.79 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.09 96.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.026 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.4 mtmt -97.23 4.24 51.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 59.1 2.95 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.308 0.575 . . . . 0.0 110.12 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' A' ' 12' ' ' LYS . 62.0 m-85 -118.89 152.3 36.54 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.0 109.895 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.97 -168.9 21.67 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -137.51 149.71 46.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.754 -0.851 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.1 138.49 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.487 0.66 . . . . 0.0 109.527 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -99.46 105.25 17.16 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.761 0.791 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.44 160.66 51.22 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 43.0 p-10 -66.59 -33.37 75.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.649 -0.912 . . . . 0.0 109.712 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 84.7 m-20 -87.99 6.46 35.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.774 -0.579 . . . . 0.0 109.496 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.84 16.95 64.39 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.5 mt-10 -93.68 118.54 31.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.99 . . . . 0.0 109.673 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 p -77.29 153.22 34.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.798 0.809 . . . . 0.0 110.06 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 98.0 m-85 -141.47 134.97 29.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.603 0.716 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -79.35 140.56 37.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.699 0.761 . . . . 0.0 110.108 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.422 ' CD2' ' C ' ' A' ' 27' ' ' LEU . 4.4 tt -112.61 115.0 27.9 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.756 0.788 . . . . 0.0 109.254 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.604 ' HD1' ' H ' ' A' ' 30' ' ' SER . 52.3 t-80 -141.25 167.32 22.45 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.841 0.829 . . . . 0.0 110.303 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 13.5 m-85 -61.65 -35.41 77.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.844 -0.535 . . . . 0.0 110.146 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.604 ' H ' ' HD1' ' A' ' 28' ' ' HIS . 77.8 p -62.99 -20.27 65.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.619 -0.675 . . . . 0.0 109.863 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -93.61 -11.02 32.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.11 116.03 28.35 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.372 -0.83 . . . . 0.0 109.569 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.52 -42.14 95.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.537 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -117.65 134.76 54.55 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.738 0.78 . . . . 0.0 109.589 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 mptm? -77.45 -12.42 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 19.2 ptmt -65.4 -41.96 93.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.717 -0.615 . . . . 0.0 110.313 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 98.0 m-20 -78.33 -8.31 58.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 109.606 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.36 -36.81 79.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 109.108 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.6 -9.75 80.76 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 68.3 mttm -98.46 -0.76 42.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.175 -1.191 . . . . 0.0 109.296 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.9 145.74 15.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.739 . . . . 0.0 110.184 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -124.18 125.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 122.018 0.913 . . . . 0.0 109.47 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' NZ ' ' O ' ' A' ' 6' ' ' VAL . 7.4 tmtm? -95.69 137.24 35.04 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.908 0.861 . . . . 0.0 110.854 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 25.93 38.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 46' ' ' MET . 8.9 t -142.06 -164.95 1.91 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.026 -1.279 . . . . 0.0 111.343 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.672 ' H ' ' HG ' ' A' ' 45' ' ' SER . 82.6 mtp -88.49 139.94 29.97 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.965 0.888 . . . . 0.0 110.961 -178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.24 159.8 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.368 0.604 . . . . 0.0 109.503 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -124.05 132.32 53.66 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 110.07 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -154.99 161.16 41.46 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.617 0.722 . . . . 0.0 109.801 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -102.73 150.69 37.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.47 159.8 50.38 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.487 2.125 . . . . 0.0 112.542 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -147.35 148.84 32.84 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 121.689 -0.632 . . . . 0.0 109.474 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 54' ' ' THR . 55.2 Cg_endo -69.62 -63.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.823 2.349 . . . . 0.0 111.742 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.64 ' HG1' ' H ' ' A' ' 58' ' ' LEU . 8.6 p 56.87 146.73 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.144 0.497 . . . . 0.0 110.27 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.54 73.24 2.28 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.579 2.186 . . . . 0.0 111.766 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 tptp 58.59 88.75 0.06 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 110.333 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.22 -25.2 0.12 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.64 ' H ' ' HG1' ' A' ' 54' ' ' THR . 59.2 mt 60.92 152.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.742 -0.857 . . . . 0.0 110.627 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.3 156.38 35.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.703 0.763 . . . . 0.0 109.728 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.31 87.86 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -89.75 148.4 23.27 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.833 0.825 . . . . 0.0 110.294 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.86 58.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.617 0.723 . . . . 0.0 109.616 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.45 129.37 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.917 0.865 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.1 m -135.79 126.38 27.05 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.645 0.735 . . . . 0.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -89.26 132.35 37.84 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -76.23 -9.7 19.1 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.412 2.075 . . . . 0.0 111.319 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -96.96 130.85 44.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.745 0.783 . . . . 0.0 109.741 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 57.4 mp0 -93.03 7.54 43.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' HIS . 85.4 t60 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.539 0.685 . . . . 0.0 109.803 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 69' ' ' HIS . 80.5 m80 47.47 179.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.865 0.841 . . . . 0.0 110.662 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 72' ' ' HIS . 99.5 m-70 -58.38 -80.22 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.77 -0.581 . . . . 0.0 109.486 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' HIS . 81.0 m80 38.83 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.593 0.711 . . . . 0.0 110.105 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.72 -40.92 88.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.321 179.898 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 tpp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -90.83 179.52 5.76 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 110.018 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.28 -166.42 28.28 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -135.13 138.25 43.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.876 -0.779 . . . . 0.0 110.313 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.434 HG11 ' H ' ' A' ' 44' ' ' GLY . 8.0 p -74.12 126.19 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.359 0.599 . . . . 0.0 109.409 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -94.37 -42.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.1 m -152.85 153.75 33.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.992 0.901 . . . . 0.0 110.524 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -161.02 117.18 2.23 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.681 0.753 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.87 110.34 17.07 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 109.231 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.64 -34.49 77.07 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.529 0.681 . . . . 0.0 109.401 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -34.33 75.53 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' TYR . 28.6 mmtp -95.7 -1.58 49.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? 57.67 6.54 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.452 0.644 . . . . 0.0 109.57 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' LYS . 47.6 m-85 -123.02 160.13 26.95 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.911 0.863 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.91 -170.16 28.43 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.03 148.34 33.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.791 -0.829 . . . . 0.0 109.604 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 17' ' ' ILE . 96.6 mt -133.69 132.89 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.74 0.781 . . . . 0.0 109.903 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -97.07 113.63 25.2 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.921 0.867 . . . . 0.0 110.078 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.88 161.47 52.3 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -64.59 -35.8 82.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.062 -0.669 . . . . 0.0 109.643 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -83.52 9.5 11.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.74 65.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 75.6 mm-40 -95.95 115.22 27.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.703 -0.881 . . . . 0.0 110.049 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.0 t -77.16 146.95 36.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.681 0.753 . . . . 0.0 110.04 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 99.0 m-85 -136.0 136.55 40.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.782 0.801 . . . . 0.0 109.529 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 63.7 m-85 -81.35 143.07 32.46 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.829 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.5 tt -111.62 121.87 46.31 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.154 0.978 . . . . 0.0 109.548 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.3 t60 -139.0 167.78 21.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.959 0.885 . . . . 0.0 109.602 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 6.2 m-85 -62.05 -38.08 87.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.405 0.621 . . . . 0.0 109.413 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.8 m -61.59 -20.85 63.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 26' ' ' PHE . 94.7 mt-10 -90.84 -11.68 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.842 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.6 mt -96.12 106.08 18.22 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.495 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -64.88 -42.22 94.99 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.61 0.719 . . . . 0.0 109.515 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -110.82 90.1 3.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -49.0 -19.5 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -66.16 -35.9 81.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.48 -12.36 61.59 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.341 0.591 . . . . 0.0 109.496 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 78.4 tt0 -66.23 -34.89 79.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.414 0.626 . . . . 0.0 109.591 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.09 -7.76 84.84 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -108.18 15.45 24.16 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.944 . . . . 0.0 109.604 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.59 151.36 46.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.815 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.56 133.3 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.122 0.963 . . . . 0.0 109.607 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -100.23 133.51 44.53 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.434 ' H ' HG11 ' A' ' 5' ' ' VAL . . . 93.33 -24.16 26.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -90.7 -178.87 5.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.979 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.81 148.39 27.81 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.793 0.806 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 160.07 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.474 0.654 . . . . 0.0 109.286 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -121.23 125.28 46.72 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.005 0.907 . . . . 0.0 110.312 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -138.36 150.96 47.09 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.333 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.49 131.12 22.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -48.45 141.68 18.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.739 2.292 . . . . 0.0 113.047 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.39 151.06 76.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.41 131.22 18.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.892 2.395 . . . . 0.0 113.097 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.95 149.42 27.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.02 -47.3 1.84 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.758 2.306 . . . . 0.0 111.668 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -171.75 111.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.741 0.782 . . . . 0.0 109.662 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.37 -16.27 3.16 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.4 mt 60.92 163.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.619 0.723 . . . . 0.0 109.999 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.71 153.7 21.38 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.76 0.79 . . . . 0.0 109.834 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.6 151.09 21.05 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.683 0.754 . . . . 0.0 109.866 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.33 138.71 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.857 0.837 . . . . 0.0 110.039 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.69 66.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.53 0.681 . . . . 0.0 110.173 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.9 130.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.618 0.723 . . . . 0.0 109.654 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -131.36 164.81 24.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.803 0.811 . . . . 0.0 109.78 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.73 79.63 23.45 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.61 16.95 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.574 2.183 . . . . 0.0 111.416 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.01 117.91 14.22 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.541 0.686 . . . . 0.0 110.335 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.91 133.93 43.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.644 0.735 . . . . 0.0 109.911 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -145.82 114.31 6.74 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.773 0.797 . . . . 0.0 109.941 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -148.82 164.47 34.35 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.441 ' C ' ' H ' ' A' ' 73' ' ' HIS . 78.3 m80 -66.21 -37.86 86.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -76.9 42.08 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.378 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.441 ' H ' ' C ' ' A' ' 71' ' ' HIS . 59.7 t-80 -64.71 -43.28 93.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.416 ' OXT' ' ND1' ' A' ' 74' ' ' HIS . 54.1 t-80 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.167 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptp . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -158.68 -163.35 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.3 -167.56 31.74 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -127.33 143.2 51.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.662 -0.905 . . . . 0.0 109.524 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.53 108.42 6.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.505 -0.747 . . . . 0.0 109.677 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -69.38 -39.26 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.635 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.1 p -159.85 165.2 32.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.707 -1.246 . . . . 0.0 110.873 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -156.7 114.23 3.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 mp -114.16 111.41 21.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.542 -0.724 . . . . 0.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.5 78.18 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.738 -0.601 . . . . 0.0 109.757 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.0 mttt -92.54 -4.44 53.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? 54.21 6.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.9 m-85 -132.89 123.52 26.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.62 -164.94 22.58 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -141.73 145.15 34.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -1.036 . . . . 0.0 109.122 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.8 136.83 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.795 -0.566 . . . . 0.0 109.825 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -100.49 110.78 22.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 109.181 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.73 155.38 53.45 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.026 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 49.1 p-10 -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.521 -0.988 . . . . 0.0 109.739 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 86.5 m-20 -86.49 10.63 14.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 108.813 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.21 15.44 71.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.1 mt-10 -94.65 109.53 21.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.968 -1.313 . . . . 0.0 109.489 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.0 t -73.98 142.48 45.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.432 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 83.7 m-85 -125.1 135.27 52.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 109.662 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -78.02 144.69 36.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.2 tt -109.36 122.42 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -127.28 149.94 49.79 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.606 0.717 . . . . 0.0 109.867 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.5 -37.97 89.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 p -61.64 -25.84 67.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.35 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.84 -1.08 46.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.7 mt -93.85 120.47 34.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.949 -1.095 . . . . 0.0 110.347 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.5 mm? -64.43 -42.44 96.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.597 -0.689 . . . . 0.0 109.768 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -117.01 109.66 17.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -65.99 -15.14 62.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.118 -0.989 . . . . 0.0 108.771 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -65.22 -38.79 91.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.388 -0.82 . . . . 0.0 109.255 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.89 -10.83 60.38 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.54 -33.75 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.001 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.9 -20.69 72.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 4.8 mptp? -90.87 -88.92 0.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.297 -1.12 . . . . 0.0 109.415 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' LYS . 53.2 mt 44.81 -175.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 0.0 109.53 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.78 159.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -122.21 124.85 44.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 110.5 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.12 -15.47 27.63 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.477 -0.765 . . . . 0.0 111.536 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 t -86.55 178.75 6.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.589 . . . . 0.0 110.868 -179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.1 mtm -79.97 145.74 32.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -0.751 . . . . 0.0 110.838 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.56 161.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -126.76 131.15 51.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.501 -0.749 . . . . 0.0 109.598 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -146.81 154.02 40.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.307 -0.871 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -97.12 164.29 18.14 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.079 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.62 143.26 95.29 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.998 1.798 . . . . 0.0 112.589 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m -153.56 87.76 3.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.24 94.22 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.749 1.633 . . . . 0.0 111.609 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 p -98.4 157.9 33.56 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.13 -22.8 3.96 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.074 1.849 . . . . 0.0 112.207 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.82 -6.4 54.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.96 -1.088 . . . . 0.0 109.796 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.32 -86.78 0.44 Allowed Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -111.62 142.84 43.41 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -1.017 . . . . 0.0 109.879 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.23 156.22 36.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.577 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.61 141.56 38.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.641 -0.662 . . . . 0.0 109.522 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.95 152.07 49.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.468 -0.77 . . . . 0.0 109.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.16 49.16 14.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.459 -0.776 . . . . 0.0 109.217 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.71 135.72 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.123 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -134.63 150.98 50.73 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.645 0.736 . . . . 0.0 110.139 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.95 95.14 32.92 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -51.18 -36.67 56.67 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.975 1.783 . . . . 0.0 111.459 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 9.7 mp -61.85 174.33 0.85 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 110.255 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' OE1' ' CB ' ' A' ' 67' ' ' LEU . 54.3 mp0 52.93 29.99 8.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 109.215 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.51 ' CG ' ' N ' ' A' ' 70' ' ' HIS . 86.6 t60 -68.06 167.21 14.42 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.353 -0.842 . . . . 0.0 109.989 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.51 ' N ' ' CG ' ' A' ' 69' ' ' HIS . 56.8 t-80 57.88 167.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.734 0.778 . . . . 0.0 110.837 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.507 ' N ' ' CG ' ' A' ' 70' ' ' HIS . 79.3 m80 -70.25 143.87 52.0 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.544 0.688 . . . . 0.0 110.572 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.446 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 84.8 t60 -78.0 60.57 2.4 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -67.26 -41.03 86.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.339 -0.851 . . . . 0.0 109.225 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.179 179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.265 0.555 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -103.54 149.08 25.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 109.991 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.31 20.47 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -131.39 143.75 50.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.857 . . . . 0.0 109.953 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -80.33 113.53 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.668 0.747 . . . . 0.0 110.338 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.06 -35.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.37 0.605 . . . . 0.0 109.465 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.617 ' HG ' ' CD2' ' A' ' 9' ' ' LEU . 45.8 t -171.78 151.15 2.78 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.235 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -105.66 -33.73 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.9 0.857 . . . . 0.0 109.032 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.617 ' CD2' ' HG ' ' A' ' 7' ' ' SER . 37.0 mt 45.93 75.22 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.62 0.724 . . . . 0.0 109.444 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.76 68.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.837 0.827 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.74 80.99 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.633 0.73 . . . . 0.0 109.606 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 14' ' ' TYR . 64.4 mttp -94.07 0.48 55.94 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 55.44 5.66 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.204 0.526 . . . . 0.0 109.945 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' LYS . 49.5 m-85 -123.14 125.07 44.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.14 164.77 19.41 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -132.2 142.16 49.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.748 -0.854 . . . . 0.0 109.89 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 17' ' ' ILE . 96.1 mt -133.15 136.51 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.51 0.672 . . . . 0.0 109.463 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -93.6 104.0 16.15 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.761 0.791 . . . . 0.0 109.674 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.82 162.86 53.82 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.19 -38.31 90.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.884 . . . . 0.0 109.691 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.25 3.98 25.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.322 -0.861 . . . . 0.0 109.084 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.26 19.72 61.97 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.19 118.44 27.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -1.17 . . . . 0.0 109.927 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.2 p -78.85 157.14 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.532 0.682 . . . . 0.0 110.196 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.57 139.77 42.41 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.568 0.699 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.73 124.96 40.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.771 -0.581 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' C ' ' CD2' ' A' ' 27' ' ' LEU . 5.5 tt -103.69 117.39 34.27 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.566 0.698 . . . . 0.0 109.194 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.457 ' CD2' ' HG ' ' A' ' 30' ' ' SER . 4.6 t60 -117.49 163.08 16.94 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.732 . . . . 0.0 109.374 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.498 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 17.3 m-85 -62.86 -36.83 84.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.743 0.782 . . . . 0.0 108.979 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.457 ' HG ' ' CD2' ' A' ' 28' ' ' HIS . 82.6 p -63.03 -18.33 63.21 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.406 0.622 . . . . 0.0 109.525 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.87 -6.89 53.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.963 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.54 117.51 30.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.114 -0.991 . . . . 0.0 109.547 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.6 mm? -63.66 -41.23 98.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -118.86 114.52 22.74 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.417 0.627 . . . . 0.0 109.397 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.32 -36.12 81.2 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.733 . . . . 0.0 109.155 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.05 -33.8 75.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 109.862 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -68.97 -4.34 16.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 109.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 81.6 tt0 -63.3 -37.56 87.72 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.95 89.84 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -96.65 3.75 52.31 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.33 -1.1 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 147.79 50.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -108.67 113.39 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.96 0.886 . . . . 0.0 109.406 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -95.38 141.59 28.77 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.491 0.662 . . . . 0.0 110.567 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 24.95 51.46 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -148.1 -165.03 2.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.95 -1.324 . . . . 0.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.88 146.86 28.63 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.502 0.668 . . . . 0.0 110.638 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.18 158.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.688 -0.632 . . . . 0.0 109.33 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.53 132.53 54.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.582 0.706 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.17 158.26 40.08 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.681 0.753 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.27 150.38 37.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.66 156.98 59.91 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.474 2.116 . . . . 0.0 111.898 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 13.8 p -141.03 143.33 30.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.632 -0.667 . . . . 0.0 109.308 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 54' ' ' THR . 76.6 Cg_exo -41.49 -68.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.259 1.972 . . . . 0.0 111.779 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 53' ' ' PRO . 2.0 m 33.11 87.25 0.11 Allowed Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.43 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 56' ' ' LYS . 59.0 Cg_endo -77.34 98.14 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.138 1.892 . . . . 0.0 111.686 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 25.9 ttpt 78.12 67.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.76 0.791 . . . . 0.0 109.755 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 172.99 -33.7 0.12 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 57' ' ' GLY . 63.4 mt 59.49 138.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.828 -0.807 . . . . 0.0 110.327 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -159.73 174.27 14.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 110.016 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.34 41.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.875 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.58 148.35 50.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.88 55.49 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.86 0.838 . . . . 0.0 109.213 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -78.52 132.03 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.384 0.612 . . . . 0.0 110.122 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 m -107.26 124.57 49.96 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.802 0.811 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.57 113.28 59.85 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' LEU . 92.5 Cg_endo -80.08 -169.7 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.317 2.011 . . . . 0.0 112.468 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 66' ' ' PRO . 80.1 mt 40.41 95.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.102 0.953 . . . . 0.0 110.258 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 57.5 mp0 -89.53 -98.32 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.661 0.743 . . . . 0.0 109.635 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -171.45 84.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -155.06 149.38 26.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.732 -0.605 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 40.04 60.28 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 109.974 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.463 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 63.5 t-80 -154.75 163.06 40.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 109.84 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.463 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 46.2 p-80 -154.43 159.02 40.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 109.744 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.475 ' OXT' ' CG ' ' A' ' 74' ' ' HIS . 51.6 p-80 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.156 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -107.84 178.24 4.58 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.604 0.716 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.82 -159.87 19.09 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -132.67 134.86 45.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.538 -0.978 . . . . 0.0 109.682 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.55 105.48 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.458 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.93 -36.42 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -150.36 144.57 25.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.936 -1.102 . . . . 0.0 109.857 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CD1' ' C ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -125.14 -68.53 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.178 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt 57.93 109.46 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.975 0.893 . . . . 0.0 109.662 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.79 -23.3 27.27 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.904 0.859 . . . . 0.0 108.76 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.43 90.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 109.681 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.5 mttt -97.77 -3.27 39.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.095 -1.003 . . . . 0.0 108.549 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? 52.19 9.35 0.09 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.464 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' LYS . 58.1 m-85 -132.25 148.17 52.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.3 -159.83 10.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.09 155.53 47.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.3 -1.118 . . . . 0.0 109.547 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.69 135.07 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -101.11 118.57 37.25 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.861 0.838 . . . . 0.0 109.768 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.75 156.66 53.36 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 48.1 p-10 -67.27 -27.62 67.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.99 . . . . 0.0 109.549 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 33.1 p-10 -89.41 9.01 27.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.518 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.34 12.51 67.34 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.66 114.69 26.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.006 -1.291 . . . . 0.0 109.917 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 t -78.75 147.75 33.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.605 -0.684 . . . . 0.0 109.672 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.99 141.68 49.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.425 -0.797 . . . . 0.0 109.835 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.41 144.15 40.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.1 tt -114.16 122.28 46.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.792 0.806 . . . . 0.0 109.304 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -139.16 160.51 39.62 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.96 -10.82 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.869 0.842 . . . . 0.0 109.082 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.3 m -67.19 -11.72 58.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 109.37 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -108.38 -23.29 11.95 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.63 128.33 36.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.871 -1.143 . . . . 0.0 109.884 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 64.3 t0 -132.03 129.57 40.24 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.909 0.861 . . . . 0.0 109.563 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 72.9 mmtt -63.92 -36.29 83.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.804 0.812 . . . . 0.0 109.28 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.61 -35.95 81.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.46 -0.775 . . . . 0.0 110.168 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.48 -6.16 2.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.948 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.41 -36.54 84.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.973 -1.079 . . . . 0.0 109.621 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.08 -7.1 81.37 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.59 0.05 52.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -1.189 . . . . 0.0 108.723 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.39 158.68 34.63 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.4 -0.812 . . . . 0.0 109.795 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.89 138.29 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.735 0.779 . . . . 0.0 109.745 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -107.29 129.98 54.82 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.94 25.21 46.08 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -140.29 173.29 11.66 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.03 -1.277 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.3 144.68 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.879 0.847 . . . . 0.0 111.157 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.74 164.93 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -116.65 129.56 56.22 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.51 163.08 38.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 109.391 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -104.59 111.37 65.2 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.39 -0.819 . . . . 0.0 109.469 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.35 137.93 30.7 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.309 2.006 . . . . 0.0 112.597 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.4 m -152.73 133.05 7.51 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.004 . . . . 0.0 109.449 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.67 164.88 33.72 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 112.748 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -172.38 149.74 2.14 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.713 179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.6 -31.85 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.541 2.161 . . . . 0.0 111.642 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -77.99 2.57 17.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.369 -0.832 . . . . 0.0 109.3 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.87 -88.17 0.46 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.02 149.26 51.82 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.357 -1.084 . . . . 0.0 109.616 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.21 144.93 43.09 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.091 -1.006 . . . . 0.0 110.237 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.83 99.1 8.87 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 124.994 2.331 . . . . 0.0 111.264 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.304 43.2 tptt -82.24 143.36 31.41 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.555 -2.566 . . . . 0.0 113.1 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 42.14 66.79 0.67 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 122.369 1.08 . . . . 0.0 110.005 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -75.05 137.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -123.8 147.91 47.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.48 -0.763 . . . . 0.0 110.071 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.99 79.72 64.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' LEU . 88.3 Cg_endo -81.63 -12.01 11.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.763 2.309 . . . . 0.0 111.579 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' PRO . 17.5 mt 33.67 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' A' ' 68' ' ' GLU . 2.1 pm0 -164.15 26.27 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 70' ' ' HIS . 25.7 p80 -61.39 -46.8 88.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.635 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 97.4 m-70 -151.96 143.64 23.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.21 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -87.72 3.8 46.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 108.865 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.502 ' C ' ' H ' ' A' ' 74' ' ' HIS . 78.9 m80 -75.52 146.8 40.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -0.902 . . . . 0.0 110.544 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.456 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 59.8 t-80 53.3 10.17 0.18 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.775 0.798 . . . . 0.0 109.203 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 72' ' ' HIS . 86.1 t60 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.907 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.873 0.844 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.24 -172.16 39.18 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.47 141.11 51.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.757 -0.849 . . . . 0.0 109.691 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.8 p -86.19 118.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.526 0.679 . . . . 0.0 109.341 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.02 -28.75 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.657 -0.652 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 t -155.96 153.07 28.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -157.02 112.72 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.598 0.713 . . . . 0.0 109.21 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.24 116.05 27.69 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.757 0.789 . . . . 0.0 109.434 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.09 76.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -37.98 85.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.596 -0.69 . . . . 0.0 109.844 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 14' ' ' TYR . 55.5 mtpt -95.88 11.07 35.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.877 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' LYS . 64.2 pttt 34.95 27.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.521 0.676 . . . . 0.0 110.341 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 12' ' ' LYS . 35.7 t80 -141.7 123.08 14.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.59 0.71 . . . . 0.0 109.347 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -114.4 -164.11 14.83 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -146.78 134.32 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.658 -0.907 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.408 HD11 HD21 ' A' ' 27' ' ' LEU . 96.6 mt -130.8 132.4 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.487 0.661 . . . . 0.0 109.271 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -100.51 116.96 33.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.84 161.56 53.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -65.08 -35.77 82.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.961 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -87.48 9.03 22.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.542 -0.724 . . . . 0.0 109.175 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.65 58.66 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -91.97 118.13 30.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -1.028 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.8 p -80.59 163.97 23.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.718 0.771 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -144.82 150.96 38.04 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.61 0.719 . . . . 0.0 109.69 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.56 143.44 28.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.567 0.698 . . . . 0.0 109.998 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' O ' ' ND1' ' A' ' 28' ' ' HIS . 66.7 mt -110.75 127.26 55.28 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.749 0.785 . . . . 0.0 109.892 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' A' ' 27' ' ' LEU . 10.0 m80 -140.73 159.42 42.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.765 0.793 . . . . 0.0 109.9 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -65.67 -35.17 80.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.1 t -62.33 -17.77 59.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -93.88 -18.56 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.507 -0.745 . . . . 0.0 109.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.0 141.04 32.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.594 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.76 152.82 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.686 0.755 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 70.7 mmtt -66.68 -39.42 88.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' GLU . 98.7 mttt -63.96 -39.38 94.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.481 0.658 . . . . 0.0 109.264 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -51.1 -9.46 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.547 -0.721 . . . . 0.0 109.405 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' LYS . 11.8 pt-20 -70.34 -36.57 74.32 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . -83.2 -8.87 84.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -94.29 0.29 55.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.966 . . . . 0.0 108.995 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.91 153.25 42.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.452 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 42' ' ' VAL . 6.5 p -113.91 120.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.045 0.926 . . . . 0.0 110.104 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -91.0 136.4 33.1 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.684 0.754 . . . . 0.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.08 26.44 40.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -149.22 -164.63 2.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 111.143 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 95.8 mtp -87.48 145.66 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.902 0.858 . . . . 0.0 110.871 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.41 161.1 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -118.91 124.76 47.88 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.864 0.84 . . . . 0.0 110.152 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -149.4 157.03 42.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.503 0.668 . . . . 0.0 109.326 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.26 150.58 38.55 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.72 -0.612 . . . . 0.0 109.365 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.86 152.81 76.86 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.701 2.267 . . . . 0.0 112.813 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.812 0.815 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.56 151.63 15.22 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.809 0.814 . . . . 0.0 109.876 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.37 159.98 14.81 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.471 0.653 . . . . 0.0 109.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -149.79 138.66 21.01 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.645 0.736 . . . . 0.0 110.273 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 58.05 68.6 0.82 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.584 0.707 . . . . 0.0 109.941 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mm -66.24 138.25 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.322 0.582 . . . . 0.0 109.507 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -132.37 141.97 49.12 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.095 0.95 . . . . 0.0 110.307 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -113.43 93.0 25.09 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.494 1.548 0 C-N-CA 122.686 2.257 . . . . 0.0 111.951 -179.311 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.5 pttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.788 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.46 -168.11 36.09 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -130.58 133.8 46.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.735 -0.862 . . . . 0.0 109.816 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.1 p -79.68 111.83 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.752 0.786 . . . . 0.0 109.089 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -73.71 -33.5 38.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.637 -0.664 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -161.63 153.91 19.8 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.014 0.911 . . . . 0.0 110.738 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.454 ' C ' HD22 ' A' ' 9' ' ' LEU . 59.9 t80 -153.16 102.4 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -96.56 112.09 23.97 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.058 0.932 . . . . 0.0 109.505 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.97 79.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.619 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.49 85.53 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 14' ' ' TYR . 51.7 mtmt -94.05 3.09 55.81 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mttp 47.08 15.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.218 0.533 . . . . 0.0 110.322 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 33.6 t80 -144.96 159.35 43.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.004 0.907 . . . . 0.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -161.58 -152.55 6.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.83 154.1 48.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.89 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 150.03 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.56 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -112.4 116.38 30.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.792 0.806 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.62 160.99 47.76 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.01 -36.2 83.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.919 -0.754 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.76 9.32 19.31 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.61 7.44 81.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -87.41 119.31 27.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.682 -0.893 . . . . 0.0 109.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.5 m -75.47 153.1 37.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.533 0.682 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 58' ' ' LEU . 86.7 m-85 -135.29 132.56 37.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.807 0.813 . . . . 0.0 109.804 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.15 140.81 40.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.646 0.736 . . . . 0.0 110.426 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.3 tt -115.51 117.46 30.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.162 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.628 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.8 t-80 -139.46 166.6 24.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.995 0.902 . . . . 0.0 110.156 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 10.1 m-85 -62.36 -40.86 97.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.86 -0.525 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.6 t -60.25 -17.75 44.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.821 -0.549 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.79 -7.24 47.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 109.045 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.2 mt -88.0 125.3 34.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.768 0.794 . . . . 0.0 110.037 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.13 -41.8 97.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -126.65 131.15 51.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.81 0.814 . . . . 0.0 109.038 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -35.75 81.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.784 -0.572 . . . . 0.0 109.545 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -60.47 -36.46 78.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.538 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.58 -10.13 16.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.753 -0.592 . . . . 0.0 109.42 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -67.27 -38.61 85.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.0 -8.97 85.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -98.73 5.11 47.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.408 -1.054 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 156.1 26.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.32 130.3 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.175 0.988 . . . . 0.0 110.088 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.7 ttmt -98.02 135.94 38.99 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.802 0.81 . . . . 0.0 110.907 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.1 59.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -135.52 173.76 11.37 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.264 -1.139 . . . . 0.0 111.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.41 142.16 37.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.739 0.78 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.73 163.5 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -121.0 135.32 55.24 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.867 0.841 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.26 156.51 39.84 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.729 0.776 . . . . 0.0 110.016 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.82 156.63 37.07 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.802 -0.561 . . . . 0.0 109.551 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.94 148.99 64.25 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.43 2.087 . . . . 0.0 112.948 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.812 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 25' ' ' TYR . 2.8 mm? . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.815 0.817 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.47 157.26 14.73 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.761 0.791 . . . . 0.0 110.379 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.29 133.66 46.84 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.87 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -114.64 135.55 54.03 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.907 0.861 . . . . 0.0 110.146 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.24 66.74 1.12 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.583 0.706 . . . . 0.0 110.383 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.06 137.27 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.561 0.696 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 p -132.04 150.28 52.2 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.743 0.782 . . . . 0.0 110.122 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 82.86 36.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 C-N-CA 122.701 2.267 . . . . 0.0 111.348 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.394 0.616 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.56 4.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.77 146.38 52.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.583 -0.951 . . . . 0.0 110.123 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -75.71 113.39 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.54 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.81 -34.33 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -148.94 146.13 27.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.976 -1.077 . . . . 0.0 110.241 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -162.76 102.08 1.02 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.8 mt -115.65 114.14 24.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 109.17 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.27 66.4 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.67 54.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 60.3 pttt -97.14 1.17 49.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.22 -0.925 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 57.71 38.69 27.59 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.296 0.569 . . . . 0.0 109.997 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 59.0 m-85 -149.14 159.45 44.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.18 33.92 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.99 157.61 45.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.458 -1.025 . . . . 0.0 109.627 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.94 135.0 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.689 -0.632 . . . . 0.0 109.565 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -94.07 99.07 11.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.05 170.68 28.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.6 -35.42 80.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.601 -0.94 . . . . 0.0 109.012 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.9 1.21 40.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.011 -1.055 . . . . 0.0 108.887 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.29 24.15 57.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 98.0 mt-10 -89.13 114.14 25.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.14 -1.212 . . . . 0.0 109.718 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' LEU . 42.6 t -74.4 147.61 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.176 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 23' ' ' GLU . 96.3 m-85 -122.36 144.71 48.85 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.469 0.652 . . . . 0.0 109.533 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.9 -43.65 98.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 27' ' ' LEU . 2.2 tt 70.4 96.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.707 ' CG ' ' HG ' ' A' ' 30' ' ' SER . 3.9 t-80 -116.47 119.04 34.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.461 0.648 . . . . 0.0 109.637 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -57.09 -21.37 31.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.707 ' HG ' ' CG ' ' A' ' 28' ' ' HIS . 77.9 p -66.94 -19.29 65.7 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -88.3 3.83 48.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 mt -77.84 133.67 38.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.89 -42.59 99.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -121.32 120.4 34.99 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.4 0.619 . . . . 0.0 109.557 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.14 -36.24 82.95 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.77 -39.17 90.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.737 . . . . 0.0 109.596 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.63 -6.56 26.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.94 -37.36 84.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.177 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.39 88.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -91.93 -3.1 56.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -1.159 . . . . 0.0 109.175 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 169.22 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.516 -0.74 . . . . 0.0 110.348 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.26 143.42 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -110.0 130.0 55.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.532 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.595 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.13 -15.42 62.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -97.39 -175.05 3.1 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.216 -1.167 . . . . 0.0 110.799 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 96.2 mtp -80.05 148.33 31.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.57 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.69 151.13 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.252 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.82 125.57 45.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.725 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.85 147.74 37.67 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.06 152.5 42.52 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.689 -0.632 . . . . 0.0 109.311 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.89 139.5 62.44 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.334 2.023 . . . . 0.0 112.201 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.488 1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.095 179.373 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 24' ' ' SER . 96.6 mt . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 121.514 0.674 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.44 153.95 39.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.23 144.83 43.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.686 -0.633 . . . . 0.0 109.494 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -128.59 143.98 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.48 0.657 . . . . 0.0 109.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.33 71.09 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.452 0.644 . . . . 0.0 110.127 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.46 129.49 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.43 -0.794 . . . . 0.0 108.886 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 m -131.06 155.52 46.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.507 -0.746 . . . . 0.0 110.011 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.86 112.41 58.03 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.255 1.97 . . . . 0.0 111.69 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.61 -167.77 33.14 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.164 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -130.99 137.21 49.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.714 -0.874 . . . . 0.0 109.417 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.7 p -81.87 105.95 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.038 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 7' ' ' SER . 15.0 p -71.02 -38.82 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.492 0.663 . . . . 0.0 109.448 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.457 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.8 p -154.49 158.73 40.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -158.4 114.89 2.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.545 -0.722 . . . . 0.0 109.148 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 100.43 8.82 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.68 72.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.759 0.79 . . . . 0.0 109.339 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.81 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.69 . . . . 0.0 109.939 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.8 mtpt -94.29 4.23 54.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 108.969 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mttp 56.29 4.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.293 0.568 . . . . 0.0 109.555 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' LYS . 59.1 m-85 -130.8 154.2 48.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.659 0.742 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.02 -169.0 22.76 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.41 151.19 51.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.487 -1.008 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.7 mt -134.19 159.35 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.43 0.633 . . . . 0.0 109.378 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.497 ' N ' HG22 ' A' ' 17' ' ' ILE . 56.2 tt0 -113.05 107.87 16.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.675 0.75 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.5 161.9 53.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 47.3 p-10 -65.01 -33.9 77.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.955 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 93.3 m-20 -90.13 7.2 39.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 108.751 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.7 14.83 64.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 98.2 mt-10 -92.23 119.27 31.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -1.108 . . . . 0.0 109.686 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -78.41 152.67 32.09 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.696 0.76 . . . . 0.0 110.657 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.4 m-85 -138.76 135.35 34.6 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.552 0.691 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.82 144.29 35.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.662 -0.649 . . . . 0.0 110.245 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.5 tt -113.76 120.16 39.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.642 ' N ' HD23 ' A' ' 27' ' ' LEU . 80.8 t60 -136.1 171.72 14.06 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.685 0.755 . . . . 0.0 109.724 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 5.3 m-85 -61.4 -39.53 91.04 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.665 0.745 . . . . 0.0 109.551 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.453 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 79.2 p -59.62 -20.29 54.89 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.712 -0.617 . . . . 0.0 110.023 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.02 -9.52 36.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 0.0 109.426 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.83 124.02 38.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 109.79 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.37 -41.67 96.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 109.438 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -130.09 114.06 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.578 -0.702 . . . . 0.0 109.243 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -49.67 -27.53 4.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.01 -37.01 85.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.28 -7.0 20.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.118 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -65.96 -33.44 75.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.748 . . . . 0.0 109.068 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 -7.82 85.24 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' CD ' ' N ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -93.8 0.65 56.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -1.128 . . . . 0.0 108.738 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.12 150.27 47.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.584 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.57 126.81 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.885 0.85 . . . . 0.0 109.893 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.91 139.33 30.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.725 0.774 . . . . 0.0 110.835 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.37 51.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -146.1 -164.85 2.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.909 -1.348 . . . . 0.0 110.949 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtm -86.35 142.73 28.27 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.724 0.773 . . . . 0.0 110.543 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.8 135.88 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.551 0.691 . . . . 0.0 109.284 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -94.98 126.94 40.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -0.76 . . . . 0.0 109.855 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 2' ' ' LYS . 55.1 p90 -150.08 149.42 30.27 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.47 150.71 36.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 179.83 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.459 179.711 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.924 0.869 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 143.69 29.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.03 167.08 12.65 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.759 0.79 . . . . 0.0 110.017 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -149.53 142.83 25.16 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.795 0.807 . . . . 0.0 110.053 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.56 74.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.838 0.828 . . . . 0.0 110.566 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.76 133.43 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 109.249 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.3 t -138.12 138.8 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.023 0.916 . . . . 0.0 110.05 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.82 127.1 55.39 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.312 -1.381 0 C-N-CA 122.005 1.803 . . . . 0.0 110.825 179.269 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.834 0.826 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.88 -174.38 36.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -133.12 142.05 48.49 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.693 -0.886 . . . . 0.0 110.049 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.909 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.4 p -82.13 113.83 22.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.846 0.831 . . . . 0.0 108.98 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -80.22 -38.38 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.425 -0.797 . . . . 0.0 109.418 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 6' ' ' VAL . 95.3 p -161.45 162.57 30.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.858 0.837 . . . . 0.0 110.217 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.453 ' C ' HD22 ' A' ' 9' ' ' LEU . 25.9 t80 -153.08 109.82 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 4.0 mm? -99.87 106.59 18.45 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.024 0.916 . . . . 0.0 109.655 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.52 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.389 0.614 . . . . 0.0 109.567 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.11 79.2 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 98.9 mttt -89.33 -4.31 58.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.391 -0.818 . . . . 0.0 109.003 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.33 -17.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 23.2 p90 -132.52 158.19 42.75 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.49 -138.73 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -148.91 151.43 34.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.669 -0.901 . . . . 0.0 110.193 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.1 133.44 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.545 0.688 . . . . 0.0 109.257 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -103.44 116.97 33.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.947 0.88 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.94 160.45 52.76 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -68.62 -24.87 64.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.82 -0.812 . . . . 0.0 109.898 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -91.29 6.86 43.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.4 -0.813 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.1 72.3 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -92.37 115.89 28.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.392 -1.063 . . . . 0.0 110.132 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.9 p -81.14 148.25 29.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.609 0.719 . . . . 0.0 110.006 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.53 136.98 43.46 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.806 0.813 . . . . 0.0 110.015 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -73.43 139.61 45.97 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.549 0.69 . . . . 0.0 109.963 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.2 tt -113.99 120.59 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.812 0.815 . . . . 0.0 109.663 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.668 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.2 163.1 32.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.852 0.834 . . . . 0.0 109.107 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.862 -0.524 . . . . 0.0 109.773 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -57.54 -17.93 16.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 109.366 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.29 -9.87 34.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.464 -0.773 . . . . 0.0 108.986 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.96 112.03 22.12 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.922 0.868 . . . . 0.0 109.593 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -63.26 -41.57 99.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.869 -0.52 . . . . 0.0 109.655 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 36' ' ' LYS . 91.1 m-20 -128.53 106.76 9.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -54.91 -6.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.565 -0.71 . . . . 0.0 109.129 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 34' ' ' ASP . 68.6 mttm -64.54 -37.88 89.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.584 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.16 -7.55 49.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.484 -0.76 . . . . 0.0 109.512 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -56.79 -44.93 82.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.637 -0.664 . . . . 0.0 109.622 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.39 -9.57 86.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 41' ' ' LEU . 33.8 mtmm -116.13 16.65 15.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.418 -1.048 . . . . 0.0 109.121 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 40' ' ' LYS . 5.3 mt -55.14 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 109.935 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG21 HG12 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -127.0 162.15 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.256 1.027 . . . . 0.0 110.636 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -145.53 95.07 2.6 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.75 0.786 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.909 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 94.55 -15.72 62.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' HG12 ' A' ' 5' ' ' VAL . 20.9 m -84.95 165.37 17.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -1.216 . . . . 0.0 110.54 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.9 mtm -66.75 143.6 56.84 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.962 0.887 . . . . 0.0 111.052 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.606 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -130.95 161.62 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 109.259 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -130.32 129.08 42.74 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.791 0.805 . . . . 0.0 110.009 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -144.01 160.57 40.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.503 0.668 . . . . 0.0 109.617 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.81 154.29 38.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.836 -0.54 . . . . 0.0 109.589 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -49.73 142.89 24.01 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.652 2.235 . . . . 0.0 112.745 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.829 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.714 0.769 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.38 155.07 14.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.698 0.761 . . . . 0.0 109.903 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.48 137.08 47.03 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.856 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -133.39 142.55 48.42 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.878 0.847 . . . . 0.0 109.898 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.51 48.81 9.26 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.627 0.727 . . . . 0.0 109.773 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.61 139.23 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.546 0.688 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -133.74 149.78 51.48 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.691 0.758 . . . . 0.0 110.028 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -105.92 103.31 43.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 C--N 1.313 -1.318 0 C-N-CA 122.788 2.326 . . . . 0.0 111.316 -179.831 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.26 -163.85 20.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -141.76 144.17 33.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.572 -0.958 . . . . 0.0 110.117 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 p -77.48 126.08 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.741 -0.599 . . . . 0.0 109.759 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.34 -35.32 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.741 . . . . 0.0 109.588 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 m -151.28 135.4 16.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.996 -1.065 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CD1' HD13 ' A' ' 27' ' ' LEU . 52.6 t80 -157.01 114.99 3.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -119.45 124.87 47.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.691 0.758 . . . . 0.0 109.287 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -24.14 67.75 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.476 0.655 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.891 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 51.6 mtmt -97.03 -3.69 40.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 109.163 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 65.61 -8.46 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.527 0.68 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 33.6 p90 -150.9 161.37 42.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.754 . . . . 0.0 109.254 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.51 -119.36 0.97 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.3 153.16 40.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.655 -0.909 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 145.58 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.532 0.682 . . . . 0.0 109.739 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -107.92 108.71 19.98 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.764 0.793 . . . . 0.0 109.379 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.24 158.48 53.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.4 p-10 -66.09 -34.3 77.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.828 -0.807 . . . . 0.0 109.89 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 52.0 t0 -89.23 10.55 21.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.213 -0.929 . . . . 0.0 109.544 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.37 14.98 69.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -97.31 121.5 39.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.158 -1.201 . . . . 0.0 109.8 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.2 p -78.16 153.56 31.95 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.736 0.779 . . . . 0.0 110.714 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -141.81 136.52 30.71 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.716 0.77 . . . . 0.0 109.656 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.73 144.19 39.46 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.617 0.722 . . . . 0.0 110.167 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.6 tt -111.54 120.82 43.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.572 0.701 . . . . 0.0 109.318 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.647 ' N ' HD23 ' A' ' 27' ' ' LEU . 39.2 m80 -128.82 138.85 52.29 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.757 0.789 . . . . 0.0 109.511 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 30' ' ' SER . 20.8 p90 -66.88 -35.1 79.26 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.068 0.937 . . . . 0.0 109.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 37.4 m -63.66 -33.12 74.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.49 0.662 . . . . 0.0 109.791 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.25 -0.7 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.91 139.54 37.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.294 -0.879 . . . . 0.0 109.659 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.77 -41.52 97.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -128.22 121.13 28.64 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -45.83 -27.72 0.92 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.568 0.699 . . . . 0.0 109.674 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -64.83 -32.57 74.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.01 -14.41 22.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.515 -0.741 . . . . 0.0 109.175 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.08 -31.48 69.08 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.73 0.776 . . . . 0.0 109.473 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.2 -3.72 75.39 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.6 7.73 32.91 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.324 -1.104 . . . . 0.0 108.852 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.7 151.1 48.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.436 0.636 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.55 137.93 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.807 0.813 . . . . 0.0 109.938 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -107.28 130.84 54.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.769 0.795 . . . . 0.0 110.453 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 92.53 -23.0 30.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -91.46 179.19 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -1.132 . . . . 0.0 111.15 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtm -82.62 153.38 25.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.507 0.67 . . . . 0.0 110.493 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.4 m -133.97 161.58 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.746 -0.596 . . . . 0.0 109.542 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -120.94 131.99 54.67 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.551 0.691 . . . . 0.0 109.436 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -150.74 159.94 44.18 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.569 0.699 . . . . 0.0 109.816 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.65 153.19 37.9 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.43 133.9 39.32 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.885 2.39 . . . . 0.0 112.966 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.303 -1.445 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.857 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.45 0.643 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.93 146.15 35.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.716 0.769 . . . . 0.0 109.658 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.93 155.72 18.52 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.551 0.691 . . . . 0.0 109.863 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.21 147.29 34.64 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.728 0.775 . . . . 0.0 109.932 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.93 51.04 14.26 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.732 0.777 . . . . 0.0 109.87 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.53 139.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.0 109.547 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.528 ' C ' HD22 ' A' ' 65' ' ' LEU . 29.4 t -129.72 149.66 51.37 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.891 0.853 . . . . 0.0 109.917 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.889 HD22 ' N ' ' A' ' 65' ' ' LEU . 1.1 mm? -111.63 81.42 3.27 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.118 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.492 1.44 0 C-N-CA 122.472 2.114 . . . . 0.0 111.589 -179.397 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.04 -159.03 9.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -133.93 149.87 51.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 109.645 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -80.74 123.35 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.403 ' H ' HG12 ' A' ' 6' ' ' VAL . 6.1 p -93.18 -31.16 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -157.18 149.28 22.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 110.071 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.414 ' H ' ' HE2' ' A' ' 43' ' ' LYS . 55.5 t80 -158.77 106.14 1.84 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 9' ' ' LEU . 10.8 mp -101.21 110.87 22.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.829 . . . . 0.0 109.025 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.28 84.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.655 -0.653 . . . . 0.0 109.865 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.23 92.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 14' ' ' TYR . 9.9 mtpm? -98.93 7.57 45.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.355 -0.84 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' LYS . 56.1 pttt 35.06 30.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.551 0.691 . . . . 0.0 110.381 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 12' ' ' LYS . 88.5 t80 -139.58 140.84 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.34 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.35 -161.75 14.02 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.3 157.85 45.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.497 -1.002 . . . . 0.0 109.494 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.85 132.61 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.63 104.11 15.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.353 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.24 158.43 52.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 39.4 p-10 -64.66 -34.03 77.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.442 -1.034 . . . . 0.0 109.106 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.8 t70 -86.88 6.46 31.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 108.991 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.11 16.89 70.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -93.6 117.94 30.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.962 -1.317 . . . . 0.0 109.636 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -74.36 149.8 40.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.475 -0.766 . . . . 0.0 109.367 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -129.21 139.45 51.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.024 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -74.44 144.05 44.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.68 . . . . 0.0 109.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 27' ' ' LEU . 5.9 tt -124.51 116.83 23.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.472 -0.768 . . . . 0.0 109.211 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 27' ' ' LEU . 36.6 t-80 -140.54 170.27 16.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.827 . . . . 0.0 109.411 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.47 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 2.7 m-85 -62.19 -44.11 97.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.106 -0.996 . . . . 0.0 109.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.3 m -55.6 -20.2 12.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.859 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.24 -6.48 53.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.107 -0.995 . . . . 0.0 109.973 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.63 130.87 36.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.78 -41.71 99.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.494 -0.754 . . . . 0.0 109.091 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -142.11 131.39 23.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.403 -0.811 . . . . 0.0 109.125 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -61.93 -31.19 71.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.211 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -59.18 -36.35 75.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 108.851 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.88 -8.29 35.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.35 -42.07 94.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.02 -20.93 71.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -84.75 -0.21 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.125 -1.221 . . . . 0.0 109.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' CZ ' ' A' ' 8' ' ' TYR . 40.8 mt -67.32 147.94 52.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -127.12 136.69 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.49 -0.756 . . . . 0.0 109.563 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.9 ttmt -101.27 138.37 38.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 0.0 110.297 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 88.24 -23.66 14.26 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 m -88.45 178.33 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.94 -1.329 . . . . 0.0 110.513 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -85.4 149.9 25.1 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.586 -0.696 . . . . 0.0 109.906 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.62 164.77 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 109.144 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -124.25 136.15 53.93 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.498 -0.751 . . . . 0.0 109.455 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.1 157.32 43.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -93.93 153.26 40.93 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.162 -0.961 . . . . 0.0 109.295 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' THR . 53.7 Cg_endo -67.13 142.17 60.2 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.638 2.225 . . . . 0.0 112.384 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.199 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.386 0.612 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -153.48 153.93 33.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -99.87 -83.04 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.312 -0.867 . . . . 0.0 109.466 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' ALA . 56.3 tttm 60.31 144.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.496 -0.752 . . . . 0.0 110.548 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.11 43.1 32.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 0.0 110.002 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.17 140.29 18.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.149 -0.969 . . . . 0.0 109.03 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 m -121.27 153.21 37.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.738 . . . . 0.0 109.208 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -133.16 82.82 52.83 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 C-N-CA 121.956 1.771 . . . . 0.0 111.152 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.742 0.782 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.58 -174.32 41.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -135.89 134.54 38.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.846 -0.796 . . . . 0.0 109.618 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.9 p -75.84 120.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.797 0.808 . . . . 0.0 109.612 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 7' ' ' SER . 8.3 p -91.27 -38.96 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.668 -0.645 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 74.8 m -134.31 147.66 50.63 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.689 0.757 . . . . 0.0 110.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.608 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 66.5 t80 -161.06 117.63 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.71 110.19 16.99 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.834 0.826 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.16 85.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 109.832 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.01 90.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.849 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.95 2.19 40.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 43.0 39.21 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.504 0.669 . . . . 0.0 110.09 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 93.3 t80 -147.64 158.0 43.81 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.68 0.753 . . . . 0.0 109.955 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -176.73 -162.84 28.02 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -133.71 155.88 48.96 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.575 0.703 . . . . 0.0 109.26 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.4 137.5 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.5 0.667 . . . . 0.0 109.447 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -95.16 109.16 21.28 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.11 149.39 49.01 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -68.76 -22.64 64.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.684 -0.892 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 58.7 t0 -76.16 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.0 56.05 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.16 130.54 35.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -1.0 . . . . 0.0 110.356 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -76.23 145.9 39.43 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.56 0.695 . . . . 0.0 110.037 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.34 139.89 50.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.905 0.86 . . . . 0.0 110.117 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.13 143.72 47.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.701 0.762 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.5 tt -108.2 119.35 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.0 109.689 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.629 ' N ' HD23 ' A' ' 27' ' ' LEU . 40.7 m80 -129.09 128.26 43.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.157 0.979 . . . . 0.0 109.395 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CG ' ' N ' ' A' ' 30' ' ' SER . 22.7 p90 -64.47 -34.75 78.93 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.964 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 29.7 m -63.29 -33.15 74.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.718 -0.613 . . . . 0.0 110.672 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 60' ' ' ALA . 98.7 mt-10 -73.07 2.77 6.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.38 143.35 33.58 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.634 0.731 . . . . 0.0 109.865 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.33 -40.17 96.56 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 36' ' ' LYS . 9.5 p30 -137.46 101.85 4.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.904 0.859 . . . . 0.0 108.775 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -52.23 -7.27 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.788 -0.57 . . . . 0.0 109.621 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 34' ' ' ASP . 43.8 pttt -68.57 -30.1 68.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.225 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 39.7 p30 -79.4 -2.68 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -49.58 -42.59 44.85 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.7 -6.99 82.32 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -95.09 1.27 54.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -1.077 . . . . 0.0 109.517 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.64 152.88 44.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 109.868 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.45 126.4 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 122.118 0.961 . . . . 0.0 109.816 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.608 ' NZ ' ' H ' ' A' ' 8' ' ' TYR . 50.0 tttp -99.34 139.01 35.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.747 0.784 . . . . 0.0 110.817 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 25.19 51.49 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.9 t -143.82 -179.6 6.57 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.137 -1.213 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.12 146.84 34.91 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.745 0.783 . . . . 0.0 110.461 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.0 161.54 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.495 0.665 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -118.16 126.06 51.46 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.863 0.84 . . . . 0.0 109.731 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.49 155.79 39.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.441 0.639 . . . . 0.0 109.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -106.61 163.2 17.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.03 147.4 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.538 2.158 . . . . 0.0 112.718 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.674 -0.641 . . . . 0.0 109.71 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.582 0.705 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.86 155.39 34.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.677 0.751 . . . . 0.0 110.015 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 31' ' ' GLU . . . -116.01 129.92 56.58 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.591 0.71 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 160.48 26.98 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.901 0.858 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.2 48.4 19.54 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.507 0.67 . . . . 0.0 109.571 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -72.31 132.1 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -135.95 154.62 51.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.764 0.792 . . . . 0.0 110.734 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.08 98.25 33.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.489 1.233 0 C-N-CA 122.792 2.328 . . . . 0.0 111.074 -179.594 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.57 0.7 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.33 -172.5 38.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -135.55 134.17 39.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.691 -0.888 . . . . 0.0 109.895 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 5' ' ' VAL . 13.6 p -78.03 106.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.766 0.793 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -72.18 -39.01 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.275 0.56 . . . . 0.0 109.662 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.41 ' N ' HG13 ' A' ' 6' ' ' VAL . 42.7 t -159.07 156.79 29.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 110.469 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' OH ' ' CZ ' ' A' ' 29' ' ' PHE . 68.3 t80 -155.03 109.59 2.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.14 116.59 30.07 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.766 0.793 . . . . 0.0 109.294 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 -25.45 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.651 . . . . 0.0 109.336 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.2 -35.85 81.67 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.626 0.727 . . . . 0.0 109.443 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 14' ' ' TYR . 1.8 mptm? -90.89 7.09 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 61.47 -7.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.387 0.613 . . . . 0.0 109.705 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.5 p90 -161.48 163.8 30.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.462 -0.774 . . . . 0.0 109.635 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.29 -131.98 2.66 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -143.34 152.27 41.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.924 . . . . 0.0 110.036 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.94 133.15 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -95.66 106.71 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.81 0.814 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.36 163.86 54.54 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.71 -39.38 94.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.757 -0.849 . . . . 0.0 109.672 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -82.31 0.91 39.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.53 -0.731 . . . . 0.0 109.386 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.52 62.22 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 80.1 mm-40 -88.55 119.46 29.02 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.085 -1.244 . . . . 0.0 110.109 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -76.37 147.71 37.89 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.662 0.744 . . . . 0.0 110.279 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.6 m-85 -136.34 137.56 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.625 0.726 . . . . 0.0 109.616 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.15 141.11 32.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.4 tt -112.83 116.82 30.65 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.809 0.814 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 13.6 m-70 -119.86 146.78 45.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 26.3 m-85 -63.56 -39.23 93.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.34 0.59 . . . . 0.0 109.918 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -57.59 -18.54 20.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.442 -0.786 . . . . 0.0 110.024 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.02 -7.46 51.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.141 -0.974 . . . . 0.0 110.304 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.25 138.03 38.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 0.0 109.784 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.75 -41.37 98.02 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.454 0.645 . . . . 0.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -135.94 125.54 25.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.9 -11.43 27.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.499 0.666 . . . . 0.0 109.509 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.42 -14.92 56.56 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -76.79 -4.84 45.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 109.384 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -55.41 -46.07 76.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.748 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.33 -4.44 84.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -94.92 -3.8 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 108.961 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.21 149.14 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.714 -0.616 . . . . 0.0 110.136 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.2 134.56 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.871 0.843 . . . . 0.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.39 133.92 41.34 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.942 0.877 . . . . 0.0 111.29 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 86.47 -12.13 61.77 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' VAL . 8.6 t -96.86 177.11 5.74 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.985 -1.303 . . . . 0.0 110.947 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.6 mtp -81.09 147.63 30.02 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.766 0.793 . . . . 0.0 110.396 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.14 157.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -113.81 132.61 55.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.41 157.67 38.85 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.63 150.78 37.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.42 163.66 38.32 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.35 2.7 . . . . 0.0 113.249 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.61 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.892 0.853 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.29 158.63 30.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.3 130.5 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.941 0.877 . . . . 0.0 110.344 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.62 55.71 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.815 0.817 . . . . 0.0 109.388 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.49 136.23 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.56 0.695 . . . . 0.0 110.636 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 m -127.43 151.87 48.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.032 0.92 . . . . 0.0 109.865 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.25 85.65 38.29 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 122.649 2.232 . . . . 0.0 111.902 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.696 0.76 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.08 -150.28 5.65 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.98 141.24 49.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.589 -0.948 . . . . 0.0 109.579 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.9 p -81.71 118.33 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.06 -31.14 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.024 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.7 m -157.06 153.95 28.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.805 -1.184 . . . . 0.0 110.839 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' LEU . 38.8 t80 -160.28 -74.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.716 0.77 . . . . 0.0 108.953 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' TYR . 9.6 mt 57.8 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.782 0.801 . . . . 0.0 110.079 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.9 68.51 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.697 0.76 . . . . 0.0 109.152 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.87 -35.18 79.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.7 mtpt -93.6 -7.46 43.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 108.792 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 57.86 -4.09 0.05 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.313 0.578 . . . . 0.0 110.112 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.0 p90 -161.04 164.18 31.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.99 -129.48 1.03 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -143.15 154.76 44.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.54 133.77 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.549 0.69 . . . . 0.0 109.23 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -90.39 97.15 11.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.759 0.79 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.11 163.04 42.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 40.5 p-10 -66.13 -34.8 78.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.789 -0.83 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 54.6 t0 -83.6 2.7 36.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.088 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.58 14.9 72.33 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 97.4 mt-10 -91.85 123.16 35.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.484 -1.009 . . . . 0.0 109.728 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 58' ' ' LEU . 88.5 p -76.78 150.37 36.19 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.585 0.707 . . . . 0.0 110.339 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.7 m-85 -138.12 137.6 37.86 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.352 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -77.81 139.94 39.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.666 -0.646 . . . . 0.0 110.019 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.1 tt -114.97 118.53 33.69 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.54 0.686 . . . . 0.0 109.475 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.627 ' N ' HD23 ' A' ' 27' ' ' LEU . 31.0 t-80 -126.05 137.89 53.67 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 6.2 p90 -59.76 -28.51 67.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.586 0.707 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -63.73 -26.27 68.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 109.397 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -79.34 -0.43 32.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.5 131.22 35.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.071 -1.018 . . . . 0.0 109.573 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LYS . 96.9 m-20 -131.41 98.85 4.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -46.3 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.673 0.749 . . . . 0.0 109.649 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 34' ' ' ASP . 25.8 mtpp -64.5 -35.79 82.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 109.833 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -73.43 -2.35 22.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.0 109.55 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.17 -32.25 73.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.501 -0.75 . . . . 0.0 109.388 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.02 -8.7 81.86 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -103.39 14.44 31.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.302 -1.117 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.05 151.71 44.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 110.082 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.43 133.26 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.779 0.8 . . . . 0.0 109.792 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -101.07 130.81 47.15 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.931 0.872 . . . . 0.0 111.075 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 91.71 -18.12 54.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -93.91 -177.25 4.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.023 -1.281 . . . . 0.0 111.816 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.74 140.53 40.83 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.715 0.769 . . . . 0.0 110.367 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.25 131.04 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -90.09 127.0 35.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.492 -0.755 . . . . 0.0 109.742 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.66 152.72 42.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.672 -0.643 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.72 152.89 38.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.41 143.42 93.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.323 2.015 . . . . 0.0 112.281 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.448 -0.782 . . . . 0.0 109.23 179.733 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 24' ' ' SER . 68.9 mt . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.569 0.7 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.51 30.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.477 -0.764 . . . . 0.0 109.2 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.71 138.3 46.28 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 110.01 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 87.5 tttt -132.85 138.61 47.1 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.476 0.655 . . . . 0.0 109.358 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.2 61.15 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.687 0.756 . . . . 0.0 109.697 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.18 133.08 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.528 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 p -139.1 153.09 47.97 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.834 0.826 . . . . 0.0 109.828 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -87.67 135.91 33.47 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.747 -0.596 . . . . 0.0 109.472 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.356 2.037 . . . . 0.0 111.44 179.141 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.261 0.553 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.6 -149.19 5.6 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.67 142.31 50.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.922 . . . . 0.0 109.687 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -82.15 107.03 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 7' ' ' SER . 10.6 p -76.48 -37.28 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 109.867 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.419 ' N ' HG13 ' A' ' 6' ' ' VAL . 70.5 m -148.23 146.93 28.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.041 -1.037 . . . . 0.0 110.474 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -158.27 105.34 1.9 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 9' ' ' LEU . 6.5 mp -108.9 111.97 23.96 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.51 -29.56 70.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.549 -0.72 . . . . 0.0 109.581 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.76 84.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' TYR . 55.5 mtpt -92.67 -3.7 54.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt 55.19 6.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.742 -0.599 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' LYS . 45.2 m-85 -130.16 154.14 47.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.639 -0.663 . . . . 0.0 109.736 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.73 -170.15 26.05 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.97 149.87 47.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.412 -1.052 . . . . 0.0 109.761 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.01 133.92 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -85.48 108.05 17.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.846 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.21 158.7 53.17 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 45.8 p-10 -65.84 -33.0 74.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.553 -0.969 . . . . 0.0 109.573 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 24.3 p30 -90.11 8.36 33.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 17.07 63.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.8 123.09 40.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -1.211 . . . . 0.0 109.753 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 p -79.41 149.17 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 110.39 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.15 132.94 45.11 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -82.77 144.47 30.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 0.0 109.707 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.2 tt -113.18 122.96 49.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.65 ' N ' HD23 ' A' ' 27' ' ' LEU . 49.4 t-80 -138.81 168.04 20.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.717 . . . . 0.0 109.387 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 14.1 m-85 -65.36 -39.67 92.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.781 . . . . 0.0 109.523 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -61.4 -18.17 57.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.325 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.4 -9.3 48.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.305 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 63' ' ' ILE . 97.0 mt -99.65 107.12 19.15 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.35 -0.844 . . . . 0.0 109.504 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.526 ' N ' HD22 ' A' ' 33' ' ' LEU . 3.9 mm? -64.76 -41.94 95.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.482 -0.761 . . . . 0.0 109.165 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -101.28 109.34 21.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.597 -0.689 . . . . 0.0 109.29 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -63.75 -32.64 74.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.184 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.1 -34.57 76.55 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.02 -7.03 31.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 0.0 108.865 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.18 -42.23 90.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.695 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.85 84.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -95.99 -1.04 49.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.271 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.58 144.68 56.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.623 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.538 ' O ' HG13 ' A' ' 42' ' ' VAL . 14.3 p -114.44 121.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.647 0.737 . . . . 0.0 109.623 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -95.2 143.04 26.94 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.934 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 25.35 50.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 t -152.83 -167.0 2.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.725 -1.456 . . . . 0.0 110.981 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.63 144.13 30.5 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.424 0.63 . . . . 0.0 110.768 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.57 161.26 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -124.38 136.22 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.457 -0.777 . . . . 0.0 109.837 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.34 155.23 42.47 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.772 . . . . 0.0 109.007 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.12 155.02 71.76 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.922 2.415 . . . . 0.0 112.108 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.557 HG21 ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.456 -0.778 . . . . 0.0 108.924 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.813 ' N ' HD22 ' A' ' 58' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.42 0.628 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 52' ' ' THR . . . -149.87 141.99 24.03 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.34 149.05 30.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.671 -0.643 . . . . 0.0 109.85 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -145.06 128.5 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.837 . . . . 0.0 109.167 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 56.24 61.16 2.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.42 -0.8 . . . . 0.0 109.239 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.43 HD12 HD21 ' A' ' 32' ' ' LEU . 96.4 mt -72.68 139.49 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.632 -0.667 . . . . 0.0 109.596 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 p -136.22 162.19 33.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.722 . . . . 0.0 109.852 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 80.49 47.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 N--CA 1.494 1.501 0 C-N-CA 123.178 2.585 . . . . 0.0 111.493 -179.576 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.519 0.676 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.66 6.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -132.82 139.56 47.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.552 -0.97 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.4 p -82.93 121.32 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.18 -32.98 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 t -154.38 144.88 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.916 -1.115 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.471 ' CE2' HD12 ' A' ' 41' ' ' LEU . 40.2 t80 -158.73 96.53 1.38 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -100.77 124.55 46.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.167 -0.958 . . . . 0.0 109.378 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.61 -35.79 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.696 0.76 . . . . 0.0 109.268 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.13 -30.06 70.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 14' ' ' TYR . 58.1 mttp -94.35 -7.03 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.015 . . . . 0.0 108.926 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 58.83 -3.94 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.565 -0.71 . . . . 0.0 109.846 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 12' ' ' LYS . 28.0 p90 -151.64 161.23 43.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.042 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 -133.59 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -141.25 157.83 44.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 109.775 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.3 mt -136.26 154.91 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.415 -0.803 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 17' ' ' ILE . 58.0 tt0 -109.79 106.56 16.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.764 0.792 . . . . 0.0 109.146 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.43 161.4 50.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -1.01 . . . . 0.0 109.338 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 30.3 p-10 -89.9 9.99 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.448 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 16.62 65.08 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.49 114.6 26.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -1.164 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -74.86 146.73 41.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 110.363 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -122.81 139.55 53.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.55 -0.718 . . . . 0.0 109.248 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.24 131.08 36.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.554 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.5 tt -104.9 123.41 47.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.088 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.622 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.8 t60 -134.36 153.12 52.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.698 . . . . 0.0 109.412 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.29 -35.57 81.28 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.783 0.801 . . . . 0.0 108.894 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.5 p -61.28 -21.09 63.61 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.446 -0.784 . . . . 0.0 109.62 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.66 -3.89 59.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.068 -1.02 . . . . 0.0 109.645 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.5 126.0 39.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 0.0 109.891 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -63.14 -41.31 99.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' LYS . 93.9 m-20 -127.17 89.72 3.02 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.84 -15.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 109.555 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' ASP . 44.0 mmtm -66.2 -34.96 79.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.163 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 36.3 p30 -73.66 -3.0 25.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.42 -36.09 82.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.39 -12.56 81.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -95.38 6.12 49.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -1.179 . . . . 0.0 109.304 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.471 HD12 ' CE2' ' A' ' 8' ' ' TYR . 94.8 mt -68.94 156.44 38.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.083 -1.01 . . . . 0.0 109.953 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.89 128.76 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.669 0.747 . . . . 0.0 109.663 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -98.76 138.16 36.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.421 -0.8 . . . . 0.0 110.874 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.6 24.91 61.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -141.63 -174.4 4.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 110.744 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtp -79.55 149.36 31.45 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.665 0.745 . . . . 0.0 110.557 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.86 164.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -127.62 133.09 49.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.54 163.51 38.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.367 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.75 152.05 38.84 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.241 -0.912 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.04 150.18 88.91 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.623 2.215 . . . . 0.0 112.734 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.817 0.818 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.21 170.72 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.948 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -101.98 -46.22 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.408 -0.808 . . . . 0.0 108.891 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ALA . 88.3 tttt 59.12 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.944 0.878 . . . . 0.0 110.903 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.14 87.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 0.0 109.833 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.2 mt -103.36 137.37 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.505 -0.747 . . . . 0.0 109.697 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 p -134.64 160.16 38.98 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.859 0.838 . . . . 0.0 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.23 81.79 22.1 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 122.755 2.303 . . . . 0.0 111.277 -179.635 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.435 0.636 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.29 -145.86 4.3 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.61 142.13 49.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -1.004 . . . . 0.0 109.751 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.4 p -81.52 112.04 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -70.35 -37.39 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.391 -0.818 . . . . 0.0 109.781 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 t -165.8 156.61 13.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' HD13 ' A' ' 27' ' ' LEU . 73.9 t80 -153.87 107.47 2.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.32 124.57 52.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.508 -0.745 . . . . 0.0 109.639 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.47 77.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.348 0.594 . . . . 0.0 109.9 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.4 73.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 109.96 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' TYR . 13.7 mptt -87.68 6.67 33.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt 64.22 -17.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.2 p90 -160.72 165.21 30.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.043 -1.035 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.32 -136.15 3.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.9 152.53 51.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.993 . . . . 0.0 109.93 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.01 137.57 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -92.55 100.73 13.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.09 174.08 44.4 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -63.52 -39.6 94.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.45 -1.029 . . . . 0.0 109.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -80.94 -0.61 40.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.65 11.75 79.15 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 128.22 34.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.239 . . . . 0.0 109.683 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.4 p -74.22 148.54 41.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.807 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.35 136.81 43.68 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -79.64 137.72 37.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.719 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 27' ' ' LEU . 2.0 tt -109.71 89.37 2.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -96.04 165.11 12.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 0.0 110.264 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.0 -40.59 96.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 t -61.77 -18.37 59.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.178 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.29 -5.34 59.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.4 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.66 125.41 47.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.57 -41.37 98.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -130.75 114.47 15.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.644 -0.66 . . . . 0.0 109.246 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -64.19 -11.68 33.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.351 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.07 -38.65 91.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.52 -5.4 23.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.29 -39.72 76.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.4 -9.19 87.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -96.35 -0.64 49.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.197 -1.178 . . . . 0.0 109.087 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.9 146.79 54.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.1 p -115.06 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.835 0.826 . . . . 0.0 109.555 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.35 140.73 29.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 110.661 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.21 50.18 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 t -147.46 -164.99 2.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.939 -1.33 . . . . 0.0 110.588 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.2 mtp -82.33 140.28 33.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.724 -0.61 . . . . 0.0 110.372 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.59 135.72 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.706 . . . . 0.0 109.256 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -94.31 128.95 41.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.669 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -144.23 155.85 44.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.73 110.64 59.32 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.531 -0.731 . . . . 0.0 109.258 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.49 146.9 24.21 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.334 2.023 . . . . 0.0 112.559 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.672 -0.643 . . . . 0.0 109.304 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.593 0.711 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.18 150.55 28.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.212 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 151.31 22.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 109.898 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -141.43 133.96 28.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.21 66.84 1.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.682 0.753 . . . . 0.0 109.886 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.81 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.2 p -131.13 148.74 52.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.453 -0.779 . . . . 0.0 109.816 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.85 145.13 29.02 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.496 1.622 0 C-N-CA 122.421 2.08 . . . . 0.0 112.041 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 121.639 0.733 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.61 -167.1 22.53 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -132.05 137.36 47.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.696 0.76 . . . . 0.0 110.018 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.3 p -76.48 122.11 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.652 0.739 . . . . 0.0 110.1 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.46 -34.83 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -156.32 160.58 39.84 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.92 0.867 . . . . 0.0 110.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -162.99 93.9 0.82 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.401 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 9' ' ' LEU . 10.5 mp -102.01 113.57 26.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.905 0.86 . . . . 0.0 108.822 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.0 -13.97 59.89 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.25 -65.94 0.45 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 109.824 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.18 17.13 14.79 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 56.7 57.83 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.688 0.756 . . . . 0.0 109.782 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' OH ' HD22 ' A' ' 9' ' ' LEU . 2.9 p90 -151.99 166.11 32.56 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.85 0.833 . . . . 0.0 110.144 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.96 174.08 45.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -133.6 150.7 51.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.765 -0.844 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.98 133.07 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.801 0.81 . . . . 0.0 109.842 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -92.58 115.09 27.79 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.867 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.66 158.33 50.05 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.3 p-10 -66.88 -23.56 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.939 -0.742 . . . . 0.0 110.119 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 82.7 m-20 -89.95 5.27 47.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 109.243 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.68 15.58 65.47 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.74 120.26 39.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.714 -0.874 . . . . 0.0 109.922 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -78.37 155.03 30.25 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 109.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.16 135.26 35.51 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.896 0.855 . . . . 0.0 110.136 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -75.59 142.84 42.62 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.728 0.775 . . . . 0.0 109.849 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.2 tt -107.98 132.06 53.91 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.746 0.784 . . . . 0.0 109.749 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 29' ' ' PHE . 2.4 t60 -134.3 146.04 49.64 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.984 0.897 . . . . 0.0 110.102 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 4.1 m-85 -62.16 -42.16 98.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 t -62.87 -18.52 63.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 2.7 mp0 -88.99 -0.52 57.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.0 109.218 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 34' ' ' ASP . 75.5 mt -90.22 -3.08 58.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.4 mt 59.27 -70.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 32' ' ' LEU . 43.2 t0 -110.05 105.71 14.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -56.69 -12.22 1.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.821 -0.549 . . . . 0.0 109.533 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.61 -36.55 84.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.0 109.979 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -77.08 -5.54 49.32 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.421 -0.799 . . . . 0.0 109.072 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 79.0 tt0 -57.37 -38.29 73.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.778 -0.576 . . . . 0.0 109.575 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.07 -8.42 86.55 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.11 0.05 50.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.284 -1.127 . . . . 0.0 109.003 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.85 152.01 46.43 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.615 0.721 . . . . 0.0 110.108 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.94 129.92 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.114 0.959 . . . . 0.0 109.722 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -95.78 138.34 33.57 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.713 0.768 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 81.21 25.29 55.41 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 t -140.01 172.59 12.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.154 -1.204 . . . . 0.0 110.707 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.1 mtt -76.3 141.56 41.58 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.938 0.875 . . . . 0.0 109.999 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.19 161.79 39.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.499 0.666 . . . . 0.0 109.682 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -122.07 129.5 52.45 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.921 0.867 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -151.39 158.98 44.44 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.827 0.822 . . . . 0.0 109.797 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.49 143.76 26.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.1 141.78 58.9 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.412 2.074 . . . . 0.0 112.123 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.756 -0.59 . . . . 0.0 109.708 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 121.777 0.799 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.39 148.68 29.77 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.739 0.78 . . . . 0.0 109.983 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.41 133.8 49.58 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.643 0.735 . . . . 0.0 109.706 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -118.29 143.84 46.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.96 0.886 . . . . 0.0 110.409 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.59 62.42 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.739 0.781 . . . . 0.0 109.884 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.79 137.09 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.576 0.703 . . . . 0.0 109.8 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.9 p -133.05 160.23 37.77 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.999 0.904 . . . . 0.0 110.107 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.11 98.33 38.7 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 C-N-CA 122.612 2.208 . . . . 0.0 111.604 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.295 0.569 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.68 -172.98 32.81 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 44' ' ' GLY . 62.3 tttm -142.99 128.31 18.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -1.088 . . . . 0.0 109.224 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.5 p -74.68 130.52 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.937 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.31 -36.4 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 p -158.48 161.97 37.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.961 -1.087 . . . . 0.0 110.556 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -165.75 93.98 0.57 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 9' ' ' LEU . 11.2 mp -101.21 122.0 42.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -77.07 -14.31 59.83 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.661 -0.65 . . . . 0.0 109.382 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.17 -67.99 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.739 -0.601 . . . . 0.0 110.593 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.93 19.26 15.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.441 -0.787 . . . . 0.0 109.072 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 56.3 66.19 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.83 170.66 21.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.229 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.64 166.79 38.78 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.65 150.89 52.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.619 -0.93 . . . . 0.0 109.282 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 27' ' ' LEU . 96.6 mt -133.96 147.81 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -94.95 117.15 29.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.463 -0.773 . . . . 0.0 109.576 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 159.46 52.69 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.72 -35.53 81.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.387 -1.066 . . . . 0.0 109.603 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -80.64 -0.75 39.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.212 -0.93 . . . . 0.0 109.485 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -5.22 63.13 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 25' ' ' TYR . 20.0 pt-20 -80.24 133.81 36.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.124 -1.221 . . . . 0.0 110.364 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.6 p -83.41 162.77 20.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 23' ' ' GLU . 62.4 m-85 -134.87 146.57 49.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.79 125.41 34.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.253 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.4 tt -103.39 122.23 44.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.815 . . . . 0.0 108.927 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.6 t-80 -135.82 166.79 22.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 11.3 m-85 -62.13 -40.04 94.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HG ' ' CE1' ' A' ' 28' ' ' HIS . 1.1 m -60.99 -21.5 63.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.453 -0.78 . . . . 0.0 109.991 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.17 -6.76 54.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.26 107.13 18.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.534 ' N ' HD22 ' A' ' 33' ' ' LEU . 3.8 mm? -64.04 -41.38 97.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -113.69 97.47 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.59 -27.01 68.65 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.831 . . . . 0.0 109.234 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.86 -27.79 66.97 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.0 -9.35 58.64 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.456 -0.777 . . . . 0.0 109.264 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -64.61 -35.42 80.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 110.01 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.42 0.97 38.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -149.92 58.08 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -1.205 . . . . 0.0 108.982 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mt -81.49 -165.95 1.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -120.84 159.84 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.749 0.785 . . . . 0.0 109.714 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.4 93.65 2.18 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 98.63 -13.85 62.3 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.6 m -86.49 -177.66 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.409 . . . . 0.0 111.021 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.06 145.95 29.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.568 -0.708 . . . . 0.0 110.434 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.542 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -133.29 164.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -135.17 135.33 40.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.374 -0.829 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.41 163.7 38.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.56 153.06 38.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.96 139.36 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.953 1.769 . . . . 0.0 112.874 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.276 0.56 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.73 151.38 21.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.32 119.43 39.46 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 32.9 ttpt -115.79 147.81 40.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.568 -0.708 . . . . 0.0 110.062 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.52 48.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.392 0.615 . . . . 0.0 109.432 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.43 135.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.808 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.9 m -126.92 149.56 49.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 109.275 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.59 97.35 36.41 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 N--CA 1.49 1.307 0 C-N-CA 122.606 2.204 . . . . 0.0 112.483 -179.606 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.212 0.53 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.34 175.64 20.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.5 145.61 47.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.87 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.2 p -88.43 112.46 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 7' ' ' SER . 7.5 p -70.77 -41.59 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.535 -0.728 . . . . 0.0 109.745 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 6' ' ' VAL . 31.1 p -160.33 160.62 32.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.573 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.488 ' C ' HD12 ' A' ' 9' ' ' LEU . 40.5 t80 -156.84 111.27 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.68 0.752 . . . . 0.0 109.61 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 8' ' ' TYR . 11.1 mp -106.83 102.4 11.77 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.2 -23.86 65.79 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.09 96.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.026 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.4 mtmt -97.23 4.24 51.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 59.1 2.95 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.308 0.575 . . . . 0.0 110.12 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' LYS . 62.0 m-85 -118.89 152.3 36.54 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.0 109.895 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.97 -168.9 21.67 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -137.51 149.71 46.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.754 -0.851 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.1 138.49 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.487 0.66 . . . . 0.0 109.527 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -99.46 105.25 17.16 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.761 0.791 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.44 160.66 51.22 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 43.0 p-10 -66.59 -33.37 75.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.649 -0.912 . . . . 0.0 109.712 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 84.7 m-20 -87.99 6.46 35.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.774 -0.579 . . . . 0.0 109.496 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.84 16.95 64.39 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.5 mt-10 -93.68 118.54 31.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.99 . . . . 0.0 109.673 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 p -77.29 153.22 34.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.798 0.809 . . . . 0.0 110.06 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 98.0 m-85 -141.47 134.97 29.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.603 0.716 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -79.35 140.56 37.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.699 0.761 . . . . 0.0 110.108 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 27' ' ' LEU . 4.4 tt -112.61 115.0 27.9 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.756 0.788 . . . . 0.0 109.254 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' N ' HD23 ' A' ' 27' ' ' LEU . 52.3 t-80 -141.25 167.32 22.45 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.841 0.829 . . . . 0.0 110.303 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 13.5 m-85 -61.65 -35.41 77.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.844 -0.535 . . . . 0.0 110.146 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.8 p -62.99 -20.27 65.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.619 -0.675 . . . . 0.0 109.863 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -93.61 -11.02 32.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.11 116.03 28.35 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.372 -0.83 . . . . 0.0 109.569 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.519 ' N ' HD22 ' A' ' 33' ' ' LEU . 3.8 mm? -64.52 -42.14 95.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.537 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -117.65 134.76 54.55 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.738 0.78 . . . . 0.0 109.589 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 mptm? -77.45 -12.42 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 19.2 ptmt -65.4 -41.96 93.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.717 -0.615 . . . . 0.0 110.313 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 98.0 m-20 -78.33 -8.31 58.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 109.606 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.36 -36.81 79.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 109.108 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.6 -9.75 80.76 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 68.3 mttm -98.46 -0.76 42.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.175 -1.191 . . . . 0.0 109.296 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.9 145.74 15.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.739 . . . . 0.0 110.184 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -124.18 125.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 122.018 0.913 . . . . 0.0 109.47 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' VAL . 7.4 tmtm? -95.69 137.24 35.04 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.908 0.861 . . . . 0.0 110.854 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 25.93 38.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 t -142.06 -164.95 1.91 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.026 -1.279 . . . . 0.0 111.343 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.6 mtp -88.49 139.94 29.97 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.965 0.888 . . . . 0.0 110.961 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.24 159.8 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.368 0.604 . . . . 0.0 109.503 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -124.05 132.32 53.66 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 110.07 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -154.99 161.16 41.46 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.617 0.722 . . . . 0.0 109.801 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -102.73 150.69 37.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.47 159.8 50.38 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.487 2.125 . . . . 0.0 112.542 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.689 -0.632 . . . . 0.0 109.474 179.826 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.753 0.787 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.3 156.38 35.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.703 0.763 . . . . 0.0 109.728 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.31 87.86 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -89.75 148.4 23.27 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.833 0.825 . . . . 0.0 110.294 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.86 58.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.617 0.723 . . . . 0.0 109.616 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.45 129.37 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.917 0.865 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.1 m -135.79 126.38 27.05 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.645 0.735 . . . . 0.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -89.26 132.35 37.84 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo . . . . . 0 N--CA 1.49 1.265 0 C-N-CA 122.412 2.075 . . . . 0.0 111.319 179.431 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.28 -166.42 28.28 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -135.13 138.25 43.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.876 -0.779 . . . . 0.0 110.313 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 44' ' ' GLY . 8.0 p -74.12 126.19 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.359 0.599 . . . . 0.0 109.409 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 7' ' ' SER . 9.2 p -94.37 -42.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.493 ' N ' HG13 ' A' ' 6' ' ' VAL . 66.1 m -152.85 153.75 33.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.992 0.901 . . . . 0.0 110.524 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -161.02 117.18 2.23 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.681 0.753 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.87 110.34 17.07 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 109.231 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.64 -34.49 77.07 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.529 0.681 . . . . 0.0 109.401 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -34.33 75.53 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' TYR . 28.6 mmtp -95.7 -1.58 49.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? 57.67 6.54 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.452 0.644 . . . . 0.0 109.57 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' LYS . 47.6 m-85 -123.02 160.13 26.95 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.911 0.863 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.91 -170.16 28.43 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.03 148.34 33.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.791 -0.829 . . . . 0.0 109.604 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.69 132.89 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.74 0.781 . . . . 0.0 109.903 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -97.07 113.63 25.2 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.921 0.867 . . . . 0.0 110.078 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.88 161.47 52.3 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -64.59 -35.8 82.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.062 -0.669 . . . . 0.0 109.643 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -83.52 9.5 11.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.74 65.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 75.6 mm-40 -95.95 115.22 27.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.703 -0.881 . . . . 0.0 110.049 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.0 t -77.16 146.95 36.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.681 0.753 . . . . 0.0 110.04 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 99.0 m-85 -136.0 136.55 40.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.782 0.801 . . . . 0.0 109.529 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 63.7 m-85 -81.35 143.07 32.46 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.829 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.611 ' C ' HD23 ' A' ' 27' ' ' LEU . 6.5 tt -111.62 121.87 46.31 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.154 0.978 . . . . 0.0 109.548 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.589 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.3 t60 -139.0 167.78 21.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.959 0.885 . . . . 0.0 109.602 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 6.2 m-85 -62.05 -38.08 87.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.405 0.621 . . . . 0.0 109.413 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.8 m -61.59 -20.85 63.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 26' ' ' PHE . 94.7 mt-10 -90.84 -11.68 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.842 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.6 mt -96.12 106.08 18.22 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 33' ' ' LEU . 4.0 mm? -64.88 -42.22 94.99 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.61 0.719 . . . . 0.0 109.515 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -110.82 90.1 3.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -49.0 -19.5 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -66.16 -35.9 81.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.48 -12.36 61.59 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.341 0.591 . . . . 0.0 109.496 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 78.4 tt0 -66.23 -34.89 79.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.414 0.626 . . . . 0.0 109.591 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.09 -7.76 84.84 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -108.18 15.45 24.16 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.944 . . . . 0.0 109.604 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.59 151.36 46.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.815 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.56 133.3 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.122 0.963 . . . . 0.0 109.607 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -100.23 133.51 44.53 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.33 -24.16 26.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -90.7 -178.87 5.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.979 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.81 148.39 27.81 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.793 0.806 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 160.07 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.474 0.654 . . . . 0.0 109.286 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -121.23 125.28 46.72 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.005 0.907 . . . . 0.0 110.312 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -138.36 150.96 47.09 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.333 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.49 131.12 22.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -48.45 141.68 18.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.739 2.292 . . . . 0.0 113.047 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.619 0.723 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.71 153.7 21.38 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.76 0.79 . . . . 0.0 109.834 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.6 151.09 21.05 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.683 0.754 . . . . 0.0 109.866 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.33 138.71 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.857 0.837 . . . . 0.0 110.039 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.69 66.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.53 0.681 . . . . 0.0 110.173 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.9 130.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.618 0.723 . . . . 0.0 109.654 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -131.36 164.81 24.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.803 0.811 . . . . 0.0 109.78 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.73 79.63 23.45 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 C-N-CA 122.574 2.183 . . . . 0.0 111.416 -179.856 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.219 0.533 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.3 -167.56 31.74 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -127.33 143.2 51.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.662 -0.905 . . . . 0.0 109.524 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 44' ' ' GLY . 0.8 OUTLIER -74.53 108.42 6.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.505 -0.747 . . . . 0.0 109.677 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 7' ' ' SER . 7.2 p -69.38 -39.26 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.635 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.411 ' N ' HG13 ' A' ' 6' ' ' VAL . 23.1 p -159.85 165.2 32.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.707 -1.246 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -156.7 114.23 3.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 mp -114.16 111.41 21.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.542 -0.724 . . . . 0.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.5 78.18 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.738 -0.601 . . . . 0.0 109.757 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.0 mttt -92.54 -4.44 53.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? 54.21 6.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.9 m-85 -132.89 123.52 26.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -106.62 -164.94 22.58 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -141.73 145.15 34.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -1.036 . . . . 0.0 109.122 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.8 136.83 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.795 -0.566 . . . . 0.0 109.825 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -100.49 110.78 22.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 109.181 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.73 155.38 53.45 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.026 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 49.1 p-10 -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.521 -0.988 . . . . 0.0 109.739 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 86.5 m-20 -86.49 10.63 14.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 108.813 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.21 15.44 71.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.65 109.53 21.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.968 -1.313 . . . . 0.0 109.489 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.0 t -73.98 142.48 45.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.1 135.27 52.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 109.662 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -78.02 144.69 36.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 27' ' ' LEU . 6.2 tt -109.36 122.42 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.535 ' N ' HD23 ' A' ' 27' ' ' LEU . 5.8 m-70 -127.28 149.94 49.79 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.606 0.717 . . . . 0.0 109.867 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.5 -37.97 89.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 p -61.64 -25.84 67.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.35 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.84 -1.08 46.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.7 mt -93.85 120.47 34.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.949 -1.095 . . . . 0.0 110.347 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 3.5 mm? -64.43 -42.44 96.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.597 -0.689 . . . . 0.0 109.768 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -117.01 109.66 17.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -65.99 -15.14 62.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.118 -0.989 . . . . 0.0 108.771 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -65.22 -38.79 91.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.388 -0.82 . . . . 0.0 109.255 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.89 -10.83 60.38 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.54 -33.75 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.001 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.9 -20.69 72.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 4.8 mptp? -90.87 -88.92 0.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.297 -1.12 . . . . 0.0 109.415 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' LYS . 53.2 mt 44.81 -175.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 0.0 109.53 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 43' ' ' LYS . 8.0 p -146.78 159.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 42' ' ' VAL . 87.4 tttt -122.21 124.85 44.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 110.5 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.637 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 82.12 -15.47 27.63 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.477 -0.765 . . . . 0.0 111.536 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.8 t -86.55 178.75 6.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.589 . . . . 0.0 110.868 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.1 mtm -79.97 145.74 32.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -0.751 . . . . 0.0 110.838 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.56 161.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -126.76 131.15 51.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.501 -0.749 . . . . 0.0 109.598 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -146.81 154.02 40.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.307 -0.871 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -97.12 164.29 18.14 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.079 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.62 143.26 95.29 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.998 1.798 . . . . 0.0 112.589 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.198 0.523 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.23 156.22 36.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.577 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.61 141.56 38.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.641 -0.662 . . . . 0.0 109.522 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.95 152.07 49.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.468 -0.77 . . . . 0.0 109.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.16 49.16 14.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.459 -0.776 . . . . 0.0 109.217 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.71 135.72 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.123 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -134.63 150.98 50.73 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.645 0.736 . . . . 0.0 110.139 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -112.95 95.14 32.92 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 C-N-CA 121.975 1.783 . . . . 0.0 111.459 -179.577 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.457 0.646 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.31 20.47 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -131.39 143.75 50.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.857 . . . . 0.0 109.953 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.4 p -80.33 113.53 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.668 0.747 . . . . 0.0 110.338 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.06 -35.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.37 0.605 . . . . 0.0 109.465 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 t -171.78 151.15 2.78 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.235 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -105.66 -33.73 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.9 0.857 . . . . 0.0 109.032 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.0 mt 45.93 75.22 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.62 0.724 . . . . 0.0 109.444 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.76 68.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.837 0.827 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.74 80.99 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.633 0.73 . . . . 0.0 109.606 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' TYR . 64.4 mttp -94.07 0.48 55.94 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 55.44 5.66 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.204 0.526 . . . . 0.0 109.945 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' LYS . 49.5 m-85 -123.14 125.07 44.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.14 164.77 19.41 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -132.2 142.16 49.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.748 -0.854 . . . . 0.0 109.89 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.15 136.51 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.51 0.672 . . . . 0.0 109.463 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -93.6 104.0 16.15 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.761 0.791 . . . . 0.0 109.674 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.82 162.86 53.82 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.19 -38.31 90.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.884 . . . . 0.0 109.691 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.25 3.98 25.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.322 -0.861 . . . . 0.0 109.084 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.26 19.72 61.97 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.19 118.44 27.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -1.17 . . . . 0.0 109.927 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.2 p -78.85 157.14 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.532 0.682 . . . . 0.0 110.196 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.57 139.77 42.41 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.568 0.699 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.73 124.96 40.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.771 -0.581 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.604 ' C ' HD23 ' A' ' 27' ' ' LEU . 5.5 tt -103.69 117.39 34.27 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.566 0.698 . . . . 0.0 109.194 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.583 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.6 t60 -117.49 163.08 16.94 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.732 . . . . 0.0 109.374 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.498 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 17.3 m-85 -62.86 -36.83 84.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.743 0.782 . . . . 0.0 108.979 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -63.03 -18.33 63.21 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.406 0.622 . . . . 0.0 109.525 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.87 -6.89 53.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.963 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.54 117.51 30.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.114 -0.991 . . . . 0.0 109.547 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.482 ' N ' ' CD2' ' A' ' 33' ' ' LEU . 3.6 mm? -63.66 -41.23 98.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -118.86 114.52 22.74 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.417 0.627 . . . . 0.0 109.397 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.32 -36.12 81.2 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.733 . . . . 0.0 109.155 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.05 -33.8 75.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 109.862 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -68.97 -4.34 16.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 109.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 81.6 tt0 -63.3 -37.56 87.72 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.95 89.84 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -96.65 3.75 52.31 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.33 -1.1 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 147.79 50.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 42' ' ' VAL . 14.6 p -108.67 113.39 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.96 0.886 . . . . 0.0 109.406 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -95.38 141.59 28.77 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.491 0.662 . . . . 0.0 110.567 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 24.95 51.46 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -148.1 -165.03 2.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.95 -1.324 . . . . 0.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.88 146.86 28.63 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.502 0.668 . . . . 0.0 110.638 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.18 158.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.688 -0.632 . . . . 0.0 109.33 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.53 132.53 54.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.582 0.706 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.17 158.26 40.08 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.681 0.753 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.27 150.38 37.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.66 156.98 59.91 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.474 2.116 . . . . 0.0 111.898 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 13.8 p . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.632 -0.667 . . . . 0.0 109.308 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 mt . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 121.763 0.792 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -159.73 174.27 14.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 110.016 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.34 41.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.875 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.58 148.35 50.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.88 55.49 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.86 0.838 . . . . 0.0 109.213 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -78.52 132.03 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.384 0.612 . . . . 0.0 110.122 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 m -107.26 124.57 49.96 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.802 0.811 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -93.57 113.28 59.85 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.317 2.011 . . . . 0.0 112.468 -179.872 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.604 0.716 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.82 -159.87 19.09 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -132.67 134.86 45.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.538 -0.978 . . . . 0.0 109.682 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.8 p -82.55 105.48 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.93 -36.42 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -150.36 144.57 25.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.936 -1.102 . . . . 0.0 109.857 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.447 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -125.14 -68.53 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.178 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt 57.93 109.46 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.975 0.893 . . . . 0.0 109.662 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.79 -23.3 27.27 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.904 0.859 . . . . 0.0 108.76 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.43 90.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 109.681 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.5 mttt -97.77 -3.27 39.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.095 -1.003 . . . . 0.0 108.549 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? 52.19 9.35 0.09 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.464 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 12' ' ' LYS . 58.1 m-85 -132.25 148.17 52.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.3 -159.83 10.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.09 155.53 47.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.3 -1.118 . . . . 0.0 109.547 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.69 135.07 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -101.11 118.57 37.25 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.861 0.838 . . . . 0.0 109.768 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.75 156.66 53.36 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 48.1 p-10 -67.27 -27.62 67.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.99 . . . . 0.0 109.549 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 33.1 p-10 -89.41 9.01 27.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.518 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.34 12.51 67.34 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.66 114.69 26.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.006 -1.291 . . . . 0.0 109.917 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 t -78.75 147.75 33.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.605 -0.684 . . . . 0.0 109.672 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.99 141.68 49.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.425 -0.797 . . . . 0.0 109.835 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.41 144.15 40.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.1 tt -114.16 122.28 46.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.792 0.806 . . . . 0.0 109.304 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 7.6 p-80 -139.16 160.51 39.62 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.96 -10.82 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.869 0.842 . . . . 0.0 109.082 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.3 m -67.19 -11.72 58.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 109.37 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -108.38 -23.29 11.95 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.63 128.33 36.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.871 -1.143 . . . . 0.0 109.884 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 64.3 t0 -132.03 129.57 40.24 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.909 0.861 . . . . 0.0 109.563 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 72.9 mmtt -63.92 -36.29 83.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.804 0.812 . . . . 0.0 109.28 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.61 -35.95 81.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.46 -0.775 . . . . 0.0 110.168 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.48 -6.16 2.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.948 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.41 -36.54 84.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.973 -1.079 . . . . 0.0 109.621 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.08 -7.1 81.37 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.59 0.05 52.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -1.189 . . . . 0.0 108.723 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 83.8 mt -69.39 158.68 34.63 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.4 -0.812 . . . . 0.0 109.795 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 5' ' ' VAL . 7.8 p -122.89 138.29 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.735 0.779 . . . . 0.0 109.745 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -107.29 129.98 54.82 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.94 25.21 46.08 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -140.29 173.29 11.66 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.03 -1.277 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.3 144.68 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.879 0.847 . . . . 0.0 111.157 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.74 164.93 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -116.65 129.56 56.22 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.51 163.08 38.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 109.391 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 62' ' ' ALA . 20.3 m-20 -104.59 111.37 65.2 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.39 -0.819 . . . . 0.0 109.469 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.35 137.93 30.7 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.309 2.006 . . . . 0.0 112.597 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.4 m . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.004 . . . . 0.0 109.449 179.642 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.626 0.727 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.21 144.93 43.09 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.091 -1.006 . . . . 0.0 110.237 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.83 99.1 8.87 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 124.994 2.331 . . . . 0.0 111.264 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.304 43.2 tptt -82.24 143.36 31.41 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.555 -2.566 . . . . 0.0 113.1 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . . . 42.14 66.79 0.67 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 122.369 1.08 . . . . 0.0 110.005 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -75.05 137.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -123.8 147.91 47.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.48 -0.763 . . . . 0.0 110.071 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -124.99 79.72 64.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 N--CA 1.494 1.532 0 C-N-CA 122.763 2.309 . . . . 0.0 111.579 -179.73 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.37 154.5 19.34 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.873 0.844 . . . . 0.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.24 -172.16 39.18 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.47 141.11 51.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.757 -0.849 . . . . 0.0 109.691 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.8 p -86.19 118.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.526 0.679 . . . . 0.0 109.341 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.02 -28.75 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.657 -0.652 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 t -155.96 153.07 28.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -157.02 112.72 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.598 0.713 . . . . 0.0 109.21 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.24 116.05 27.69 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.757 0.789 . . . . 0.0 109.434 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.09 76.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -37.98 85.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.596 -0.69 . . . . 0.0 109.844 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 14' ' ' TYR . 55.5 mtpt -95.88 11.07 35.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.877 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' LYS . 64.2 pttt 34.95 27.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.521 0.676 . . . . 0.0 110.341 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 12' ' ' LYS . 35.7 t80 -141.7 123.08 14.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.59 0.71 . . . . 0.0 109.347 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -114.4 -164.11 14.83 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -146.78 134.32 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.658 -0.907 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.408 HD11 HD21 ' A' ' 27' ' ' LEU . 96.6 mt -130.8 132.4 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.487 0.661 . . . . 0.0 109.271 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -100.51 116.96 33.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.84 161.56 53.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -65.08 -35.77 82.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.961 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -87.48 9.03 22.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.542 -0.724 . . . . 0.0 109.175 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.65 58.66 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -91.97 118.13 30.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -1.028 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.8 p -80.59 163.97 23.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.718 0.771 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -144.82 150.96 38.04 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.61 0.719 . . . . 0.0 109.69 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.56 143.44 28.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.567 0.698 . . . . 0.0 109.998 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' O ' ' ND1' ' A' ' 28' ' ' HIS . 66.7 mt -110.75 127.26 55.28 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.749 0.785 . . . . 0.0 109.892 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' A' ' 27' ' ' LEU . 10.0 m80 -140.73 159.42 42.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.765 0.793 . . . . 0.0 109.9 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -65.67 -35.17 80.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.1 t -62.33 -17.77 59.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -93.88 -18.56 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.507 -0.745 . . . . 0.0 109.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.0 141.04 32.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.594 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.76 152.82 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.686 0.755 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 70.7 mmtt -66.68 -39.42 88.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' GLU . 98.7 mttt -63.96 -39.38 94.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.481 0.658 . . . . 0.0 109.264 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -51.1 -9.46 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.547 -0.721 . . . . 0.0 109.405 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' LYS . 11.8 pt-20 -70.34 -36.57 74.32 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . -83.2 -8.87 84.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -94.29 0.29 55.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.966 . . . . 0.0 108.995 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.91 153.25 42.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.452 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 42' ' ' VAL . 6.5 p -113.91 120.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.045 0.926 . . . . 0.0 110.104 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -91.0 136.4 33.1 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.684 0.754 . . . . 0.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.08 26.44 40.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -149.22 -164.63 2.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 111.143 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 95.8 mtp -87.48 145.66 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.902 0.858 . . . . 0.0 110.871 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.41 161.1 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -118.91 124.76 47.88 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.864 0.84 . . . . 0.0 110.152 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -149.4 157.03 42.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.503 0.668 . . . . 0.0 109.326 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.26 150.58 38.55 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.72 -0.612 . . . . 0.0 109.365 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.86 152.81 76.86 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.701 2.267 . . . . 0.0 112.813 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.45 132.22 7.11 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' A' ' 54' ' ' THR . 56.1 Cg_endo -73.09 -71.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.362 2.041 . . . . 0.0 112.07 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.441 ' H ' ' HG2' ' A' ' 53' ' ' PRO . 6.1 p 58.38 149.29 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.978 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.39 -36.6 18.03 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.378 2.052 . . . . 0.0 111.768 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.43 -41.77 98.69 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.404 ' C ' HD22 ' A' ' 58' ' ' LEU . . . 123.28 -75.59 0.37 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 58' ' ' LEU . 3.9 mm? -95.66 128.03 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.879 . . . . 0.0 110.279 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.56 151.63 15.22 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.809 0.814 . . . . 0.0 109.876 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.37 159.98 14.81 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.471 0.653 . . . . 0.0 109.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -149.79 138.66 21.01 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.645 0.736 . . . . 0.0 110.273 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 58.05 68.6 0.82 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.584 0.707 . . . . 0.0 109.941 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mm -66.24 138.25 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.322 0.582 . . . . 0.0 109.507 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -132.37 141.97 49.12 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.095 0.95 . . . . 0.0 110.307 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -113.43 93.0 25.09 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.74 3.13 7.18 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.686 2.257 . . . . 0.0 111.951 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -75.07 154.23 38.01 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 58.0 mp0 -41.78 139.1 1.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.684 0.754 . . . . 0.0 110.227 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.95 -43.46 87.89 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.57 101.58 9.0 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.762 0.791 . . . . 0.0 109.187 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -68.69 -40.19 80.18 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -85.49 134.0 34.06 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.704 0.764 . . . . 0.0 110.167 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -113.96 147.23 38.94 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.752 0.787 . . . . 0.0 110.055 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.378 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -168.2 -164.22 0.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.788 . . . . 0.0 110.164 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.46 -168.11 36.09 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -130.58 133.8 46.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.735 -0.862 . . . . 0.0 109.816 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.1 p -79.68 111.83 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.752 0.786 . . . . 0.0 109.089 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -73.71 -33.5 38.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.637 -0.664 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -161.63 153.91 19.8 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.014 0.911 . . . . 0.0 110.738 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.454 ' C ' HD22 ' A' ' 9' ' ' LEU . 59.9 t80 -153.16 102.4 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -96.56 112.09 23.97 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.058 0.932 . . . . 0.0 109.505 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.97 79.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.619 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.49 85.53 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 14' ' ' TYR . 51.7 mtmt -94.05 3.09 55.81 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mttp 47.08 15.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.218 0.533 . . . . 0.0 110.322 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 33.6 t80 -144.96 159.35 43.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.004 0.907 . . . . 0.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -161.58 -152.55 6.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.83 154.1 48.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.89 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 150.03 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.56 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -112.4 116.38 30.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.792 0.806 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.62 160.99 47.76 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.01 -36.2 83.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.919 -0.754 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.76 9.32 19.31 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.61 7.44 81.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -87.41 119.31 27.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.682 -0.893 . . . . 0.0 109.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.5 m -75.47 153.1 37.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.533 0.682 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 58' ' ' LEU . 86.7 m-85 -135.29 132.56 37.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.807 0.813 . . . . 0.0 109.804 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' CE1' ' O ' ' A' ' 57' ' ' GLY . 16.5 m-85 -77.15 140.81 40.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.646 0.736 . . . . 0.0 110.426 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.3 tt -115.51 117.46 30.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.162 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.628 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.8 t-80 -139.46 166.6 24.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.995 0.902 . . . . 0.0 110.156 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 10.1 m-85 -62.36 -40.86 97.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.86 -0.525 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.6 t -60.25 -17.75 44.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.821 -0.549 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.79 -7.24 47.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 109.045 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.2 mt -88.0 125.3 34.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.768 0.794 . . . . 0.0 110.037 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.13 -41.8 97.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -126.65 131.15 51.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.81 0.814 . . . . 0.0 109.038 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -35.75 81.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.784 -0.572 . . . . 0.0 109.545 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -60.47 -36.46 78.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.538 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.58 -10.13 16.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.753 -0.592 . . . . 0.0 109.42 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -67.27 -38.61 85.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.0 -8.97 85.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -98.73 5.11 47.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.408 -1.054 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 156.1 26.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.32 130.3 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.175 0.988 . . . . 0.0 110.088 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.7 ttmt -98.02 135.94 38.99 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.802 0.81 . . . . 0.0 110.907 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.1 59.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -135.52 173.76 11.37 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.264 -1.139 . . . . 0.0 111.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.41 142.16 37.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.739 0.78 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.73 163.5 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -121.0 135.32 55.24 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.867 0.841 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.26 156.51 39.84 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.729 0.776 . . . . 0.0 110.016 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.82 156.63 37.07 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.802 -0.561 . . . . 0.0 109.551 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.94 148.99 64.25 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.43 2.087 . . . . 0.0 112.948 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -130.54 94.96 28.06 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -52.79 139.11 59.71 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.532 2.155 . . . . 0.0 113.016 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -178.01 145.27 0.53 Allowed Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.64 -33.93 43.33 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.68 2.253 . . . . 0.0 111.471 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -173.24 131.72 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.604 0.716 . . . . 0.0 109.888 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' ' CE1' ' A' ' 26' ' ' PHE . . . 137.94 -32.08 2.4 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 25' ' ' TYR . 2.8 mm? 59.18 146.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.651 -0.911 . . . . 0.0 110.578 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.47 157.26 14.73 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.761 0.791 . . . . 0.0 110.379 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.29 133.66 46.84 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.87 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -114.64 135.55 54.03 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.907 0.861 . . . . 0.0 110.146 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.24 66.74 1.12 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.583 0.706 . . . . 0.0 110.383 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.06 137.27 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.561 0.696 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 p -132.04 150.28 52.2 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.743 0.782 . . . . 0.0 110.122 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 82.86 36.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 3.68 7.41 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.701 2.267 . . . . 0.0 111.348 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.488 HD12 ' N ' ' A' ' 67' ' ' LEU . 10.9 mp -84.77 -3.04 58.42 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -72.35 -151.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.557 0.694 . . . . 0.0 110.078 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 59.15 73.43 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.682 0.753 . . . . 0.0 109.291 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -164.12 76.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.576 0.703 . . . . 0.0 109.474 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.526 ' C ' ' HD1' ' A' ' 71' ' ' HIS . 1.3 p80 -152.17 166.52 31.46 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.614 0.721 . . . . 0.0 110.01 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -166.1 119.14 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.713 0.768 . . . . 0.0 109.634 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -154.79 140.57 18.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.724 0.773 . . . . 0.0 110.141 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.186 179.684 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 27.4 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -117.23 134.7 54.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.761 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.56 4.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.77 146.38 52.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.583 -0.951 . . . . 0.0 110.123 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -75.71 113.39 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.54 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.81 -34.33 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -148.94 146.13 27.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.976 -1.077 . . . . 0.0 110.241 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -162.76 102.08 1.02 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.8 mt -115.65 114.14 24.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 109.17 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.27 66.4 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.67 54.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 60.3 pttt -97.14 1.17 49.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.22 -0.925 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 57.71 38.69 27.59 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.296 0.569 . . . . 0.0 109.997 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 59.0 m-85 -149.14 159.45 44.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.18 33.92 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.99 157.61 45.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.458 -1.025 . . . . 0.0 109.627 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.94 135.0 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.689 -0.632 . . . . 0.0 109.565 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -94.07 99.07 11.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.05 170.68 28.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.6 -35.42 80.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.601 -0.94 . . . . 0.0 109.012 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.9 1.21 40.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.011 -1.055 . . . . 0.0 108.887 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.29 24.15 57.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 98.0 mt-10 -89.13 114.14 25.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.14 -1.212 . . . . 0.0 109.718 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' LEU . 42.6 t -74.4 147.61 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.176 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 23' ' ' GLU . 96.3 m-85 -122.36 144.71 48.85 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.469 0.652 . . . . 0.0 109.533 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.9 -43.65 98.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 27' ' ' LEU . 2.2 tt 70.4 96.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.707 ' CG ' ' HG ' ' A' ' 30' ' ' SER . 3.9 t-80 -116.47 119.04 34.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.461 0.648 . . . . 0.0 109.637 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -57.09 -21.37 31.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.707 ' HG ' ' CG ' ' A' ' 28' ' ' HIS . 77.9 p -66.94 -19.29 65.7 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -88.3 3.83 48.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 mt -77.84 133.67 38.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.89 -42.59 99.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -121.32 120.4 34.99 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.4 0.619 . . . . 0.0 109.557 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.14 -36.24 82.95 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.77 -39.17 90.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.737 . . . . 0.0 109.596 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.63 -6.56 26.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.94 -37.36 84.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.177 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.39 88.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -91.93 -3.1 56.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -1.159 . . . . 0.0 109.175 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 169.22 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.516 -0.74 . . . . 0.0 110.348 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.26 143.42 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -110.0 130.0 55.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.532 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.595 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.13 -15.42 62.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -97.39 -175.05 3.1 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.216 -1.167 . . . . 0.0 110.799 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 96.2 mtp -80.05 148.33 31.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.57 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.69 151.13 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.252 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.82 125.57 45.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.725 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 1' ' ' MET . 54.3 p90 -141.85 147.74 37.67 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.06 152.5 42.52 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.689 -0.632 . . . . 0.0 109.311 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.89 139.5 62.44 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.334 2.023 . . . . 0.0 112.201 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.4 m -154.17 88.54 3.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.095 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.7 139.23 67.94 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.339 2.026 . . . . 0.0 112.454 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.9 156.53 35.7 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -18.5 65.37 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.509 2.14 . . . . 0.0 111.791 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.9 1.77 33.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.32 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.28 -86.6 0.42 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 24' ' ' SER . 96.6 mt -128.69 146.83 50.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -1.012 . . . . 0.0 110.203 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.44 153.95 39.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.23 144.83 43.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.686 -0.633 . . . . 0.0 109.494 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -128.59 143.98 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.48 0.657 . . . . 0.0 109.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.33 71.09 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.452 0.644 . . . . 0.0 110.127 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.46 129.49 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.43 -0.794 . . . . 0.0 108.886 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 m -131.06 155.52 46.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.507 -0.746 . . . . 0.0 110.011 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.86 112.41 58.03 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.4 1.97 8.74 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.255 1.97 . . . . 0.0 111.69 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.7 mp -74.68 137.32 42.07 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 67' ' ' LEU . 97.8 mt-10 54.49 166.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.68 0.752 . . . . 0.0 110.866 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -152.35 159.81 43.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.37 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -108.3 119.74 40.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.658 -0.651 . . . . 0.0 109.879 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -96.25 139.71 31.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.406 -0.809 . . . . 0.0 109.813 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -59.67 -40.51 88.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 110.198 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.61 127.52 53.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.728 -179.856 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' NE2' ' A' ' 48' ' ' HIS . 6.2 ptt? . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.808 0.813 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -90.42 0.75 57.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.61 -167.77 33.14 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.164 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -130.99 137.21 49.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.714 -0.874 . . . . 0.0 109.417 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.7 p -81.87 105.95 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.038 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 7' ' ' SER . 15.0 p -71.02 -38.82 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.492 0.663 . . . . 0.0 109.448 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.457 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.8 p -154.49 158.73 40.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -158.4 114.89 2.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.545 -0.722 . . . . 0.0 109.148 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 100.43 8.82 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.68 72.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.759 0.79 . . . . 0.0 109.339 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.81 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.69 . . . . 0.0 109.939 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.8 mtpt -94.29 4.23 54.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 108.969 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mttp 56.29 4.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.293 0.568 . . . . 0.0 109.555 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' LYS . 59.1 m-85 -130.8 154.2 48.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.659 0.742 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.02 -169.0 22.76 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.41 151.19 51.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.487 -1.008 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.7 mt -134.19 159.35 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.43 0.633 . . . . 0.0 109.378 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.497 ' N ' HG22 ' A' ' 17' ' ' ILE . 56.2 tt0 -113.05 107.87 16.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.675 0.75 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.5 161.9 53.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 47.3 p-10 -65.01 -33.9 77.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.955 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 93.3 m-20 -90.13 7.2 39.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 108.751 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.7 14.83 64.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 98.2 mt-10 -92.23 119.27 31.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -1.108 . . . . 0.0 109.686 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -78.41 152.67 32.09 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.696 0.76 . . . . 0.0 110.657 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.4 m-85 -138.76 135.35 34.6 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.552 0.691 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.82 144.29 35.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.662 -0.649 . . . . 0.0 110.245 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.5 tt -113.76 120.16 39.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.642 ' N ' HD23 ' A' ' 27' ' ' LEU . 80.8 t60 -136.1 171.72 14.06 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.685 0.755 . . . . 0.0 109.724 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 5.3 m-85 -61.4 -39.53 91.04 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.665 0.745 . . . . 0.0 109.551 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.453 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 79.2 p -59.62 -20.29 54.89 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.712 -0.617 . . . . 0.0 110.023 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.02 -9.52 36.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 0.0 109.426 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.83 124.02 38.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 109.79 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.37 -41.67 96.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 109.438 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -130.09 114.06 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.578 -0.702 . . . . 0.0 109.243 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -49.67 -27.53 4.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.01 -37.01 85.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.28 -7.0 20.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.118 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -65.96 -33.44 75.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.748 . . . . 0.0 109.068 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 -7.82 85.24 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' N ' ' CD ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -93.8 0.65 56.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -1.128 . . . . 0.0 108.738 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.12 150.27 47.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.584 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.57 126.81 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.885 0.85 . . . . 0.0 109.893 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.91 139.33 30.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.725 0.774 . . . . 0.0 110.835 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.37 51.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -146.1 -164.85 2.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.909 -1.348 . . . . 0.0 110.949 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtm -86.35 142.73 28.27 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.724 0.773 . . . . 0.0 110.543 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.8 135.88 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.551 0.691 . . . . 0.0 109.284 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.626 ' NE2' ' N ' ' A' ' 1' ' ' MET . 22.8 m170 -94.98 126.94 40.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -0.76 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 2' ' ' LYS . 55.1 p90 -150.08 149.42 30.27 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.47 150.71 36.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 179.83 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 p -140.73 151.3 62.72 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.459 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 54' ' ' THR . 51.2 Cg_exo -50.14 -39.91 51.31 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.199 1.933 . . . . 0.0 111.289 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 53' ' ' PRO . 41.7 m -35.37 99.43 0.17 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.62 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.64 -18.15 13.77 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.341 2.027 . . . . 0.0 111.202 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -125.01 118.01 25.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 113.3 -29.55 7.89 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' GLY . 64.1 mt 58.4 128.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.885 . . . . 0.0 110.05 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 143.69 29.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.03 167.08 12.65 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.759 0.79 . . . . 0.0 110.017 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -149.53 142.83 25.16 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.795 0.807 . . . . 0.0 110.053 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.56 74.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.838 0.828 . . . . 0.0 110.566 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.76 133.43 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 109.249 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.3 t -138.12 138.8 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.023 0.916 . . . . 0.0 110.05 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.82 127.1 55.39 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 -9.47 23.11 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.005 1.803 . . . . 0.0 110.825 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -82.22 137.43 34.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.538 0.685 . . . . 0.0 109.74 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.55 177.75 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.823 0.82 . . . . 0.0 110.722 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -66.7 142.48 57.4 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.869 0.843 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -71.51 128.98 37.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.831 0.824 . . . . 0.0 110.111 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -153.29 -36.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -75.05 139.38 42.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -67.18 -39.36 86.41 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.587 0.708 . . . . 0.0 109.587 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.885 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mmm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.383 0.611 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -109.7 142.12 41.33 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.834 0.826 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.88 -174.38 36.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -133.12 142.05 48.49 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.693 -0.886 . . . . 0.0 110.049 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.909 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.4 p -82.13 113.83 22.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.846 0.831 . . . . 0.0 108.98 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -80.22 -38.38 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.425 -0.797 . . . . 0.0 109.418 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 6' ' ' VAL . 95.3 p -161.45 162.57 30.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.858 0.837 . . . . 0.0 110.217 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.453 ' C ' HD22 ' A' ' 9' ' ' LEU . 25.9 t80 -153.08 109.82 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' A' ' 9' ' ' LEU . 4.0 mm? -99.87 106.59 18.45 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.024 0.916 . . . . 0.0 109.655 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.52 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.389 0.614 . . . . 0.0 109.567 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.11 79.2 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 98.9 mttt -89.33 -4.31 58.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.391 -0.818 . . . . 0.0 109.003 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.33 -17.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 23.2 p90 -132.52 158.19 42.75 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.49 -138.73 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -148.91 151.43 34.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.669 -0.901 . . . . 0.0 110.193 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.1 133.44 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.545 0.688 . . . . 0.0 109.257 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -103.44 116.97 33.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.947 0.88 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.94 160.45 52.76 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -68.62 -24.87 64.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.82 -0.812 . . . . 0.0 109.898 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -91.29 6.86 43.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.4 -0.813 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.1 72.3 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -92.37 115.89 28.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.392 -1.063 . . . . 0.0 110.132 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.9 p -81.14 148.25 29.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.609 0.719 . . . . 0.0 110.006 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.53 136.98 43.46 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.806 0.813 . . . . 0.0 110.015 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -73.43 139.61 45.97 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.549 0.69 . . . . 0.0 109.963 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.2 tt -113.99 120.59 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.812 0.815 . . . . 0.0 109.663 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.668 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.2 163.1 32.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.852 0.834 . . . . 0.0 109.107 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.862 -0.524 . . . . 0.0 109.773 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -57.54 -17.93 16.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 109.366 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.29 -9.87 34.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.464 -0.773 . . . . 0.0 108.986 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.96 112.03 22.12 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.922 0.868 . . . . 0.0 109.593 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -63.26 -41.57 99.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.869 -0.52 . . . . 0.0 109.655 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 36' ' ' LYS . 91.1 m-20 -128.53 106.76 9.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -54.91 -6.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.565 -0.71 . . . . 0.0 109.129 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 34' ' ' ASP . 68.6 mttm -64.54 -37.88 89.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.584 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.16 -7.55 49.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.484 -0.76 . . . . 0.0 109.512 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -56.79 -44.93 82.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.637 -0.664 . . . . 0.0 109.622 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.39 -9.57 86.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 41' ' ' LEU . 33.8 mtmm -116.13 16.65 15.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.418 -1.048 . . . . 0.0 109.121 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 40' ' ' LYS . 5.3 mt -55.14 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 109.935 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG21 HG12 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -127.0 162.15 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.256 1.027 . . . . 0.0 110.636 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -145.53 95.07 2.6 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.75 0.786 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.909 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 94.55 -15.72 62.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' HG12 ' A' ' 5' ' ' VAL . 20.9 m -84.95 165.37 17.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -1.216 . . . . 0.0 110.54 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.9 mtm -66.75 143.6 56.84 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.962 0.887 . . . . 0.0 111.052 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.606 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -130.95 161.62 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 109.259 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -130.32 129.08 42.74 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.791 0.805 . . . . 0.0 110.009 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -144.01 160.57 40.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.503 0.668 . . . . 0.0 109.617 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.81 154.29 38.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.836 -0.54 . . . . 0.0 109.589 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -49.73 142.89 24.01 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.652 2.235 . . . . 0.0 112.745 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' OG1' ' A' ' 54' ' ' THR . 2.5 p -126.77 147.79 62.42 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.24 57.2 2.16 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.741 2.294 . . . . 0.0 111.657 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 58' ' ' LEU . 12.9 p -135.3 58.82 28.5 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 109.287 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.96 -17.6 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.494 2.13 . . . . 0.0 110.311 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -110.83 48.42 0.92 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.538 0.685 . . . . 0.0 109.199 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.98 -20.38 0.17 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 54' ' ' THR . 79.6 mt 60.56 145.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.656 -0.908 . . . . 0.0 110.288 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.38 155.07 14.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.698 0.761 . . . . 0.0 109.903 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.48 137.08 47.03 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.856 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -133.39 142.55 48.42 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.878 0.847 . . . . 0.0 109.898 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.51 48.81 9.26 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.627 0.727 . . . . 0.0 109.773 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.61 139.23 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.546 0.688 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -133.74 149.78 51.48 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.691 0.758 . . . . 0.0 110.028 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -105.92 103.31 43.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -81.58 -2.69 11.61 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.788 2.326 . . . . 0.0 111.316 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 tp -65.17 139.01 58.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.714 0.769 . . . . 0.0 110.655 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 59.17 87.4 0.08 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.603 0.716 . . . . 0.0 109.612 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 70' ' ' HIS . 45.4 m80 -79.54 148.79 31.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.923 0.868 . . . . 0.0 110.106 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 69' ' ' HIS . 85.5 t60 55.18 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.659 0.742 . . . . 0.0 110.054 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 71' ' ' HIS . 14.4 p80 -64.43 139.1 58.73 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.613 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -84.07 -12.62 54.82 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -152.08 162.17 41.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.425 ' OXT' ' CG ' ' A' ' 74' ' ' HIS . 54.7 t-80 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.354 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.85 -173.87 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.26 -163.85 20.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -141.76 144.17 33.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.572 -0.958 . . . . 0.0 110.117 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 p -77.48 126.08 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.741 -0.599 . . . . 0.0 109.759 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.34 -35.32 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.741 . . . . 0.0 109.588 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 m -151.28 135.4 16.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.996 -1.065 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CD1' HD13 ' A' ' 27' ' ' LEU . 52.6 t80 -157.01 114.99 3.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -119.45 124.87 47.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.691 0.758 . . . . 0.0 109.287 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -24.14 67.75 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.476 0.655 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.891 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 51.6 mtmt -97.03 -3.69 40.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 109.163 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 65.61 -8.46 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.527 0.68 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 33.6 p90 -150.9 161.37 42.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.754 . . . . 0.0 109.254 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.51 -119.36 0.97 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.3 153.16 40.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.655 -0.909 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 145.58 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.532 0.682 . . . . 0.0 109.739 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -107.92 108.71 19.98 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.764 0.793 . . . . 0.0 109.379 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.24 158.48 53.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.4 p-10 -66.09 -34.3 77.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.828 -0.807 . . . . 0.0 109.89 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 52.0 t0 -89.23 10.55 21.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.213 -0.929 . . . . 0.0 109.544 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.37 14.98 69.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -97.31 121.5 39.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.158 -1.201 . . . . 0.0 109.8 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.2 p -78.16 153.56 31.95 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.736 0.779 . . . . 0.0 110.714 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -141.81 136.52 30.71 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.716 0.77 . . . . 0.0 109.656 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.73 144.19 39.46 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.617 0.722 . . . . 0.0 110.167 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.6 tt -111.54 120.82 43.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.572 0.701 . . . . 0.0 109.318 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.647 ' N ' HD23 ' A' ' 27' ' ' LEU . 39.2 m80 -128.82 138.85 52.29 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.757 0.789 . . . . 0.0 109.511 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 30' ' ' SER . 20.8 p90 -66.88 -35.1 79.26 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.068 0.937 . . . . 0.0 109.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 37.4 m -63.66 -33.12 74.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.49 0.662 . . . . 0.0 109.791 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.25 -0.7 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.91 139.54 37.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.294 -0.879 . . . . 0.0 109.659 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.77 -41.52 97.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -128.22 121.13 28.64 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -45.83 -27.72 0.92 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.568 0.699 . . . . 0.0 109.674 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -64.83 -32.57 74.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.01 -14.41 22.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.515 -0.741 . . . . 0.0 109.175 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.08 -31.48 69.08 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.73 0.776 . . . . 0.0 109.473 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.2 -3.72 75.39 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.6 7.73 32.91 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.324 -1.104 . . . . 0.0 108.852 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.7 151.1 48.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.436 0.636 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.55 137.93 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.807 0.813 . . . . 0.0 109.938 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -107.28 130.84 54.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.769 0.795 . . . . 0.0 110.453 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 92.53 -23.0 30.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -91.46 179.19 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -1.132 . . . . 0.0 111.15 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtm -82.62 153.38 25.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.507 0.67 . . . . 0.0 110.493 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.4 m -133.97 161.58 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.746 -0.596 . . . . 0.0 109.542 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -120.94 131.99 54.67 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.551 0.691 . . . . 0.0 109.436 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -150.74 159.94 44.18 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.569 0.699 . . . . 0.0 109.816 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.65 153.19 37.9 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.43 133.9 39.32 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.885 2.39 . . . . 0.0 112.966 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 m -154.03 94.66 2.85 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.98 89.28 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.728 2.285 . . . . 0.0 112.364 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.45 157.28 88.09 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.94 -17.47 60.13 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.58 2.186 . . . . 0.0 111.131 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.85 -3.42 51.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.03 -88.81 0.29 Allowed Glycine 0 N--CA 1.5 2.962 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 mt -139.8 130.94 26.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.483 -1.01 . . . . 0.0 110.235 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.93 146.15 35.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.716 0.769 . . . . 0.0 109.658 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.93 155.72 18.52 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.551 0.691 . . . . 0.0 109.863 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.21 147.29 34.64 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.728 0.775 . . . . 0.0 109.932 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.93 51.04 14.26 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.732 0.777 . . . . 0.0 109.87 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.53 139.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.0 109.547 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.528 ' C ' HD22 ' A' ' 65' ' ' LEU . 29.4 t -129.72 149.66 51.37 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.891 0.853 . . . . 0.0 109.917 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.889 HD22 ' N ' ' A' ' 65' ' ' LEU . 1.1 mm? -111.63 81.42 3.27 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.118 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.43 41.09 0.57 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.472 2.114 . . . . 0.0 111.589 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 mt -56.7 141.82 42.46 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.649 0.738 . . . . 0.0 110.102 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.03 86.14 2.34 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.677 0.751 . . . . 0.0 109.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -82.69 -68.36 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.663 0.744 . . . . 0.0 109.691 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.71 -43.43 80.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 72' ' ' HIS . 78.3 m80 -77.24 146.11 37.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.806 0.813 . . . . 0.0 109.927 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' HIS . 99.1 m-70 48.94 179.53 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.927 0.87 . . . . 0.0 110.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.8 m80 44.43 83.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.896 0.855 . . . . 0.0 109.861 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.803 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -107.19 179.63 4.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.496 -0.753 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.04 -159.03 9.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -133.93 149.87 51.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 109.645 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -80.74 123.35 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.403 ' H ' HG12 ' A' ' 6' ' ' VAL . 6.1 p -93.18 -31.16 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -157.18 149.28 22.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 110.071 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.414 ' H ' ' HE2' ' A' ' 43' ' ' LYS . 55.5 t80 -158.77 106.14 1.84 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 9' ' ' LEU . 10.8 mp -101.21 110.87 22.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.829 . . . . 0.0 109.025 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.28 84.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.655 -0.653 . . . . 0.0 109.865 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.23 92.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 14' ' ' TYR . 9.9 mtpm? -98.93 7.57 45.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.355 -0.84 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' LYS . 56.1 pttt 35.06 30.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.551 0.691 . . . . 0.0 110.381 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 12' ' ' LYS . 88.5 t80 -139.58 140.84 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.34 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.35 -161.75 14.02 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.3 157.85 45.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.497 -1.002 . . . . 0.0 109.494 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.85 132.61 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.63 104.11 15.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.353 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.24 158.43 52.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 39.4 p-10 -64.66 -34.03 77.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.442 -1.034 . . . . 0.0 109.106 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.8 t70 -86.88 6.46 31.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 108.991 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.11 16.89 70.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -93.6 117.94 30.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.962 -1.317 . . . . 0.0 109.636 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -74.36 149.8 40.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.475 -0.766 . . . . 0.0 109.367 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -129.21 139.45 51.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.024 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -74.44 144.05 44.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.68 . . . . 0.0 109.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 27' ' ' LEU . 5.9 tt -124.51 116.83 23.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.472 -0.768 . . . . 0.0 109.211 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 27' ' ' LEU . 36.6 t-80 -140.54 170.27 16.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.827 . . . . 0.0 109.411 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.47 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 2.7 m-85 -62.19 -44.11 97.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.106 -0.996 . . . . 0.0 109.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.3 m -55.6 -20.2 12.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.859 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.24 -6.48 53.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.107 -0.995 . . . . 0.0 109.973 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.63 130.87 36.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.78 -41.71 99.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.494 -0.754 . . . . 0.0 109.091 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -142.11 131.39 23.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.403 -0.811 . . . . 0.0 109.125 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -61.93 -31.19 71.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.211 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -59.18 -36.35 75.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 108.851 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.88 -8.29 35.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.35 -42.07 94.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.02 -20.93 71.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -84.75 -0.21 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.125 -1.221 . . . . 0.0 109.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' CZ ' ' A' ' 8' ' ' TYR . 40.8 mt -67.32 147.94 52.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -127.12 136.69 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.49 -0.756 . . . . 0.0 109.563 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.9 ttmt -101.27 138.37 38.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 0.0 110.297 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 88.24 -23.66 14.26 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 m -88.45 178.33 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.94 -1.329 . . . . 0.0 110.513 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -85.4 149.9 25.1 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.586 -0.696 . . . . 0.0 109.906 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.62 164.77 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 109.144 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -124.25 136.15 53.93 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.498 -0.751 . . . . 0.0 109.455 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.1 157.32 43.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -93.93 153.26 40.93 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.162 -0.961 . . . . 0.0 109.295 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' THR . 53.7 Cg_endo -67.13 142.17 60.2 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.638 2.225 . . . . 0.0 112.384 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 5.0 p -154.29 88.76 3.39 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.199 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 54' ' ' THR . 51.0 Cg_exo -53.13 -47.3 28.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.996 1.797 . . . . 0.0 111.719 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.512 ' O ' ' O ' ' A' ' 53' ' ' PRO . 1.2 p 52.55 157.18 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.975 0 CA-C-O 121.075 0.464 . . . . 0.0 110.811 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.49 -38.58 74.9 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.551 1.501 . . . . 0.0 111.247 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -63.42 -42.71 98.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.547 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.77 -64.35 0.61 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.46 132.37 53.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.438 -1.036 . . . . 0.0 110.123 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -153.48 153.93 33.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -99.87 -83.04 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.312 -0.867 . . . . 0.0 109.466 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' ALA . 56.3 tttm 60.31 144.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.496 -0.752 . . . . 0.0 110.548 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.11 43.1 32.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 0.0 110.002 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.17 140.29 18.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.149 -0.969 . . . . 0.0 109.03 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 m -121.27 153.21 37.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.738 . . . . 0.0 109.208 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' H ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -133.16 82.82 52.83 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 0.88 9.47 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.956 1.771 . . . . 0.0 111.152 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.9 mm? -91.3 122.21 33.72 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.502 -0.749 . . . . 0.0 109.34 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -144.56 10.38 1.42 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -89.84 109.26 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -67.23 -37.86 84.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.476 -0.765 . . . . 0.0 109.92 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -131.28 160.49 34.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -105.44 144.84 31.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.592 -0.693 . . . . 0.0 109.607 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -147.32 137.15 22.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.564 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.19 146.28 50.03 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.742 0.782 . . . . 0.0 110.178 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.58 -174.32 41.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -135.89 134.54 38.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.846 -0.796 . . . . 0.0 109.618 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.9 p -75.84 120.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.797 0.808 . . . . 0.0 109.612 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 7' ' ' SER . 8.3 p -91.27 -38.96 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.668 -0.645 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 74.8 m -134.31 147.66 50.63 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.689 0.757 . . . . 0.0 110.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.608 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 66.5 t80 -161.06 117.63 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.71 110.19 16.99 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.834 0.826 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.16 85.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 109.832 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.01 90.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.849 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.95 2.19 40.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 43.0 39.21 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.504 0.669 . . . . 0.0 110.09 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 93.3 t80 -147.64 158.0 43.81 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.68 0.753 . . . . 0.0 109.955 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -176.73 -162.84 28.02 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -133.71 155.88 48.96 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.575 0.703 . . . . 0.0 109.26 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.4 137.5 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.5 0.667 . . . . 0.0 109.447 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -95.16 109.16 21.28 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.11 149.39 49.01 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -68.76 -22.64 64.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.684 -0.892 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 58.7 t0 -76.16 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.0 56.05 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.16 130.54 35.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -1.0 . . . . 0.0 110.356 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -76.23 145.9 39.43 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.56 0.695 . . . . 0.0 110.037 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.34 139.89 50.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.905 0.86 . . . . 0.0 110.117 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.13 143.72 47.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.701 0.762 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.5 tt -108.2 119.35 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.0 109.689 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.629 ' N ' HD23 ' A' ' 27' ' ' LEU . 40.7 m80 -129.09 128.26 43.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.157 0.979 . . . . 0.0 109.395 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CG ' ' N ' ' A' ' 30' ' ' SER . 22.7 p90 -64.47 -34.75 78.93 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.964 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 29.7 m -63.29 -33.15 74.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.718 -0.613 . . . . 0.0 110.672 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 60' ' ' ALA . 98.7 mt-10 -73.07 2.77 6.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.38 143.35 33.58 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.634 0.731 . . . . 0.0 109.865 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.33 -40.17 96.56 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 36' ' ' LYS . 9.5 p30 -137.46 101.85 4.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.904 0.859 . . . . 0.0 108.775 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -52.23 -7.27 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.788 -0.57 . . . . 0.0 109.621 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 34' ' ' ASP . 43.8 pttt -68.57 -30.1 68.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.225 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 39.7 p30 -79.4 -2.68 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -49.58 -42.59 44.85 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.7 -6.99 82.32 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -95.09 1.27 54.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -1.077 . . . . 0.0 109.517 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.64 152.88 44.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 109.868 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.45 126.4 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 122.118 0.961 . . . . 0.0 109.816 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.608 ' NZ ' ' H ' ' A' ' 8' ' ' TYR . 50.0 tttp -99.34 139.01 35.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.747 0.784 . . . . 0.0 110.817 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 25.19 51.49 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.9 t -143.82 -179.6 6.57 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.137 -1.213 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.12 146.84 34.91 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.745 0.783 . . . . 0.0 110.461 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.0 161.54 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.495 0.665 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -118.16 126.06 51.46 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.863 0.84 . . . . 0.0 109.731 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.49 155.79 39.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.441 0.639 . . . . 0.0 109.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -106.61 163.2 17.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.03 147.4 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.538 2.158 . . . . 0.0 112.718 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -150.52 87.96 4.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.674 -0.641 . . . . 0.0 109.71 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.2 131.48 46.57 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.363 2.042 . . . . 0.0 112.237 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -148.72 152.63 37.99 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.813 -0.555 . . . . 0.0 109.712 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 -15.68 40.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -83.31 -2.34 55.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.753 -0.592 . . . . 0.0 109.446 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.59 -87.11 0.4 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.44 154.43 48.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.858 -0.79 . . . . 0.0 110.115 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.86 155.39 34.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.677 0.751 . . . . 0.0 110.015 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 31' ' ' GLU . . . -116.01 129.92 56.58 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.591 0.71 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 160.48 26.98 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.901 0.858 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.2 48.4 19.54 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.507 0.67 . . . . 0.0 109.571 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -72.31 132.1 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -135.95 154.62 51.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.764 0.792 . . . . 0.0 110.734 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.08 98.25 33.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.1 -0.62 10.8 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.792 2.328 . . . . 0.0 111.074 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.17 123.13 32.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -105.21 -161.02 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.508 0.67 . . . . 0.0 109.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -75.16 132.58 41.27 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.893 0.854 . . . . 0.0 110.072 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -66.47 -40.35 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.751 -0.593 . . . . 0.0 109.686 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 73' ' ' HIS . 78.7 m80 -59.03 -40.53 85.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.805 -0.559 . . . . 0.0 109.921 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 t60 42.64 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.571 0.7 . . . . 0.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' HIS . 57.7 t-80 -73.91 130.59 40.2 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.906 0.86 . . . . 0.0 110.322 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.205 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -107.6 151.81 25.13 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.57 0.7 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.33 -172.5 38.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -135.55 134.17 39.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.691 -0.888 . . . . 0.0 109.895 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 5' ' ' VAL . 13.6 p -78.03 106.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.766 0.793 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -72.18 -39.01 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.275 0.56 . . . . 0.0 109.662 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.41 ' N ' HG13 ' A' ' 6' ' ' VAL . 42.7 t -159.07 156.79 29.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 110.469 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' OH ' ' CZ ' ' A' ' 29' ' ' PHE . 68.3 t80 -155.03 109.59 2.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.14 116.59 30.07 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.766 0.793 . . . . 0.0 109.294 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 -25.45 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.651 . . . . 0.0 109.336 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.2 -35.85 81.67 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.626 0.727 . . . . 0.0 109.443 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 14' ' ' TYR . 1.8 mptm? -90.89 7.09 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 61.47 -7.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.387 0.613 . . . . 0.0 109.705 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.5 p90 -161.48 163.8 30.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.462 -0.774 . . . . 0.0 109.635 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.29 -131.98 2.66 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -143.34 152.27 41.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.924 . . . . 0.0 110.036 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.94 133.15 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -95.66 106.71 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.81 0.814 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.36 163.86 54.54 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.71 -39.38 94.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.757 -0.849 . . . . 0.0 109.672 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -82.31 0.91 39.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.53 -0.731 . . . . 0.0 109.386 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.52 62.22 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 80.1 mm-40 -88.55 119.46 29.02 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.085 -1.244 . . . . 0.0 110.109 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -76.37 147.71 37.89 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.662 0.744 . . . . 0.0 110.279 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.6 m-85 -136.34 137.56 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.625 0.726 . . . . 0.0 109.616 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.15 141.11 32.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.4 tt -112.83 116.82 30.65 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.809 0.814 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 13.6 m-70 -119.86 146.78 45.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 26.3 m-85 -63.56 -39.23 93.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.34 0.59 . . . . 0.0 109.918 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -57.59 -18.54 20.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.442 -0.786 . . . . 0.0 110.024 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.02 -7.46 51.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.141 -0.974 . . . . 0.0 110.304 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.25 138.03 38.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 0.0 109.784 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.75 -41.37 98.02 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.454 0.645 . . . . 0.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -135.94 125.54 25.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.9 -11.43 27.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.499 0.666 . . . . 0.0 109.509 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.42 -14.92 56.56 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -76.79 -4.84 45.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 109.384 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -55.41 -46.07 76.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.748 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.33 -4.44 84.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -94.92 -3.8 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 108.961 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.21 149.14 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.714 -0.616 . . . . 0.0 110.136 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.2 134.56 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.871 0.843 . . . . 0.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.39 133.92 41.34 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.942 0.877 . . . . 0.0 111.29 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 86.47 -12.13 61.77 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' VAL . 8.6 t -96.86 177.11 5.74 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.985 -1.303 . . . . 0.0 110.947 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.6 mtp -81.09 147.63 30.02 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.766 0.793 . . . . 0.0 110.396 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.14 157.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -113.81 132.61 55.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.41 157.67 38.85 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.63 150.78 37.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.42 163.66 38.32 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.35 2.7 . . . . 0.0 113.249 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.5 p -123.61 149.31 58.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 54' ' ' THR . 50.0 Cg_exo -50.88 -49.58 16.49 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.134 1.889 . . . . 0.0 111.925 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.65 99.55 0.18 Allowed Pre-proline 0 N--CA 1.495 1.82 0 CA-C-O 120.99 0.424 . . . . 0.0 110.512 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.66 -15.88 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.255 1.97 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -122.34 94.7 4.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.516 0.674 . . . . 0.0 110.065 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 134.52 -32.16 2.66 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' GLY . 64.5 mt 58.81 146.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.892 0.853 . . . . 0.0 110.565 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.29 158.63 30.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.3 130.5 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.941 0.877 . . . . 0.0 110.344 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.62 55.71 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.815 0.817 . . . . 0.0 109.388 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.49 136.23 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.56 0.695 . . . . 0.0 110.636 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 m -127.43 151.87 48.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.032 0.92 . . . . 0.0 109.865 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.25 85.65 38.29 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.11 0.92 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.649 2.232 . . . . 0.0 111.902 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.2 mp -99.06 125.88 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.465 -0.772 . . . . 0.0 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.89 147.5 23.31 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.851 0.834 . . . . 0.0 110.33 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.96 132.86 44.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.954 0.883 . . . . 0.0 110.401 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.55 ' CG ' ' H ' ' A' ' 71' ' ' HIS . 35.8 t-80 -147.46 -129.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.55 ' H ' ' CG ' ' A' ' 70' ' ' HIS . 86.6 t60 50.11 79.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.797 0.808 . . . . 0.0 109.738 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -80.65 136.85 36.28 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.724 0.774 . . . . 0.0 110.154 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -67.49 -42.19 83.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.409 0.624 . . . . 0.0 109.718 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.645 -179.662 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -106.82 152.04 24.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.696 0.76 . . . . 0.0 110.238 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.08 -150.28 5.65 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.98 141.24 49.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.589 -0.948 . . . . 0.0 109.579 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.9 p -81.71 118.33 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.06 -31.14 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.024 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.7 m -157.06 153.95 28.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.805 -1.184 . . . . 0.0 110.839 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' LEU . 38.8 t80 -160.28 -74.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.716 0.77 . . . . 0.0 108.953 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' TYR . 9.6 mt 57.8 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.782 0.801 . . . . 0.0 110.079 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.9 68.51 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.697 0.76 . . . . 0.0 109.152 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.87 -35.18 79.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.7 mtpt -93.6 -7.46 43.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 108.792 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 57.86 -4.09 0.05 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.313 0.578 . . . . 0.0 110.112 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.0 p90 -161.04 164.18 31.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.99 -129.48 1.03 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -143.15 154.76 44.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.54 133.77 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.549 0.69 . . . . 0.0 109.23 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -90.39 97.15 11.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.759 0.79 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.11 163.04 42.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 40.5 p-10 -66.13 -34.8 78.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.789 -0.83 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 54.6 t0 -83.6 2.7 36.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.088 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.58 14.9 72.33 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 97.4 mt-10 -91.85 123.16 35.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.484 -1.009 . . . . 0.0 109.728 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 58' ' ' LEU . 88.5 p -76.78 150.37 36.19 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.585 0.707 . . . . 0.0 110.339 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.7 m-85 -138.12 137.6 37.86 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.352 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -77.81 139.94 39.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.666 -0.646 . . . . 0.0 110.019 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.1 tt -114.97 118.53 33.69 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.54 0.686 . . . . 0.0 109.475 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.627 ' N ' HD23 ' A' ' 27' ' ' LEU . 31.0 t-80 -126.05 137.89 53.67 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 6.2 p90 -59.76 -28.51 67.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.586 0.707 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -63.73 -26.27 68.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 109.397 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -79.34 -0.43 32.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.5 131.22 35.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.071 -1.018 . . . . 0.0 109.573 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LYS . 96.9 m-20 -131.41 98.85 4.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -46.3 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.673 0.749 . . . . 0.0 109.649 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 34' ' ' ASP . 25.8 mtpp -64.5 -35.79 82.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 109.833 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -73.43 -2.35 22.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.0 109.55 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.17 -32.25 73.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.501 -0.75 . . . . 0.0 109.388 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.02 -8.7 81.86 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -103.39 14.44 31.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.302 -1.117 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.05 151.71 44.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 110.082 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.43 133.26 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.779 0.8 . . . . 0.0 109.792 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -101.07 130.81 47.15 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.931 0.872 . . . . 0.0 111.075 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 91.71 -18.12 54.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -93.91 -177.25 4.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.023 -1.281 . . . . 0.0 111.816 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.74 140.53 40.83 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.715 0.769 . . . . 0.0 110.367 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.25 131.04 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -90.09 127.0 35.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.492 -0.755 . . . . 0.0 109.742 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.66 152.72 42.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.672 -0.643 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.72 152.89 38.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.41 143.42 93.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.323 2.015 . . . . 0.0 112.281 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -152.42 87.84 4.12 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.448 -0.782 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.1 89.24 1.22 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.712 2.274 . . . . 0.0 111.667 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -94.24 176.54 2.33 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 109.481 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.56 -33.41 78.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.691 2.261 . . . . 0.0 111.647 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.92 -42.37 99.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.87 -86.64 0.23 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 24' ' ' SER . 68.9 mt -105.23 130.97 53.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -1.023 . . . . 0.0 109.96 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.51 30.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.477 -0.764 . . . . 0.0 109.2 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.71 138.3 46.28 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 110.01 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 87.5 tttt -132.85 138.61 47.1 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.476 0.655 . . . . 0.0 109.358 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.2 61.15 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.687 0.756 . . . . 0.0 109.697 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.18 133.08 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.528 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 p -139.1 153.09 47.97 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.834 0.826 . . . . 0.0 109.828 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -87.67 135.91 33.47 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.747 -0.596 . . . . 0.0 109.472 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.68 -5.33 16.72 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.356 2.037 . . . . 0.0 111.44 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.6 mp -70.75 141.14 51.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.721 0.772 . . . . 0.0 110.168 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 48.93 98.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.758 0.79 . . . . 0.0 110.048 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' ND1' ' C ' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -156.5 -171.07 3.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.1 t60 53.81 75.66 0.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.808 0.813 . . . . 0.0 109.876 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -155.59 152.03 28.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.904 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -155.49 -44.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.66 0.743 . . . . 0.0 109.399 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.84 -43.3 99.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.36 -0.837 . . . . 0.0 110.253 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.504 ' ND1' ' OXT' ' A' ' 74' ' ' HIS . 54.7 t-80 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.755 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.32 154.38 42.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.318 -0.864 . . . . 0.0 109.87 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.6 -149.19 5.6 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.67 142.31 50.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.922 . . . . 0.0 109.687 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -82.15 107.03 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 7' ' ' SER . 10.6 p -76.48 -37.28 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 109.867 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.419 ' N ' HG13 ' A' ' 6' ' ' VAL . 70.5 m -148.23 146.93 28.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.041 -1.037 . . . . 0.0 110.474 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -158.27 105.34 1.9 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 9' ' ' LEU . 6.5 mp -108.9 111.97 23.96 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.51 -29.56 70.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.549 -0.72 . . . . 0.0 109.581 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.76 84.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' TYR . 55.5 mtpt -92.67 -3.7 54.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt 55.19 6.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.742 -0.599 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' LYS . 45.2 m-85 -130.16 154.14 47.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.639 -0.663 . . . . 0.0 109.736 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.73 -170.15 26.05 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.97 149.87 47.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.412 -1.052 . . . . 0.0 109.761 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.01 133.92 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -85.48 108.05 17.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.846 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.21 158.7 53.17 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 45.8 p-10 -65.84 -33.0 74.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.553 -0.969 . . . . 0.0 109.573 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 24.3 p30 -90.11 8.36 33.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 17.07 63.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.8 123.09 40.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -1.211 . . . . 0.0 109.753 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 p -79.41 149.17 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 110.39 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.15 132.94 45.11 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -82.77 144.47 30.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 0.0 109.707 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.2 tt -113.18 122.96 49.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.65 ' N ' HD23 ' A' ' 27' ' ' LEU . 49.4 t-80 -138.81 168.04 20.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.717 . . . . 0.0 109.387 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 14.1 m-85 -65.36 -39.67 92.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.781 . . . . 0.0 109.523 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -61.4 -18.17 57.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.325 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.4 -9.3 48.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.305 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 63' ' ' ILE . 97.0 mt -99.65 107.12 19.15 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.35 -0.844 . . . . 0.0 109.504 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.9 mm? -64.76 -41.94 95.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.482 -0.761 . . . . 0.0 109.165 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -101.28 109.34 21.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.597 -0.689 . . . . 0.0 109.29 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -63.75 -32.64 74.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.184 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.1 -34.57 76.55 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.02 -7.03 31.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 0.0 108.865 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.18 -42.23 90.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.695 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.85 84.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -95.99 -1.04 49.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.271 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.58 144.68 56.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.623 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.538 ' O ' HG13 ' A' ' 42' ' ' VAL . 14.3 p -114.44 121.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.647 0.737 . . . . 0.0 109.623 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -95.2 143.04 26.94 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.934 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 25.35 50.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 t -152.83 -167.0 2.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.725 -1.456 . . . . 0.0 110.981 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.63 144.13 30.5 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.424 0.63 . . . . 0.0 110.768 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.57 161.26 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -124.38 136.22 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.457 -0.777 . . . . 0.0 109.837 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.34 155.23 42.47 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.772 . . . . 0.0 109.007 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.12 155.02 71.76 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.922 2.415 . . . . 0.0 112.108 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.557 HG21 ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -103.02 155.45 36.58 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.456 -0.778 . . . . 0.0 108.924 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.41 -19.14 65.12 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.773 2.315 . . . . 0.0 111.113 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' LYS . 70.2 p -41.98 152.48 0.31 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.769 -0.582 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -38.54 -22.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.341 2.028 . . . . 0.0 111.19 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' THR . 19.6 tptm -145.29 -76.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.572 -0.705 . . . . 0.0 109.333 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . 168.92 -83.08 0.09 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 58' ' ' LEU . 2.1 mm? 41.58 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.865 -0.786 . . . . 0.0 109.782 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 52' ' ' THR . . . -149.87 141.99 24.03 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.34 149.05 30.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.671 -0.643 . . . . 0.0 109.85 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -145.06 128.5 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.837 . . . . 0.0 109.167 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 56.24 61.16 2.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.42 -0.8 . . . . 0.0 109.239 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.43 HD12 HD21 ' A' ' 32' ' ' LEU . 96.4 mt -72.68 139.49 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.632 -0.667 . . . . 0.0 109.596 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 p -136.22 162.19 33.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.722 . . . . 0.0 109.852 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 80.49 47.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -84.93 27.27 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 123.178 2.585 . . . . 0.0 111.493 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.3 mp -70.5 -106.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.47 -0.769 . . . . 0.0 111.259 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -101.33 126.43 48.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.33 -0.857 . . . . 0.0 110.687 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -140.56 143.75 35.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.583 -0.698 . . . . 0.0 109.548 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.466 ' NE2' ' CE1' ' A' ' 71' ' ' HIS . 50.6 p-80 -83.26 -13.73 54.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.23 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.466 ' CE1' ' NE2' ' A' ' 70' ' ' HIS . 85.0 m-70 -75.04 140.72 43.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 110.035 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -66.49 -38.8 88.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.456 -0.777 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -152.91 155.74 37.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.105 -0.997 . . . . 0.0 110.161 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.462 ' ND1' ' OXT' ' A' ' 74' ' ' HIS . 47.5 t-80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.993 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.604 ' N ' ' CE2' ' A' ' 49' ' ' PHE . 66.2 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -129.9 138.57 51.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.777 . . . . 0.0 109.386 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.66 6.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -132.82 139.56 47.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.552 -0.97 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.4 p -82.93 121.32 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.18 -32.98 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 t -154.38 144.88 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.916 -1.115 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.471 ' CE2' HD12 ' A' ' 41' ' ' LEU . 40.2 t80 -158.73 96.53 1.38 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -100.77 124.55 46.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.167 -0.958 . . . . 0.0 109.378 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.61 -35.79 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.696 0.76 . . . . 0.0 109.268 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.13 -30.06 70.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 14' ' ' TYR . 58.1 mttp -94.35 -7.03 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.015 . . . . 0.0 108.926 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 58.83 -3.94 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.565 -0.71 . . . . 0.0 109.846 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 12' ' ' LYS . 28.0 p90 -151.64 161.23 43.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.042 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 -133.59 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -141.25 157.83 44.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 109.775 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.3 mt -136.26 154.91 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.415 -0.803 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 17' ' ' ILE . 58.0 tt0 -109.79 106.56 16.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.764 0.792 . . . . 0.0 109.146 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.43 161.4 50.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -1.01 . . . . 0.0 109.338 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 30.3 p-10 -89.9 9.99 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.448 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 16.62 65.08 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.49 114.6 26.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -1.164 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -74.86 146.73 41.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 110.363 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -122.81 139.55 53.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.55 -0.718 . . . . 0.0 109.248 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.24 131.08 36.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.554 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.5 tt -104.9 123.41 47.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.088 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.622 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.8 t60 -134.36 153.12 52.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.698 . . . . 0.0 109.412 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.29 -35.57 81.28 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.783 0.801 . . . . 0.0 108.894 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.5 p -61.28 -21.09 63.61 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.446 -0.784 . . . . 0.0 109.62 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.66 -3.89 59.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.068 -1.02 . . . . 0.0 109.645 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.5 126.0 39.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 0.0 109.891 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -63.14 -41.31 99.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' LYS . 93.9 m-20 -127.17 89.72 3.02 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.84 -15.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 109.555 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' ASP . 44.0 mmtm -66.2 -34.96 79.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.163 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 36.3 p30 -73.66 -3.0 25.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.42 -36.09 82.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.39 -12.56 81.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -95.38 6.12 49.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -1.179 . . . . 0.0 109.304 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.471 HD12 ' CE2' ' A' ' 8' ' ' TYR . 94.8 mt -68.94 156.44 38.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.083 -1.01 . . . . 0.0 109.953 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.89 128.76 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.669 0.747 . . . . 0.0 109.663 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -98.76 138.16 36.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.421 -0.8 . . . . 0.0 110.874 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.6 24.91 61.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -141.63 -174.4 4.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 110.744 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtp -79.55 149.36 31.45 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.665 0.745 . . . . 0.0 110.557 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.86 164.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -127.62 133.09 49.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.604 ' CE2' ' N ' ' A' ' 1' ' ' MET . 52.3 p90 -150.54 163.51 38.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.367 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.75 152.05 38.84 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.241 -0.912 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.04 150.18 88.91 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.623 2.215 . . . . 0.0 112.734 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -148.94 88.04 5.26 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.95 88.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.403 2.069 . . . . 0.0 111.915 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 56' ' ' LYS . 7.2 p -137.17 68.3 55.66 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.06 12.43 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.653 2.236 . . . . 0.0 111.305 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 54' ' ' THR . 9.8 ptpp? -105.79 8.75 32.98 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.723 0.773 . . . . 0.0 109.223 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.31 -17.91 0.08 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.1 mt 62.7 147.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.754 -0.851 . . . . 0.0 110.457 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.21 170.72 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.948 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -101.98 -46.22 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.408 -0.808 . . . . 0.0 108.891 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ALA . 88.3 tttt 59.12 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.944 0.878 . . . . 0.0 110.903 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.14 87.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 0.0 109.833 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.2 mt -103.36 137.37 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.505 -0.747 . . . . 0.0 109.697 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 p -134.64 160.16 38.98 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.859 0.838 . . . . 0.0 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.23 81.79 22.1 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.4 -1.95 10.39 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.755 2.303 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 68' ' ' GLU . 37.5 tp -94.97 128.28 41.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.152 -0.967 . . . . 0.0 110.756 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 67' ' ' LEU . 75.1 mm-40 53.89 110.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.974 0.892 . . . . 0.0 109.868 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -97.73 132.92 42.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -74.11 128.8 36.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.724 0.773 . . . . 0.0 109.931 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.538 ' CD2' ' O ' ' A' ' 73' ' ' HIS . 43.4 p-80 -82.99 144.25 30.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.106 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -83.72 -13.0 55.07 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.731 0.776 . . . . 0.0 109.098 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.538 ' O ' ' CD2' ' A' ' 71' ' ' HIS . 57.2 t-80 -74.93 154.99 37.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.994 -1.003 . . . . 0.0 108.851 179.848 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -111.08 170.9 7.8 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.435 0.636 . . . . 0.0 109.857 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.29 -145.86 4.3 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.61 142.13 49.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -1.004 . . . . 0.0 109.751 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.4 p -81.52 112.04 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -70.35 -37.39 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.391 -0.818 . . . . 0.0 109.781 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 t -165.8 156.61 13.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' HD13 ' A' ' 27' ' ' LEU . 73.9 t80 -153.87 107.47 2.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.32 124.57 52.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.508 -0.745 . . . . 0.0 109.639 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.47 77.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.348 0.594 . . . . 0.0 109.9 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.4 73.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 109.96 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' TYR . 13.7 mptt -87.68 6.67 33.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt 64.22 -17.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.2 p90 -160.72 165.21 30.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.043 -1.035 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.32 -136.15 3.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.9 152.53 51.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.993 . . . . 0.0 109.93 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.01 137.57 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -92.55 100.73 13.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.09 174.08 44.4 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -63.52 -39.6 94.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.45 -1.029 . . . . 0.0 109.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -80.94 -0.61 40.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.65 11.75 79.15 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 128.22 34.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.239 . . . . 0.0 109.683 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.4 p -74.22 148.54 41.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.807 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.35 136.81 43.68 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -79.64 137.72 37.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.719 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.464 ' C ' HD23 ' A' ' 27' ' ' LEU . 2.0 tt -109.71 89.37 2.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -96.04 165.11 12.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 0.0 110.264 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.0 -40.59 96.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 t -61.77 -18.37 59.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.178 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.29 -5.34 59.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.4 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.66 125.41 47.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.57 -41.37 98.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -130.75 114.47 15.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.644 -0.66 . . . . 0.0 109.246 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -64.19 -11.68 33.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.351 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.07 -38.65 91.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.52 -5.4 23.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.29 -39.72 76.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.4 -9.19 87.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -96.35 -0.64 49.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.197 -1.178 . . . . 0.0 109.087 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.9 146.79 54.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.1 p -115.06 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.835 0.826 . . . . 0.0 109.555 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.35 140.73 29.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 110.661 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.21 50.18 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 t -147.46 -164.99 2.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.939 -1.33 . . . . 0.0 110.588 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.2 mtp -82.33 140.28 33.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.724 -0.61 . . . . 0.0 110.372 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.59 135.72 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.706 . . . . 0.0 109.256 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -94.31 128.95 41.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.669 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -144.23 155.85 44.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.73 110.64 59.32 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.531 -0.731 . . . . 0.0 109.258 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.49 146.9 24.21 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.334 2.023 . . . . 0.0 112.559 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p -109.39 150.31 40.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.672 -0.643 . . . . 0.0 109.304 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.49 88.62 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.336 2.024 . . . . 0.0 111.822 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 82.3 0.52 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.809 . . . . 0.0 108.965 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -31.58 66.25 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.653 2.235 . . . . 0.0 111.458 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -110.49 105.94 15.07 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.463 0.649 . . . . 0.0 109.379 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 128.72 -45.58 1.14 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 57' ' ' GLY . 54.6 mt 58.43 128.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.804 -0.821 . . . . 0.0 110.123 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.18 150.55 28.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.212 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 151.31 22.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 109.898 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -141.43 133.96 28.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.21 66.84 1.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.682 0.753 . . . . 0.0 109.886 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.81 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.2 p -131.13 148.74 52.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.453 -0.779 . . . . 0.0 109.816 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.85 145.13 29.02 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . 56.0 Cg_endo -71.61 -84.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.421 2.08 . . . . 0.0 112.041 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp 42.36 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.418 0.628 . . . . 0.0 109.581 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' PRO . 96.2 mt-10 52.92 -110.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.686 -0.634 . . . . 0.0 110.263 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -149.2 146.06 27.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -71.5 148.5 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.461 -0.774 . . . . 0.0 110.566 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -69.78 136.87 51.39 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.678 0.751 . . . . 0.0 110.523 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 46.57 88.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.607 0.717 . . . . 0.0 110.062 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -83.18 135.06 34.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 0.0 110.024 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.683 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.2 156.55 45.33 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.639 0.733 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.61 -167.1 22.53 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -132.05 137.36 47.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.696 0.76 . . . . 0.0 110.018 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.3 p -76.48 122.11 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.652 0.739 . . . . 0.0 110.1 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.46 -34.83 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -156.32 160.58 39.84 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.92 0.867 . . . . 0.0 110.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -162.99 93.9 0.82 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.401 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 9' ' ' LEU . 10.5 mp -102.01 113.57 26.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.905 0.86 . . . . 0.0 108.822 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.0 -13.97 59.89 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.25 -65.94 0.45 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 109.824 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.18 17.13 14.79 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 56.7 57.83 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.688 0.756 . . . . 0.0 109.782 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' OH ' HD22 ' A' ' 9' ' ' LEU . 2.9 p90 -151.99 166.11 32.56 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.85 0.833 . . . . 0.0 110.144 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.96 174.08 45.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -133.6 150.7 51.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.765 -0.844 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.98 133.07 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.801 0.81 . . . . 0.0 109.842 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -92.58 115.09 27.79 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.867 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.66 158.33 50.05 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.3 p-10 -66.88 -23.56 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.939 -0.742 . . . . 0.0 110.119 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 82.7 m-20 -89.95 5.27 47.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 109.243 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.68 15.58 65.47 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.74 120.26 39.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.714 -0.874 . . . . 0.0 109.922 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -78.37 155.03 30.25 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 109.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.16 135.26 35.51 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.896 0.855 . . . . 0.0 110.136 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -75.59 142.84 42.62 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.728 0.775 . . . . 0.0 109.849 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.2 tt -107.98 132.06 53.91 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.746 0.784 . . . . 0.0 109.749 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 29' ' ' PHE . 2.4 t60 -134.3 146.04 49.64 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.984 0.897 . . . . 0.0 110.102 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 4.1 m-85 -62.16 -42.16 98.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 t -62.87 -18.52 63.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 31' ' ' GLU . 2.7 mp0 -88.99 -0.52 57.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.0 109.218 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 34' ' ' ASP . 75.5 mt -90.22 -3.08 58.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.4 mt 59.27 -70.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 32' ' ' LEU . 43.2 t0 -110.05 105.71 14.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -56.69 -12.22 1.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.821 -0.549 . . . . 0.0 109.533 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.61 -36.55 84.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.0 109.979 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -77.08 -5.54 49.32 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.421 -0.799 . . . . 0.0 109.072 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 79.0 tt0 -57.37 -38.29 73.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.778 -0.576 . . . . 0.0 109.575 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.07 -8.42 86.55 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.11 0.05 50.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.284 -1.127 . . . . 0.0 109.003 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.85 152.01 46.43 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.615 0.721 . . . . 0.0 110.108 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.94 129.92 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.114 0.959 . . . . 0.0 109.722 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -95.78 138.34 33.57 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.713 0.768 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 81.21 25.29 55.41 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 t -140.01 172.59 12.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.154 -1.204 . . . . 0.0 110.707 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.1 mtt -76.3 141.56 41.58 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.938 0.875 . . . . 0.0 109.999 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.19 161.79 39.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.499 0.666 . . . . 0.0 109.682 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -122.07 129.5 52.45 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.921 0.867 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -151.39 158.98 44.44 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.827 0.822 . . . . 0.0 109.797 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.49 143.76 26.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.1 141.78 58.9 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.412 2.074 . . . . 0.0 112.123 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 m -153.6 90.46 3.39 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.756 -0.59 . . . . 0.0 109.708 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -55.52 140.34 83.12 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.337 2.025 . . . . 0.0 111.801 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.52 160.35 59.59 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.93 -38.18 18.01 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.894 2.396 . . . . 0.0 112.089 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -64.25 -41.37 96.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.15 -86.89 0.15 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt -113.92 134.98 54.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.644 -0.915 . . . . 0.0 109.96 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.39 148.68 29.77 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.739 0.78 . . . . 0.0 109.983 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.41 133.8 49.58 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.643 0.735 . . . . 0.0 109.706 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -118.29 143.84 46.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.96 0.886 . . . . 0.0 110.409 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.59 62.42 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.739 0.781 . . . . 0.0 109.884 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.79 137.09 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.576 0.703 . . . . 0.0 109.8 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.9 p -133.05 160.23 37.77 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.999 0.904 . . . . 0.0 110.107 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.11 98.33 38.7 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.63 -35.87 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.612 2.208 . . . . 0.0 111.604 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -77.96 128.09 33.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.727 0.775 . . . . 0.0 109.485 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 57.2 mp0 -97.45 127.1 43.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.81 0.814 . . . . 0.0 110.146 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -93.32 121.09 34.35 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.52 0.676 . . . . 0.0 110.344 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -149.54 164.95 33.66 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.747 0.784 . . . . 0.0 110.209 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -73.62 130.06 39.25 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.731 0.777 . . . . 0.0 110.196 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -84.42 149.17 26.17 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.784 0.802 . . . . 0.0 110.707 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 11.5 p80 -69.11 142.75 54.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.629 0.728 . . . . 0.0 110.152 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.453 ' O ' ' CG ' ' A' ' 74' ' ' HIS . 55.6 p-80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.431 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 97.8 mmm . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.53 165.54 11.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.416 -0.803 . . . . 0.0 109.993 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.68 -172.98 32.81 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 44' ' ' GLY . 62.3 tttm -142.99 128.31 18.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -1.088 . . . . 0.0 109.224 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.5 p -74.68 130.52 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.937 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.31 -36.4 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 p -158.48 161.97 37.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.961 -1.087 . . . . 0.0 110.556 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -165.75 93.98 0.57 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' LEU . 11.2 mp -101.21 122.0 42.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -77.07 -14.31 59.83 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.661 -0.65 . . . . 0.0 109.382 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.17 -67.99 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.739 -0.601 . . . . 0.0 110.593 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.93 19.26 15.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.441 -0.787 . . . . 0.0 109.072 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 56.3 66.19 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.83 170.66 21.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.229 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.64 166.79 38.78 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.65 150.89 52.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.619 -0.93 . . . . 0.0 109.282 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 27' ' ' LEU . 96.6 mt -133.96 147.81 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -94.95 117.15 29.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.463 -0.773 . . . . 0.0 109.576 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 159.46 52.69 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.72 -35.53 81.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.387 -1.066 . . . . 0.0 109.603 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -80.64 -0.75 39.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.212 -0.93 . . . . 0.0 109.485 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -5.22 63.13 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 25' ' ' TYR . 20.0 pt-20 -80.24 133.81 36.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.124 -1.221 . . . . 0.0 110.364 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.6 p -83.41 162.77 20.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 23' ' ' GLU . 62.4 m-85 -134.87 146.57 49.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.79 125.41 34.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.253 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.4 tt -103.39 122.23 44.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.815 . . . . 0.0 108.927 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.6 t-80 -135.82 166.79 22.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 11.3 m-85 -62.13 -40.04 94.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HG ' ' CE1' ' A' ' 28' ' ' HIS . 1.1 m -60.99 -21.5 63.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.453 -0.78 . . . . 0.0 109.991 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.17 -6.76 54.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.26 107.13 18.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.04 -41.38 97.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -113.69 97.47 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.59 -27.01 68.65 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.831 . . . . 0.0 109.234 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.86 -27.79 66.97 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.0 -9.35 58.64 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.456 -0.777 . . . . 0.0 109.264 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -64.61 -35.42 80.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 110.01 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.42 0.97 38.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -149.92 58.08 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -1.205 . . . . 0.0 108.982 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mt -81.49 -165.95 1.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -120.84 159.84 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.749 0.785 . . . . 0.0 109.714 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.4 93.65 2.18 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 98.63 -13.85 62.3 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.506 ' OG ' HD22 ' A' ' 67' ' ' LEU . 16.6 m -86.49 -177.66 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.409 . . . . 0.0 111.021 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.06 145.95 29.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.568 -0.708 . . . . 0.0 110.434 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.542 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -133.29 164.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 1' ' ' MET . 75.1 t60 -135.17 135.33 40.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.374 -0.829 . . . . 0.0 109.456 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.41 163.7 38.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.56 153.06 38.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.96 139.36 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.953 1.769 . . . . 0.0 112.874 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.513 HG22 HG23 ' A' ' 54' ' ' THR . 4.0 m -153.55 87.91 3.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 54' ' ' THR . 54.1 Cg_exo -53.58 -43.17 60.02 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.231 1.954 . . . . 0.0 111.542 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.513 HG23 HG22 ' A' ' 52' ' ' THR . 0.1 OUTLIER 53.58 161.02 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 CA-C-O 121.222 0.534 . . . . 0.0 110.472 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -41.33 73.17 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.32 2.013 . . . . 0.0 112.04 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.74 -43.04 97.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.752 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.96 -63.59 0.61 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.6 mt -109.85 125.71 53.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.308 -1.113 . . . . 0.0 110.055 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -158.73 151.38 21.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.32 119.43 39.46 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 32.9 ttpt -115.79 147.81 40.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.568 -0.708 . . . . 0.0 110.062 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.52 48.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.392 0.615 . . . . 0.0 109.432 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.43 135.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.808 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.9 m -126.92 149.56 49.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 109.275 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.59 97.35 36.41 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.2 5.97 6.02 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.606 2.204 . . . . 0.0 112.483 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.506 HD22 ' OG ' ' A' ' 45' ' ' SER . 10.7 tp -81.75 -0.56 43.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 108.907 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.6 142.15 45.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' HIS . 99.5 m-70 -107.96 115.14 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.578 -0.701 . . . . 0.0 109.488 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' HIS . 61.5 m170 52.88 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.616 0.722 . . . . 0.0 110.842 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -67.24 -44.43 79.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.598 ' CG ' ' N ' ' A' ' 73' ' ' HIS . 41.3 t-80 -139.44 -109.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.726 . . . . 0.0 109.642 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.598 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 96.4 m-70 43.18 87.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.618 -0.676 . . . . 0.0 109.994 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 74' ' ' HIS . 52.6 t-80 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.037 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.455 0.645 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -71.37 -80.98 0.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.678 -0.639 . . . . 0.0 109.755 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.34 175.64 20.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.5 145.61 47.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.87 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.2 p -88.43 112.46 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 7' ' ' SER . 7.5 p -70.77 -41.59 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.535 -0.728 . . . . 0.0 109.745 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 6' ' ' VAL . 31.1 p -160.33 160.62 32.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.573 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.488 ' C ' HD12 ' A' ' 9' ' ' LEU . 40.5 t80 -156.84 111.27 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.68 0.752 . . . . 0.0 109.61 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 8' ' ' TYR . 11.1 mp -106.83 102.4 11.77 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.2 -23.86 65.79 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.09 96.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.026 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.4 mtmt -97.23 4.24 51.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 59.1 2.95 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.308 0.575 . . . . 0.0 110.12 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' LYS . 62.0 m-85 -118.89 152.3 36.54 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.0 109.895 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.97 -168.9 21.67 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -137.51 149.71 46.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.754 -0.851 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.1 138.49 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.487 0.66 . . . . 0.0 109.527 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -99.46 105.25 17.16 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.761 0.791 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.44 160.66 51.22 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 43.0 p-10 -66.59 -33.37 75.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.649 -0.912 . . . . 0.0 109.712 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 84.7 m-20 -87.99 6.46 35.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.774 -0.579 . . . . 0.0 109.496 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.84 16.95 64.39 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.5 mt-10 -93.68 118.54 31.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.99 . . . . 0.0 109.673 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 p -77.29 153.22 34.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.798 0.809 . . . . 0.0 110.06 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 98.0 m-85 -141.47 134.97 29.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.603 0.716 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -79.35 140.56 37.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.699 0.761 . . . . 0.0 110.108 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 27' ' ' LEU . 4.4 tt -112.61 115.0 27.9 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.756 0.788 . . . . 0.0 109.254 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' N ' HD23 ' A' ' 27' ' ' LEU . 52.3 t-80 -141.25 167.32 22.45 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.841 0.829 . . . . 0.0 110.303 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 13.5 m-85 -61.65 -35.41 77.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.844 -0.535 . . . . 0.0 110.146 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.8 p -62.99 -20.27 65.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.619 -0.675 . . . . 0.0 109.863 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -93.61 -11.02 32.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.11 116.03 28.35 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.372 -0.83 . . . . 0.0 109.569 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.52 -42.14 95.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.537 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -117.65 134.76 54.55 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.738 0.78 . . . . 0.0 109.589 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 mptm? -77.45 -12.42 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 19.2 ptmt -65.4 -41.96 93.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.717 -0.615 . . . . 0.0 110.313 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 98.0 m-20 -78.33 -8.31 58.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 109.606 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.36 -36.81 79.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 109.108 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.6 -9.75 80.76 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 68.3 mttm -98.46 -0.76 42.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.175 -1.191 . . . . 0.0 109.296 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.9 145.74 15.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.739 . . . . 0.0 110.184 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -124.18 125.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 122.018 0.913 . . . . 0.0 109.47 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' VAL . 7.4 tmtm? -95.69 137.24 35.04 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.908 0.861 . . . . 0.0 110.854 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 25.93 38.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 t -142.06 -164.95 1.91 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.026 -1.279 . . . . 0.0 111.343 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.6 mtp -88.49 139.94 29.97 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.965 0.888 . . . . 0.0 110.961 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.24 159.8 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.368 0.604 . . . . 0.0 109.503 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -124.05 132.32 53.66 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 110.07 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -154.99 161.16 41.46 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.617 0.722 . . . . 0.0 109.801 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -102.73 150.69 37.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.47 159.8 50.38 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.487 2.125 . . . . 0.0 112.542 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -147.35 148.84 32.84 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 121.689 -0.632 . . . . 0.0 109.474 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 54' ' ' THR . 55.2 Cg_endo -69.62 -63.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.823 2.349 . . . . 0.0 111.742 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 53' ' ' PRO . 8.6 p 56.87 146.73 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.144 0.497 . . . . 0.0 110.27 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.54 73.24 2.28 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.579 2.186 . . . . 0.0 111.766 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 tptp 58.59 88.75 0.06 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 110.333 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.22 -25.2 0.12 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt 60.92 152.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.742 -0.857 . . . . 0.0 110.627 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.3 156.38 35.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.703 0.763 . . . . 0.0 109.728 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.31 87.86 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -89.75 148.4 23.27 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.833 0.825 . . . . 0.0 110.294 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.86 58.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.617 0.723 . . . . 0.0 109.616 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.45 129.37 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.917 0.865 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.1 m -135.79 126.38 27.05 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.645 0.735 . . . . 0.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -89.26 132.35 37.84 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -76.23 -9.7 19.1 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.412 2.075 . . . . 0.0 111.319 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -96.96 130.85 44.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.745 0.783 . . . . 0.0 109.741 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.539 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 57.4 mp0 -93.03 7.54 43.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' HIS . 50.8 t-80 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.539 0.685 . . . . 0.0 109.803 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 69' ' ' HIS . 80.5 m80 47.47 179.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.865 0.841 . . . . 0.0 110.662 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 72' ' ' HIS . 99.5 m-70 -58.38 -80.22 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.77 -0.581 . . . . 0.0 109.486 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' HIS . 81.0 m80 38.83 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.593 0.711 . . . . 0.0 110.105 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.72 -40.92 88.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.321 179.898 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 tpp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -90.83 179.52 5.76 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 110.018 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.28 -166.42 28.28 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -135.13 138.25 43.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.876 -0.779 . . . . 0.0 110.313 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 44' ' ' GLY . 8.0 p -74.12 126.19 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.359 0.599 . . . . 0.0 109.409 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 7' ' ' SER . 9.2 p -94.37 -42.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.493 ' N ' HG13 ' A' ' 6' ' ' VAL . 66.1 m -152.85 153.75 33.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.992 0.901 . . . . 0.0 110.524 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -161.02 117.18 2.23 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.681 0.753 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.87 110.34 17.07 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 109.231 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.64 -34.49 77.07 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.529 0.681 . . . . 0.0 109.401 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -34.33 75.53 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' TYR . 28.6 mmtp -95.7 -1.58 49.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? 57.67 6.54 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.452 0.644 . . . . 0.0 109.57 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' LYS . 47.6 m-85 -123.02 160.13 26.95 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.911 0.863 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.91 -170.16 28.43 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.03 148.34 33.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.791 -0.829 . . . . 0.0 109.604 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.69 132.89 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.74 0.781 . . . . 0.0 109.903 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -97.07 113.63 25.2 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.921 0.867 . . . . 0.0 110.078 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.88 161.47 52.3 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -64.59 -35.8 82.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.062 -0.669 . . . . 0.0 109.643 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -83.52 9.5 11.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.6 21.74 65.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 75.6 mm-40 -95.95 115.22 27.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.703 -0.881 . . . . 0.0 110.049 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.0 t -77.16 146.95 36.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.681 0.753 . . . . 0.0 110.04 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 99.0 m-85 -136.0 136.55 40.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.782 0.801 . . . . 0.0 109.529 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 63.7 m-85 -81.35 143.07 32.46 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.829 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.611 ' C ' HD23 ' A' ' 27' ' ' LEU . 6.5 tt -111.62 121.87 46.31 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.154 0.978 . . . . 0.0 109.548 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.589 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.3 t60 -139.0 167.78 21.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.959 0.885 . . . . 0.0 109.602 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 6.2 m-85 -62.05 -38.08 87.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.405 0.621 . . . . 0.0 109.413 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.8 m -61.59 -20.85 63.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 26' ' ' PHE . 94.7 mt-10 -90.84 -11.68 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.842 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.6 mt -96.12 106.08 18.22 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 33' ' ' LEU . 4.0 mm? -64.88 -42.22 94.99 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.61 0.719 . . . . 0.0 109.515 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -110.82 90.1 3.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -49.0 -19.5 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -66.16 -35.9 81.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.48 -12.36 61.59 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.341 0.591 . . . . 0.0 109.496 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 78.4 tt0 -66.23 -34.89 79.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.414 0.626 . . . . 0.0 109.591 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.09 -7.76 84.84 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -108.18 15.45 24.16 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.944 . . . . 0.0 109.604 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.59 151.36 46.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.815 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.56 133.3 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.122 0.963 . . . . 0.0 109.607 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -100.23 133.51 44.53 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.33 -24.16 26.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -90.7 -178.87 5.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.979 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.81 148.39 27.81 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.793 0.806 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 160.07 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.474 0.654 . . . . 0.0 109.286 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -121.23 125.28 46.72 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.005 0.907 . . . . 0.0 110.312 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -138.36 150.96 47.09 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.333 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.49 131.12 22.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -48.45 141.68 18.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.739 2.292 . . . . 0.0 113.047 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.39 151.06 76.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.41 131.22 18.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.892 2.395 . . . . 0.0 113.097 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.95 149.42 27.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.02 -47.3 1.84 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.758 2.306 . . . . 0.0 111.668 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -171.75 111.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.741 0.782 . . . . 0.0 109.662 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.37 -16.27 3.16 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.4 mt 60.92 163.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.619 0.723 . . . . 0.0 109.999 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.71 153.7 21.38 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.76 0.79 . . . . 0.0 109.834 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.6 151.09 21.05 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.683 0.754 . . . . 0.0 109.866 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.33 138.71 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.857 0.837 . . . . 0.0 110.039 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.69 66.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.53 0.681 . . . . 0.0 110.173 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.9 130.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.618 0.723 . . . . 0.0 109.654 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -131.36 164.81 24.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.803 0.811 . . . . 0.0 109.78 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.73 79.63 23.45 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.61 16.95 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.574 2.183 . . . . 0.0 111.416 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -72.01 117.91 14.22 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.541 0.686 . . . . 0.0 110.335 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.591 ' N ' HD13 ' A' ' 67' ' ' LEU . 97.0 mt-10 -73.91 133.93 43.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.644 0.735 . . . . 0.0 109.911 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -145.82 114.31 6.74 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.773 0.797 . . . . 0.0 109.941 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -148.82 164.47 34.35 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -66.21 -37.86 86.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -76.9 42.08 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.378 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -64.71 -43.28 93.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.416 ' ND1' ' OXT' ' A' ' 74' ' ' HIS . 54.1 t-80 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.167 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptp . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -158.68 -163.35 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.3 -167.56 31.74 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -127.33 143.2 51.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.662 -0.905 . . . . 0.0 109.524 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 44' ' ' GLY . 0.8 OUTLIER -74.53 108.42 6.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.505 -0.747 . . . . 0.0 109.677 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 7' ' ' SER . 7.2 p -69.38 -39.26 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.635 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.411 ' N ' HG13 ' A' ' 6' ' ' VAL . 23.1 p -159.85 165.2 32.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.707 -1.246 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -156.7 114.23 3.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 mp -114.16 111.41 21.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.542 -0.724 . . . . 0.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.5 78.18 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.738 -0.601 . . . . 0.0 109.757 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.0 mttt -92.54 -4.44 53.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? 54.21 6.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' H ' ' C ' ' A' ' 12' ' ' LYS . 52.9 m-85 -132.89 123.52 26.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -106.62 -164.94 22.58 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -141.73 145.15 34.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -1.036 . . . . 0.0 109.122 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.8 136.83 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.795 -0.566 . . . . 0.0 109.825 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -100.49 110.78 22.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 109.181 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.73 155.38 53.45 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.026 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 49.1 p-10 -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.521 -0.988 . . . . 0.0 109.739 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 86.5 m-20 -86.49 10.63 14.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 108.813 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.21 15.44 71.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.65 109.53 21.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.968 -1.313 . . . . 0.0 109.489 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.0 t -73.98 142.48 45.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.1 135.27 52.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 109.662 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -78.02 144.69 36.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.2 tt -109.36 122.42 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.535 ' N ' HD23 ' A' ' 27' ' ' LEU . 8.9 m80 -127.28 149.94 49.79 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.606 0.717 . . . . 0.0 109.867 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.5 -37.97 89.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 p -61.64 -25.84 67.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.35 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.84 -1.08 46.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.7 mt -93.85 120.47 34.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.949 -1.095 . . . . 0.0 110.347 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.5 mm? -64.43 -42.44 96.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.597 -0.689 . . . . 0.0 109.768 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -117.01 109.66 17.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -65.99 -15.14 62.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.118 -0.989 . . . . 0.0 108.771 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -65.22 -38.79 91.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.388 -0.82 . . . . 0.0 109.255 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.89 -10.83 60.38 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.54 -33.75 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.001 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.9 -20.69 72.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 4.8 mptp? -90.87 -88.92 0.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.297 -1.12 . . . . 0.0 109.415 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' LYS . 53.2 mt 44.81 -175.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 0.0 109.53 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 43' ' ' LYS . 8.0 p -146.78 159.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 42' ' ' VAL . 87.4 tttt -122.21 124.85 44.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 110.5 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.637 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 82.12 -15.47 27.63 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.477 -0.765 . . . . 0.0 111.536 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.8 t -86.55 178.75 6.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.589 . . . . 0.0 110.868 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.1 mtm -79.97 145.74 32.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -0.751 . . . . 0.0 110.838 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.56 161.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -126.76 131.15 51.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.501 -0.749 . . . . 0.0 109.598 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -146.81 154.02 40.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.307 -0.871 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -97.12 164.29 18.14 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.079 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.62 143.26 95.29 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.998 1.798 . . . . 0.0 112.589 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m -153.56 87.76 3.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.24 94.22 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.749 1.633 . . . . 0.0 111.609 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 59' ' ' ALA . 2.5 p -98.4 157.9 33.56 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.13 -22.8 3.96 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.074 1.849 . . . . 0.0 112.207 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.82 -6.4 54.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.96 -1.088 . . . . 0.0 109.796 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.32 -86.78 0.44 Allowed Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -111.62 142.84 43.41 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -1.017 . . . . 0.0 109.879 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB2' ' OG1' ' A' ' 54' ' ' THR . . . -154.23 156.22 36.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.577 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.61 141.56 38.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.641 -0.662 . . . . 0.0 109.522 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.95 152.07 49.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.468 -0.77 . . . . 0.0 109.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.16 49.16 14.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.459 -0.776 . . . . 0.0 109.217 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.71 135.72 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.123 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -134.63 150.98 50.73 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.645 0.736 . . . . 0.0 110.139 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -112.95 95.14 32.92 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -51.18 -36.67 56.67 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.975 1.783 . . . . 0.0 111.459 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.609 HD12 ' N ' ' A' ' 67' ' ' LEU . 9.7 mp -61.85 174.33 0.85 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 110.255 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' OE1' ' CB ' ' A' ' 67' ' ' LEU . 54.3 mp0 52.93 29.99 8.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 109.215 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.51 ' CG ' ' N ' ' A' ' 70' ' ' HIS . 86.6 t60 -68.06 167.21 14.42 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.353 -0.842 . . . . 0.0 109.989 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.51 ' N ' ' CG ' ' A' ' 69' ' ' HIS . 56.8 t-80 57.88 167.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.734 0.778 . . . . 0.0 110.837 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.507 ' N ' ' CG ' ' A' ' 70' ' ' HIS . 79.3 m80 -70.25 143.87 52.0 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.544 0.688 . . . . 0.0 110.572 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' A' ' 72' ' ' HIS . 51.4 t-80 -78.0 60.57 2.4 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -67.26 -41.03 86.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.339 -0.851 . . . . 0.0 109.225 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.179 179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.265 0.555 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -103.54 149.08 25.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 109.991 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.31 20.47 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -131.39 143.75 50.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.857 . . . . 0.0 109.953 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.4 p -80.33 113.53 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.668 0.747 . . . . 0.0 110.338 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.06 -35.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.37 0.605 . . . . 0.0 109.465 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 t -171.78 151.15 2.78 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.235 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -105.66 -33.73 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.9 0.857 . . . . 0.0 109.032 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.0 mt 45.93 75.22 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.62 0.724 . . . . 0.0 109.444 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.76 68.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.837 0.827 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.74 80.99 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.633 0.73 . . . . 0.0 109.606 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' TYR . 64.4 mttp -94.07 0.48 55.94 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 55.44 5.66 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.204 0.526 . . . . 0.0 109.945 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' LYS . 49.5 m-85 -123.14 125.07 44.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.14 164.77 19.41 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -132.2 142.16 49.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.748 -0.854 . . . . 0.0 109.89 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.15 136.51 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.51 0.672 . . . . 0.0 109.463 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -93.6 104.0 16.15 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.761 0.791 . . . . 0.0 109.674 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.82 162.86 53.82 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.19 -38.31 90.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.884 . . . . 0.0 109.691 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.25 3.98 25.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.322 -0.861 . . . . 0.0 109.084 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.26 19.72 61.97 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.19 118.44 27.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -1.17 . . . . 0.0 109.927 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.2 p -78.85 157.14 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.532 0.682 . . . . 0.0 110.196 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.57 139.77 42.41 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.568 0.699 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.73 124.96 40.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.771 -0.581 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 27' ' ' LEU . 5.5 tt -103.69 117.39 34.27 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.566 0.698 . . . . 0.0 109.194 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.583 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.6 t60 -117.49 163.08 16.94 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.732 . . . . 0.0 109.374 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.498 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 17.3 m-85 -62.86 -36.83 84.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.743 0.782 . . . . 0.0 108.979 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -63.03 -18.33 63.21 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.406 0.622 . . . . 0.0 109.525 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.87 -6.89 53.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.963 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.54 117.51 30.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.114 -0.991 . . . . 0.0 109.547 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.6 mm? -63.66 -41.23 98.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -118.86 114.52 22.74 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.417 0.627 . . . . 0.0 109.397 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.32 -36.12 81.2 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.733 . . . . 0.0 109.155 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.05 -33.8 75.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 109.862 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -68.97 -4.34 16.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 109.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 81.6 tt0 -63.3 -37.56 87.72 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.95 89.84 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -96.65 3.75 52.31 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.33 -1.1 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 147.79 50.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 42' ' ' VAL . 14.6 p -108.67 113.39 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.96 0.886 . . . . 0.0 109.406 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -95.38 141.59 28.77 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.491 0.662 . . . . 0.0 110.567 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 24.95 51.46 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -148.1 -165.03 2.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.95 -1.324 . . . . 0.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.88 146.86 28.63 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.502 0.668 . . . . 0.0 110.638 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.18 158.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.688 -0.632 . . . . 0.0 109.33 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.53 132.53 54.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.582 0.706 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.17 158.26 40.08 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.681 0.753 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.27 150.38 37.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.66 156.98 59.91 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.474 2.116 . . . . 0.0 111.898 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 13.8 p -141.03 143.33 30.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.632 -0.667 . . . . 0.0 109.308 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 54' ' ' THR . 76.6 Cg_exo -41.49 -68.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.259 1.972 . . . . 0.0 111.779 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 53' ' ' PRO . 2.0 m 33.11 87.25 0.11 Allowed Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.43 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 56' ' ' LYS . 59.0 Cg_endo -77.34 98.14 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.138 1.892 . . . . 0.0 111.686 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 25.9 ttpt 78.12 67.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.76 0.791 . . . . 0.0 109.755 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 172.99 -33.7 0.12 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 57' ' ' GLY . 63.4 mt 59.49 138.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.828 -0.807 . . . . 0.0 110.327 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -159.73 174.27 14.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 110.016 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.34 41.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.875 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.58 148.35 50.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.88 55.49 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.86 0.838 . . . . 0.0 109.213 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -78.52 132.03 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.384 0.612 . . . . 0.0 110.122 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 m -107.26 124.57 49.96 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.802 0.811 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -93.57 113.28 59.85 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' LEU . 92.5 Cg_endo -80.08 -169.7 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.317 2.011 . . . . 0.0 112.468 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 66' ' ' PRO . 80.1 mt 40.41 95.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.102 0.953 . . . . 0.0 110.258 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 57.5 mp0 -89.53 -98.32 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.661 0.743 . . . . 0.0 109.635 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -171.45 84.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -155.06 149.38 26.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.732 -0.605 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 40.04 60.28 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 109.974 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.463 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 63.5 t-80 -154.75 163.06 40.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 109.84 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.463 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 46.2 p-80 -154.43 159.02 40.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 109.744 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.475 ' OXT' ' CG ' ' A' ' 74' ' ' HIS . 51.6 p-80 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.156 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -107.84 178.24 4.58 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.604 0.716 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.82 -159.87 19.09 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -132.67 134.86 45.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.538 -0.978 . . . . 0.0 109.682 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.8 p -82.55 105.48 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.93 -36.42 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -150.36 144.57 25.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.936 -1.102 . . . . 0.0 109.857 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.447 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -125.14 -68.53 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.178 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt 57.93 109.46 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.975 0.893 . . . . 0.0 109.662 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.79 -23.3 27.27 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.904 0.859 . . . . 0.0 108.76 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.43 90.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 109.681 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.5 mttt -97.77 -3.27 39.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.095 -1.003 . . . . 0.0 108.549 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? 52.19 9.35 0.09 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.464 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 12' ' ' LYS . 58.1 m-85 -132.25 148.17 52.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.3 -159.83 10.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.09 155.53 47.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.3 -1.118 . . . . 0.0 109.547 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.69 135.07 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -101.11 118.57 37.25 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.861 0.838 . . . . 0.0 109.768 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.75 156.66 53.36 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 48.1 p-10 -67.27 -27.62 67.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.99 . . . . 0.0 109.549 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 33.1 p-10 -89.41 9.01 27.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.518 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.34 12.51 67.34 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.66 114.69 26.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.006 -1.291 . . . . 0.0 109.917 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 t -78.75 147.75 33.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.605 -0.684 . . . . 0.0 109.672 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.99 141.68 49.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.425 -0.797 . . . . 0.0 109.835 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.41 144.15 40.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.1 tt -114.16 122.28 46.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.792 0.806 . . . . 0.0 109.304 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 7.6 p-80 -139.16 160.51 39.62 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.96 -10.82 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.869 0.842 . . . . 0.0 109.082 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.3 m -67.19 -11.72 58.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 109.37 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -108.38 -23.29 11.95 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.63 128.33 36.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.871 -1.143 . . . . 0.0 109.884 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 64.3 t0 -132.03 129.57 40.24 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.909 0.861 . . . . 0.0 109.563 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 72.9 mmtt -63.92 -36.29 83.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.804 0.812 . . . . 0.0 109.28 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.61 -35.95 81.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.46 -0.775 . . . . 0.0 110.168 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.48 -6.16 2.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.948 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.41 -36.54 84.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.973 -1.079 . . . . 0.0 109.621 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.08 -7.1 81.37 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.59 0.05 52.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -1.189 . . . . 0.0 108.723 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 83.8 mt -69.39 158.68 34.63 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.4 -0.812 . . . . 0.0 109.795 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 5' ' ' VAL . 7.8 p -122.89 138.29 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.735 0.779 . . . . 0.0 109.745 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -107.29 129.98 54.82 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.94 25.21 46.08 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -140.29 173.29 11.66 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.03 -1.277 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.3 144.68 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.879 0.847 . . . . 0.0 111.157 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.74 164.93 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -116.65 129.56 56.22 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.51 163.08 38.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 109.391 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 62' ' ' ALA . 20.3 m-20 -104.59 111.37 65.2 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.39 -0.819 . . . . 0.0 109.469 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.35 137.93 30.7 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.309 2.006 . . . . 0.0 112.597 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.4 m -152.73 133.05 7.51 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.004 . . . . 0.0 109.449 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.67 164.88 33.72 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 112.748 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -172.38 149.74 2.14 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.713 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.6 -31.85 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.541 2.161 . . . . 0.0 111.642 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -77.99 2.57 17.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.369 -0.832 . . . . 0.0 109.3 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.87 -88.17 0.46 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.02 149.26 51.82 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.357 -1.084 . . . . 0.0 109.616 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 54' ' ' THR . . . -137.21 144.93 43.09 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.091 -1.006 . . . . 0.0 110.237 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.83 99.1 8.87 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 124.994 2.331 . . . . 0.0 111.264 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.304 43.2 tptt -82.24 143.36 31.41 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.555 -2.566 . . . . 0.0 113.1 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . . . 42.14 66.79 0.67 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 122.369 1.08 . . . . 0.0 110.005 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -75.05 137.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -123.8 147.91 47.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.48 -0.763 . . . . 0.0 110.071 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -124.99 79.72 64.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' LEU . 88.3 Cg_endo -81.63 -12.01 11.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.763 2.309 . . . . 0.0 111.579 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' PRO . 17.5 mt 33.67 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.453 ' N ' ' CD ' ' A' ' 68' ' ' GLU . 2.1 pm0 -164.15 26.27 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 70' ' ' HIS . 25.7 p80 -61.39 -46.8 88.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.635 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 97.4 m-70 -151.96 143.64 23.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.21 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -87.72 3.8 46.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 108.865 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.455 ' C ' ' H ' ' A' ' 74' ' ' HIS . 78.9 m80 -75.52 146.8 40.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -0.902 . . . . 0.0 110.544 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 73' ' ' HIS . 59.8 t-80 53.3 10.17 0.18 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.775 0.798 . . . . 0.0 109.203 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.455 ' H ' ' C ' ' A' ' 72' ' ' HIS . 86.1 t60 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.907 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.873 0.844 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.24 -172.16 39.18 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.47 141.11 51.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.757 -0.849 . . . . 0.0 109.691 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.8 p -86.19 118.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.526 0.679 . . . . 0.0 109.341 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.02 -28.75 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.657 -0.652 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 t -155.96 153.07 28.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -157.02 112.72 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.598 0.713 . . . . 0.0 109.21 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.24 116.05 27.69 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.757 0.789 . . . . 0.0 109.434 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.09 76.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -37.98 85.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.596 -0.69 . . . . 0.0 109.844 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 14' ' ' TYR . 55.5 mtpt -95.88 11.07 35.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.877 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' LYS . 64.2 pttt 34.95 27.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.521 0.676 . . . . 0.0 110.341 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 12' ' ' LYS . 35.7 t80 -141.7 123.08 14.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.59 0.71 . . . . 0.0 109.347 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -114.4 -164.11 14.83 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -146.78 134.32 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.658 -0.907 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.408 HD11 HD21 ' A' ' 27' ' ' LEU . 96.6 mt -130.8 132.4 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.487 0.661 . . . . 0.0 109.271 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -100.51 116.96 33.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.84 161.56 53.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -65.08 -35.77 82.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.961 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -87.48 9.03 22.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.542 -0.724 . . . . 0.0 109.175 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.65 58.66 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -91.97 118.13 30.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -1.028 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.8 p -80.59 163.97 23.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.718 0.771 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -144.82 150.96 38.04 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.61 0.719 . . . . 0.0 109.69 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.56 143.44 28.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.567 0.698 . . . . 0.0 109.998 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' O ' ' ND1' ' A' ' 28' ' ' HIS . 66.7 mt -110.75 127.26 55.28 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.749 0.785 . . . . 0.0 109.892 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' A' ' 27' ' ' LEU . 10.0 m80 -140.73 159.42 42.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.765 0.793 . . . . 0.0 109.9 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -65.67 -35.17 80.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.1 t -62.33 -17.77 59.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -93.88 -18.56 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.507 -0.745 . . . . 0.0 109.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.0 141.04 32.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.594 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.76 152.82 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.686 0.755 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 70.7 mmtt -66.68 -39.42 88.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' GLU . 98.7 mttt -63.96 -39.38 94.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.481 0.658 . . . . 0.0 109.264 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -51.1 -9.46 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.547 -0.721 . . . . 0.0 109.405 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' LYS . 11.8 pt-20 -70.34 -36.57 74.32 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . -83.2 -8.87 84.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -94.29 0.29 55.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.966 . . . . 0.0 108.995 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.91 153.25 42.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.452 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 42' ' ' VAL . 6.5 p -113.91 120.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.045 0.926 . . . . 0.0 110.104 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -91.0 136.4 33.1 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.684 0.754 . . . . 0.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.08 26.44 40.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -149.22 -164.63 2.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 111.143 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 95.8 mtp -87.48 145.66 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.902 0.858 . . . . 0.0 110.871 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.41 161.1 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -118.91 124.76 47.88 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.864 0.84 . . . . 0.0 110.152 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -149.4 157.03 42.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.503 0.668 . . . . 0.0 109.326 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.26 150.58 38.55 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.72 -0.612 . . . . 0.0 109.365 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.86 152.81 76.86 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.701 2.267 . . . . 0.0 112.813 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.812 0.815 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.56 151.63 15.22 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.809 0.814 . . . . 0.0 109.876 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.37 159.98 14.81 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.471 0.653 . . . . 0.0 109.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -149.79 138.66 21.01 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.645 0.736 . . . . 0.0 110.273 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 58.05 68.6 0.82 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.584 0.707 . . . . 0.0 109.941 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mm -66.24 138.25 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.322 0.582 . . . . 0.0 109.507 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -132.37 141.97 49.12 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.095 0.95 . . . . 0.0 110.307 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -113.43 93.0 25.09 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.494 1.548 0 C-N-CA 122.686 2.257 . . . . 0.0 111.951 -179.311 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.5 pttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.788 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.46 -168.11 36.09 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -130.58 133.8 46.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.735 -0.862 . . . . 0.0 109.816 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.1 p -79.68 111.83 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.752 0.786 . . . . 0.0 109.089 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -73.71 -33.5 38.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.637 -0.664 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -161.63 153.91 19.8 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.014 0.911 . . . . 0.0 110.738 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.454 ' C ' HD22 ' A' ' 9' ' ' LEU . 59.9 t80 -153.16 102.4 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 9' ' ' LEU . 4.1 mm? -96.56 112.09 23.97 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.058 0.932 . . . . 0.0 109.505 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.97 79.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.619 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.49 85.53 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 14' ' ' TYR . 51.7 mtmt -94.05 3.09 55.81 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mttp 47.08 15.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.218 0.533 . . . . 0.0 110.322 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 33.6 t80 -144.96 159.35 43.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.004 0.907 . . . . 0.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -161.58 -152.55 6.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.83 154.1 48.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.89 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 150.03 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.56 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -112.4 116.38 30.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.792 0.806 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.62 160.99 47.76 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.01 -36.2 83.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.919 -0.754 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.76 9.32 19.31 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.61 7.44 81.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -87.41 119.31 27.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.682 -0.893 . . . . 0.0 109.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.5 m -75.47 153.1 37.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.533 0.682 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 58' ' ' LEU . 86.7 m-85 -135.29 132.56 37.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.807 0.813 . . . . 0.0 109.804 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -77.15 140.81 40.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.646 0.736 . . . . 0.0 110.426 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.3 tt -115.51 117.46 30.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.162 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.628 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.8 t-80 -139.46 166.6 24.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.995 0.902 . . . . 0.0 110.156 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 10.1 m-85 -62.36 -40.86 97.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.86 -0.525 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.6 t -60.25 -17.75 44.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.821 -0.549 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.79 -7.24 47.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 109.045 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.2 mt -88.0 125.3 34.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.768 0.794 . . . . 0.0 110.037 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.13 -41.8 97.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -126.65 131.15 51.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.81 0.814 . . . . 0.0 109.038 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -35.75 81.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.784 -0.572 . . . . 0.0 109.545 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -60.47 -36.46 78.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.538 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.58 -10.13 16.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.753 -0.592 . . . . 0.0 109.42 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -67.27 -38.61 85.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.0 -8.97 85.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -98.73 5.11 47.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.408 -1.054 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 156.1 26.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.32 130.3 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.175 0.988 . . . . 0.0 110.088 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.7 ttmt -98.02 135.94 38.99 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.802 0.81 . . . . 0.0 110.907 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.1 59.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -135.52 173.76 11.37 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.264 -1.139 . . . . 0.0 111.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.41 142.16 37.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.739 0.78 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.73 163.5 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -121.0 135.32 55.24 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.867 0.841 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.26 156.51 39.84 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.729 0.776 . . . . 0.0 110.016 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.82 156.63 37.07 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.802 -0.561 . . . . 0.0 109.551 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.94 148.99 64.25 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.43 2.087 . . . . 0.0 112.948 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.812 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 25' ' ' TYR . 2.8 mm? . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.815 0.817 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.47 157.26 14.73 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.761 0.791 . . . . 0.0 110.379 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.29 133.66 46.84 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.87 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -114.64 135.55 54.03 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.907 0.861 . . . . 0.0 110.146 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.24 66.74 1.12 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.583 0.706 . . . . 0.0 110.383 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.06 137.27 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.561 0.696 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 p -132.04 150.28 52.2 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.743 0.782 . . . . 0.0 110.122 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 82.86 36.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 C-N-CA 122.701 2.267 . . . . 0.0 111.348 -179.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.394 0.616 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.56 4.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.77 146.38 52.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.583 -0.951 . . . . 0.0 110.123 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -75.71 113.39 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.54 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.81 -34.33 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -148.94 146.13 27.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.976 -1.077 . . . . 0.0 110.241 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -162.76 102.08 1.02 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.8 mt -115.65 114.14 24.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 109.17 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.27 66.4 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.67 54.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 60.3 pttt -97.14 1.17 49.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.22 -0.925 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 57.71 38.69 27.59 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.296 0.569 . . . . 0.0 109.997 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 59.0 m-85 -149.14 159.45 44.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.18 33.92 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.99 157.61 45.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.458 -1.025 . . . . 0.0 109.627 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.94 135.0 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.689 -0.632 . . . . 0.0 109.565 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -94.07 99.07 11.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.05 170.68 28.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.6 -35.42 80.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.601 -0.94 . . . . 0.0 109.012 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.9 1.21 40.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.011 -1.055 . . . . 0.0 108.887 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.29 24.15 57.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 98.0 mt-10 -89.13 114.14 25.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.14 -1.212 . . . . 0.0 109.718 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' LEU . 42.6 t -74.4 147.61 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.176 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 23' ' ' GLU . 96.3 m-85 -122.36 144.71 48.85 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.469 0.652 . . . . 0.0 109.533 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.9 -43.65 98.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 27' ' ' LEU . 2.2 tt 70.4 96.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.707 ' CG ' ' HG ' ' A' ' 30' ' ' SER . 3.9 t-80 -116.47 119.04 34.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.461 0.648 . . . . 0.0 109.637 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -57.09 -21.37 31.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.707 ' HG ' ' CG ' ' A' ' 28' ' ' HIS . 77.9 p -66.94 -19.29 65.7 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -88.3 3.83 48.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 mt -77.84 133.67 38.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.89 -42.59 99.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -121.32 120.4 34.99 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.4 0.619 . . . . 0.0 109.557 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.14 -36.24 82.95 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.77 -39.17 90.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.737 . . . . 0.0 109.596 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.63 -6.56 26.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.94 -37.36 84.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.177 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.39 88.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -91.93 -3.1 56.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -1.159 . . . . 0.0 109.175 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 169.22 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.516 -0.74 . . . . 0.0 110.348 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.26 143.42 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -110.0 130.0 55.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.532 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.595 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.13 -15.42 62.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -97.39 -175.05 3.1 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.216 -1.167 . . . . 0.0 110.799 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 96.2 mtp -80.05 148.33 31.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.57 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.69 151.13 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.252 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.82 125.57 45.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.725 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.85 147.74 37.67 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.06 152.5 42.52 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.689 -0.632 . . . . 0.0 109.311 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.89 139.5 62.44 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.334 2.023 . . . . 0.0 112.201 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.488 1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.095 179.373 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 24' ' ' SER . 96.6 mt . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 121.514 0.674 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.44 153.95 39.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.23 144.83 43.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.686 -0.633 . . . . 0.0 109.494 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -128.59 143.98 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.48 0.657 . . . . 0.0 109.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.33 71.09 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.452 0.644 . . . . 0.0 110.127 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.46 129.49 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.43 -0.794 . . . . 0.0 108.886 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 m -131.06 155.52 46.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.507 -0.746 . . . . 0.0 110.011 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.86 112.41 58.03 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.493 1.449 0 C-N-CA 122.255 1.97 . . . . 0.0 111.69 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.61 -167.77 33.14 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.164 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -130.99 137.21 49.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.714 -0.874 . . . . 0.0 109.417 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.7 p -81.87 105.95 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.038 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 7' ' ' SER . 15.0 p -71.02 -38.82 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.492 0.663 . . . . 0.0 109.448 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.457 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.8 p -154.49 158.73 40.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -158.4 114.89 2.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.545 -0.722 . . . . 0.0 109.148 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 100.43 8.82 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.68 72.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.759 0.79 . . . . 0.0 109.339 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.81 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.69 . . . . 0.0 109.939 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.8 mtpt -94.29 4.23 54.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 108.969 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mttp 56.29 4.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.293 0.568 . . . . 0.0 109.555 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' LYS . 59.1 m-85 -130.8 154.2 48.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.659 0.742 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.02 -169.0 22.76 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.41 151.19 51.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.487 -1.008 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.7 mt -134.19 159.35 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.43 0.633 . . . . 0.0 109.378 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.497 ' N ' HG22 ' A' ' 17' ' ' ILE . 56.2 tt0 -113.05 107.87 16.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.675 0.75 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.5 161.9 53.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 47.3 p-10 -65.01 -33.9 77.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.955 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 93.3 m-20 -90.13 7.2 39.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 108.751 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.7 14.83 64.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 98.2 mt-10 -92.23 119.27 31.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -1.108 . . . . 0.0 109.686 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -78.41 152.67 32.09 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.696 0.76 . . . . 0.0 110.657 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.4 m-85 -138.76 135.35 34.6 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.552 0.691 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.82 144.29 35.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.662 -0.649 . . . . 0.0 110.245 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.5 tt -113.76 120.16 39.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.642 ' N ' HD23 ' A' ' 27' ' ' LEU . 80.8 t60 -136.1 171.72 14.06 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.685 0.755 . . . . 0.0 109.724 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.508 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 5.3 m-85 -61.4 -39.53 91.04 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.665 0.745 . . . . 0.0 109.551 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.453 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 79.2 p -59.62 -20.29 54.89 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.712 -0.617 . . . . 0.0 110.023 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.02 -9.52 36.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 0.0 109.426 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.83 124.02 38.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 109.79 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.37 -41.67 96.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 109.438 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -130.09 114.06 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.578 -0.702 . . . . 0.0 109.243 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -49.67 -27.53 4.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.01 -37.01 85.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.28 -7.0 20.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.118 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -65.96 -33.44 75.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.748 . . . . 0.0 109.068 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 -7.82 85.24 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' CD ' ' N ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -93.8 0.65 56.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -1.128 . . . . 0.0 108.738 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.12 150.27 47.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.584 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.57 126.81 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.885 0.85 . . . . 0.0 109.893 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.91 139.33 30.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.725 0.774 . . . . 0.0 110.835 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.37 51.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -146.1 -164.85 2.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.909 -1.348 . . . . 0.0 110.949 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtm -86.35 142.73 28.27 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.724 0.773 . . . . 0.0 110.543 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.8 135.88 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.551 0.691 . . . . 0.0 109.284 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -94.98 126.94 40.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -0.76 . . . . 0.0 109.855 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 2' ' ' LYS . 55.1 p90 -150.08 149.42 30.27 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.47 150.71 36.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 179.83 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.486 1.369 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.459 179.711 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.924 0.869 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 143.69 29.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.03 167.08 12.65 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.759 0.79 . . . . 0.0 110.017 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -149.53 142.83 25.16 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.795 0.807 . . . . 0.0 110.053 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.56 74.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.838 0.828 . . . . 0.0 110.566 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.76 133.43 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 109.249 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.3 t -138.12 138.8 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.023 0.916 . . . . 0.0 110.05 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.82 127.1 55.39 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo . . . . . 0 C--N 1.312 -1.381 0 C-N-CA 122.005 1.803 . . . . 0.0 110.825 179.269 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttm . . . . . 0 N--CA 1.497 1.901 0 CA-C-O 121.834 0.826 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.88 -174.38 36.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -133.12 142.05 48.49 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.693 -0.886 . . . . 0.0 110.049 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.909 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.4 p -82.13 113.83 22.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.846 0.831 . . . . 0.0 108.98 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -80.22 -38.38 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.425 -0.797 . . . . 0.0 109.418 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 6' ' ' VAL . 95.3 p -161.45 162.57 30.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.858 0.837 . . . . 0.0 110.217 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.453 ' C ' HD22 ' A' ' 9' ' ' LEU . 25.9 t80 -153.08 109.82 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.0 mm? -99.87 106.59 18.45 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.024 0.916 . . . . 0.0 109.655 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.52 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.389 0.614 . . . . 0.0 109.567 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.11 79.2 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 98.9 mttt -89.33 -4.31 58.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.391 -0.818 . . . . 0.0 109.003 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.33 -17.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 23.2 p90 -132.52 158.19 42.75 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.49 -138.73 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -148.91 151.43 34.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.669 -0.901 . . . . 0.0 110.193 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.1 133.44 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.545 0.688 . . . . 0.0 109.257 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -103.44 116.97 33.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.947 0.88 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.94 160.45 52.76 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -68.62 -24.87 64.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.82 -0.812 . . . . 0.0 109.898 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -91.29 6.86 43.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.4 -0.813 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.1 72.3 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -92.37 115.89 28.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.392 -1.063 . . . . 0.0 110.132 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.9 p -81.14 148.25 29.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.609 0.719 . . . . 0.0 110.006 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.53 136.98 43.46 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.806 0.813 . . . . 0.0 110.015 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -73.43 139.61 45.97 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.549 0.69 . . . . 0.0 109.963 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.2 tt -113.99 120.59 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.812 0.815 . . . . 0.0 109.663 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.668 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.2 163.1 32.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.852 0.834 . . . . 0.0 109.107 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.862 -0.524 . . . . 0.0 109.773 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -57.54 -17.93 16.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 109.366 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.29 -9.87 34.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.464 -0.773 . . . . 0.0 108.986 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.96 112.03 22.12 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.922 0.868 . . . . 0.0 109.593 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -63.26 -41.57 99.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.869 -0.52 . . . . 0.0 109.655 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 36' ' ' LYS . 91.1 m-20 -128.53 106.76 9.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -54.91 -6.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.565 -0.71 . . . . 0.0 109.129 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 34' ' ' ASP . 68.6 mttm -64.54 -37.88 89.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.584 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.16 -7.55 49.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.484 -0.76 . . . . 0.0 109.512 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -56.79 -44.93 82.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.637 -0.664 . . . . 0.0 109.622 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.39 -9.57 86.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 41' ' ' LEU . 33.8 mtmm -116.13 16.65 15.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.418 -1.048 . . . . 0.0 109.121 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 40' ' ' LYS . 5.3 mt -55.14 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 109.935 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG21 HG12 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -127.0 162.15 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.256 1.027 . . . . 0.0 110.636 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -145.53 95.07 2.6 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.75 0.786 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.909 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 94.55 -15.72 62.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' HG12 ' A' ' 5' ' ' VAL . 20.9 m -84.95 165.37 17.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -1.216 . . . . 0.0 110.54 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.9 mtm -66.75 143.6 56.84 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.962 0.887 . . . . 0.0 111.052 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.606 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -130.95 161.62 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 109.259 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -130.32 129.08 42.74 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.791 0.805 . . . . 0.0 110.009 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -144.01 160.57 40.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.503 0.668 . . . . 0.0 109.617 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.81 154.29 38.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.836 -0.54 . . . . 0.0 109.589 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -49.73 142.89 24.01 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.652 2.235 . . . . 0.0 112.745 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 p . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.714 0.769 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.38 155.07 14.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.698 0.761 . . . . 0.0 109.903 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.48 137.08 47.03 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.856 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -133.39 142.55 48.42 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.878 0.847 . . . . 0.0 109.898 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.51 48.81 9.26 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.627 0.727 . . . . 0.0 109.773 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.61 139.23 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.546 0.688 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -133.74 149.78 51.48 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.691 0.758 . . . . 0.0 110.028 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -105.92 103.31 43.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 C--N 1.313 -1.318 0 C-N-CA 122.788 2.326 . . . . 0.0 111.316 -179.831 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.26 -163.85 20.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -141.76 144.17 33.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.572 -0.958 . . . . 0.0 110.117 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 p -77.48 126.08 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.741 -0.599 . . . . 0.0 109.759 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.34 -35.32 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.741 . . . . 0.0 109.588 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 m -151.28 135.4 16.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.996 -1.065 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CD1' HD13 ' A' ' 27' ' ' LEU . 52.6 t80 -157.01 114.99 3.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -119.45 124.87 47.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.691 0.758 . . . . 0.0 109.287 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -24.14 67.75 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.476 0.655 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.891 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 51.6 mtmt -97.03 -3.69 40.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 109.163 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 65.61 -8.46 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.527 0.68 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 33.6 p90 -150.9 161.37 42.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.754 . . . . 0.0 109.254 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.51 -119.36 0.97 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.3 153.16 40.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.655 -0.909 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 145.58 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.532 0.682 . . . . 0.0 109.739 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -107.92 108.71 19.98 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.764 0.793 . . . . 0.0 109.379 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.24 158.48 53.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.4 p-10 -66.09 -34.3 77.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.828 -0.807 . . . . 0.0 109.89 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 52.0 t0 -89.23 10.55 21.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.213 -0.929 . . . . 0.0 109.544 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.37 14.98 69.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -97.31 121.5 39.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.158 -1.201 . . . . 0.0 109.8 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.2 p -78.16 153.56 31.95 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.736 0.779 . . . . 0.0 110.714 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -141.81 136.52 30.71 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.716 0.77 . . . . 0.0 109.656 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.73 144.19 39.46 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.617 0.722 . . . . 0.0 110.167 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.6 tt -111.54 120.82 43.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.572 0.701 . . . . 0.0 109.318 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.647 ' N ' HD23 ' A' ' 27' ' ' LEU . 39.2 m80 -128.82 138.85 52.29 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.757 0.789 . . . . 0.0 109.511 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 30' ' ' SER . 20.8 p90 -66.88 -35.1 79.26 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.068 0.937 . . . . 0.0 109.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 37.4 m -63.66 -33.12 74.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.49 0.662 . . . . 0.0 109.791 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.25 -0.7 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.91 139.54 37.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.294 -0.879 . . . . 0.0 109.659 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.77 -41.52 97.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -128.22 121.13 28.64 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -45.83 -27.72 0.92 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.568 0.699 . . . . 0.0 109.674 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -64.83 -32.57 74.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.01 -14.41 22.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.515 -0.741 . . . . 0.0 109.175 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.08 -31.48 69.08 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.73 0.776 . . . . 0.0 109.473 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.2 -3.72 75.39 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.6 7.73 32.91 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.324 -1.104 . . . . 0.0 108.852 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.7 151.1 48.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.436 0.636 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.55 137.93 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.807 0.813 . . . . 0.0 109.938 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -107.28 130.84 54.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.769 0.795 . . . . 0.0 110.453 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 92.53 -23.0 30.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -91.46 179.19 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -1.132 . . . . 0.0 111.15 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtm -82.62 153.38 25.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.507 0.67 . . . . 0.0 110.493 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.4 m -133.97 161.58 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.746 -0.596 . . . . 0.0 109.542 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -120.94 131.99 54.67 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.551 0.691 . . . . 0.0 109.436 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -150.74 159.94 44.18 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.569 0.699 . . . . 0.0 109.816 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.65 153.19 37.9 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.43 133.9 39.32 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.885 2.39 . . . . 0.0 112.966 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.303 -1.445 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.857 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.45 0.643 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.93 146.15 35.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.716 0.769 . . . . 0.0 109.658 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.93 155.72 18.52 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.551 0.691 . . . . 0.0 109.863 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.21 147.29 34.64 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.728 0.775 . . . . 0.0 109.932 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.93 51.04 14.26 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.732 0.777 . . . . 0.0 109.87 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.53 139.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.0 109.547 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.528 ' C ' HD22 ' A' ' 65' ' ' LEU . 29.4 t -129.72 149.66 51.37 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.891 0.853 . . . . 0.0 109.917 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.889 HD22 ' N ' ' A' ' 65' ' ' LEU . 1.1 mm? -111.63 81.42 3.27 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.118 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 N--CA 1.492 1.44 0 C-N-CA 122.472 2.114 . . . . 0.0 111.589 -179.397 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 pttt . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.04 -159.03 9.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -133.93 149.87 51.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 109.645 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -80.74 123.35 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.403 ' H ' HG12 ' A' ' 6' ' ' VAL . 6.1 p -93.18 -31.16 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -157.18 149.28 22.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 110.071 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.414 ' H ' ' HE2' ' A' ' 43' ' ' LYS . 55.5 t80 -158.77 106.14 1.84 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.523 HD12 ' N ' ' A' ' 9' ' ' LEU . 10.8 mp -101.21 110.87 22.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.829 . . . . 0.0 109.025 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.28 84.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.655 -0.653 . . . . 0.0 109.865 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.23 92.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 14' ' ' TYR . 9.9 mtpm? -98.93 7.57 45.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.355 -0.84 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' LYS . 56.1 pttt 35.06 30.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.551 0.691 . . . . 0.0 110.381 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 12' ' ' LYS . 88.5 t80 -139.58 140.84 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.34 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.35 -161.75 14.02 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.3 157.85 45.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.497 -1.002 . . . . 0.0 109.494 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.85 132.61 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.63 104.11 15.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.353 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.24 158.43 52.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 39.4 p-10 -64.66 -34.03 77.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.442 -1.034 . . . . 0.0 109.106 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.8 t70 -86.88 6.46 31.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 108.991 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.11 16.89 70.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -93.6 117.94 30.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.962 -1.317 . . . . 0.0 109.636 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -74.36 149.8 40.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.475 -0.766 . . . . 0.0 109.367 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -129.21 139.45 51.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.024 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -74.44 144.05 44.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.68 . . . . 0.0 109.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.578 HD23 ' C ' ' A' ' 27' ' ' LEU . 5.9 tt -124.51 116.83 23.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.472 -0.768 . . . . 0.0 109.211 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 27' ' ' LEU . 84.7 t60 -140.54 170.27 16.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.827 . . . . 0.0 109.411 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.47 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 2.7 m-85 -62.19 -44.11 97.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.106 -0.996 . . . . 0.0 109.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.459 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 16.3 m -55.6 -20.2 12.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.859 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.24 -6.48 53.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.107 -0.995 . . . . 0.0 109.973 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.63 130.87 36.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.78 -41.71 99.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.494 -0.754 . . . . 0.0 109.091 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -142.11 131.39 23.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.403 -0.811 . . . . 0.0 109.125 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -61.93 -31.19 71.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.211 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -59.18 -36.35 75.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 108.851 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.88 -8.29 35.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.35 -42.07 94.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.02 -20.93 71.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -84.75 -0.21 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.125 -1.221 . . . . 0.0 109.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' CZ ' ' A' ' 8' ' ' TYR . 40.8 mt -67.32 147.94 52.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -127.12 136.69 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.49 -0.756 . . . . 0.0 109.563 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.9 ttmt -101.27 138.37 38.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 0.0 110.297 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 88.24 -23.66 14.26 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 m -88.45 178.33 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.94 -1.329 . . . . 0.0 110.513 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -85.4 149.9 25.1 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.586 -0.696 . . . . 0.0 109.906 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.62 164.77 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 109.144 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -124.25 136.15 53.93 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.498 -0.751 . . . . 0.0 109.455 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.1 157.32 43.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -93.93 153.26 40.93 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.162 -0.961 . . . . 0.0 109.295 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' THR . 53.7 Cg_endo -67.13 142.17 60.2 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.638 2.225 . . . . 0.0 112.384 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 5.0 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.199 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.3 mt . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.386 0.612 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -153.48 153.93 33.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -99.87 -83.04 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.312 -0.867 . . . . 0.0 109.466 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' ALA . 56.3 tttm 60.31 144.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.496 -0.752 . . . . 0.0 110.548 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.11 43.1 32.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 0.0 110.002 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.17 140.29 18.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.149 -0.969 . . . . 0.0 109.03 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 m -121.27 153.21 37.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.738 . . . . 0.0 109.208 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -133.16 82.82 52.83 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 C--N 1.312 -1.369 0 C-N-CA 121.956 1.771 . . . . 0.0 111.152 -179.817 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt . . . . . 0 N--CA 1.5 2.031 0 CA-C-O 121.742 0.782 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.58 -174.32 41.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -135.89 134.54 38.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.846 -0.796 . . . . 0.0 109.618 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.9 p -75.84 120.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.797 0.808 . . . . 0.0 109.612 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 7' ' ' SER . 8.3 p -91.27 -38.96 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.668 -0.645 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 74.8 m -134.31 147.66 50.63 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.689 0.757 . . . . 0.0 110.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.608 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 66.5 t80 -161.06 117.63 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.71 110.19 16.99 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.834 0.826 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.16 85.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 109.832 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.01 90.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.849 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.95 2.19 40.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 43.0 39.21 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.504 0.669 . . . . 0.0 110.09 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 93.3 t80 -147.64 158.0 43.81 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.68 0.753 . . . . 0.0 109.955 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -176.73 -162.84 28.02 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -133.71 155.88 48.96 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.575 0.703 . . . . 0.0 109.26 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.4 137.5 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.5 0.667 . . . . 0.0 109.447 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -95.16 109.16 21.28 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.11 149.39 49.01 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -68.76 -22.64 64.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.684 -0.892 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 58.7 t0 -76.16 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.0 56.05 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.16 130.54 35.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -1.0 . . . . 0.0 110.356 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -76.23 145.9 39.43 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.56 0.695 . . . . 0.0 110.037 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.34 139.89 50.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.905 0.86 . . . . 0.0 110.117 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.13 143.72 47.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.701 0.762 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.5 tt -108.2 119.35 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.0 109.689 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.629 ' N ' HD23 ' A' ' 27' ' ' LEU . 40.7 m80 -129.09 128.26 43.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.157 0.979 . . . . 0.0 109.395 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CG ' ' N ' ' A' ' 30' ' ' SER . 22.7 p90 -64.47 -34.75 78.93 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.964 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 29.7 m -63.29 -33.15 74.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.718 -0.613 . . . . 0.0 110.672 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 60' ' ' ALA . 98.7 mt-10 -73.07 2.77 6.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.38 143.35 33.58 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.634 0.731 . . . . 0.0 109.865 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.33 -40.17 96.56 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 36' ' ' LYS . 9.5 p30 -137.46 101.85 4.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.904 0.859 . . . . 0.0 108.775 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -52.23 -7.27 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.788 -0.57 . . . . 0.0 109.621 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 34' ' ' ASP . 43.8 pttt -68.57 -30.1 68.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.225 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 39.7 p30 -79.4 -2.68 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -49.58 -42.59 44.85 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.7 -6.99 82.32 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -95.09 1.27 54.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -1.077 . . . . 0.0 109.517 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.64 152.88 44.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 109.868 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.45 126.4 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 122.118 0.961 . . . . 0.0 109.816 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.608 ' NZ ' ' H ' ' A' ' 8' ' ' TYR . 50.0 tttp -99.34 139.01 35.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.747 0.784 . . . . 0.0 110.817 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 25.19 51.49 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.9 t -143.82 -179.6 6.57 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.137 -1.213 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.12 146.84 34.91 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.745 0.783 . . . . 0.0 110.461 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.0 161.54 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.495 0.665 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -118.16 126.06 51.46 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.863 0.84 . . . . 0.0 109.731 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.49 155.79 39.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.441 0.639 . . . . 0.0 109.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -106.61 163.2 17.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.03 147.4 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.538 2.158 . . . . 0.0 112.718 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.674 -0.641 . . . . 0.0 109.71 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.3 mt . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 121.582 0.705 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.86 155.39 34.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.677 0.751 . . . . 0.0 110.015 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 31' ' ' GLU . . . -116.01 129.92 56.58 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.591 0.71 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 160.48 26.98 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.901 0.858 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.2 48.4 19.54 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.507 0.67 . . . . 0.0 109.571 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -72.31 132.1 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -135.95 154.62 51.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.764 0.792 . . . . 0.0 110.734 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.08 98.25 33.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.489 1.233 0 C-N-CA 122.792 2.328 . . . . 0.0 111.074 -179.594 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 mttp . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.57 0.7 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.33 -172.5 38.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -135.55 134.17 39.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.691 -0.888 . . . . 0.0 109.895 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 5' ' ' VAL . 13.6 p -78.03 106.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.766 0.793 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -72.18 -39.01 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.275 0.56 . . . . 0.0 109.662 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.41 ' N ' HG13 ' A' ' 6' ' ' VAL . 42.7 t -159.07 156.79 29.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 110.469 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' OH ' ' CZ ' ' A' ' 29' ' ' PHE . 68.3 t80 -155.03 109.59 2.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.14 116.59 30.07 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.766 0.793 . . . . 0.0 109.294 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 -25.45 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.651 . . . . 0.0 109.336 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.2 -35.85 81.67 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.626 0.727 . . . . 0.0 109.443 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 14' ' ' TYR . 1.8 mptm? -90.89 7.09 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 61.47 -7.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.387 0.613 . . . . 0.0 109.705 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.5 p90 -161.48 163.8 30.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.462 -0.774 . . . . 0.0 109.635 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.29 -131.98 2.66 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -143.34 152.27 41.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.924 . . . . 0.0 110.036 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.94 133.15 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -95.66 106.71 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.81 0.814 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.36 163.86 54.54 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.71 -39.38 94.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.757 -0.849 . . . . 0.0 109.672 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -82.31 0.91 39.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.53 -0.731 . . . . 0.0 109.386 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.52 62.22 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 80.1 mm-40 -88.55 119.46 29.02 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.085 -1.244 . . . . 0.0 110.109 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -76.37 147.71 37.89 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.662 0.744 . . . . 0.0 110.279 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.6 m-85 -136.34 137.56 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.625 0.726 . . . . 0.0 109.616 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.15 141.11 32.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.4 tt -112.83 116.82 30.65 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.809 0.814 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 13.6 m-70 -119.86 146.78 45.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 26.3 m-85 -63.56 -39.23 93.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.34 0.59 . . . . 0.0 109.918 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -57.59 -18.54 20.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.442 -0.786 . . . . 0.0 110.024 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.02 -7.46 51.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.141 -0.974 . . . . 0.0 110.304 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.25 138.03 38.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 0.0 109.784 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.75 -41.37 98.02 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.454 0.645 . . . . 0.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -135.94 125.54 25.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.9 -11.43 27.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.499 0.666 . . . . 0.0 109.509 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.42 -14.92 56.56 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -76.79 -4.84 45.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 109.384 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -55.41 -46.07 76.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.748 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.33 -4.44 84.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -94.92 -3.8 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 108.961 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.21 149.14 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.714 -0.616 . . . . 0.0 110.136 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.2 134.56 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.871 0.843 . . . . 0.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.39 133.92 41.34 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.942 0.877 . . . . 0.0 111.29 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 86.47 -12.13 61.77 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' VAL . 8.6 t -96.86 177.11 5.74 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.985 -1.303 . . . . 0.0 110.947 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.6 mtp -81.09 147.63 30.02 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.766 0.793 . . . . 0.0 110.396 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.14 157.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -113.81 132.61 55.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.41 157.67 38.85 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.63 150.78 37.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.42 163.66 38.32 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.35 2.7 . . . . 0.0 113.249 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.61 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 121.892 0.853 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.29 158.63 30.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.3 130.5 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.941 0.877 . . . . 0.0 110.344 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.62 55.71 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.815 0.817 . . . . 0.0 109.388 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.49 136.23 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.56 0.695 . . . . 0.0 110.636 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 m -127.43 151.87 48.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.032 0.92 . . . . 0.0 109.865 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.25 85.65 38.29 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo . . . . . 0 C--N 1.307 -1.657 0 C-N-CA 122.649 2.232 . . . . 0.0 111.902 -179.373 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.696 0.76 . . . . 0.0 110.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.08 -150.28 5.65 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.98 141.24 49.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.589 -0.948 . . . . 0.0 109.579 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.9 p -81.71 118.33 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.06 -31.14 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.024 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.7 m -157.06 153.95 28.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.805 -1.184 . . . . 0.0 110.839 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' LEU . 38.8 t80 -160.28 -74.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.716 0.77 . . . . 0.0 108.953 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' TYR . 9.6 mt 57.8 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.782 0.801 . . . . 0.0 110.079 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.9 68.51 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.697 0.76 . . . . 0.0 109.152 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.87 -35.18 79.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.7 mtpt -93.6 -7.46 43.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 108.792 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 57.86 -4.09 0.05 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.313 0.578 . . . . 0.0 110.112 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.0 p90 -161.04 164.18 31.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.99 -129.48 1.03 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -143.15 154.76 44.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.54 133.77 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.549 0.69 . . . . 0.0 109.23 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -90.39 97.15 11.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.759 0.79 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.11 163.04 42.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 40.5 p-10 -66.13 -34.8 78.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.789 -0.83 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 54.6 t0 -83.6 2.7 36.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.088 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.58 14.9 72.33 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 97.4 mt-10 -91.85 123.16 35.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.484 -1.009 . . . . 0.0 109.728 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 58' ' ' LEU . 88.5 p -76.78 150.37 36.19 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.585 0.707 . . . . 0.0 110.339 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.7 m-85 -138.12 137.6 37.86 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.352 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -77.81 139.94 39.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.666 -0.646 . . . . 0.0 110.019 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.1 tt -114.97 118.53 33.69 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.54 0.686 . . . . 0.0 109.475 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.627 ' N ' HD23 ' A' ' 27' ' ' LEU . 31.0 t-80 -126.05 137.89 53.67 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 6.2 p90 -59.76 -28.51 67.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.586 0.707 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -63.73 -26.27 68.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 109.397 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -79.34 -0.43 32.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.5 131.22 35.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.071 -1.018 . . . . 0.0 109.573 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LYS . 96.9 m-20 -131.41 98.85 4.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -46.3 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.673 0.749 . . . . 0.0 109.649 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 34' ' ' ASP . 25.8 mtpp -64.5 -35.79 82.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 109.833 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -73.43 -2.35 22.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.0 109.55 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.17 -32.25 73.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.501 -0.75 . . . . 0.0 109.388 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.02 -8.7 81.86 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -103.39 14.44 31.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.302 -1.117 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.05 151.71 44.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 110.082 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.43 133.26 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.779 0.8 . . . . 0.0 109.792 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -101.07 130.81 47.15 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.931 0.872 . . . . 0.0 111.075 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 91.71 -18.12 54.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -93.91 -177.25 4.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.023 -1.281 . . . . 0.0 111.816 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.74 140.53 40.83 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.715 0.769 . . . . 0.0 110.367 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.25 131.04 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -90.09 127.0 35.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.492 -0.755 . . . . 0.0 109.742 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.66 152.72 42.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.672 -0.643 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.72 152.89 38.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.41 143.42 93.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.323 2.015 . . . . 0.0 112.281 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.488 1.436 0 O-C-N 121.448 -0.782 . . . . 0.0 109.23 179.733 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 24' ' ' SER . 68.9 mt . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.569 0.7 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.51 30.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.477 -0.764 . . . . 0.0 109.2 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.71 138.3 46.28 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 110.01 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 87.5 tttt -132.85 138.61 47.1 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.476 0.655 . . . . 0.0 109.358 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.2 61.15 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.687 0.756 . . . . 0.0 109.697 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.18 133.08 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.528 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 p -139.1 153.09 47.97 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.834 0.826 . . . . 0.0 109.828 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -87.67 135.91 33.47 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.747 -0.596 . . . . 0.0 109.472 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo . . . . . 0 C--N 1.311 -1.431 0 C-N-CA 122.356 2.037 . . . . 0.0 111.44 179.141 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.261 0.553 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.6 -149.19 5.6 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.67 142.31 50.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.922 . . . . 0.0 109.687 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -82.15 107.03 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 7' ' ' SER . 10.6 p -76.48 -37.28 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 109.867 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.419 ' N ' HG13 ' A' ' 6' ' ' VAL . 70.5 m -148.23 146.93 28.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.041 -1.037 . . . . 0.0 110.474 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -158.27 105.34 1.9 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.473 HD12 ' N ' ' A' ' 9' ' ' LEU . 6.5 mp -108.9 111.97 23.96 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.51 -29.56 70.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.549 -0.72 . . . . 0.0 109.581 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.76 84.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' TYR . 55.5 mtpt -92.67 -3.7 54.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt 55.19 6.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.742 -0.599 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' LYS . 45.2 m-85 -130.16 154.14 47.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.639 -0.663 . . . . 0.0 109.736 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.73 -170.15 26.05 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.97 149.87 47.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.412 -1.052 . . . . 0.0 109.761 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.01 133.92 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -85.48 108.05 17.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.846 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.21 158.7 53.17 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 45.8 p-10 -65.84 -33.0 74.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.553 -0.969 . . . . 0.0 109.573 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 24.3 p30 -90.11 8.36 33.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 17.07 63.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.8 123.09 40.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -1.211 . . . . 0.0 109.753 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 p -79.41 149.17 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 110.39 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.15 132.94 45.11 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -82.77 144.47 30.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 0.0 109.707 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.2 tt -113.18 122.96 49.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.65 ' N ' HD23 ' A' ' 27' ' ' LEU . 49.4 t-80 -138.81 168.04 20.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.717 . . . . 0.0 109.387 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 14.1 m-85 -65.36 -39.67 92.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.781 . . . . 0.0 109.523 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -61.4 -18.17 57.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.325 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.4 -9.3 48.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.305 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 63' ' ' ILE . 97.0 mt -99.65 107.12 19.15 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.35 -0.844 . . . . 0.0 109.504 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.9 mm? -64.76 -41.94 95.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.482 -0.761 . . . . 0.0 109.165 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -101.28 109.34 21.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.597 -0.689 . . . . 0.0 109.29 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -63.75 -32.64 74.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.184 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.1 -34.57 76.55 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.02 -7.03 31.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 0.0 108.865 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.18 -42.23 90.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.695 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.85 84.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -95.99 -1.04 49.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.271 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.58 144.68 56.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.623 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 42' ' ' VAL . 14.3 p -114.44 121.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.647 0.737 . . . . 0.0 109.623 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -95.2 143.04 26.94 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.934 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 25.35 50.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 t -152.83 -167.0 2.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.725 -1.456 . . . . 0.0 110.981 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.63 144.13 30.5 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.424 0.63 . . . . 0.0 110.768 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.57 161.26 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.437 ' CD2' ' CG ' ' A' ' 66' ' ' PRO . 42.3 m-70 -124.38 136.22 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.457 -0.777 . . . . 0.0 109.837 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.34 155.23 42.47 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.772 . . . . 0.0 109.007 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.12 155.02 71.76 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.922 2.415 . . . . 0.0 112.108 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.557 HG21 ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.456 -0.778 . . . . 0.0 108.924 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 58' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.42 0.628 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 52' ' ' THR . . . -149.87 141.99 24.03 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.34 149.05 30.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.671 -0.643 . . . . 0.0 109.85 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -145.06 128.5 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.837 . . . . 0.0 109.167 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 56.24 61.16 2.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.42 -0.8 . . . . 0.0 109.239 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.43 HD12 HD21 ' A' ' 32' ' ' LEU . 96.4 mt -72.68 139.49 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.632 -0.667 . . . . 0.0 109.596 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 p -136.22 162.19 33.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.722 . . . . 0.0 109.852 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 80.49 47.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' CG ' ' CD2' ' A' ' 48' ' ' HIS . 67.1 Cg_endo . . . . . 0 N--CA 1.494 1.501 0 C-N-CA 123.178 2.585 . . . . 0.0 111.493 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.0 tttt . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.519 0.676 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.66 6.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -132.82 139.56 47.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.552 -0.97 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.4 p -82.93 121.32 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.18 -32.98 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 t -154.38 144.88 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.916 -1.115 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.471 ' CE2' HD12 ' A' ' 41' ' ' LEU . 40.2 t80 -158.73 96.53 1.38 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -100.77 124.55 46.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.167 -0.958 . . . . 0.0 109.378 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.61 -35.79 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.696 0.76 . . . . 0.0 109.268 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.13 -30.06 70.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 14' ' ' TYR . 58.1 mttp -94.35 -7.03 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.015 . . . . 0.0 108.926 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 58.83 -3.94 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.565 -0.71 . . . . 0.0 109.846 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 12' ' ' LYS . 28.0 p90 -151.64 161.23 43.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.042 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 -133.59 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -141.25 157.83 44.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 109.775 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.3 mt -136.26 154.91 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.415 -0.803 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 17' ' ' ILE . 58.0 tt0 -109.79 106.56 16.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.764 0.792 . . . . 0.0 109.146 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.43 161.4 50.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -1.01 . . . . 0.0 109.338 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 30.3 p-10 -89.9 9.99 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.448 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 16.62 65.08 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.49 114.6 26.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -1.164 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -74.86 146.73 41.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 110.363 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -122.81 139.55 53.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.55 -0.718 . . . . 0.0 109.248 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.24 131.08 36.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.554 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.5 tt -104.9 123.41 47.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.088 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.622 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.8 t60 -134.36 153.12 52.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.698 . . . . 0.0 109.412 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.29 -35.57 81.28 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.783 0.801 . . . . 0.0 108.894 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.5 p -61.28 -21.09 63.61 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.446 -0.784 . . . . 0.0 109.62 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.66 -3.89 59.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.068 -1.02 . . . . 0.0 109.645 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.5 126.0 39.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 0.0 109.891 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -63.14 -41.31 99.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' LYS . 93.9 m-20 -127.17 89.72 3.02 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.84 -15.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 109.555 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' ASP . 44.0 mmtm -66.2 -34.96 79.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.163 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 36.3 p30 -73.66 -3.0 25.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.42 -36.09 82.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.39 -12.56 81.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -95.38 6.12 49.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -1.179 . . . . 0.0 109.304 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.471 HD12 ' CE2' ' A' ' 8' ' ' TYR . 94.8 mt -68.94 156.44 38.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.083 -1.01 . . . . 0.0 109.953 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.89 128.76 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.669 0.747 . . . . 0.0 109.663 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -98.76 138.16 36.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.421 -0.8 . . . . 0.0 110.874 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.6 24.91 61.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -141.63 -174.4 4.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 110.744 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtp -79.55 149.36 31.45 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.665 0.745 . . . . 0.0 110.557 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.86 164.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -127.62 133.09 49.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -150.54 163.51 38.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.367 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.75 152.05 38.84 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.241 -0.912 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.04 150.18 88.91 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.623 2.215 . . . . 0.0 112.734 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 121.817 0.818 . . . . 0.0 110.457 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.21 170.72 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.948 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -101.98 -46.22 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.408 -0.808 . . . . 0.0 108.891 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ALA . 88.3 tttt 59.12 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.944 0.878 . . . . 0.0 110.903 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.14 87.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 0.0 109.833 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.2 mt -103.36 137.37 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.505 -0.747 . . . . 0.0 109.697 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 p -134.64 160.16 38.98 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.859 0.838 . . . . 0.0 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.23 81.79 22.1 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo . . . . . 0 C--N 1.308 -1.577 0 C-N-CA 122.755 2.303 . . . . 0.0 111.277 -179.635 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 pttp . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.435 0.636 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.29 -145.86 4.3 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.61 142.13 49.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -1.004 . . . . 0.0 109.751 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.4 p -81.52 112.04 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -70.35 -37.39 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.391 -0.818 . . . . 0.0 109.781 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 t -165.8 156.61 13.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' HD13 ' A' ' 27' ' ' LEU . 73.9 t80 -153.87 107.47 2.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.32 124.57 52.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.508 -0.745 . . . . 0.0 109.639 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.47 77.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.348 0.594 . . . . 0.0 109.9 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.4 73.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 109.96 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' TYR . 13.7 mptt -87.68 6.67 33.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt 64.22 -17.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.2 p90 -160.72 165.21 30.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.043 -1.035 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.32 -136.15 3.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.9 152.53 51.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.993 . . . . 0.0 109.93 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.01 137.57 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -92.55 100.73 13.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.09 174.08 44.4 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -63.52 -39.6 94.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.45 -1.029 . . . . 0.0 109.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -80.94 -0.61 40.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.65 11.75 79.15 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 128.22 34.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.239 . . . . 0.0 109.683 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.4 p -74.22 148.54 41.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.807 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.35 136.81 43.68 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -79.64 137.72 37.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.719 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 27' ' ' LEU . 2.0 tt -109.71 89.37 2.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -96.04 165.11 12.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 0.0 110.264 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.0 -40.59 96.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 t -61.77 -18.37 59.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.178 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.29 -5.34 59.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.4 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.66 125.41 47.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.57 -41.37 98.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -130.75 114.47 15.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.644 -0.66 . . . . 0.0 109.246 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -64.19 -11.68 33.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.351 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.07 -38.65 91.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.52 -5.4 23.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.29 -39.72 76.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.4 -9.19 87.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -96.35 -0.64 49.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.197 -1.178 . . . . 0.0 109.087 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.9 146.79 54.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 42' ' ' VAL . 7.1 p -115.06 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.835 0.826 . . . . 0.0 109.555 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.35 140.73 29.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 110.661 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.21 50.18 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 t -147.46 -164.99 2.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.939 -1.33 . . . . 0.0 110.588 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.2 mtp -82.33 140.28 33.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.724 -0.61 . . . . 0.0 110.372 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.59 135.72 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.706 . . . . 0.0 109.256 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -94.31 128.95 41.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.669 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -144.23 155.85 44.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.73 110.64 59.32 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.531 -0.731 . . . . 0.0 109.258 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.49 146.9 24.21 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.334 2.023 . . . . 0.0 112.559 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.672 -0.643 . . . . 0.0 109.304 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.593 0.711 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.18 150.55 28.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.212 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 151.31 22.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 109.898 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -141.43 133.96 28.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.21 66.84 1.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.682 0.753 . . . . 0.0 109.886 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.81 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.2 p -131.13 148.74 52.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.453 -0.779 . . . . 0.0 109.816 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.85 145.13 29.02 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.496 1.622 0 C-N-CA 122.421 2.08 . . . . 0.0 112.041 179.731 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 121.639 0.733 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.61 -167.1 22.53 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -132.05 137.36 47.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.696 0.76 . . . . 0.0 110.018 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.3 p -76.48 122.11 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.652 0.739 . . . . 0.0 110.1 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.46 -34.83 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -156.32 160.58 39.84 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.92 0.867 . . . . 0.0 110.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -162.99 93.9 0.82 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.401 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 9' ' ' LEU . 10.5 mp -102.01 113.57 26.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.905 0.86 . . . . 0.0 108.822 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.0 -13.97 59.89 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.25 -65.94 0.45 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 109.824 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.18 17.13 14.79 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 56.7 57.83 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.688 0.756 . . . . 0.0 109.782 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.401 ' OH ' HD22 ' A' ' 9' ' ' LEU . 2.9 p90 -151.99 166.11 32.56 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.85 0.833 . . . . 0.0 110.144 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.96 174.08 45.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -133.6 150.7 51.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.765 -0.844 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.98 133.07 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.801 0.81 . . . . 0.0 109.842 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -92.58 115.09 27.79 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.867 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.66 158.33 50.05 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.3 p-10 -66.88 -23.56 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.939 -0.742 . . . . 0.0 110.119 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 82.7 m-20 -89.95 5.27 47.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 109.243 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.68 15.58 65.47 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.74 120.26 39.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.714 -0.874 . . . . 0.0 109.922 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -78.37 155.03 30.25 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 109.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.16 135.26 35.51 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.896 0.855 . . . . 0.0 110.136 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -75.59 142.84 42.62 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.728 0.775 . . . . 0.0 109.849 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 27' ' ' LEU . 9.2 tt -107.98 132.06 53.91 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.746 0.784 . . . . 0.0 109.749 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 29' ' ' PHE . 2.4 t60 -134.3 146.04 49.64 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.984 0.897 . . . . 0.0 110.102 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 4.1 m-85 -62.16 -42.16 98.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 t -62.87 -18.52 63.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 2.7 mp0 -88.99 -0.52 57.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.0 109.218 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 34' ' ' ASP . 75.5 mt -90.22 -3.08 58.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.4 mt 59.27 -70.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 32' ' ' LEU . 43.2 t0 -110.05 105.71 14.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -56.69 -12.22 1.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.821 -0.549 . . . . 0.0 109.533 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.61 -36.55 84.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.0 109.979 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -77.08 -5.54 49.32 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.421 -0.799 . . . . 0.0 109.072 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 79.0 tt0 -57.37 -38.29 73.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.778 -0.576 . . . . 0.0 109.575 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.07 -8.42 86.55 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.11 0.05 50.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.284 -1.127 . . . . 0.0 109.003 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.85 152.01 46.43 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.615 0.721 . . . . 0.0 110.108 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.94 129.92 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.114 0.959 . . . . 0.0 109.722 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -95.78 138.34 33.57 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.713 0.768 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 81.21 25.29 55.41 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 t -140.01 172.59 12.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.154 -1.204 . . . . 0.0 110.707 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.1 mtt -76.3 141.56 41.58 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.938 0.875 . . . . 0.0 109.999 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.19 161.79 39.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.499 0.666 . . . . 0.0 109.682 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -122.07 129.5 52.45 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.921 0.867 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -151.39 158.98 44.44 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.827 0.822 . . . . 0.0 109.797 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.49 143.76 26.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.1 141.78 58.9 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.412 2.074 . . . . 0.0 112.123 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 m . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.756 -0.59 . . . . 0.0 109.708 179.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.501 2.084 0 CA-C-O 121.777 0.799 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.39 148.68 29.77 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.739 0.78 . . . . 0.0 109.983 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.41 133.8 49.58 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.643 0.735 . . . . 0.0 109.706 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -118.29 143.84 46.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.96 0.886 . . . . 0.0 110.409 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.59 62.42 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.739 0.781 . . . . 0.0 109.884 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.79 137.09 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.576 0.703 . . . . 0.0 109.8 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.9 p -133.05 160.23 37.77 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.999 0.904 . . . . 0.0 110.107 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.11 98.33 38.7 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 N--CA 1.493 1.459 0 C-N-CA 122.612 2.208 . . . . 0.0 111.604 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.295 0.569 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.68 -172.98 32.81 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 44' ' ' GLY . 62.3 tttm -142.99 128.31 18.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -1.088 . . . . 0.0 109.224 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.5 p -74.68 130.52 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.937 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.31 -36.4 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 p -158.48 161.97 37.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.961 -1.087 . . . . 0.0 110.556 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -165.75 93.98 0.57 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 9' ' ' LEU . 11.2 mp -101.21 122.0 42.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -77.07 -14.31 59.83 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.661 -0.65 . . . . 0.0 109.382 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.17 -67.99 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.739 -0.601 . . . . 0.0 110.593 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.93 19.26 15.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.441 -0.787 . . . . 0.0 109.072 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 56.3 66.19 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.83 170.66 21.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.229 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.64 166.79 38.78 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.65 150.89 52.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.619 -0.93 . . . . 0.0 109.282 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 27' ' ' LEU . 96.6 mt -133.96 147.81 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -94.95 117.15 29.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.463 -0.773 . . . . 0.0 109.576 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 159.46 52.69 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.72 -35.53 81.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.387 -1.066 . . . . 0.0 109.603 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -80.64 -0.75 39.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.212 -0.93 . . . . 0.0 109.485 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -5.22 63.13 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 25' ' ' TYR . 20.0 pt-20 -80.24 133.81 36.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.124 -1.221 . . . . 0.0 110.364 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.6 p -83.41 162.77 20.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 23' ' ' GLU . 62.4 m-85 -134.87 146.57 49.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.79 125.41 34.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.253 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.4 tt -103.39 122.23 44.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.815 . . . . 0.0 108.927 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.6 t-80 -135.82 166.79 22.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 11.3 m-85 -62.13 -40.04 94.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HG ' ' CE1' ' A' ' 28' ' ' HIS . 1.1 m -60.99 -21.5 63.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.453 -0.78 . . . . 0.0 109.991 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.17 -6.76 54.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.26 107.13 18.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.04 -41.38 97.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -113.69 97.47 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.59 -27.01 68.65 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.831 . . . . 0.0 109.234 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.86 -27.79 66.97 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.0 -9.35 58.64 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.456 -0.777 . . . . 0.0 109.264 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -64.61 -35.42 80.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 110.01 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.42 0.97 38.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -149.92 58.08 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -1.205 . . . . 0.0 108.982 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mt -81.49 -165.95 1.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -120.84 159.84 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.749 0.785 . . . . 0.0 109.714 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.4 93.65 2.18 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 98.63 -13.85 62.3 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.6 m -86.49 -177.66 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.409 . . . . 0.0 111.021 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.06 145.95 29.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.568 -0.708 . . . . 0.0 110.434 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.542 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -133.29 164.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -135.17 135.33 40.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.374 -0.829 . . . . 0.0 109.456 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.41 163.7 38.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.56 153.06 38.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.96 139.36 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.953 1.769 . . . . 0.0 112.874 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.408 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.6 mt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 121.276 0.56 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.73 151.38 21.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.32 119.43 39.46 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 32.9 ttpt -115.79 147.81 40.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.568 -0.708 . . . . 0.0 110.062 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.52 48.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.392 0.615 . . . . 0.0 109.432 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.43 135.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.808 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.9 m -126.92 149.56 49.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 109.275 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.59 97.35 36.41 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo . . . . . 0 N--CA 1.49 1.307 0 C-N-CA 122.606 2.204 . . . . 0.0 112.483 -179.606 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.212 0.53 . . . . 0.0 109.755 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.34 175.64 20.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.5 145.61 47.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.87 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.2 p -88.43 112.46 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 7' ' ' SER . 7.5 p -70.77 -41.59 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.535 -0.728 . . . . 0.0 109.745 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 6' ' ' VAL . 31.1 p -160.33 160.62 32.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.573 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.488 ' C ' HD12 ' A' ' 9' ' ' LEU . 40.5 t80 -156.84 111.27 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.68 0.752 . . . . 0.0 109.61 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 8' ' ' TYR . 11.1 mp -106.83 102.4 11.77 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.2 -23.86 65.79 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.09 96.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.026 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.4 mtmt -97.23 4.24 51.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 59.1 2.95 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.308 0.575 . . . . 0.0 110.12 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' LYS . 62.0 m-85 -118.89 152.3 36.54 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.0 109.895 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.97 -168.9 21.67 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -137.51 149.71 46.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.754 -0.851 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.1 138.49 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.487 0.66 . . . . 0.0 109.527 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -99.46 105.25 17.16 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.761 0.791 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.44 160.66 51.22 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 43.0 p-10 -66.59 -33.37 75.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.649 -0.912 . . . . 0.0 109.712 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 84.7 m-20 -87.99 6.46 35.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.774 -0.579 . . . . 0.0 109.496 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.84 16.95 64.39 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.5 mt-10 -93.68 118.54 31.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.99 . . . . 0.0 109.673 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 p -77.29 153.22 34.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.798 0.809 . . . . 0.0 110.06 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 98.0 m-85 -141.47 134.97 29.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.603 0.716 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -79.35 140.56 37.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.699 0.761 . . . . 0.0 110.108 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.58 HD23 ' C ' ' A' ' 27' ' ' LEU . 4.4 tt -112.61 115.0 27.9 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.756 0.788 . . . . 0.0 109.254 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' N ' HD23 ' A' ' 27' ' ' LEU . 52.3 t-80 -141.25 167.32 22.45 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.841 0.829 . . . . 0.0 110.303 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 13.5 m-85 -61.65 -35.41 77.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.844 -0.535 . . . . 0.0 110.146 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.8 p -62.99 -20.27 65.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.619 -0.675 . . . . 0.0 109.863 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -93.61 -11.02 32.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.11 116.03 28.35 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.372 -0.83 . . . . 0.0 109.569 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.52 -42.14 95.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.537 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -117.65 134.76 54.55 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.738 0.78 . . . . 0.0 109.589 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 mptm? -77.45 -12.42 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 19.2 ptmt -65.4 -41.96 93.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.717 -0.615 . . . . 0.0 110.313 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 98.0 m-20 -78.33 -8.31 58.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 109.606 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.36 -36.81 79.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 109.108 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.6 -9.75 80.76 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 68.3 mttm -98.46 -0.76 42.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.175 -1.191 . . . . 0.0 109.296 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.9 145.74 15.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.739 . . . . 0.0 110.184 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -124.18 125.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 122.018 0.913 . . . . 0.0 109.47 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' VAL . 7.4 tmtm? -95.69 137.24 35.04 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.908 0.861 . . . . 0.0 110.854 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 25.93 38.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 t -142.06 -164.95 1.91 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.026 -1.279 . . . . 0.0 111.343 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.6 mtp -88.49 139.94 29.97 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.965 0.888 . . . . 0.0 110.961 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.24 159.8 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.368 0.604 . . . . 0.0 109.503 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -124.05 132.32 53.66 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 110.07 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -154.99 161.16 41.46 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.617 0.722 . . . . 0.0 109.801 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -102.73 150.69 37.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.47 159.8 50.38 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.487 2.125 . . . . 0.0 112.542 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.689 -0.632 . . . . 0.0 109.474 179.826 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt . . . . . 0 N--CA 1.494 1.748 0 CA-C-O 121.753 0.787 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.3 156.38 35.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.703 0.763 . . . . 0.0 109.728 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.31 87.86 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -89.75 148.4 23.27 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.833 0.825 . . . . 0.0 110.294 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.86 58.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.617 0.723 . . . . 0.0 109.616 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.45 129.37 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.917 0.865 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.1 m -135.79 126.38 27.05 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.645 0.735 . . . . 0.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -89.26 132.35 37.84 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo . . . . . 0 N--CA 1.49 1.265 0 C-N-CA 122.412 2.075 . . . . 0.0 111.319 179.431 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.28 -166.42 28.28 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -135.13 138.25 43.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.876 -0.779 . . . . 0.0 110.313 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 44' ' ' GLY . 8.0 p -74.12 126.19 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.359 0.599 . . . . 0.0 109.409 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 7' ' ' SER . 9.2 p -94.37 -42.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.493 ' N ' HG13 ' A' ' 6' ' ' VAL . 66.1 m -152.85 153.75 33.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.992 0.901 . . . . 0.0 110.524 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -161.02 117.18 2.23 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.681 0.753 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.87 110.34 17.07 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 109.231 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.64 -34.49 77.07 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.529 0.681 . . . . 0.0 109.401 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -34.33 75.53 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' TYR . 28.6 mmtp -95.7 -1.58 49.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? 57.67 6.54 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.452 0.644 . . . . 0.0 109.57 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' LYS . 47.6 m-85 -123.02 160.13 26.95 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.911 0.863 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.91 -170.16 28.43 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.03 148.34 33.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.791 -0.829 . . . . 0.0 109.604 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.69 132.89 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.74 0.781 . . . . 0.0 109.903 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.412 HE21 ' HA2' ' A' ' 22' ' ' GLY . 61.7 tp60 -97.07 113.63 25.2 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.921 0.867 . . . . 0.0 110.078 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.88 161.47 52.3 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -64.59 -35.8 82.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.062 -0.669 . . . . 0.0 109.643 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -83.52 9.5 11.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' HE21 ' A' ' 18' ' ' GLN . . . 79.6 21.74 65.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 75.6 mm-40 -95.95 115.22 27.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.703 -0.881 . . . . 0.0 110.049 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.0 t -77.16 146.95 36.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.681 0.753 . . . . 0.0 110.04 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 99.0 m-85 -136.0 136.55 40.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.782 0.801 . . . . 0.0 109.529 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 63.7 m-85 -81.35 143.07 32.46 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.829 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.5 tt -111.62 121.87 46.31 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.154 0.978 . . . . 0.0 109.548 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.589 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.3 t60 -139.0 167.78 21.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.959 0.885 . . . . 0.0 109.602 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 6.2 m-85 -62.05 -38.08 87.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.405 0.621 . . . . 0.0 109.413 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.8 m -61.59 -20.85 63.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 26' ' ' PHE . 94.7 mt-10 -90.84 -11.68 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.842 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.6 mt -96.12 106.08 18.22 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -64.88 -42.22 94.99 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.61 0.719 . . . . 0.0 109.515 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -110.82 90.1 3.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -49.0 -19.5 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -66.16 -35.9 81.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.48 -12.36 61.59 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.341 0.591 . . . . 0.0 109.496 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 78.4 tt0 -66.23 -34.89 79.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.414 0.626 . . . . 0.0 109.591 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.09 -7.76 84.84 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -108.18 15.45 24.16 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.944 . . . . 0.0 109.604 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.59 151.36 46.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.815 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.56 133.3 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.122 0.963 . . . . 0.0 109.607 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -100.23 133.51 44.53 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.33 -24.16 26.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -90.7 -178.87 5.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.979 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.81 148.39 27.81 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.793 0.806 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 160.07 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.474 0.654 . . . . 0.0 109.286 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -121.23 125.28 46.72 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.005 0.907 . . . . 0.0 110.312 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -138.36 150.96 47.09 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.333 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.49 131.12 22.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -48.45 141.68 18.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.739 2.292 . . . . 0.0 113.047 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.4 mt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.619 0.723 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.71 153.7 21.38 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.76 0.79 . . . . 0.0 109.834 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.6 151.09 21.05 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.683 0.754 . . . . 0.0 109.866 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.33 138.71 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.857 0.837 . . . . 0.0 110.039 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.69 66.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.53 0.681 . . . . 0.0 110.173 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.9 130.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.618 0.723 . . . . 0.0 109.654 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -131.36 164.81 24.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.803 0.811 . . . . 0.0 109.78 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.73 79.63 23.45 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo . . . . . 0 C--N 1.306 -1.697 0 C-N-CA 122.574 2.183 . . . . 0.0 111.416 -179.856 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.219 0.533 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.3 -167.56 31.74 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -127.33 143.2 51.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.662 -0.905 . . . . 0.0 109.524 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 44' ' ' GLY . 0.8 OUTLIER -74.53 108.42 6.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.505 -0.747 . . . . 0.0 109.677 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 7' ' ' SER . 7.2 p -69.38 -39.26 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.635 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.411 ' N ' HG13 ' A' ' 6' ' ' VAL . 23.1 p -159.85 165.2 32.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.707 -1.246 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -156.7 114.23 3.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 mp -114.16 111.41 21.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.542 -0.724 . . . . 0.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.5 78.18 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.738 -0.601 . . . . 0.0 109.757 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 99.0 mttt -92.54 -4.44 53.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? 54.21 6.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 52.9 m-85 -132.89 123.52 26.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -106.62 -164.94 22.58 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -141.73 145.15 34.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -1.036 . . . . 0.0 109.122 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.8 136.83 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.795 -0.566 . . . . 0.0 109.825 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -100.49 110.78 22.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 109.181 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.73 155.38 53.45 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.026 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 49.1 p-10 -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.521 -0.988 . . . . 0.0 109.739 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 86.5 m-20 -86.49 10.63 14.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 108.813 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.21 15.44 71.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.65 109.53 21.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.968 -1.313 . . . . 0.0 109.489 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.0 t -73.98 142.48 45.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.1 135.27 52.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 109.662 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -78.02 144.69 36.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.2 tt -109.36 122.42 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.535 ' N ' HD23 ' A' ' 27' ' ' LEU . 5.8 m-70 -127.28 149.94 49.79 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.606 0.717 . . . . 0.0 109.867 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.5 -37.97 89.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 p -61.64 -25.84 67.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.35 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.84 -1.08 46.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.7 mt -93.85 120.47 34.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.949 -1.095 . . . . 0.0 110.347 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.5 mm? -64.43 -42.44 96.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.597 -0.689 . . . . 0.0 109.768 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -117.01 109.66 17.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -65.99 -15.14 62.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.118 -0.989 . . . . 0.0 108.771 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -65.22 -38.79 91.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.388 -0.82 . . . . 0.0 109.255 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.89 -10.83 60.38 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.54 -33.75 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.001 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.9 -20.69 72.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 4.8 mptp? -90.87 -88.92 0.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.297 -1.12 . . . . 0.0 109.415 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' LYS . 53.2 mt 44.81 -175.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 0.0 109.53 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 43' ' ' LYS . 8.0 p -146.78 159.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 42' ' ' VAL . 87.4 tttt -122.21 124.85 44.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 110.5 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.637 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 82.12 -15.47 27.63 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.477 -0.765 . . . . 0.0 111.536 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.8 t -86.55 178.75 6.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.589 . . . . 0.0 110.868 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.1 mtm -79.97 145.74 32.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -0.751 . . . . 0.0 110.838 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.56 161.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -126.76 131.15 51.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.501 -0.749 . . . . 0.0 109.598 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -146.81 154.02 40.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.307 -0.871 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -97.12 164.29 18.14 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.079 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.62 143.26 95.29 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.998 1.798 . . . . 0.0 112.589 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.968 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.498 1.949 0 CA-C-O 121.198 0.523 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.23 156.22 36.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.577 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.61 141.56 38.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.641 -0.662 . . . . 0.0 109.522 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.95 152.07 49.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.468 -0.77 . . . . 0.0 109.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.16 49.16 14.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.459 -0.776 . . . . 0.0 109.217 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.71 135.72 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.123 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -134.63 150.98 50.73 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.645 0.736 . . . . 0.0 110.139 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -112.95 95.14 32.92 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo . . . . . 0 N--CA 1.494 1.518 0 C-N-CA 121.975 1.783 . . . . 0.0 111.459 -179.577 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttp . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.457 0.646 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.31 20.47 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -131.39 143.75 50.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.857 . . . . 0.0 109.953 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.4 p -80.33 113.53 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.668 0.747 . . . . 0.0 110.338 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.06 -35.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.37 0.605 . . . . 0.0 109.465 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 t -171.78 151.15 2.78 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.235 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -105.66 -33.73 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.9 0.857 . . . . 0.0 109.032 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.0 mt 45.93 75.22 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.62 0.724 . . . . 0.0 109.444 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.76 68.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.837 0.827 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.74 80.99 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.633 0.73 . . . . 0.0 109.606 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' TYR . 64.4 mttp -94.07 0.48 55.94 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 55.44 5.66 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.204 0.526 . . . . 0.0 109.945 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' LYS . 49.5 m-85 -123.14 125.07 44.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.14 164.77 19.41 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -132.2 142.16 49.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.748 -0.854 . . . . 0.0 109.89 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.15 136.51 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.51 0.672 . . . . 0.0 109.463 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -93.6 104.0 16.15 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.761 0.791 . . . . 0.0 109.674 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.82 162.86 53.82 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.19 -38.31 90.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.884 . . . . 0.0 109.691 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.25 3.98 25.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.322 -0.861 . . . . 0.0 109.084 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.26 19.72 61.97 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.19 118.44 27.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -1.17 . . . . 0.0 109.927 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.2 p -78.85 157.14 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.532 0.682 . . . . 0.0 110.196 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.57 139.77 42.41 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.568 0.699 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.73 124.96 40.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.771 -0.581 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 27' ' ' LEU . 5.5 tt -103.69 117.39 34.27 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.566 0.698 . . . . 0.0 109.194 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.583 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.6 t60 -117.49 163.08 16.94 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.732 . . . . 0.0 109.374 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.498 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 17.3 m-85 -62.86 -36.83 84.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.743 0.782 . . . . 0.0 108.979 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -63.03 -18.33 63.21 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.406 0.622 . . . . 0.0 109.525 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.87 -6.89 53.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.963 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.54 117.51 30.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.114 -0.991 . . . . 0.0 109.547 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.6 mm? -63.66 -41.23 98.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -118.86 114.52 22.74 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.417 0.627 . . . . 0.0 109.397 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.32 -36.12 81.2 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.733 . . . . 0.0 109.155 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.05 -33.8 75.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 109.862 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -68.97 -4.34 16.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 109.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 81.6 tt0 -63.3 -37.56 87.72 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.95 89.84 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -96.65 3.75 52.31 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.33 -1.1 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 147.79 50.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 42' ' ' VAL . 14.6 p -108.67 113.39 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.96 0.886 . . . . 0.0 109.406 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -95.38 141.59 28.77 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.491 0.662 . . . . 0.0 110.567 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 24.95 51.46 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -148.1 -165.03 2.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.95 -1.324 . . . . 0.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.88 146.86 28.63 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.502 0.668 . . . . 0.0 110.638 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.18 158.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.688 -0.632 . . . . 0.0 109.33 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.53 132.53 54.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.582 0.706 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.17 158.26 40.08 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.681 0.753 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.27 150.38 37.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.66 156.98 59.91 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.474 2.116 . . . . 0.0 111.898 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 13.8 p . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.632 -0.667 . . . . 0.0 109.308 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.4 mt . . . . . 0 N--CA 1.5 2.041 0 CA-C-O 121.763 0.792 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -159.73 174.27 14.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 110.016 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.34 41.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.875 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.58 148.35 50.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.88 55.49 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.86 0.838 . . . . 0.0 109.213 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -78.52 132.03 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.384 0.612 . . . . 0.0 110.122 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 m -107.26 124.57 49.96 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.802 0.811 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -93.57 113.28 59.85 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo . . . . . 0 C--N 1.309 -1.515 0 C-N-CA 122.317 2.011 . . . . 0.0 112.468 -179.872 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? . . . . . 0 N--CA 1.496 1.863 0 CA-C-O 121.604 0.716 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.82 -159.87 19.09 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -132.67 134.86 45.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.538 -0.978 . . . . 0.0 109.682 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.8 p -82.55 105.48 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.93 -36.42 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -150.36 144.57 25.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.936 -1.102 . . . . 0.0 109.857 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.447 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -125.14 -68.53 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt 57.93 109.46 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.975 0.893 . . . . 0.0 109.662 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.79 -23.3 27.27 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.904 0.859 . . . . 0.0 108.76 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.43 90.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 109.681 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.5 mttt -97.77 -3.27 39.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.095 -1.003 . . . . 0.0 108.549 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? 52.19 9.35 0.09 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.464 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 12' ' ' LYS . 58.1 m-85 -132.25 148.17 52.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.3 -159.83 10.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.09 155.53 47.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.3 -1.118 . . . . 0.0 109.547 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.69 135.07 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -101.11 118.57 37.25 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.861 0.838 . . . . 0.0 109.768 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.75 156.66 53.36 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 48.1 p-10 -67.27 -27.62 67.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.99 . . . . 0.0 109.549 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 33.1 p-10 -89.41 9.01 27.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.518 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.34 12.51 67.34 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.66 114.69 26.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.006 -1.291 . . . . 0.0 109.917 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 t -78.75 147.75 33.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.605 -0.684 . . . . 0.0 109.672 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.99 141.68 49.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.425 -0.797 . . . . 0.0 109.835 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.41 144.15 40.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.1 tt -114.16 122.28 46.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.792 0.806 . . . . 0.0 109.304 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 7.6 p-80 -139.16 160.51 39.62 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.96 -10.82 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.869 0.842 . . . . 0.0 109.082 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.3 m -67.19 -11.72 58.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 109.37 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -108.38 -23.29 11.95 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.63 128.33 36.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.871 -1.143 . . . . 0.0 109.884 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 64.3 t0 -132.03 129.57 40.24 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.909 0.861 . . . . 0.0 109.563 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 72.9 mmtt -63.92 -36.29 83.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.804 0.812 . . . . 0.0 109.28 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.61 -35.95 81.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.46 -0.775 . . . . 0.0 110.168 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.48 -6.16 2.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.948 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.41 -36.54 84.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.973 -1.079 . . . . 0.0 109.621 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.08 -7.1 81.37 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.59 0.05 52.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -1.189 . . . . 0.0 108.723 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 83.8 mt -69.39 158.68 34.63 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.4 -0.812 . . . . 0.0 109.795 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 5' ' ' VAL . 7.8 p -122.89 138.29 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.735 0.779 . . . . 0.0 109.745 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -107.29 129.98 54.82 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.94 25.21 46.08 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -140.29 173.29 11.66 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.03 -1.277 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.3 144.68 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.879 0.847 . . . . 0.0 111.157 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.74 164.93 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -116.65 129.56 56.22 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.51 163.08 38.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 109.391 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 62' ' ' ALA . 20.3 m-20 -104.59 111.37 65.2 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.39 -0.819 . . . . 0.0 109.469 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.35 137.93 30.7 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.309 2.006 . . . . 0.0 112.597 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.4 m . . . . . 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.004 . . . . 0.0 109.449 179.642 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.501 2.076 0 CA-C-O 121.626 0.727 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -137.21 144.93 43.09 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.091 -1.006 . . . . 0.0 110.237 -179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.83 99.1 8.87 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 124.994 2.331 . . . . 0.0 111.264 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.304 43.2 tptt -82.24 143.36 31.41 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.555 -2.566 . . . . 0.0 113.1 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . . . 42.14 66.79 0.67 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 122.369 1.08 . . . . 0.0 110.005 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -75.05 137.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -123.8 147.91 47.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.48 -0.763 . . . . 0.0 110.071 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -124.99 79.72 64.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 N--CA 1.494 1.532 0 C-N-CA 122.763 2.309 . . . . 0.0 111.579 -179.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mmm . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -103.37 154.5 19.34 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.873 0.844 . . . . 0.0 110.303 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.24 -172.16 39.18 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -128.47 141.11 51.49 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.757 -0.849 . . . . 0.0 109.691 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.8 p -86.19 118.99 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 121.526 0.679 . . . . 0.0 109.341 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.02 -28.75 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.657 -0.652 . . . . 0.0 109.632 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.2 t -155.96 153.07 28.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.108 -0.995 . . . . 0.0 110.986 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -157.02 112.72 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.598 0.713 . . . . 0.0 109.21 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.8 mt -115.24 116.05 27.69 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.757 0.789 . . . . 0.0 109.434 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -36.09 76.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.243 0.544 . . . . 0.0 109.938 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -37.98 85.31 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.596 -0.69 . . . . 0.0 109.844 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.574 ' O ' ' N ' ' A' ' 14' ' ' TYR . 55.5 mtpt -95.88 11.07 35.09 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.31 -0.869 . . . . 0.0 108.877 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 12' ' ' LYS . 64.2 pttt 34.95 27.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-O 121.521 0.676 . . . . 0.0 110.341 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' N ' ' O ' ' A' ' 12' ' ' LYS . 35.7 t80 -141.7 123.08 14.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.59 0.71 . . . . 0.0 109.347 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -114.4 -164.11 14.83 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -146.78 134.32 20.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.658 -0.907 . . . . 0.0 109.937 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.408 HD11 HD21 ' A' ' 27' ' ' LEU . 96.6 mt -130.8 132.4 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.487 0.661 . . . . 0.0 109.271 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.1 tp60 -100.51 116.96 33.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.704 0.764 . . . . 0.0 109.677 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.84 161.56 53.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -65.08 -35.77 82.19 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.842 . . . . 0.0 109.961 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -87.48 9.03 22.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.542 -0.724 . . . . 0.0 109.175 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.65 58.66 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -91.97 118.13 30.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.452 -1.028 . . . . 0.0 110.027 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.8 p -80.59 163.97 23.27 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.718 0.771 . . . . 0.0 110.473 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -144.82 150.96 38.04 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.61 0.719 . . . . 0.0 109.69 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -97.56 143.44 28.25 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.567 0.698 . . . . 0.0 109.998 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' O ' ' ND1' ' A' ' 28' ' ' HIS . 66.7 mt -110.75 127.26 55.28 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.749 0.785 . . . . 0.0 109.892 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' A' ' 27' ' ' LEU . 10.0 m80 -140.73 159.42 42.23 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.765 0.793 . . . . 0.0 109.9 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -65.67 -35.17 80.0 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.1 t -62.33 -17.77 59.69 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -93.88 -18.56 21.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.507 -0.745 . . . . 0.0 109.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.0 141.04 32.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.594 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.26 -41.71 99.08 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -137.76 152.82 49.58 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.686 0.755 . . . . 0.0 109.468 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 70.7 mmtt -66.68 -39.42 88.11 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 38' ' ' GLU . 98.7 mttt -63.96 -39.38 94.0 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.481 0.658 . . . . 0.0 109.264 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -51.1 -9.46 0.06 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.547 -0.721 . . . . 0.0 109.405 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' A' ' 36' ' ' LYS . 11.8 pt-20 -70.34 -36.57 74.32 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' N ' ' CG ' ' A' ' 38' ' ' GLU . . . -83.2 -8.87 84.79 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -94.29 0.29 55.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.558 -0.966 . . . . 0.0 108.995 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 74.3 mt -70.91 153.25 42.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.729 . . . . 0.0 109.452 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 42' ' ' VAL . 6.5 p -113.91 120.72 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 122.045 0.926 . . . . 0.0 110.104 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -91.0 136.4 33.1 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.684 0.754 . . . . 0.0 110.37 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.08 26.44 40.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 m -149.22 -164.63 2.07 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 111.143 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 95.8 mtp -87.48 145.66 26.16 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.902 0.858 . . . . 0.0 110.871 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.41 161.1 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -118.91 124.76 47.88 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.864 0.84 . . . . 0.0 110.152 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -149.4 157.03 42.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.503 0.668 . . . . 0.0 109.326 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -104.26 150.58 38.55 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.72 -0.612 . . . . 0.0 109.365 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.86 152.81 76.86 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.701 2.267 . . . . 0.0 112.813 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.45 132.22 7.11 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' A' ' 54' ' ' THR . 56.1 Cg_endo -73.09 -71.52 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.362 2.041 . . . . 0.0 112.07 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.441 ' H ' ' HG2' ' A' ' 53' ' ' PRO . 6.1 p 58.38 149.29 0.07 OUTLIER Pre-proline 0 C--N 1.3 -1.553 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.978 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -46.39 -36.6 18.03 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.378 2.052 . . . . 0.0 111.768 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.43 -41.77 98.69 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.404 ' C ' HD22 ' A' ' 58' ' ' LEU . . . 123.28 -75.59 0.37 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 58' ' ' LEU . 3.9 mm? -95.66 128.03 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.706 -0.879 . . . . 0.0 110.279 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -162.56 151.63 15.22 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.809 0.814 . . . . 0.0 109.876 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.37 159.98 14.81 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.471 0.653 . . . . 0.0 109.38 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -149.79 138.66 21.01 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.645 0.736 . . . . 0.0 110.273 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 58.05 68.6 0.82 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.584 0.707 . . . . 0.0 109.941 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.7 mm -66.24 138.25 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 CA-C-O 121.322 0.582 . . . . 0.0 109.507 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -132.37 141.97 49.12 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.095 0.95 . . . . 0.0 110.307 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -113.43 93.0 25.09 Favored Pre-proline 0 N--CA 1.491 1.593 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.74 3.13 7.18 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.686 2.257 . . . . 0.0 111.951 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.8 mm? -75.07 154.23 38.01 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.793 0.806 . . . . 0.0 110.335 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 58.0 mp0 -41.78 139.1 1.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.684 0.754 . . . . 0.0 110.227 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -65.95 -43.46 87.89 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.57 101.58 9.0 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.762 0.791 . . . . 0.0 109.187 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -68.69 -40.19 80.18 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -85.49 134.0 34.06 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.704 0.764 . . . . 0.0 110.167 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -113.96 147.23 38.94 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.752 0.787 . . . . 0.0 110.055 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.378 -179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -168.2 -164.22 0.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.756 0.788 . . . . 0.0 110.164 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -176.46 -168.11 36.09 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.9 tttp -130.58 133.8 46.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.735 -0.862 . . . . 0.0 109.816 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.1 p -79.68 111.83 16.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.752 0.786 . . . . 0.0 109.089 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -73.71 -33.5 38.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.637 -0.664 . . . . 0.0 109.689 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.4 t -161.63 153.91 19.8 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.014 0.911 . . . . 0.0 110.738 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.454 ' C ' HD22 ' A' ' 9' ' ' LEU . 59.9 t80 -153.16 102.4 2.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -96.56 112.09 23.97 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.058 0.932 . . . . 0.0 109.505 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.01 -35.97 79.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.619 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.8 -38.49 85.53 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' A' ' 14' ' ' TYR . 51.7 mtmt -94.05 3.09 55.81 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.1 mttp 47.08 15.73 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.218 0.533 . . . . 0.0 110.322 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.493 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 33.6 t80 -144.96 159.35 43.07 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.004 0.907 . . . . 0.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -161.58 -152.55 6.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -138.83 154.1 48.42 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.89 . . . . 0.0 110.144 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 150.03 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-O 121.463 0.649 . . . . 0.0 109.56 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -112.4 116.38 30.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.792 0.806 . . . . 0.0 109.508 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.62 160.99 47.76 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -65.01 -36.2 83.64 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.919 -0.754 . . . . 0.0 109.441 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -86.76 9.32 19.31 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.61 7.44 81.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -87.41 119.31 27.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.682 -0.893 . . . . 0.0 109.924 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.5 m -75.47 153.1 37.77 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.533 0.682 . . . . 0.0 110.203 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 58' ' ' LEU . 86.7 m-85 -135.29 132.56 37.89 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.807 0.813 . . . . 0.0 109.804 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' CE1' ' O ' ' A' ' 57' ' ' GLY . 16.5 m-85 -77.15 140.81 40.3 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.646 0.736 . . . . 0.0 110.426 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.628 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.3 tt -115.51 117.46 30.43 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.731 0.777 . . . . 0.0 109.162 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.628 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.8 t-80 -139.46 166.6 24.14 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.995 0.902 . . . . 0.0 110.156 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.466 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 10.1 m-85 -62.36 -40.86 97.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.86 -0.525 . . . . 0.0 109.68 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 38.6 t -60.25 -17.75 44.17 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.821 -0.549 . . . . 0.0 109.945 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -92.79 -7.24 47.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -0.88 . . . . 0.0 109.045 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.2 mt -88.0 125.3 34.46 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.768 0.794 . . . . 0.0 110.037 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.13 -41.8 97.08 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -126.65 131.15 51.5 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.81 0.814 . . . . 0.0 109.038 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -63.55 -35.75 81.5 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.784 -0.572 . . . . 0.0 109.545 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -60.47 -36.46 78.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.695 -0.628 . . . . 0.0 109.538 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.58 -10.13 16.87 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.753 -0.592 . . . . 0.0 109.42 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -67.27 -38.61 85.37 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.526 -0.734 . . . . 0.0 109.598 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.0 -8.97 85.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.814 -1.315 . . . . 0.0 109.814 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -98.73 5.11 47.8 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.408 -1.054 . . . . 0.0 109.21 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.2 156.1 26.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.617 -0.677 . . . . 0.0 110.324 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -124.32 130.3 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 122.175 0.988 . . . . 0.0 110.088 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.7 ttmt -98.02 135.94 38.99 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.802 0.81 . . . . 0.0 110.907 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.1 59.31 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -135.52 173.76 11.37 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.264 -1.139 . . . . 0.0 111.197 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.6 mtt -78.41 142.16 37.79 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.739 0.78 . . . . 0.0 110.25 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -132.73 163.5 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -121.0 135.32 55.24 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.867 0.841 . . . . 0.0 109.906 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -152.26 156.51 39.84 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.729 0.776 . . . . 0.0 110.016 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.82 156.63 37.07 Favored Pre-proline 0 C--N 1.306 -1.302 0 O-C-N 121.802 -0.561 . . . . 0.0 109.551 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -56.94 148.99 64.25 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.43 2.087 . . . . 0.0 112.948 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.5 m -130.54 94.96 28.06 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -52.79 139.11 59.71 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.532 2.155 . . . . 0.0 113.016 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 t -178.01 145.27 0.53 Allowed Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.64 -33.93 43.33 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.68 2.253 . . . . 0.0 111.471 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -173.24 131.72 0.48 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.604 0.716 . . . . 0.0 109.888 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.457 ' O ' ' CE1' ' A' ' 26' ' ' PHE . . . 137.94 -32.08 2.4 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.62 HD12 ' CE1' ' A' ' 25' ' ' TYR . 2.8 mm? 59.18 146.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.651 -0.911 . . . . 0.0 110.578 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -165.47 157.26 14.73 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.761 0.791 . . . . 0.0 110.379 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.29 133.66 46.84 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.87 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.9 tttp -114.64 135.55 54.03 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.907 0.861 . . . . 0.0 110.146 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 52.24 66.74 1.12 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.583 0.706 . . . . 0.0 110.383 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -73.06 137.27 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.561 0.696 . . . . 0.0 109.784 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.8 p -132.04 150.28 52.2 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.743 0.782 . . . . 0.0 110.122 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.91 82.86 36.32 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -80.06 3.68 7.41 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.701 2.267 . . . . 0.0 111.348 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.9 mp -84.77 -3.04 58.42 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -72.35 -151.17 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.557 0.694 . . . . 0.0 110.078 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 59.15 73.43 0.48 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.682 0.753 . . . . 0.0 109.291 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -164.12 76.21 0.34 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.576 0.703 . . . . 0.0 109.474 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.526 ' C ' ' HD1' ' A' ' 71' ' ' HIS . 1.3 p80 -152.17 166.52 31.46 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.614 0.721 . . . . 0.0 110.01 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -166.1 119.14 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.713 0.768 . . . . 0.0 109.634 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -154.79 140.57 18.11 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.724 0.773 . . . . 0.0 110.141 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 118.191 -0.909 . . . . 0.0 109.186 179.684 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' O ' ' CZ ' ' A' ' 49' ' ' PHE . 27.4 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -117.23 134.7 54.48 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.682 -0.636 . . . . 0.0 109.761 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -165.04 -145.56 4.45 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.77 146.38 52.12 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.583 -0.951 . . . . 0.0 110.123 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 5' ' ' VAL . 10.0 p -75.71 113.39 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 119.84 -0.744 . . . . 0.0 109.54 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.81 -34.33 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.2 t -148.94 146.13 27.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.976 -1.077 . . . . 0.0 110.241 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -162.76 102.08 1.02 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.8 mt -115.65 114.14 24.49 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.606 -0.683 . . . . 0.0 109.17 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.98 -21.27 66.4 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.29 0.567 . . . . 0.0 109.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.62 -52.67 54.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.0 110.284 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 60.3 pttt -97.14 1.17 49.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.22 -0.925 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.8 mttp 57.71 38.69 27.59 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.296 0.569 . . . . 0.0 109.997 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.529 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 59.0 m-85 -149.14 159.45 44.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.263 -0.898 . . . . 0.0 109.817 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.28 -169.18 33.92 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -138.99 157.61 45.68 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.458 -1.025 . . . . 0.0 109.627 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.94 135.0 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.689 -0.632 . . . . 0.0 109.565 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -94.07 99.07 11.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.418 -0.801 . . . . 0.0 109.462 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.05 170.68 28.99 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -64.6 -35.42 80.93 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.601 -0.94 . . . . 0.0 109.012 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -82.9 1.21 40.62 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.011 -1.055 . . . . 0.0 108.887 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.29 24.15 57.53 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CE1' ' A' ' 25' ' ' TYR . 98.0 mt-10 -89.13 114.14 25.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.14 -1.212 . . . . 0.0 109.718 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.417 ' O ' HD12 ' A' ' 58' ' ' LEU . 42.6 t -74.4 147.61 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.437 -0.789 . . . . 0.0 110.176 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.436 ' CE1' ' O ' ' A' ' 23' ' ' GLU . 96.3 m-85 -122.36 144.71 48.85 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.469 0.652 . . . . 0.0 109.533 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -60.9 -43.65 98.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.549 -0.719 . . . . 0.0 109.573 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 27' ' ' LEU . 2.2 tt 70.4 96.77 0.07 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.707 ' CG ' ' HG ' ' A' ' 30' ' ' SER . 3.9 t-80 -116.47 119.04 34.35 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.461 0.648 . . . . 0.0 109.637 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -57.09 -21.37 31.37 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.707 ' HG ' ' CG ' ' A' ' 28' ' ' HIS . 77.9 p -66.94 -19.29 65.7 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.513 -0.742 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -88.3 3.83 48.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.4 mt -77.84 133.67 38.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.119 -0.988 . . . . 0.0 110.217 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 99.0 mt -62.89 -42.59 99.83 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -121.32 120.4 34.99 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.4 0.619 . . . . 0.0 109.557 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -63.14 -36.24 82.95 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.77 -39.17 90.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.52 -0.737 . . . . 0.0 109.596 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -68.63 -6.56 26.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.351 -0.843 . . . . 0.0 109.804 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -61.94 -37.36 84.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.177 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.39 88.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.3 tppt? -91.93 -3.1 56.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -1.159 . . . . 0.0 109.175 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.4 mt -61.48 169.22 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.516 -0.74 . . . . 0.0 110.348 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.6 p -127.26 143.42 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -110.0 130.0 55.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.733 -0.604 . . . . 0.0 110.532 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.595 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.13 -15.42 62.92 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -97.39 -175.05 3.1 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.216 -1.167 . . . . 0.0 110.799 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 96.2 mtp -80.05 148.33 31.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.57 . . . . 0.0 110.447 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.8 m -138.69 151.13 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.53 -0.731 . . . . 0.0 109.252 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.82 125.57 45.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.51 -0.744 . . . . 0.0 109.725 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 1' ' ' MET . 54.3 p90 -141.85 147.74 37.67 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.06 152.5 42.52 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 121.689 -0.632 . . . . 0.0 109.311 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.89 139.5 62.44 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.334 2.023 . . . . 0.0 112.201 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.4 m -154.17 88.54 3.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.378 -0.826 . . . . 0.0 109.095 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.7 139.23 67.94 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.339 2.026 . . . . 0.0 112.454 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.9 156.53 35.7 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -63.11 -18.5 65.37 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.509 2.14 . . . . 0.0 111.791 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -81.9 1.77 33.59 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.166 -0.959 . . . . 0.0 109.32 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.28 -86.6 0.42 Allowed Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD12 ' O ' ' A' ' 24' ' ' SER . 96.6 mt -128.69 146.83 50.77 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.479 -1.012 . . . . 0.0 110.203 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -148.44 153.95 39.21 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.23 144.83 43.11 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.686 -0.633 . . . . 0.0 109.494 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 ttmp? -128.59 143.98 51.06 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.48 0.657 . . . . 0.0 109.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.33 71.09 0.6 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.452 0.644 . . . . 0.0 110.127 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.46 129.49 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.43 -0.794 . . . . 0.0 108.886 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.2 m -131.06 155.52 46.77 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.507 -0.746 . . . . 0.0 110.011 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.86 112.41 58.03 Favored Pre-proline 0 N--CA 1.487 1.408 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -79.4 1.97 8.74 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.255 1.97 . . . . 0.0 111.69 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 67' ' ' LEU . 10.7 mp -74.68 137.32 42.07 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.35 -0.844 . . . . 0.0 110.218 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.402 ' O ' ' O ' ' A' ' 67' ' ' LEU . 97.8 mt-10 54.49 166.62 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.68 0.752 . . . . 0.0 110.866 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -152.35 159.81 43.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.37 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -108.3 119.74 40.38 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.658 -0.651 . . . . 0.0 109.879 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -96.25 139.71 31.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.406 -0.809 . . . . 0.0 109.813 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -59.67 -40.51 88.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.417 -0.802 . . . . 0.0 110.198 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -107.61 127.52 53.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.728 -179.856 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.626 ' N ' ' NE2' ' A' ' 48' ' ' HIS . 6.2 ptt? . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.808 0.813 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.539 ' CD ' ' N ' ' A' ' 2' ' ' LYS . 0.8 OUTLIER -90.42 0.75 57.16 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 155.61 -167.77 33.14 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.801 -1.19 . . . . 0.0 110.164 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -130.99 137.21 49.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.714 -0.874 . . . . 0.0 109.417 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.7 p -81.87 105.95 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.543 0.687 . . . . 0.0 110.038 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.457 HG13 ' N ' ' A' ' 7' ' ' SER . 15.0 p -71.02 -38.82 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-O 121.492 0.663 . . . . 0.0 109.448 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.457 ' N ' HG13 ' A' ' 6' ' ' VAL . 24.8 p -154.49 158.73 40.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.177 -0.952 . . . . 0.0 110.075 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -158.4 114.89 2.78 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.545 -0.722 . . . . 0.0 109.148 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -112.2 100.43 8.82 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.68 72.77 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.759 0.79 . . . . 0.0 109.339 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.38 -36.81 78.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.596 -0.69 . . . . 0.0 109.939 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.8 mtpt -94.29 4.23 54.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.262 -0.899 . . . . 0.0 108.969 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mttp 56.29 4.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.293 0.568 . . . . 0.0 109.555 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' LYS . 59.1 m-85 -130.8 154.2 48.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.659 0.742 . . . . 0.0 110.092 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.02 -169.0 22.76 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -133.41 151.19 51.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.487 -1.008 . . . . 0.0 109.8 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.7 mt -134.19 159.35 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.43 0.633 . . . . 0.0 109.378 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.497 ' N ' HG22 ' A' ' 17' ' ' ILE . 56.2 tt0 -113.05 107.87 16.54 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.675 0.75 . . . . 0.0 109.661 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.5 161.9 53.52 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 47.3 p-10 -65.01 -33.9 77.15 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.859 -0.789 . . . . 0.0 109.955 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.553 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 93.3 m-20 -90.13 7.2 39.13 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.322 -0.861 . . . . 0.0 108.751 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.7 14.83 64.61 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.4 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 98.2 mt-10 -92.23 119.27 31.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.317 -1.108 . . . . 0.0 109.686 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -78.41 152.67 32.09 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 121.696 0.76 . . . . 0.0 110.657 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.4 m-85 -138.76 135.35 34.6 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.552 0.691 . . . . 0.0 109.376 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -78.82 144.29 35.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.662 -0.649 . . . . 0.0 110.245 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.642 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.5 tt -113.76 120.16 39.84 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.642 ' N ' HD23 ' A' ' 27' ' ' LEU . 80.8 t60 -136.1 171.72 14.06 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.685 0.755 . . . . 0.0 109.724 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.508 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 5.3 m-85 -61.4 -39.53 91.04 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.665 0.745 . . . . 0.0 109.551 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.453 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 79.2 p -59.62 -20.29 54.89 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.712 -0.617 . . . . 0.0 110.023 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.02 -9.52 36.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.144 -0.972 . . . . 0.0 109.426 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.6 mt -94.83 124.02 38.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.041 . . . . 0.0 109.79 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.4 mt -64.37 -41.67 96.59 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.677 -0.639 . . . . 0.0 109.438 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -130.09 114.06 15.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.578 -0.702 . . . . 0.0 109.243 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -49.67 -27.53 4.82 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.01 -37.01 85.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.541 -0.724 . . . . 0.0 109.482 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -67.28 -7.0 20.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.386 -0.821 . . . . 0.0 109.118 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -65.96 -33.44 75.83 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.504 -0.748 . . . . 0.0 109.068 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.81 -7.82 85.24 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' CD ' ' N ' ' A' ' 40' ' ' LYS . 0.9 OUTLIER -93.8 0.65 56.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.282 -1.128 . . . . 0.0 108.738 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.12 150.27 47.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.446 -0.784 . . . . 0.0 109.584 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.1 p -121.57 126.81 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.885 0.85 . . . . 0.0 109.893 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -92.91 139.33 30.65 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.725 0.774 . . . . 0.0 110.835 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.35 25.37 51.48 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 m -146.1 -164.85 2.06 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.909 -1.348 . . . . 0.0 110.949 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtm -86.35 142.73 28.27 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.724 0.773 . . . . 0.0 110.543 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.8 135.88 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.551 0.691 . . . . 0.0 109.284 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.626 ' NE2' ' N ' ' A' ' 1' ' ' MET . 22.8 m170 -94.98 126.94 40.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -0.76 . . . . 0.0 109.855 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' H ' ' HB2' ' A' ' 2' ' ' LYS . 55.1 p90 -150.08 149.42 30.27 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.47 150.71 36.99 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 179.83 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.573 2.182 . . . . 0.0 112.372 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.0 p -140.73 151.3 62.72 Favored Pre-proline 0 N--CA 1.486 1.369 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.459 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' O ' ' C ' ' A' ' 54' ' ' THR . 51.2 Cg_exo -50.14 -39.91 51.31 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.199 1.933 . . . . 0.0 111.289 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 53' ' ' PRO . 41.7 m -35.37 99.43 0.17 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.62 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -77.64 -18.15 13.77 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.341 2.027 . . . . 0.0 111.202 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -125.01 118.01 25.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 113.3 -29.55 7.89 Favored Glycine 0 N--CA 1.498 2.809 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 57' ' ' GLY . 64.1 mt 58.4 128.38 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.695 -0.885 . . . . 0.0 110.05 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -146.56 143.69 29.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 109.874 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.03 167.08 12.65 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.759 0.79 . . . . 0.0 110.017 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -149.53 142.83 25.16 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.795 0.807 . . . . 0.0 110.053 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.56 74.75 0.23 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.838 0.828 . . . . 0.0 110.566 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.76 133.43 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 109.249 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.3 t -138.12 138.8 39.03 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.023 0.916 . . . . 0.0 110.05 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.553 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -89.82 127.1 55.39 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 -9.47 23.11 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.005 1.803 . . . . 0.0 110.825 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -82.22 137.43 34.9 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.538 0.685 . . . . 0.0 109.74 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -76.55 177.75 7.21 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.823 0.82 . . . . 0.0 110.722 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -66.7 142.48 57.4 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 121.869 0.843 . . . . 0.0 110.409 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -71.51 128.98 37.6 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.831 0.824 . . . . 0.0 110.111 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -153.29 -36.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -75.05 139.38 42.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.363 -0.836 . . . . 0.0 110.436 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -67.18 -39.36 86.41 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.587 0.708 . . . . 0.0 109.587 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.885 -179.733 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mmm . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.383 0.611 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -109.7 142.12 41.33 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.834 0.826 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.88 -174.38 36.07 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -133.12 142.05 48.49 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.693 -0.886 . . . . 0.0 110.049 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.909 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.4 p -82.13 113.83 22.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.846 0.831 . . . . 0.0 108.98 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.404 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -80.22 -38.38 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.425 -0.797 . . . . 0.0 109.418 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.404 ' N ' HG13 ' A' ' 6' ' ' VAL . 95.3 p -161.45 162.57 30.57 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.858 0.837 . . . . 0.0 110.217 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.453 ' C ' HD22 ' A' ' 9' ' ' LEU . 25.9 t80 -153.08 109.82 3.43 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 4.0 mm? -99.87 106.59 18.45 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.024 0.916 . . . . 0.0 109.655 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.52 80.55 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.389 0.614 . . . . 0.0 109.567 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.11 79.2 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.453 0.644 . . . . 0.0 109.952 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' A' ' 14' ' ' TYR . 98.9 mttt -89.33 -4.31 58.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.391 -0.818 . . . . 0.0 109.003 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 69.33 -17.65 0.21 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 12' ' ' LYS . 23.2 p90 -132.52 158.19 42.75 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -146.49 -138.73 3.22 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -148.91 151.43 34.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.669 -0.901 . . . . 0.0 110.193 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -133.1 133.44 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 121.545 0.688 . . . . 0.0 109.257 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -103.44 116.97 33.41 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.947 0.88 . . . . 0.0 109.539 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.94 160.45 52.76 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.7 p-10 -68.62 -24.87 64.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.82 -0.812 . . . . 0.0 109.898 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -91.29 6.86 43.56 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.4 -0.813 . . . . 0.0 109.38 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 86.5 11.1 72.3 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -92.37 115.89 28.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.392 -1.063 . . . . 0.0 110.132 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.9 p -81.14 148.25 29.67 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.609 0.719 . . . . 0.0 110.006 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -134.53 136.98 43.46 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 121.806 0.813 . . . . 0.0 110.015 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -73.43 139.61 45.97 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.549 0.69 . . . . 0.0 109.963 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.2 tt -113.99 120.59 41.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.812 0.815 . . . . 0.0 109.663 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.668 ' N ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -138.2 163.1 32.58 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.852 0.834 . . . . 0.0 109.107 179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -66.31 -35.08 79.46 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.862 -0.524 . . . . 0.0 109.773 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.8 t -57.54 -17.93 16.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.541 -0.724 . . . . 0.0 109.366 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.29 -9.87 34.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.464 -0.773 . . . . 0.0 108.986 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.1 mt -87.96 112.03 22.12 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.922 0.868 . . . . 0.0 109.593 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -63.26 -41.57 99.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.869 -0.52 . . . . 0.0 109.655 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 36' ' ' LYS . 91.1 m-20 -128.53 106.76 9.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -54.91 -6.64 0.13 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.565 -0.71 . . . . 0.0 109.129 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 34' ' ' ASP . 68.6 mttm -64.54 -37.88 89.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.584 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -72.16 -7.55 49.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.484 -0.76 . . . . 0.0 109.512 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -56.79 -44.93 82.37 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.637 -0.664 . . . . 0.0 109.622 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -80.39 -9.57 86.36 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' A' ' 41' ' ' LEU . 33.8 mtmm -116.13 16.65 15.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.418 -1.048 . . . . 0.0 109.121 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 40' ' ' LYS . 5.3 mt -55.14 -168.95 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.497 -0.752 . . . . 0.0 109.935 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG21 HG12 ' A' ' 47' ' ' VAL . 0.9 OUTLIER -127.0 162.15 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.256 1.027 . . . . 0.0 110.636 -179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -145.53 95.07 2.6 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.75 0.786 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.909 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 94.55 -15.72 62.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.515 ' O ' HG12 ' A' ' 5' ' ' VAL . 20.9 m -84.95 165.37 17.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.132 -1.216 . . . . 0.0 110.54 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 77.9 mtm -66.75 143.6 56.84 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.962 0.887 . . . . 0.0 111.052 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.606 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -130.95 161.62 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.483 0.659 . . . . 0.0 109.259 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -130.32 129.08 42.74 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.791 0.805 . . . . 0.0 110.009 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -144.01 160.57 40.63 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.503 0.668 . . . . 0.0 109.617 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.81 154.29 38.12 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.836 -0.54 . . . . 0.0 109.589 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -49.73 142.89 24.01 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.652 2.235 . . . . 0.0 112.745 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.419 ' OG1' ' OG1' ' A' ' 54' ' ' THR . 2.5 p -126.77 147.79 62.42 Favored Pre-proline 0 N--CA 1.494 1.733 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.24 57.2 2.16 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.741 2.294 . . . . 0.0 111.657 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 58' ' ' LEU . 12.9 p -135.3 58.82 28.5 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 0.0 109.287 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.96 -17.6 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.494 2.13 . . . . 0.0 110.311 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -110.83 48.42 0.92 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.538 0.685 . . . . 0.0 109.199 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 162.98 -20.38 0.17 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 54' ' ' THR . 79.6 mt 60.56 145.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.656 -0.908 . . . . 0.0 110.288 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.38 155.07 14.98 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.698 0.761 . . . . 0.0 109.903 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.48 137.08 47.03 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.738 0.78 . . . . 0.0 109.856 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -133.39 142.55 48.42 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.878 0.847 . . . . 0.0 109.898 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 59.51 48.81 9.26 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.627 0.727 . . . . 0.0 109.773 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.61 139.23 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-O 121.546 0.688 . . . . 0.0 109.713 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.8 t -133.74 149.78 51.48 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.691 0.758 . . . . 0.0 110.028 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -105.92 103.31 43.79 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.448 ' O ' ' CE1' ' A' ' 69' ' ' HIS . 95.2 Cg_endo -81.58 -2.69 11.61 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.788 2.326 . . . . 0.0 111.316 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.3 tp -65.17 139.01 58.63 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.714 0.769 . . . . 0.0 110.655 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 59.17 87.4 0.08 Allowed 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.603 0.716 . . . . 0.0 109.612 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.448 ' CE1' ' O ' ' A' ' 66' ' ' PRO . 97.6 m-70 -79.54 148.79 31.65 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.923 0.868 . . . . 0.0 110.106 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 69' ' ' HIS . 85.5 t60 55.18 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.659 0.742 . . . . 0.0 110.054 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' A' ' 71' ' ' HIS . 14.4 p80 -64.43 139.1 58.73 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.614 0.721 . . . . 0.0 109.613 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -84.07 -12.62 54.82 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.3 p-80 -152.08 162.17 41.51 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.483 -0.761 . . . . 0.0 110.332 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.425 ' OXT' ' CG ' ' A' ' 74' ' ' HIS . 54.7 t-80 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.354 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ptt? . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.85 -173.87 3.84 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.678 0.751 . . . . 0.0 110.513 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.26 -163.85 20.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -141.76 144.17 33.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.572 -0.958 . . . . 0.0 110.117 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' O ' HG13 ' A' ' 5' ' ' VAL . 4.4 p -77.48 126.08 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.741 -0.599 . . . . 0.0 109.759 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -101.34 -35.32 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.515 -0.741 . . . . 0.0 109.588 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.2 m -151.28 135.4 16.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.996 -1.065 . . . . 0.0 110.573 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CD1' HD13 ' A' ' 27' ' ' LEU . 52.6 t80 -157.01 114.99 3.2 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 82.4 mt -119.45 124.87 47.55 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.691 0.758 . . . . 0.0 109.287 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.17 -24.14 67.75 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.476 0.655 . . . . 0.0 109.511 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.3 -39.32 90.04 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.498 -0.751 . . . . 0.0 109.891 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 51.6 mtmt -97.03 -3.69 40.99 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.237 -0.914 . . . . 0.0 109.163 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt 65.61 -8.46 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.527 0.68 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 33.6 p90 -150.9 161.37 42.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.494 -0.754 . . . . 0.0 109.254 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -149.51 -119.36 0.97 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -146.3 153.16 40.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.655 -0.909 . . . . 0.0 109.833 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.81 145.58 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.532 0.682 . . . . 0.0 109.739 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -107.92 108.71 19.98 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.764 0.793 . . . . 0.0 109.379 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -71.24 158.48 53.67 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.4 p-10 -66.09 -34.3 77.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.828 -0.807 . . . . 0.0 109.89 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 52.0 t0 -89.23 10.55 21.72 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.213 -0.929 . . . . 0.0 109.544 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.37 14.98 69.96 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -97.31 121.5 39.27 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.158 -1.201 . . . . 0.0 109.8 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.2 p -78.16 153.56 31.95 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.736 0.779 . . . . 0.0 110.714 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -141.81 136.52 30.71 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.716 0.77 . . . . 0.0 109.656 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -76.73 144.19 39.46 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.617 0.722 . . . . 0.0 110.167 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.647 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.6 tt -111.54 120.82 43.38 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.572 0.701 . . . . 0.0 109.318 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.647 ' N ' HD23 ' A' ' 27' ' ' LEU . 39.2 m80 -128.82 138.85 52.29 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.757 0.789 . . . . 0.0 109.511 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CG ' ' N ' ' A' ' 30' ' ' SER . 20.8 p90 -66.88 -35.1 79.26 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.068 0.937 . . . . 0.0 109.443 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 37.4 m -63.66 -33.12 74.93 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.49 0.662 . . . . 0.0 109.791 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -71.25 -0.7 10.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.513 -0.742 . . . . 0.0 109.589 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 87.5 mt -79.91 139.54 37.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.294 -0.879 . . . . 0.0 109.659 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.77 -41.52 97.95 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -128.22 121.13 28.64 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -45.83 -27.72 0.92 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.568 0.699 . . . . 0.0 109.674 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -64.83 -32.57 74.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.5 -0.75 . . . . 0.0 109.408 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -61.01 -14.41 22.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.515 -0.741 . . . . 0.0 109.175 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -70.08 -31.48 69.08 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.73 0.776 . . . . 0.0 109.473 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.2 -3.72 75.39 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.6 7.73 32.91 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.324 -1.104 . . . . 0.0 108.852 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.7 151.1 48.07 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.436 0.636 . . . . 0.0 110.168 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.55 137.93 56.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 CA-C-O 121.807 0.813 . . . . 0.0 109.938 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -107.28 130.84 54.71 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.769 0.795 . . . . 0.0 110.453 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.477 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 92.53 -23.0 30.06 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.3 m -91.46 179.19 5.74 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.276 -1.132 . . . . 0.0 111.15 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 68.1 mtm -82.62 153.38 25.47 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.507 0.67 . . . . 0.0 110.493 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.4 m -133.97 161.58 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.746 -0.596 . . . . 0.0 109.542 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -120.94 131.99 54.67 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.551 0.691 . . . . 0.0 109.436 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -150.74 159.94 44.18 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.569 0.699 . . . . 0.0 109.816 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.65 153.19 37.9 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.43 133.9 39.32 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.885 2.39 . . . . 0.0 112.966 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 m -154.03 94.66 2.85 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.98 89.28 1.34 Allowed 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.728 2.285 . . . . 0.0 112.364 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.45 157.28 88.09 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -62.94 -17.47 60.13 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.58 2.186 . . . . 0.0 111.131 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -80.85 -3.42 51.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.512 -0.742 . . . . 0.0 109.695 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.03 -88.81 0.29 Allowed Glycine 0 N--CA 1.5 2.962 0 N-CA-C 110.474 -1.05 . . . . 0.0 110.474 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.2 mt -139.8 130.94 26.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.483 -1.01 . . . . 0.0 110.235 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.93 146.15 35.35 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.716 0.769 . . . . 0.0 109.658 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.93 155.72 18.52 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.551 0.691 . . . . 0.0 109.863 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -143.21 147.29 34.64 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.728 0.775 . . . . 0.0 109.932 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 54.93 51.04 14.26 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.732 0.777 . . . . 0.0 109.87 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 94.5 mt -67.53 139.47 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.712 -0.618 . . . . 0.0 109.547 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.528 ' C ' HD22 ' A' ' 65' ' ' LEU . 29.4 t -129.72 149.66 51.37 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.891 0.853 . . . . 0.0 109.917 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.889 HD22 ' N ' ' A' ' 65' ' ' LEU . 1.1 mm? -111.63 81.42 3.27 Favored Pre-proline 0 N--CA 1.496 1.836 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.118 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.43 41.09 0.57 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.472 2.114 . . . . 0.0 111.589 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.5 mt -56.7 141.82 42.46 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.649 0.738 . . . . 0.0 110.102 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -131.03 86.14 2.34 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.677 0.751 . . . . 0.0 109.161 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -82.69 -68.36 0.71 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.663 0.744 . . . . 0.0 109.691 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -67.71 -43.43 80.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.501 -0.749 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 72' ' ' HIS . 78.3 m80 -77.24 146.11 37.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.806 0.813 . . . . 0.0 109.927 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' HIS . 99.1 m-70 48.94 179.53 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.927 0.87 . . . . 0.0 110.512 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.8 m80 44.43 83.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.896 0.855 . . . . 0.0 109.861 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.496 1.858 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.803 179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -107.19 179.63 4.2 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.496 -0.753 . . . . 0.0 109.427 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.04 -159.03 9.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -133.93 149.87 51.29 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.477 -1.014 . . . . 0.0 109.645 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -80.74 123.35 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 0.0 110.01 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.403 ' H ' HG12 ' A' ' 6' ' ' VAL . 6.1 p -93.18 -31.16 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.263 -0.898 . . . . 0.0 109.471 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.8 t -157.18 149.28 22.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.068 -1.02 . . . . 0.0 110.071 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.414 ' H ' ' HE2' ' A' ' 43' ' ' LYS . 55.5 t80 -158.77 106.14 1.84 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.523 ' N ' HD12 ' A' ' 9' ' ' LEU . 10.8 mp -101.21 110.87 22.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.829 . . . . 0.0 109.025 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.52 -37.28 84.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.655 -0.653 . . . . 0.0 109.865 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.23 92.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.193 -0.942 . . . . 0.0 109.615 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 14' ' ' TYR . 9.9 mtpm? -98.93 7.57 45.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.355 -0.84 . . . . 0.0 109.323 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 12' ' ' LYS . 56.1 pttt 35.06 30.97 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.551 0.691 . . . . 0.0 110.381 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.514 ' N ' ' O ' ' A' ' 12' ' ' LYS . 88.5 t80 -139.58 140.84 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.555 -0.716 . . . . 0.0 109.34 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -164.35 -161.75 14.02 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.3 157.85 45.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.497 -1.002 . . . . 0.0 109.494 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -128.85 132.61 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.63 104.11 15.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.353 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.24 158.43 52.15 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 39.4 p-10 -64.66 -34.03 77.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.442 -1.034 . . . . 0.0 109.106 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 38.8 t70 -86.88 6.46 31.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 108.991 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.11 16.89 70.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -93.6 117.94 30.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.962 -1.317 . . . . 0.0 109.636 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -74.36 149.8 40.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.475 -0.766 . . . . 0.0 109.367 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -129.21 139.45 51.86 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.024 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -74.44 144.05 44.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.613 -0.68 . . . . 0.0 109.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.578 ' C ' HD23 ' A' ' 27' ' ' LEU . 5.9 tt -124.51 116.83 23.12 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.472 -0.768 . . . . 0.0 109.211 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 27' ' ' LEU . 84.7 t60 -140.54 170.27 16.1 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.378 -0.827 . . . . 0.0 109.411 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.47 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 2.7 m-85 -62.19 -44.11 97.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.106 -0.996 . . . . 0.0 109.911 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.459 ' H ' ' CD2' ' A' ' 28' ' ' HIS . 16.3 m -55.6 -20.2 12.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.119 -0.988 . . . . 0.0 109.859 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -91.24 -6.48 53.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.107 -0.995 . . . . 0.0 109.973 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 86.1 mt -90.63 130.87 36.6 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 109.576 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.7 mt -62.78 -41.71 99.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.494 -0.754 . . . . 0.0 109.091 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -142.11 131.39 23.52 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.403 -0.811 . . . . 0.0 109.125 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -61.93 -31.19 71.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.211 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -59.18 -36.35 75.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 108.851 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -67.88 -8.29 35.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.35 -42.07 94.97 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.15 -0.969 . . . . 0.0 109.285 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -67.02 -20.93 71.27 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -84.75 -0.21 52.89 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.125 -1.221 . . . . 0.0 109.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.404 HD13 ' CZ ' ' A' ' 8' ' ' TYR . 40.8 mt -67.32 147.94 52.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.167 -0.958 . . . . 0.0 109.272 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 p -127.12 136.69 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.49 -0.756 . . . . 0.0 109.563 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HE2' ' H ' ' A' ' 8' ' ' TYR . 37.9 ttmt -101.27 138.37 38.38 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.306 -0.871 . . . . 0.0 110.297 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 88.24 -23.66 14.26 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 m -88.45 178.33 6.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.94 -1.329 . . . . 0.0 110.513 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -85.4 149.9 25.1 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.586 -0.696 . . . . 0.0 109.906 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -133.62 164.77 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.527 -0.733 . . . . 0.0 109.144 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -124.25 136.15 53.93 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.498 -0.751 . . . . 0.0 109.455 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -147.1 157.32 43.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.247 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -93.93 153.26 40.93 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 121.162 -0.961 . . . . 0.0 109.295 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' O ' HG23 ' A' ' 52' ' ' THR . 53.7 Cg_endo -67.13 142.17 60.2 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.638 2.225 . . . . 0.0 112.384 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 5.0 p -154.29 88.76 3.39 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.434 -0.791 . . . . 0.0 109.199 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 54' ' ' THR . 51.0 Cg_exo -53.13 -47.3 28.26 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.996 1.797 . . . . 0.0 111.719 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.512 ' O ' ' O ' ' A' ' 53' ' ' PRO . 1.2 p 52.55 157.18 0.05 OUTLIER Pre-proline 0 N--CA 1.498 1.975 0 CA-C-O 121.075 0.464 . . . . 0.0 110.811 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.49 -38.58 74.9 Favored 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 121.551 1.501 . . . . 0.0 111.247 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -63.42 -42.71 98.74 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.547 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.77 -64.35 0.61 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.3 mt -108.46 132.37 53.86 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.438 -1.036 . . . . 0.0 110.123 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -153.48 153.93 33.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 109.568 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -99.87 -83.04 0.44 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.312 -0.867 . . . . 0.0 109.466 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' ALA . 56.3 tttm 60.31 144.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.496 -0.752 . . . . 0.0 110.548 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.11 43.1 32.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.722 . . . . 0.0 110.002 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.17 140.29 18.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.149 -0.969 . . . . 0.0 109.03 179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.0 m -121.27 153.21 37.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.52 -0.738 . . . . 0.0 109.208 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' H ' HD12 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -133.16 82.82 52.83 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.12 0.88 9.47 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 121.956 1.771 . . . . 0.0 111.152 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 67' ' ' LEU . 3.9 mm? -91.3 122.21 33.72 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.502 -0.749 . . . . 0.0 109.34 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -144.56 10.38 1.42 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -89.84 109.26 20.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.399 -0.813 . . . . 0.0 109.702 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -67.23 -37.86 84.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.476 -0.765 . . . . 0.0 109.92 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -131.28 160.49 34.77 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.44 -0.787 . . . . 0.0 109.83 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -105.44 144.84 31.65 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.592 -0.693 . . . . 0.0 109.607 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -147.32 137.15 22.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.268 -0.895 . . . . 0.0 109.523 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.564 -179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -126.19 146.28 50.03 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.742 0.782 . . . . 0.0 110.178 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -174.58 -174.32 41.22 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -135.89 134.54 38.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.846 -0.796 . . . . 0.0 109.618 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.9 p -75.84 120.06 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 121.797 0.808 . . . . 0.0 109.612 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 7' ' ' SER . 8.3 p -91.27 -38.96 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.668 -0.645 . . . . 0.0 109.494 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.433 ' N ' HG13 ' A' ' 6' ' ' VAL . 74.8 m -134.31 147.66 50.63 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.689 0.757 . . . . 0.0 110.324 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.608 ' H ' ' NZ ' ' A' ' 43' ' ' LYS . 66.5 t80 -161.06 117.63 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.3 mt -118.71 110.19 16.99 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.834 0.826 . . . . 0.0 109.514 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.16 85.26 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 109.832 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.01 90.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.849 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -100.95 2.19 40.48 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.477 -0.765 . . . . 0.0 108.951 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 43.0 39.21 1.7 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.504 0.669 . . . . 0.0 110.09 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' A' ' 15' ' ' GLY . 93.3 t80 -147.64 158.0 43.81 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.68 0.753 . . . . 0.0 109.955 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 14' ' ' TYR . . . -176.73 -162.84 28.02 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -133.71 155.88 48.96 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.575 0.703 . . . . 0.0 109.26 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -133.4 137.5 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 121.5 0.667 . . . . 0.0 109.447 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -95.16 109.16 21.28 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.888 0.851 . . . . 0.0 109.652 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.11 149.39 49.01 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -68.76 -22.64 64.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.684 -0.892 . . . . 0.0 109.205 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 21' ' ' ASP . 58.7 t0 -76.16 -3.1 34.38 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.84 -19.0 56.05 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -88.16 130.54 35.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.5 -1.0 . . . . 0.0 110.356 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 t -76.23 145.9 39.43 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.56 0.695 . . . . 0.0 110.037 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.34 139.89 50.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.905 0.86 . . . . 0.0 110.117 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -73.13 143.72 47.2 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.701 0.762 . . . . 0.0 110.009 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.5 tt -108.2 119.35 39.23 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.595 0.712 . . . . 0.0 109.689 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.629 ' N ' HD23 ' A' ' 27' ' ' LEU . 40.7 m80 -129.09 128.26 43.17 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 122.157 0.979 . . . . 0.0 109.395 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' CG ' ' N ' ' A' ' 30' ' ' SER . 22.7 p90 -64.47 -34.75 78.93 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.964 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 29.7 m -63.29 -33.15 74.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.718 -0.613 . . . . 0.0 110.672 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' OE1' ' O ' ' A' ' 60' ' ' ALA . 98.7 mt-10 -73.07 2.77 6.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.296 -0.878 . . . . 0.0 109.92 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.38 143.35 33.58 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.634 0.731 . . . . 0.0 109.865 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 94.0 mt -63.33 -40.17 96.56 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 36' ' ' LYS . 9.5 p30 -137.46 101.85 4.62 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.904 0.859 . . . . 0.0 108.775 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -52.23 -7.27 0.06 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.788 -0.57 . . . . 0.0 109.621 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' H ' ' C ' ' A' ' 34' ' ' ASP . 43.8 pttt -68.57 -30.1 68.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 109.225 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' OD2' ' OD1' ' A' ' 34' ' ' ASP . 39.7 p30 -79.4 -2.68 42.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -49.58 -42.59 44.85 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.7 -6.99 82.32 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.5 ttmt -95.09 1.27 54.93 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.369 -1.077 . . . . 0.0 109.517 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.64 152.88 44.48 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.694 -0.629 . . . . 0.0 109.868 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.9 p -115.45 126.4 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 122.118 0.961 . . . . 0.0 109.816 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.608 ' NZ ' ' H ' ' A' ' 8' ' ' TYR . 50.0 tttp -99.34 139.01 35.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.747 0.784 . . . . 0.0 110.817 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.56 25.19 51.49 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.9 t -143.82 -179.6 6.57 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.137 -1.213 . . . . 0.0 110.905 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.12 146.84 34.91 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.745 0.783 . . . . 0.0 110.461 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.0 161.54 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.495 0.665 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -118.16 126.06 51.46 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.863 0.84 . . . . 0.0 109.731 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -151.49 155.79 39.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.441 0.639 . . . . 0.0 109.306 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -106.61 163.2 17.48 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.165 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.03 147.4 82.79 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.538 2.158 . . . . 0.0 112.718 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.3 m -150.52 87.96 4.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.674 -0.641 . . . . 0.0 109.71 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -55.2 131.48 46.57 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.363 2.042 . . . . 0.0 112.237 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p -148.72 152.63 37.99 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.813 -0.555 . . . . 0.0 109.712 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.88 -15.68 40.56 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -83.31 -2.34 55.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.753 -0.592 . . . . 0.0 109.446 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.59 -87.11 0.4 Allowed Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.3 mt -131.44 154.43 48.7 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.858 -0.79 . . . . 0.0 110.115 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.86 155.39 34.28 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.677 0.751 . . . . 0.0 110.015 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' O ' ' OE1' ' A' ' 31' ' ' GLU . . . -116.01 129.92 56.58 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.591 0.71 . . . . 0.0 109.785 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.6 160.48 26.98 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.901 0.858 . . . . 0.0 109.668 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.2 48.4 19.54 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.507 0.67 . . . . 0.0 109.571 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 81.6 mt -72.31 132.1 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.0 t -135.95 154.62 51.05 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.764 0.792 . . . . 0.0 110.734 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.08 98.25 33.9 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.1 -0.62 10.8 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 122.792 2.328 . . . . 0.0 111.074 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.17 123.13 32.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.753 0.787 . . . . 0.0 109.588 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -105.21 -161.02 0.78 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.508 0.67 . . . . 0.0 109.788 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -75.16 132.58 41.27 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.893 0.854 . . . . 0.0 110.072 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -66.47 -40.35 89.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.751 -0.593 . . . . 0.0 109.686 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 73' ' ' HIS . 78.7 m80 -59.03 -40.53 85.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.805 -0.559 . . . . 0.0 109.921 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 t60 42.64 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.571 0.7 . . . . 0.0 110.282 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.562 ' N ' ' O ' ' A' ' 71' ' ' HIS . 57.7 t-80 -73.91 130.59 40.2 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.906 0.86 . . . . 0.0 110.322 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.205 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -107.6 151.81 25.13 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.57 0.7 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -172.33 -172.5 38.21 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -135.55 134.17 39.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.691 -0.888 . . . . 0.0 109.895 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.68 ' O ' HG13 ' A' ' 5' ' ' VAL . 13.6 p -78.03 106.79 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 CA-C-O 121.766 0.793 . . . . 0.0 109.796 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 7' ' ' SER . 7.1 p -72.18 -39.01 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.275 0.56 . . . . 0.0 109.662 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.41 ' N ' HG13 ' A' ' 6' ' ' VAL . 42.7 t -159.07 156.79 29.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.854 . . . . 0.0 110.469 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' OH ' ' CZ ' ' A' ' 29' ' ' PHE . 68.3 t80 -155.03 109.59 2.97 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -113.14 116.59 30.07 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.766 0.793 . . . . 0.0 109.294 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.27 -25.45 64.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.468 0.651 . . . . 0.0 109.336 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.2 -35.85 81.67 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.626 0.727 . . . . 0.0 109.443 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 14' ' ' TYR . 1.8 mptm? -90.89 7.09 41.78 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 61.47 -7.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.387 0.613 . . . . 0.0 109.705 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 12' ' ' LYS . 33.5 p90 -161.48 163.8 30.12 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.462 -0.774 . . . . 0.0 109.635 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.29 -131.98 2.66 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -143.34 152.27 41.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.63 -0.924 . . . . 0.0 110.036 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.94 133.15 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 121.526 0.679 . . . . 0.0 109.502 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -95.66 106.71 18.84 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.81 0.814 . . . . 0.0 109.584 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.36 163.86 54.54 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.71 -39.38 94.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.757 -0.849 . . . . 0.0 109.672 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -82.31 0.91 39.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.53 -0.731 . . . . 0.0 109.386 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.52 62.22 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 80.1 mm-40 -88.55 119.46 29.02 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.085 -1.244 . . . . 0.0 110.109 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.8 p -76.37 147.71 37.89 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.662 0.744 . . . . 0.0 110.279 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.6 m-85 -136.34 137.56 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.625 0.726 . . . . 0.0 109.616 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -83.15 141.11 32.19 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.4 tt -112.83 116.82 30.65 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.809 0.814 . . . . 0.0 109.607 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 13.6 m-70 -119.86 146.78 45.43 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.452 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 26.3 m-85 -63.56 -39.23 93.87 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.34 0.59 . . . . 0.0 109.918 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 t -57.59 -18.54 20.37 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.442 -0.786 . . . . 0.0 110.024 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -91.02 -7.46 51.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.141 -0.974 . . . . 0.0 110.304 -179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -78.25 138.03 38.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.172 -0.955 . . . . 0.0 109.784 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.1 mt -63.75 -41.37 98.02 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.454 0.645 . . . . 0.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -135.94 125.54 25.29 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -63.9 -11.43 27.82 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.499 0.666 . . . . 0.0 109.509 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -81.42 -14.92 56.56 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -76.79 -4.84 45.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.711 -0.618 . . . . 0.0 109.384 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -55.41 -46.07 76.64 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.502 -0.748 . . . . 0.0 109.559 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.33 -4.44 84.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -94.92 -3.8 47.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.251 -1.147 . . . . 0.0 108.961 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 19.8 mt -70.21 149.14 47.8 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.714 -0.616 . . . . 0.0 110.136 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.6 p -127.2 134.56 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.871 0.843 . . . . 0.0 109.471 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.39 133.92 41.34 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.942 0.877 . . . . 0.0 111.29 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.517 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 86.47 -12.13 61.77 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 5' ' ' VAL . 8.6 t -96.86 177.11 5.74 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.985 -1.303 . . . . 0.0 110.947 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.6 mtp -81.09 147.63 30.02 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.766 0.793 . . . . 0.0 110.396 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.14 157.88 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -113.81 132.61 55.8 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.003 0.906 . . . . 0.0 110.503 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -154.41 157.67 38.85 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.63 150.78 37.99 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.42 163.66 38.32 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 123.35 2.7 . . . . 0.0 113.249 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.5 p -123.61 149.31 58.46 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 54' ' ' THR . 50.0 Cg_exo -50.88 -49.58 16.49 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.134 1.889 . . . . 0.0 111.925 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 ' C ' ' O ' ' A' ' 53' ' ' PRO . 0.0 OUTLIER -35.65 99.55 0.18 Allowed Pre-proline 0 N--CA 1.495 1.82 0 CA-C-O 120.99 0.424 . . . . 0.0 110.512 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.66 -15.88 13.42 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.255 1.97 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -122.34 94.7 4.37 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.516 0.674 . . . . 0.0 110.065 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 134.52 -32.16 2.66 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 108.954 -1.658 . . . . 0.0 108.954 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 57' ' ' GLY . 64.5 mt 58.81 146.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.892 0.853 . . . . 0.0 110.565 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.29 158.63 30.17 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -121.3 130.5 53.68 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.941 0.877 . . . . 0.0 110.344 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -127.71 149.59 50.15 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.62 55.71 6.94 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.815 0.817 . . . . 0.0 109.388 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.49 136.23 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.56 0.695 . . . . 0.0 110.636 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.0 m -127.43 151.87 48.26 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.032 0.92 . . . . 0.0 109.865 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.25 85.65 38.29 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.11 0.92 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.649 2.232 . . . . 0.0 111.902 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 11.2 mp -99.06 125.88 44.66 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.465 -0.772 . . . . 0.0 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -94.89 147.5 23.31 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.851 0.834 . . . . 0.0 110.33 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.96 132.86 44.9 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.954 0.883 . . . . 0.0 110.401 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.55 ' CG ' ' H ' ' A' ' 71' ' ' HIS . 35.8 t-80 -147.46 -129.7 0.06 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.55 ' H ' ' CG ' ' A' ' 70' ' ' HIS . 86.6 t60 50.11 79.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.797 0.808 . . . . 0.0 109.738 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -80.65 136.85 36.28 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.724 0.774 . . . . 0.0 110.154 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -67.49 -42.19 83.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.409 0.624 . . . . 0.0 109.718 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.724 ' CD2' ' H ' ' A' ' 74' ' ' HIS . 3.8 p80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.645 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -106.82 152.04 24.39 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.696 0.76 . . . . 0.0 110.238 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.08 -150.28 5.65 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.98 141.24 49.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.589 -0.948 . . . . 0.0 109.579 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.589 ' O ' HG13 ' A' ' 5' ' ' VAL . 8.9 p -81.71 118.33 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.712 . . . . 0.0 109.606 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.06 -31.14 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 110.024 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.7 m -157.06 153.95 28.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.805 -1.184 . . . . 0.0 110.839 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.424 ' O ' ' O ' ' A' ' 9' ' ' LEU . 38.8 t80 -160.28 -74.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.716 0.77 . . . . 0.0 108.953 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' TYR . 9.6 mt 57.8 116.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.782 0.801 . . . . 0.0 110.079 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.9 68.51 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.697 0.76 . . . . 0.0 109.152 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.87 -35.18 79.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.585 -0.697 . . . . 0.0 109.721 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' TYR . 54.7 mtpt -93.6 -7.46 43.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.252 -0.905 . . . . 0.0 108.792 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.7 mttm 57.86 -4.09 0.05 Allowed 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.313 0.578 . . . . 0.0 110.112 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' LYS . 26.0 p90 -161.04 164.18 31.05 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -160.99 -129.48 1.03 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -143.15 154.76 44.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.42 -1.047 . . . . 0.0 109.449 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.54 133.77 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.549 0.69 . . . . 0.0 109.23 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -90.39 97.15 11.02 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.759 0.79 . . . . 0.0 109.351 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.11 163.04 42.25 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 40.5 p-10 -66.13 -34.8 78.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.789 -0.83 . . . . 0.0 109.869 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 54.6 t0 -83.6 2.7 36.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.891 . . . . 0.0 109.088 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.58 14.9 72.33 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 97.4 mt-10 -91.85 123.16 35.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.484 -1.009 . . . . 0.0 109.728 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.463 ' O ' HD13 ' A' ' 58' ' ' LEU . 88.5 p -76.78 150.37 36.19 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.585 0.707 . . . . 0.0 110.339 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.414 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 97.7 m-85 -138.12 137.6 37.86 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.538 0.685 . . . . 0.0 109.352 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -77.81 139.94 39.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.666 -0.646 . . . . 0.0 110.019 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.627 HD23 ' N ' ' A' ' 28' ' ' HIS . 4.1 tt -114.97 118.53 33.69 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.54 0.686 . . . . 0.0 109.475 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.627 ' N ' HD23 ' A' ' 27' ' ' LEU . 31.0 t-80 -126.05 137.89 53.67 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.405 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 6.2 p90 -59.76 -28.51 67.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.586 0.707 . . . . 0.0 109.726 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -63.73 -26.27 68.57 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.383 -0.823 . . . . 0.0 109.397 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -79.34 -0.43 32.51 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.363 -0.836 . . . . 0.0 109.797 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.5 131.22 35.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.071 -1.018 . . . . 0.0 109.573 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -63.93 -39.21 93.64 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 36' ' ' LYS . 96.9 m-20 -131.41 98.85 4.64 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -46.3 -14.71 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.673 0.749 . . . . 0.0 109.649 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 34' ' ' ASP . 25.8 mtpp -64.5 -35.79 82.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.478 -0.764 . . . . 0.0 109.833 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 p-10 -73.43 -2.35 22.07 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.0 109.55 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.17 -32.25 73.76 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.501 -0.75 . . . . 0.0 109.388 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.02 -8.7 81.86 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm -103.39 14.44 31.43 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.302 -1.117 . . . . 0.0 109.48 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.05 151.71 44.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.423 -0.798 . . . . 0.0 110.082 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.43 133.26 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.779 0.8 . . . . 0.0 109.792 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -101.07 130.81 47.15 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.931 0.872 . . . . 0.0 111.075 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 91.71 -18.12 54.01 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 m -93.91 -177.25 4.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.023 -1.281 . . . . 0.0 111.816 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.8 mtt -76.74 140.53 40.83 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.715 0.769 . . . . 0.0 110.367 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.0 m -127.25 131.04 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -90.09 127.0 35.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.492 -0.755 . . . . 0.0 109.742 -179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -142.66 152.72 42.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.672 -0.643 . . . . 0.0 109.51 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.72 152.89 38.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.41 143.42 93.42 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.323 2.015 . . . . 0.0 112.281 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.7 m -152.42 87.84 4.12 Favored Pre-proline 0 N--CA 1.488 1.436 0 O-C-N 121.448 -0.782 . . . . 0.0 109.23 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -82.1 89.24 1.22 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.712 2.274 . . . . 0.0 111.667 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.425 HG23 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -94.24 176.54 2.33 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 109.481 -179.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.56 -33.41 78.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.691 2.261 . . . . 0.0 111.647 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -62.92 -42.37 99.77 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.591 -0.693 . . . . 0.0 109.225 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.87 -86.64 0.23 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 24' ' ' SER . 68.9 mt -105.23 130.97 53.26 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -1.023 . . . . 0.0 109.96 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.5 153.51 30.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.477 -0.764 . . . . 0.0 109.2 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.71 138.3 46.28 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 110.01 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 87.5 tttt -132.85 138.61 47.1 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.476 0.655 . . . . 0.0 109.358 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.2 61.15 0.61 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.687 0.756 . . . . 0.0 109.697 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.4 mt -87.18 133.08 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.0 109.528 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.3 p -139.1 153.09 47.97 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.834 0.826 . . . . 0.0 109.828 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -87.67 135.91 33.47 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.747 -0.596 . . . . 0.0 109.472 -179.259 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.68 -5.33 16.72 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.356 2.037 . . . . 0.0 111.44 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.6 mp -70.75 141.14 51.49 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.721 0.772 . . . . 0.0 110.168 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 48.93 98.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 121.758 0.79 . . . . 0.0 110.048 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.402 ' C ' ' ND1' ' A' ' 69' ' ' HIS . 0.0 OUTLIER -156.5 -171.07 3.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.435 -0.79 . . . . 0.0 110.044 179.893 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 86.1 t60 53.81 75.66 0.26 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.808 0.813 . . . . 0.0 109.876 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -155.59 152.03 28.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 0.0 109.904 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -155.49 -44.01 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.66 0.743 . . . . 0.0 109.399 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.84 -43.3 99.17 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.36 -0.837 . . . . 0.0 110.253 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.504 ' ND1' ' OXT' ' A' ' 74' ' ' HIS . 54.7 t-80 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.755 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -144.32 154.38 42.98 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.318 -0.864 . . . . 0.0 109.87 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.6 -149.19 5.6 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -129.67 142.31 50.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.633 -0.922 . . . . 0.0 109.687 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.1 p -82.15 107.03 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.476 -0.765 . . . . 0.0 109.54 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 7' ' ' SER . 10.6 p -76.48 -37.28 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 109.867 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.419 ' N ' HG13 ' A' ' 6' ' ' VAL . 70.5 m -148.23 146.93 28.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.041 -1.037 . . . . 0.0 110.474 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -158.27 105.34 1.9 Allowed 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' N ' HD12 ' A' ' 9' ' ' LEU . 6.5 mp -108.9 111.97 23.96 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.51 -29.56 70.59 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.549 -0.72 . . . . 0.0 109.581 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.53 -36.76 84.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 0.0 109.704 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' C ' ' H ' ' A' ' 14' ' ' TYR . 55.5 mtpt -92.67 -3.7 54.48 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt 55.19 6.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.742 -0.599 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.471 ' H ' ' C ' ' A' ' 12' ' ' LYS . 45.2 m-85 -130.16 154.14 47.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.639 -0.663 . . . . 0.0 109.736 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.73 -170.15 26.05 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -136.97 149.87 47.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.412 -1.052 . . . . 0.0 109.761 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.01 133.92 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -85.48 108.05 17.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.222 -0.924 . . . . 0.0 109.846 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.21 158.7 53.17 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 45.8 p-10 -65.84 -33.0 74.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.553 -0.969 . . . . 0.0 109.573 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 24.3 p30 -90.11 8.36 33.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 17.07 63.54 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -96.8 123.09 40.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.141 -1.211 . . . . 0.0 109.753 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.3 p -79.41 149.17 31.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.383 -0.823 . . . . 0.0 110.39 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -131.15 132.94 45.11 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -82.77 144.47 30.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.485 -0.759 . . . . 0.0 109.707 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.65 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.2 tt -113.18 122.96 49.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.668 -0.645 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.65 ' N ' HD23 ' A' ' 27' ' ' LEU . 49.4 t-80 -138.81 168.04 20.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.717 . . . . 0.0 109.387 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 14.1 m-85 -65.36 -39.67 92.62 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.451 -0.781 . . . . 0.0 109.523 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -61.4 -18.17 57.55 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 0.0 109.325 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -90.4 -9.3 48.1 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.356 -0.84 . . . . 0.0 109.305 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 63' ' ' ILE . 97.0 mt -99.65 107.12 19.15 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.35 -0.844 . . . . 0.0 109.504 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.9 mm? -64.76 -41.94 95.5 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.482 -0.761 . . . . 0.0 109.165 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -101.28 109.34 21.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.597 -0.689 . . . . 0.0 109.29 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -63.75 -32.64 74.21 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.184 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.1 -34.57 76.55 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -69.02 -7.03 31.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.192 -0.943 . . . . 0.0 108.865 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -59.18 -42.23 90.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.538 -0.726 . . . . 0.0 109.695 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.54 -2.85 84.56 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -95.99 -1.04 49.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -1.19 . . . . 0.0 109.271 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 79.4 mt -63.58 144.68 56.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -0.852 . . . . 0.0 109.623 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.538 ' O ' HG13 ' A' ' 42' ' ' VAL . 14.3 p -114.44 121.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-O 121.647 0.737 . . . . 0.0 109.623 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -95.2 143.04 26.94 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.658 -0.651 . . . . 0.0 110.934 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 25.35 50.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 t -152.83 -167.0 2.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.725 -1.456 . . . . 0.0 110.981 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.63 144.13 30.5 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.424 0.63 . . . . 0.0 110.768 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.0 m -135.57 161.26 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.437 ' CD2' ' CG ' ' A' ' 66' ' ' PRO . 42.3 m-70 -124.38 136.22 53.9 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.457 -0.777 . . . . 0.0 109.837 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.34 155.23 42.47 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.86 154.5 37.36 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.464 -0.772 . . . . 0.0 109.007 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.12 155.02 71.76 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.922 2.415 . . . . 0.0 112.108 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.557 HG21 ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -103.02 155.45 36.58 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.456 -0.778 . . . . 0.0 108.924 -179.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.41 -19.14 65.12 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.773 2.315 . . . . 0.0 111.113 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.551 ' O ' ' N ' ' A' ' 56' ' ' LYS . 70.2 p -41.98 152.48 0.31 Allowed Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.769 -0.582 . . . . 0.0 110.222 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -38.54 -22.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.341 2.028 . . . . 0.0 111.19 179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 54' ' ' THR . 19.6 tptm -145.29 -76.22 0.21 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.572 -0.705 . . . . 0.0 109.333 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.532 ' O ' ' N ' ' A' ' 59' ' ' ALA . . . 168.92 -83.08 0.09 OUTLIER Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.813 ' N ' HD22 ' A' ' 58' ' ' LEU . 2.1 mm? 41.58 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.865 -0.786 . . . . 0.0 109.782 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' HG21 ' A' ' 52' ' ' THR . . . -149.87 141.99 24.03 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.211 -0.931 . . . . 0.0 109.204 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -80.34 149.05 30.41 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.671 -0.643 . . . . 0.0 109.85 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -145.06 128.5 16.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.36 -0.837 . . . . 0.0 109.167 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 56.24 61.16 2.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.42 -0.8 . . . . 0.0 109.239 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.43 HD12 HD21 ' A' ' 32' ' ' LEU . 96.4 mt -72.68 139.49 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.632 -0.667 . . . . 0.0 109.596 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 31.3 p -136.22 162.19 33.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.546 -0.722 . . . . 0.0 109.852 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.59 80.49 47.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' CG ' ' CD2' ' A' ' 48' ' ' HIS . 67.1 Cg_endo -84.93 27.27 0.61 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 123.178 2.585 . . . . 0.0 111.493 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.3 mp -70.5 -106.61 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.47 -0.769 . . . . 0.0 111.259 -178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -101.33 126.43 48.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.33 -0.857 . . . . 0.0 110.687 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -140.56 143.75 35.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.583 -0.698 . . . . 0.0 109.548 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.621 ' NE2' ' CE1' ' A' ' 71' ' ' HIS . 50.6 p-80 -83.26 -13.73 54.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 109.23 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.621 ' CE1' ' NE2' ' A' ' 70' ' ' HIS . 35.7 m80 -75.04 140.72 43.74 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 110.035 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -66.49 -38.8 88.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.456 -0.777 . . . . 0.0 109.622 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 46.4 p-80 -152.91 155.74 37.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.105 -0.997 . . . . 0.0 110.161 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.462 ' ND1' ' OXT' ' A' ' 74' ' ' HIS . 47.5 t-80 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.993 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.604 ' N ' ' CE2' ' A' ' 49' ' ' PHE . 66.2 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -129.9 138.57 51.0 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.777 . . . . 0.0 109.386 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.66 6.73 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -132.82 139.56 47.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.552 -0.97 . . . . 0.0 109.335 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.547 ' O ' HG13 ' A' ' 5' ' ' VAL . 12.4 p -82.93 121.32 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.279 -0.888 . . . . 0.0 109.874 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 p -91.18 -32.98 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.305 -0.872 . . . . 0.0 109.162 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 t -154.38 144.88 22.23 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.916 -1.115 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.471 ' CE2' HD12 ' A' ' 41' ' ' LEU . 40.2 t80 -158.73 96.53 1.38 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.295 -0.878 . . . . 0.0 108.84 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 9' ' ' LEU . 4.1 mm? -100.77 124.55 46.57 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.167 -0.958 . . . . 0.0 109.378 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.61 -35.79 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.696 0.76 . . . . 0.0 109.268 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.13 -30.06 70.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.494 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.559 ' C ' ' H ' ' A' ' 14' ' ' TYR . 58.1 mttp -94.35 -7.03 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.075 -1.015 . . . . 0.0 108.926 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 58.83 -3.94 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.565 -0.71 . . . . 0.0 109.846 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 12' ' ' LYS . 28.0 p90 -151.64 161.23 43.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.801 -1.187 . . . . 0.0 109.042 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -155.98 -133.59 1.7 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -141.25 157.83 44.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.168 -1.195 . . . . 0.0 109.775 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 18' ' ' GLN . 96.3 mt -136.26 154.91 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.415 -0.803 . . . . 0.0 109.241 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 17' ' ' ILE . 58.0 tt0 -109.79 106.56 16.22 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.764 0.792 . . . . 0.0 109.146 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.43 161.4 50.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -64.16 -37.21 86.63 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -1.01 . . . . 0.0 109.338 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 30.3 p-10 -89.9 9.99 25.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.116 -0.99 . . . . 0.0 109.448 -179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 16.62 65.08 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.49 114.6 26.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.222 -1.164 . . . . 0.0 109.202 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.8 m -74.86 146.73 41.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 110.363 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -122.81 139.55 53.88 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.55 -0.718 . . . . 0.0 109.248 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -79.24 131.08 36.06 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.402 -0.811 . . . . 0.0 109.554 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.5 tt -104.9 123.41 47.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.436 -0.79 . . . . 0.0 109.088 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.622 ' N ' HD23 ' A' ' 27' ' ' LEU . 1.8 t60 -134.36 153.12 52.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.584 -0.698 . . . . 0.0 109.412 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.29 -35.57 81.28 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.783 0.801 . . . . 0.0 108.894 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.5 p -61.28 -21.09 63.61 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.446 -0.784 . . . . 0.0 109.62 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.66 -3.89 59.1 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.068 -1.02 . . . . 0.0 109.645 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.8 mt -94.5 126.0 39.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 0.0 109.891 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -63.14 -41.31 99.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.415 -0.803 . . . . 0.0 109.273 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' LYS . 93.9 m-20 -127.17 89.72 3.02 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -45.84 -15.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.548 -0.72 . . . . 0.0 109.555 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' ASP . 44.0 mmtm -66.2 -34.96 79.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 109.163 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 36.3 p30 -73.66 -3.0 25.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.752 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.42 -36.09 82.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.223 -0.923 . . . . 0.0 109.539 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.39 -12.56 81.86 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -95.38 6.12 49.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.197 -1.179 . . . . 0.0 109.304 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.471 HD12 ' CE2' ' A' ' 8' ' ' TYR . 94.8 mt -68.94 156.44 38.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.083 -1.01 . . . . 0.0 109.953 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.89 128.76 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.669 0.747 . . . . 0.0 109.663 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -98.76 138.16 36.31 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.421 -0.8 . . . . 0.0 110.874 -179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.6 24.91 61.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.416 -1.074 . . . . 0.0 110.416 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -141.63 -174.4 4.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.975 -1.309 . . . . 0.0 110.744 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.0 mtp -79.55 149.36 31.45 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.665 0.745 . . . . 0.0 110.557 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.4 m -134.86 164.13 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -127.62 133.09 49.69 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.604 ' CE2' ' N ' ' A' ' 1' ' ' MET . 52.3 p90 -150.54 163.51 38.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.367 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -95.75 152.05 38.84 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.241 -0.912 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.04 150.18 88.91 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.623 2.215 . . . . 0.0 112.734 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -148.94 88.04 5.26 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.95 88.8 0.02 OUTLIER 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.403 2.069 . . . . 0.0 111.915 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 56' ' ' LYS . 7.2 p -137.17 68.3 55.66 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.06 12.43 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.653 2.236 . . . . 0.0 111.305 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 54' ' ' THR . 9.8 ptpp? -105.79 8.75 32.98 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.723 0.773 . . . . 0.0 109.223 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.31 -17.91 0.08 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 -179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.1 mt 62.7 147.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.754 -0.851 . . . . 0.0 110.457 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.21 170.72 19.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.948 . . . . 0.0 109.685 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 61' ' ' LYS . . . -101.98 -46.22 4.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.408 -0.808 . . . . 0.0 108.891 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 60' ' ' ALA . 88.3 tttt 59.12 129.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.944 0.878 . . . . 0.0 110.903 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 48.14 87.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 0.0 109.833 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.2 mt -103.36 137.37 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.505 -0.747 . . . . 0.0 109.697 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.6 p -134.64 160.16 38.98 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.859 0.838 . . . . 0.0 109.834 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.23 81.79 22.1 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -83.4 -1.95 10.39 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.755 2.303 . . . . 0.0 111.277 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 68' ' ' GLU . 37.5 tp -94.97 128.28 41.67 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.152 -0.967 . . . . 0.0 110.756 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 67' ' ' LEU . 75.1 mm-40 53.89 110.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.974 0.892 . . . . 0.0 109.868 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -97.73 132.92 42.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.31 -0.869 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -74.11 128.8 36.48 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.724 0.773 . . . . 0.0 109.931 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.508 ' CD2' ' H ' ' A' ' 71' ' ' HIS . 9.0 p80 -82.99 144.25 30.09 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.403 -0.811 . . . . 0.0 110.106 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -83.72 -13.0 55.07 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.731 0.776 . . . . 0.0 109.098 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -74.93 154.99 37.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.359 -0.838 . . . . 0.0 110.532 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.441 ' CD2' ' N ' ' A' ' 74' ' ' HIS . 4.1 p80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.994 -1.003 . . . . 0.0 108.851 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.3 mmm . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -111.08 170.9 7.8 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.435 0.636 . . . . 0.0 109.857 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.29 -145.86 4.3 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.61 142.13 49.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.494 -1.004 . . . . 0.0 109.751 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 5' ' ' VAL . 5.4 p -81.52 112.04 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -70.35 -37.39 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.391 -0.818 . . . . 0.0 109.781 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.0 t -165.8 156.61 13.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 110.337 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.44 ' CD1' HD13 ' A' ' 27' ' ' LEU . 73.9 t80 -153.87 107.47 2.97 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -112.32 124.57 52.76 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.508 -0.745 . . . . 0.0 109.639 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.47 77.28 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.348 0.594 . . . . 0.0 109.9 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.21 -36.4 73.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 109.96 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.583 ' C ' ' H ' ' A' ' 14' ' ' TYR . 13.7 mptt -87.68 6.67 33.68 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt 64.22 -17.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.583 ' H ' ' C ' ' A' ' 12' ' ' LYS . 42.2 p90 -160.72 165.21 30.84 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.043 -1.035 . . . . 0.0 109.165 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.32 -136.15 3.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.9 152.53 51.87 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.511 -0.993 . . . . 0.0 109.93 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -134.01 137.57 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -92.55 100.73 13.21 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 0.0 109.532 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.09 174.08 44.4 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -63.52 -39.6 94.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.45 -1.029 . . . . 0.0 109.912 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -80.94 -0.61 40.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.079 -1.013 . . . . 0.0 109.116 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.65 11.75 79.15 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -84.66 128.22 34.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.094 -1.239 . . . . 0.0 109.683 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.4 p -74.22 148.54 41.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.408 -0.807 . . . . 0.0 110.342 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.35 136.81 43.68 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.522 -0.736 . . . . 0.0 109.107 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -79.64 137.72 37.18 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 109.719 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.464 HD23 ' C ' ' A' ' 27' ' ' LEU . 2.0 tt -109.71 89.37 2.99 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -96.04 165.11 12.41 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 0.0 110.264 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -64.0 -40.59 96.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.509 -0.744 . . . . 0.0 109.782 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.3 t -61.77 -18.37 59.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 110.178 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -84.29 -5.34 59.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.4 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 94.0 mt -100.66 125.41 47.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.9 mt -63.57 -41.37 98.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -130.75 114.47 15.4 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.644 -0.66 . . . . 0.0 109.246 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -64.19 -11.68 33.15 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.278 -0.889 . . . . 0.0 109.351 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -64.07 -38.65 91.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.348 -0.845 . . . . 0.0 109.313 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.52 -5.4 23.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.41 -0.806 . . . . 0.0 109.421 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -57.29 -39.72 76.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.4 -9.19 87.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -96.35 -0.64 49.17 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.197 -1.178 . . . . 0.0 109.087 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.0 mt -64.9 146.79 54.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 42' ' ' VAL . 7.1 p -115.06 119.02 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.835 0.826 . . . . 0.0 109.555 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -92.35 140.73 29.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 110.661 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.96 25.21 50.18 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 t -147.46 -164.99 2.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.939 -1.33 . . . . 0.0 110.588 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 97.2 mtp -82.33 140.28 33.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.724 -0.61 . . . . 0.0 110.372 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -132.59 135.72 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.57 -0.706 . . . . 0.0 109.256 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 -94.31 128.95 41.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.369 -0.832 . . . . 0.0 109.669 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -144.23 155.85 44.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.337 -0.852 . . . . 0.0 109.458 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.73 110.64 59.32 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 121.531 -0.731 . . . . 0.0 109.258 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -51.49 146.9 24.21 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.334 2.023 . . . . 0.0 112.559 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.5 p -109.39 150.31 40.96 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.672 -0.643 . . . . 0.0 109.304 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -66.49 88.62 0.27 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.336 2.024 . . . . 0.0 111.822 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.98 82.3 0.52 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.809 . . . . 0.0 108.965 179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.16 -31.58 66.25 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.653 2.235 . . . . 0.0 111.458 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -110.49 105.94 15.07 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.463 0.649 . . . . 0.0 109.379 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 128.72 -45.58 1.14 Allowed Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 57' ' ' GLY . 54.6 mt 58.43 128.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.804 -0.821 . . . . 0.0 110.123 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.18 150.55 28.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 0.0 109.212 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.08 151.31 22.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.409 -0.807 . . . . 0.0 109.898 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -141.43 133.96 28.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.21 66.84 1.12 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.682 0.753 . . . . 0.0 109.886 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -83.81 134.8 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.546 -0.721 . . . . 0.0 109.515 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.2 p -131.13 148.74 52.76 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.453 -0.779 . . . . 0.0 109.816 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -94.85 145.13 29.02 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.526 ' O ' ' N ' ' A' ' 68' ' ' GLU . 56.0 Cg_endo -71.61 -84.07 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.421 2.08 . . . . 0.0 112.041 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.7 tp 42.36 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 121.418 0.628 . . . . 0.0 109.581 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 66' ' ' PRO . 96.2 mt-10 52.92 -110.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.686 -0.634 . . . . 0.0 110.263 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -149.2 146.06 27.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.166 -0.959 . . . . 0.0 109.659 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -71.5 148.5 46.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.461 -0.774 . . . . 0.0 110.566 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -69.78 136.87 51.39 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.678 0.751 . . . . 0.0 110.523 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 65.8 t-80 46.57 88.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.607 0.717 . . . . 0.0 110.062 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -83.18 135.06 34.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.534 -0.729 . . . . 0.0 110.024 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.683 -179.893 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.2 156.55 45.33 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.639 0.733 . . . . 0.0 109.755 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -162.61 -167.1 22.53 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.141 -1.028 . . . . 0.0 110.653 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.2 tttp -132.05 137.36 47.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.696 0.76 . . . . 0.0 110.018 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.3 p -76.48 122.11 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 121.652 0.739 . . . . 0.0 110.1 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -93.46 -34.83 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -156.32 160.58 39.84 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.92 0.867 . . . . 0.0 110.245 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -162.99 93.9 0.82 Allowed 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.706 0.765 . . . . 0.0 109.401 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.513 HD12 ' N ' ' A' ' 9' ' ' LEU . 10.5 mp -102.01 113.57 26.92 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.905 0.86 . . . . 0.0 108.822 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.0 -13.97 59.89 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -44.25 -65.94 0.45 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 109.824 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.18 17.13 14.79 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mttp 56.7 57.83 4.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.688 0.756 . . . . 0.0 109.782 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.401 ' OH ' HD22 ' A' ' 9' ' ' LEU . 2.9 p90 -151.99 166.11 32.56 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.85 0.833 . . . . 0.0 110.144 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.96 174.08 45.76 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -133.6 150.7 51.61 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.765 -0.844 . . . . 0.0 109.342 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.98 133.07 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.801 0.81 . . . . 0.0 109.842 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -92.58 115.09 27.79 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.843 0.83 . . . . 0.0 109.867 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.66 158.33 50.05 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.286 -1.125 . . . . 0.0 110.286 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 46.3 p-10 -66.88 -23.56 66.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.939 -0.742 . . . . 0.0 110.119 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 82.7 m-20 -89.95 5.27 47.18 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.404 -0.81 . . . . 0.0 109.243 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.68 15.58 65.47 Favored Glycine 0 N--CA 1.495 2.622 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -99.74 120.26 39.45 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.714 -0.874 . . . . 0.0 109.922 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -78.37 155.03 30.25 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 109.703 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -138.16 135.26 35.51 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.896 0.855 . . . . 0.0 110.136 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -75.59 142.84 42.62 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.728 0.775 . . . . 0.0 109.849 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.404 HD23 ' C ' ' A' ' 27' ' ' LEU . 9.2 tt -107.98 132.06 53.91 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.746 0.784 . . . . 0.0 109.749 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 29' ' ' PHE . 2.4 t60 -134.3 146.04 49.64 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.984 0.897 . . . . 0.0 110.102 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.431 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 4.1 m-85 -62.16 -42.16 98.99 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 t -62.87 -18.52 63.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.586 ' N ' ' OE1' ' A' ' 31' ' ' GLU . 2.7 mp0 -88.99 -0.52 57.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.0 109.218 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 34' ' ' ASP . 75.5 mt -90.22 -3.08 58.06 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.4 mt 59.27 -70.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 32' ' ' LEU . 43.2 t0 -110.05 105.71 14.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -56.69 -12.22 1.74 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.821 -0.549 . . . . 0.0 109.533 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.61 -36.55 84.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.686 -0.634 . . . . 0.0 109.979 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -77.08 -5.54 49.32 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.421 -0.799 . . . . 0.0 109.072 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 79.0 tt0 -57.37 -38.29 73.97 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.778 -0.576 . . . . 0.0 109.575 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.07 -8.42 86.55 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -96.11 0.05 50.88 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.284 -1.127 . . . . 0.0 109.003 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.85 152.01 46.43 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.615 0.721 . . . . 0.0 110.108 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.4 p -122.94 129.92 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 CA-C-O 122.114 0.959 . . . . 0.0 109.722 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -95.78 138.34 33.57 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.713 0.768 . . . . 0.0 110.347 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 81.21 25.29 55.41 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.724 -0.951 . . . . 0.0 110.724 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 t -140.01 172.59 12.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.154 -1.204 . . . . 0.0 110.707 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 67.1 mtt -76.3 141.56 41.58 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.938 0.875 . . . . 0.0 109.999 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.19 161.79 39.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.499 0.666 . . . . 0.0 109.682 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -122.07 129.5 52.45 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.921 0.867 . . . . 0.0 109.858 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -151.39 158.98 44.44 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.827 0.822 . . . . 0.0 109.797 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.49 143.76 26.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.1 141.78 58.9 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.412 2.074 . . . . 0.0 112.123 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 m -153.6 90.46 3.39 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.756 -0.59 . . . . 0.0 109.708 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -55.52 140.34 83.12 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.337 2.025 . . . . 0.0 111.801 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.52 160.35 59.59 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -45.93 -38.18 18.01 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.894 2.396 . . . . 0.0 112.089 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -64.25 -41.37 96.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.15 -86.89 0.15 Allowed Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.1 mt -113.92 134.98 54.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.644 -0.915 . . . . 0.0 109.96 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.39 148.68 29.77 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.739 0.78 . . . . 0.0 109.983 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.41 133.8 49.58 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.643 0.735 . . . . 0.0 109.706 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -118.29 143.84 46.28 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.96 0.886 . . . . 0.0 110.409 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.59 62.42 2.14 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.739 0.781 . . . . 0.0 109.884 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.8 mt -75.79 137.09 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.576 0.703 . . . . 0.0 109.8 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.9 p -133.05 160.23 37.77 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.999 0.904 . . . . 0.0 110.107 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.11 98.33 38.7 Favored Pre-proline 0 N--CA 1.492 1.636 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.63 -35.87 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.612 2.208 . . . . 0.0 111.604 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -77.96 128.09 33.36 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.727 0.775 . . . . 0.0 109.485 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 57.2 mp0 -97.45 127.1 43.14 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.81 0.814 . . . . 0.0 110.146 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -93.32 121.09 34.35 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.52 0.676 . . . . 0.0 110.344 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -149.54 164.95 33.66 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.747 0.784 . . . . 0.0 110.209 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -73.62 130.06 39.25 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.731 0.777 . . . . 0.0 110.196 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -84.42 149.17 26.17 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.784 0.802 . . . . 0.0 110.707 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.477 ' O ' ' ND1' ' A' ' 73' ' ' HIS . 11.5 p80 -69.11 142.75 54.35 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.629 0.728 . . . . 0.0 110.152 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.453 ' CG ' ' O ' ' A' ' 74' ' ' HIS . 55.6 p-80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.431 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' ND1' ' A' ' 48' ' ' HIS . 97.8 mmm . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.53 165.54 11.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.416 -0.803 . . . . 0.0 109.993 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.68 -172.98 32.81 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' NZ ' ' O ' ' A' ' 44' ' ' GLY . 62.3 tttm -142.99 128.31 18.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -1.088 . . . . 0.0 109.224 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.779 HG13 ' H ' ' A' ' 44' ' ' GLY . 1.5 p -74.68 130.52 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.937 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.0 p -102.31 -36.4 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.748 . . . . 0.0 109.2 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 p -158.48 161.97 37.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.961 -1.087 . . . . 0.0 110.556 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -165.75 93.98 0.57 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 9' ' ' LEU . 11.2 mp -101.21 122.0 42.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.366 -0.834 . . . . 0.0 109.19 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 11' ' ' ALA . . . -77.07 -14.31 59.83 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.661 -0.65 . . . . 0.0 109.382 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 10' ' ' ALA . . . -41.17 -67.99 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.739 -0.601 . . . . 0.0 110.593 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -98.93 19.26 15.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.441 -0.787 . . . . 0.0 109.072 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttp 56.3 66.19 1.25 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.701 -0.624 . . . . 0.0 110.006 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -155.83 170.66 21.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.375 -0.828 . . . . 0.0 109.229 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -174.64 166.79 38.78 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -132.65 150.89 52.09 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.619 -0.93 . . . . 0.0 109.282 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.401 HD11 HD12 ' A' ' 27' ' ' LEU . 96.6 mt -133.96 147.81 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -94.95 117.15 29.65 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.463 -0.773 . . . . 0.0 109.576 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -74.12 159.46 52.69 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.72 -35.53 81.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.387 -1.066 . . . . 0.0 109.603 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -80.64 -0.75 39.42 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.212 -0.93 . . . . 0.0 109.485 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 97.13 -5.22 63.13 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' OE2' ' OH ' ' A' ' 25' ' ' TYR . 20.0 pt-20 -80.24 133.81 36.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.124 -1.221 . . . . 0.0 110.364 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.6 p -83.41 162.77 20.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.353 -0.842 . . . . 0.0 110.48 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' OH ' ' OE2' ' A' ' 23' ' ' GLU . 62.4 m-85 -134.87 146.57 49.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.488 -0.758 . . . . 0.0 109.502 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.79 125.41 34.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.398 -0.814 . . . . 0.0 109.253 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 28' ' ' HIS . 5.4 tt -103.39 122.23 44.43 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.397 -0.815 . . . . 0.0 108.927 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.651 ' N ' HD23 ' A' ' 27' ' ' LEU . 53.6 t-80 -135.82 166.79 22.47 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.592 -0.693 . . . . 0.0 109.467 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.401 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 11.3 m-85 -62.13 -40.04 94.6 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HG ' ' CE1' ' A' ' 28' ' ' HIS . 1.1 m -60.99 -21.5 63.6 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.453 -0.78 . . . . 0.0 109.991 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.17 -6.76 54.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.992 . . . . 0.0 109.484 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.26 107.13 18.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 109.746 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.04 -41.38 97.43 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -113.69 97.47 6.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -64.59 -27.01 68.65 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.371 -0.831 . . . . 0.0 109.234 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -59.86 -27.79 66.97 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.428 -0.795 . . . . 0.0 109.032 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -73.0 -9.35 58.64 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.456 -0.777 . . . . 0.0 109.264 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -64.61 -35.42 80.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 110.01 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.42 0.97 38.3 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -149.92 58.08 0.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -1.205 . . . . 0.0 108.982 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.8 mt -81.49 -165.95 1.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.251 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -120.84 159.84 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.749 0.785 . . . . 0.0 109.714 -179.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -148.4 93.65 2.18 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.779 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 98.63 -13.85 62.3 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.506 ' OG ' HD22 ' A' ' 67' ' ' LEU . 16.6 m -86.49 -177.66 6.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.804 -1.409 . . . . 0.0 111.021 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.06 145.95 29.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.568 -0.708 . . . . 0.0 110.434 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.542 HG12 HG21 ' A' ' 42' ' ' VAL . 2.5 m -133.29 164.03 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 1' ' ' MET . 75.1 t60 -135.17 135.33 40.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.374 -0.829 . . . . 0.0 109.456 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.41 163.7 38.99 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.56 153.06 38.12 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.378 -0.826 . . . . 0.0 109.656 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.96 139.36 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.953 1.769 . . . . 0.0 112.874 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.513 HG22 HG23 ' A' ' 54' ' ' THR . 4.0 m -153.55 87.91 3.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 54' ' ' THR . 54.1 Cg_exo -53.58 -43.17 60.02 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.231 1.954 . . . . 0.0 111.542 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.513 HG23 HG22 ' A' ' 52' ' ' THR . 0.1 OUTLIER 53.58 161.02 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.719 0 CA-C-O 121.222 0.534 . . . . 0.0 110.472 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.21 -41.33 73.17 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.32 2.013 . . . . 0.0 112.04 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.74 -43.04 97.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.267 -0.895 . . . . 0.0 109.752 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.96 -63.59 0.61 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 78.6 mt -109.85 125.71 53.06 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.308 -1.113 . . . . 0.0 110.055 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB3' ' OG1' ' A' ' 54' ' ' THR . . . -158.73 151.38 21.96 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.256 -0.903 . . . . 0.0 109.241 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.32 119.43 39.46 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 32.9 ttpt -115.79 147.81 40.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.568 -0.708 . . . . 0.0 110.062 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 61' ' ' LYS . . . 66.52 48.92 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.392 0.615 . . . . 0.0 109.432 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.43 135.98 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.408 -0.808 . . . . 0.0 109.522 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 56.9 m -126.92 149.56 49.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.575 -0.703 . . . . 0.0 109.275 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.59 97.35 36.41 Favored Pre-proline 0 N--CA 1.494 1.741 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -84.2 5.97 6.02 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.606 2.204 . . . . 0.0 112.483 -179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.506 HD22 ' OG ' ' A' ' 45' ' ' SER . 10.7 tp -81.75 -0.56 43.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 108.907 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.6 142.15 45.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.383 -0.823 . . . . 0.0 110.202 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 70' ' ' HIS . 99.5 m-70 -107.96 115.14 29.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.578 -0.701 . . . . 0.0 109.488 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 69' ' ' HIS . 61.5 m170 52.88 168.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.616 0.722 . . . . 0.0 110.842 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.555 ' CD2' ' H ' ' A' ' 71' ' ' HIS . 7.4 p80 -67.24 -44.43 79.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.541 -0.724 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.649 ' CD2' ' H ' ' A' ' 73' ' ' HIS . 84.0 t60 -139.44 -109.25 0.16 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.726 . . . . 0.0 109.642 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.649 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 96.4 m-70 43.18 87.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.618 -0.676 . . . . 0.0 109.994 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.451 ' O ' ' CD2' ' A' ' 74' ' ' HIS . 84.0 t60 . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.037 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mpp? . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.455 0.645 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -71.37 -80.98 0.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.678 -0.639 . . . . 0.0 109.755 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 147.34 175.64 20.35 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -135.5 145.61 47.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.721 -0.87 . . . . 0.0 109.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 5' ' ' VAL . 9.2 p -88.43 112.46 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' N ' ' A' ' 7' ' ' SER . 7.5 p -70.77 -41.59 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.535 -0.728 . . . . 0.0 109.745 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.451 ' N ' HG13 ' A' ' 6' ' ' VAL . 31.1 p -160.33 160.62 32.67 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.573 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.488 ' C ' HD12 ' A' ' 9' ' ' LEU . 40.5 t80 -156.84 111.27 2.74 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.68 0.752 . . . . 0.0 109.61 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 8' ' ' TYR . 11.1 mp -106.83 102.4 11.77 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.2 -23.86 65.79 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -42.09 96.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.593 . . . . 0.0 110.026 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 14' ' ' TYR . 51.4 mtmt -97.23 4.24 51.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.407 -0.808 . . . . 0.0 109.38 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 59.1 2.95 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.308 0.575 . . . . 0.0 110.12 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.438 ' H ' ' C ' ' A' ' 12' ' ' LYS . 62.0 m-85 -118.89 152.3 36.54 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.606 -0.684 . . . . 0.0 109.895 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -158.97 -168.9 21.67 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -137.51 149.71 46.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.754 -0.851 . . . . 0.0 110.284 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.8 mt -134.1 138.49 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.487 0.66 . . . . 0.0 109.527 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -99.46 105.25 17.16 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.761 0.791 . . . . 0.0 109.741 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.44 160.66 51.22 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 43.0 p-10 -66.59 -33.37 75.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.649 -0.912 . . . . 0.0 109.712 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 84.7 m-20 -87.99 6.46 35.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.774 -0.579 . . . . 0.0 109.496 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.84 16.95 64.39 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' OE1' ' OH ' ' A' ' 25' ' ' TYR . 97.5 mt-10 -93.68 118.54 31.53 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.518 -0.99 . . . . 0.0 109.673 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.0 p -77.29 153.22 34.11 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.798 0.809 . . . . 0.0 110.06 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' OE1' ' A' ' 23' ' ' GLU . 98.0 m-85 -141.47 134.97 29.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.603 0.716 . . . . 0.0 109.581 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -79.35 140.56 37.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.699 0.761 . . . . 0.0 110.108 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.58 ' C ' HD23 ' A' ' 27' ' ' LEU . 4.4 tt -112.61 115.0 27.9 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.756 0.788 . . . . 0.0 109.254 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' N ' HD23 ' A' ' 27' ' ' LEU . 52.3 t-80 -141.25 167.32 22.45 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.841 0.829 . . . . 0.0 110.303 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' N ' ' CG ' ' A' ' 28' ' ' HIS . 13.5 m-85 -61.65 -35.41 77.87 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.844 -0.535 . . . . 0.0 110.146 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 77.8 p -62.99 -20.27 65.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.619 -0.675 . . . . 0.0 109.863 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -93.61 -11.02 32.68 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.264 -0.897 . . . . 0.0 109.609 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.7 mt -96.11 116.03 28.35 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.372 -0.83 . . . . 0.0 109.569 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.8 mm? -64.52 -42.14 95.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.804 -0.56 . . . . 0.0 109.537 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -117.65 134.76 54.55 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.738 0.78 . . . . 0.0 109.589 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' N ' ' CD ' ' A' ' 35' ' ' LYS . 1.2 mptm? -77.45 -12.42 59.96 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.48 ' CG ' ' N ' ' A' ' 37' ' ' ASP . 19.2 ptmt -65.4 -41.96 93.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.717 -0.615 . . . . 0.0 110.313 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.48 ' N ' ' CG ' ' A' ' 36' ' ' LYS . 98.0 m-20 -78.33 -8.31 58.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 109.606 -178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -68.36 -36.81 79.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 109.108 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.6 -9.75 80.76 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.479 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 68.3 mttm -98.46 -0.76 42.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.175 -1.191 . . . . 0.0 109.296 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.8 mt -53.9 145.74 15.64 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.517 -0.739 . . . . 0.0 110.184 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 p -124.18 125.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 122.018 0.913 . . . . 0.0 109.47 -179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' VAL . 7.4 tmtm? -95.69 137.24 35.04 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.908 0.861 . . . . 0.0 110.854 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.22 25.93 38.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 t -142.06 -164.95 1.91 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.026 -1.279 . . . . 0.0 111.343 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.6 mtp -88.49 139.94 29.97 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.965 0.888 . . . . 0.0 110.961 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.24 159.8 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-O 121.368 0.604 . . . . 0.0 109.503 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -124.05 132.32 53.66 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 121.908 0.861 . . . . 0.0 110.07 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -154.99 161.16 41.46 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.617 0.722 . . . . 0.0 109.801 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -102.73 150.69 37.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.47 159.8 50.38 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.487 2.125 . . . . 0.0 112.542 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -147.35 148.84 32.84 Favored Pre-proline 0 C--N 1.304 -1.407 0 O-C-N 121.689 -0.632 . . . . 0.0 109.474 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 54' ' ' THR . 55.2 Cg_endo -69.62 -63.84 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.823 2.349 . . . . 0.0 111.742 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 53' ' ' PRO . 8.6 p 56.87 146.73 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.144 0.497 . . . . 0.0 110.27 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.54 73.24 2.28 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.579 2.186 . . . . 0.0 111.766 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.1 tptp 58.59 88.75 0.06 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.413 0.625 . . . . 0.0 110.333 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.22 -25.2 0.12 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.2 mt 60.92 152.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.742 -0.857 . . . . 0.0 110.627 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.3 156.38 35.4 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.703 0.763 . . . . 0.0 109.728 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.31 87.86 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -89.75 148.4 23.27 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.833 0.825 . . . . 0.0 110.294 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 62.86 58.1 1.59 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.617 0.723 . . . . 0.0 109.616 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 97.8 mt -82.45 129.37 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.917 0.865 . . . . 0.0 109.917 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.1 m -135.79 126.38 27.05 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.645 0.735 . . . . 0.0 109.335 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.479 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -89.26 132.35 37.84 Favored Pre-proline 0 N--CA 1.487 1.382 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -76.23 -9.7 19.1 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 122.412 2.075 . . . . 0.0 111.319 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.1 mt -96.96 130.85 44.21 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.745 0.783 . . . . 0.0 109.741 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 57.4 mp0 -93.03 7.54 43.71 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 70' ' ' HIS . 85.4 t60 53.1 57.23 6.51 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.539 0.685 . . . . 0.0 109.803 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 69' ' ' HIS . 80.5 m80 47.47 179.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.865 0.841 . . . . 0.0 110.662 179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.417 ' O ' ' C ' ' A' ' 72' ' ' HIS . 99.5 m-70 -58.38 -80.22 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.77 -0.581 . . . . 0.0 109.486 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' HIS . 81.0 m80 38.83 82.17 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.593 0.711 . . . . 0.0 110.105 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -66.72 -40.92 88.59 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.321 179.898 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 tpp . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -90.83 179.52 5.76 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.689 0.757 . . . . 0.0 110.018 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.28 -166.42 28.28 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -135.13 138.25 43.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.876 -0.779 . . . . 0.0 110.313 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG13 ' H ' ' A' ' 44' ' ' GLY . 8.0 p -74.12 126.19 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.359 0.599 . . . . 0.0 109.409 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 7' ' ' SER . 9.2 p -94.37 -42.72 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.493 ' N ' HG13 ' A' ' 6' ' ' VAL . 66.1 m -152.85 153.75 33.72 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.992 0.901 . . . . 0.0 110.524 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -161.02 117.18 2.23 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.681 0.753 . . . . 0.0 109.523 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -118.87 110.34 17.07 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.855 0.836 . . . . 0.0 109.231 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.64 -34.49 77.07 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.529 0.681 . . . . 0.0 109.401 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.66 -34.33 75.53 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 14' ' ' TYR . 28.6 mmtp -95.7 -1.58 49.72 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? 57.67 6.54 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.452 0.644 . . . . 0.0 109.57 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.448 ' H ' ' C ' ' A' ' 12' ' ' LYS . 47.6 m-85 -123.02 160.13 26.95 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.911 0.863 . . . . 0.0 110.227 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.91 -170.16 28.43 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -145.03 148.34 33.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.791 -0.829 . . . . 0.0 109.604 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.6 mt -133.69 132.89 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.74 0.781 . . . . 0.0 109.903 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.412 HE21 ' HA2' ' A' ' 22' ' ' GLY . 61.7 tp60 -97.07 113.63 25.2 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.921 0.867 . . . . 0.0 110.078 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.88 161.47 52.3 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.289 -1.125 . . . . 0.0 110.289 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -64.59 -35.8 82.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 122.062 -0.669 . . . . 0.0 109.643 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -83.52 9.5 11.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' HA2' HE21 ' A' ' 18' ' ' GLN . . . 79.6 21.74 65.93 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CE2' ' A' ' 25' ' ' TYR . 75.6 mm-40 -95.95 115.22 27.1 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.703 -0.881 . . . . 0.0 110.049 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 40.0 t -77.16 146.95 36.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.681 0.753 . . . . 0.0 110.04 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 23' ' ' GLU . 99.0 m-85 -136.0 136.55 40.41 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.782 0.801 . . . . 0.0 109.529 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.42 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 63.7 m-85 -81.35 143.07 32.46 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.829 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.611 HD23 ' C ' ' A' ' 27' ' ' LEU . 6.5 tt -111.62 121.87 46.31 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.154 0.978 . . . . 0.0 109.548 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.589 ' N ' HD23 ' A' ' 27' ' ' LEU . 22.3 t60 -139.0 167.78 21.3 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.959 0.885 . . . . 0.0 109.602 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 6.2 m-85 -62.05 -38.08 87.39 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.405 0.621 . . . . 0.0 109.413 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.8 m -61.59 -20.85 63.78 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.42 ' OE1' ' O ' ' A' ' 26' ' ' PHE . 94.7 mt-10 -90.84 -11.68 38.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.414 -0.804 . . . . 0.0 109.842 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.6 mt -96.12 106.08 18.22 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.172 -0.955 . . . . 0.0 109.655 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 33' ' ' LEU . 4.0 mm? -64.88 -42.22 94.99 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.61 0.719 . . . . 0.0 109.515 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -110.82 90.1 3.23 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -49.0 -19.5 0.41 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.2 ttmm -66.16 -35.9 81.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -69.48 -12.36 61.59 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.341 0.591 . . . . 0.0 109.496 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.519 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 78.4 tt0 -66.23 -34.89 79.04 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.414 0.626 . . . . 0.0 109.591 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -84.09 -7.76 84.84 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -108.18 15.45 24.16 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.596 -0.944 . . . . 0.0 109.604 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.59 151.36 46.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.815 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.56 133.3 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.122 0.963 . . . . 0.0 109.607 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -100.23 133.51 44.53 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.473 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 93.33 -24.16 26.58 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -90.7 -178.87 5.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.536 -0.979 . . . . 0.0 110.685 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.2 mtt -82.81 148.39 27.81 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.793 0.806 . . . . 0.0 110.837 -179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 160.07 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.474 0.654 . . . . 0.0 109.286 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -121.23 125.28 46.72 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 122.005 0.907 . . . . 0.0 110.312 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -138.36 150.96 47.09 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.333 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -103.49 131.12 22.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -48.45 141.68 18.95 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.739 2.292 . . . . 0.0 113.047 179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.39 151.06 76.79 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -71.41 131.22 18.55 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.892 2.395 . . . . 0.0 113.097 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.95 149.42 27.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.02 -47.3 1.84 Allowed 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.758 2.306 . . . . 0.0 111.668 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -171.75 111.58 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.741 0.782 . . . . 0.0 109.662 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 139.37 -16.27 3.16 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.4 mt 60.92 163.09 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.619 0.723 . . . . 0.0 109.999 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.71 153.7 21.38 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.76 0.79 . . . . 0.0 109.834 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.6 151.09 21.05 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.683 0.754 . . . . 0.0 109.866 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -140.33 138.71 35.11 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.857 0.837 . . . . 0.0 110.039 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 55.69 66.34 1.24 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.53 0.681 . . . . 0.0 110.173 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.9 130.3 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.618 0.723 . . . . 0.0 109.654 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.3 m -131.36 164.81 24.86 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.803 0.811 . . . . 0.0 109.78 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.73 79.63 23.45 Favored Pre-proline 0 N--CA 1.495 1.804 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.61 16.95 1.34 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.574 2.183 . . . . 0.0 111.416 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 68' ' ' GLU . 0.2 OUTLIER -72.01 117.91 14.22 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.541 0.686 . . . . 0.0 110.335 -179.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.591 ' N ' HD13 ' A' ' 67' ' ' LEU . 97.0 mt-10 -73.91 133.93 43.14 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.644 0.735 . . . . 0.0 109.911 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -145.82 114.31 6.74 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.773 0.797 . . . . 0.0 109.941 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -148.82 164.47 34.35 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.815 0.817 . . . . 0.0 110.074 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -66.21 -37.86 86.58 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -76.9 42.08 0.3 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.54 0.686 . . . . 0.0 109.378 -179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -64.71 -43.28 93.95 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.416 ' OXT' ' ND1' ' A' ' 74' ' ' HIS . 54.1 t-80 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.167 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ptp . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -158.68 -163.35 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 109.687 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.3 -167.56 31.74 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.9 mtmm -127.33 143.2 51.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.662 -0.905 . . . . 0.0 109.524 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 44' ' ' GLY . 0.8 OUTLIER -74.53 108.42 6.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.505 -0.747 . . . . 0.0 109.677 -179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.411 HG13 ' N ' ' A' ' 7' ' ' SER . 7.2 p -69.38 -39.26 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.635 179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.411 ' N ' HG13 ' A' ' 6' ' ' VAL . 23.1 p -159.85 165.2 32.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.707 -1.246 . . . . 0.0 110.873 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -156.7 114.23 3.18 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 mp -114.16 111.41 21.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.542 -0.724 . . . . 0.0 109.936 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.16 -34.5 78.18 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.738 -0.601 . . . . 0.0 109.757 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.85 -34.67 73.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.472 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 99.0 mttt -92.54 -4.44 53.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.8 mtpm? 54.21 6.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.536 -0.728 . . . . 0.0 109.505 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.495 ' CD2' ' O ' ' A' ' 12' ' ' LYS . 52.9 m-85 -132.89 123.52 26.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 27' ' ' LEU . . . -106.62 -164.94 22.58 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -141.73 145.15 34.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.439 -1.036 . . . . 0.0 109.122 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.3 mt -131.8 136.83 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.795 -0.566 . . . . 0.0 109.825 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -100.49 110.78 22.98 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.362 -0.836 . . . . 0.0 109.181 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.73 155.38 53.45 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.026 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.559 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 49.1 p-10 -65.86 -32.61 74.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.521 -0.988 . . . . 0.0 109.739 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.559 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 86.5 m-20 -86.49 10.63 14.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.879 -1.138 . . . . 0.0 108.813 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.21 15.44 71.94 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.65 109.53 21.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.968 -1.313 . . . . 0.0 109.489 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.0 t -73.98 142.48 45.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.1 135.27 52.52 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.553 -0.717 . . . . 0.0 109.662 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -78.02 144.69 36.44 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.885 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 27' ' ' LEU . 6.2 tt -109.36 122.42 47.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.535 ' N ' HD23 ' A' ' 27' ' ' LEU . 5.8 m-70 -127.28 149.94 49.79 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.606 0.717 . . . . 0.0 109.867 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -64.5 -37.97 89.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 p -61.64 -25.84 67.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.35 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.84 -1.08 46.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 77.7 mt -93.85 120.47 34.15 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.949 -1.095 . . . . 0.0 110.347 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.5 mm? -64.43 -42.44 96.02 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.597 -0.689 . . . . 0.0 109.768 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -117.01 109.66 17.27 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.491 -0.756 . . . . 0.0 109.341 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -65.99 -15.14 62.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.118 -0.989 . . . . 0.0 108.771 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -65.22 -38.79 91.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.388 -0.82 . . . . 0.0 109.255 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -70.89 -10.83 60.38 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -57.54 -33.75 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 109.001 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.9 -20.69 72.92 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.498 ' O ' ' O ' ' A' ' 41' ' ' LEU . 4.8 mptp? -90.87 -88.92 0.17 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.297 -1.12 . . . . 0.0 109.415 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' O ' ' O ' ' A' ' 40' ' ' LYS . 53.2 mt 44.81 -175.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.805 -0.559 . . . . 0.0 109.53 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 43' ' ' LYS . 8.0 p -146.78 159.62 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 120.723 -1.235 . . . . 0.0 110.257 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 42' ' ' VAL . 87.4 tttt -122.21 124.85 44.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 110.5 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.637 ' H ' HG13 ' A' ' 5' ' ' VAL . . . 82.12 -15.47 27.63 Favored Glycine 0 N--CA 1.495 2.588 0 O-C-N 121.477 -0.765 . . . . 0.0 111.536 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 5' ' ' VAL . 5.8 t -86.55 178.75 6.98 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.499 -1.589 . . . . 0.0 110.868 -179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.1 mtm -79.97 145.74 32.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.498 -0.751 . . . . 0.0 110.838 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.56 161.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -126.76 131.15 51.38 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.501 -0.749 . . . . 0.0 109.598 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -146.81 154.02 40.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.307 -0.871 . . . . 0.0 109.482 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -97.12 164.29 18.14 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.454 -0.779 . . . . 0.0 109.079 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.62 143.26 95.29 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.998 1.798 . . . . 0.0 112.589 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.2 m -153.56 87.76 3.75 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.127 -0.983 . . . . 0.0 109.462 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -77.24 94.22 1.07 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.749 1.633 . . . . 0.0 111.609 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 59' ' ' ALA . 2.5 p -98.4 157.9 33.56 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.378 -0.826 . . . . 0.0 109.23 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.13 -22.8 3.96 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.074 1.849 . . . . 0.0 112.207 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.82 -6.4 54.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.96 -1.088 . . . . 0.0 109.796 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 112.32 -86.78 0.44 Allowed Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 178.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 87.3 mt -111.62 142.84 43.41 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.471 -1.017 . . . . 0.0 109.879 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HB2' ' OG1' ' A' ' 54' ' ' THR . . . -154.23 156.22 36.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.577 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.61 141.56 38.9 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.641 -0.662 . . . . 0.0 109.522 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.95 152.07 49.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.468 -0.77 . . . . 0.0 109.686 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.16 49.16 14.02 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.459 -0.776 . . . . 0.0 109.217 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.71 135.72 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.357 -0.839 . . . . 0.0 109.123 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -134.63 150.98 50.73 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.645 0.736 . . . . 0.0 110.139 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -112.95 95.14 32.92 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.69 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -51.18 -36.67 56.67 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 C-N-CA 121.975 1.783 . . . . 0.0 111.459 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.609 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.7 mp -61.85 174.33 0.85 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.49 -0.756 . . . . 0.0 110.255 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.415 ' OE1' ' CB ' ' A' ' 67' ' ' LEU . 54.3 mp0 52.93 29.99 8.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.786 . . . . 0.0 109.215 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.51 ' CG ' ' N ' ' A' ' 70' ' ' HIS . 86.6 t60 -68.06 167.21 14.42 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.353 -0.842 . . . . 0.0 109.989 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.51 ' N ' ' CG ' ' A' ' 69' ' ' HIS . 56.8 t-80 57.88 167.19 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.734 0.778 . . . . 0.0 110.837 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.507 ' N ' ' CG ' ' A' ' 70' ' ' HIS . 79.3 m80 -70.25 143.87 52.0 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 121.544 0.688 . . . . 0.0 110.572 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.446 ' O ' ' CD2' ' A' ' 72' ' ' HIS . 84.8 t60 -78.0 60.57 2.4 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.308 -0.87 . . . . 0.0 109.511 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -67.26 -41.03 86.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.339 -0.851 . . . . 0.0 109.225 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.303 -1.433 0 CA-C-O 117.881 -1.057 . . . . 0.0 109.179 179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.265 0.555 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -103.54 149.08 25.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.544 -0.723 . . . . 0.0 109.991 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.78 -158.31 20.47 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -131.39 143.75 50.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.743 -0.857 . . . . 0.0 109.953 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.4 p -80.33 113.53 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 121.668 0.747 . . . . 0.0 110.338 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.06 -35.58 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.37 0.605 . . . . 0.0 109.465 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 45.8 t -171.78 151.15 2.78 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.235 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -105.66 -33.73 7.95 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.9 0.857 . . . . 0.0 109.032 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.0 mt 45.93 75.22 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.62 0.724 . . . . 0.0 109.444 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.82 -25.76 68.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.837 0.827 . . . . 0.0 109.046 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.74 80.99 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.633 0.73 . . . . 0.0 109.606 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 14' ' ' TYR . 64.4 mttp -94.07 0.48 55.94 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt 55.44 5.66 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.204 0.526 . . . . 0.0 109.945 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.475 ' H ' ' C ' ' A' ' 12' ' ' LYS . 49.5 m-85 -123.14 125.07 44.45 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.14 164.77 19.41 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -132.2 142.16 49.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.748 -0.854 . . . . 0.0 109.89 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.1 mt -133.15 136.51 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.51 0.672 . . . . 0.0 109.463 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -93.6 104.0 16.15 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.761 0.791 . . . . 0.0 109.674 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.82 162.86 53.82 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.19 -38.31 90.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.698 -0.884 . . . . 0.0 109.691 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -82.25 3.98 25.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.322 -0.861 . . . . 0.0 109.084 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.26 19.72 61.97 Favored Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -88.19 118.44 27.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.211 -1.17 . . . . 0.0 109.927 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.2 p -78.85 157.14 28.4 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.532 0.682 . . . . 0.0 110.196 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.57 139.77 42.41 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.568 0.699 . . . . 0.0 109.418 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -96.73 124.96 40.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.771 -0.581 . . . . 0.0 109.46 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.604 ' C ' HD23 ' A' ' 27' ' ' LEU . 5.5 tt -103.69 117.39 34.27 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 121.566 0.698 . . . . 0.0 109.194 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.583 ' N ' HD23 ' A' ' 27' ' ' LEU . 4.6 t60 -117.49 163.08 16.94 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.732 . . . . 0.0 109.374 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.498 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 17.3 m-85 -62.86 -36.83 84.54 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.743 0.782 . . . . 0.0 108.979 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -63.03 -18.33 63.21 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.406 0.622 . . . . 0.0 109.525 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -90.87 -6.89 53.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.16 -0.963 . . . . 0.0 109.447 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.54 117.51 30.24 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.114 -0.991 . . . . 0.0 109.547 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.482 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.6 mm? -63.66 -41.23 98.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -118.86 114.52 22.74 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.417 0.627 . . . . 0.0 109.397 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -62.32 -36.12 81.2 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.638 0.733 . . . . 0.0 109.155 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.05 -33.8 75.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.486 -0.759 . . . . 0.0 109.862 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -68.97 -4.34 16.35 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.396 -0.815 . . . . 0.0 109.245 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' OE2' ' CZ ' ' A' ' 29' ' ' PHE . 81.6 tt0 -63.3 -37.56 87.72 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.394 -0.816 . . . . 0.0 109.437 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.77 -4.95 89.84 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -96.65 3.75 52.31 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.33 -1.1 . . . . 0.0 109.267 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.9 mt -69.38 147.79 50.54 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.398 -0.814 . . . . 0.0 110.179 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 42' ' ' VAL . 14.6 p -108.67 113.39 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 121.96 0.886 . . . . 0.0 109.406 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -95.38 141.59 28.77 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.491 0.662 . . . . 0.0 110.567 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 24.95 51.46 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.2 t -148.1 -165.03 2.16 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.95 -1.324 . . . . 0.0 110.703 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.4 mtm -82.88 146.86 28.63 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.502 0.668 . . . . 0.0 110.638 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -136.18 158.99 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.688 -0.632 . . . . 0.0 109.33 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -121.53 132.53 54.75 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.582 0.706 . . . . 0.0 109.773 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.17 158.26 40.08 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.681 0.753 . . . . 0.0 110.294 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.27 150.38 37.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.66 156.98 59.91 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.474 2.116 . . . . 0.0 111.898 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 13.8 p -141.03 143.33 30.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.632 -0.667 . . . . 0.0 109.308 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 54' ' ' THR . 76.6 Cg_exo -41.49 -68.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.259 1.972 . . . . 0.0 111.779 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 53' ' ' PRO . 2.0 m 33.11 87.25 0.11 Allowed Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.43 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 56' ' ' LYS . 59.0 Cg_endo -77.34 98.14 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.138 1.892 . . . . 0.0 111.686 -178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' CB ' ' O ' ' A' ' 55' ' ' PRO . 25.9 ttpt 78.12 67.14 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.76 0.791 . . . . 0.0 109.755 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' O ' ' O ' ' A' ' 58' ' ' LEU . . . 172.99 -33.7 0.12 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 57' ' ' GLY . 63.4 mt 59.49 138.36 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.828 -0.807 . . . . 0.0 110.327 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 52' ' ' THR . . . -159.73 174.27 14.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.489 -0.757 . . . . 0.0 110.016 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.76 139.34 41.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.593 0.711 . . . . 0.0 109.875 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -127.58 148.35 50.35 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 57.88 55.49 5.34 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.86 0.838 . . . . 0.0 109.213 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 89.3 mt -78.52 132.03 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 CA-C-O 121.384 0.612 . . . . 0.0 110.122 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.7 m -107.26 124.57 49.96 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.802 0.811 . . . . 0.0 109.401 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -93.57 113.28 59.85 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.622 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 67' ' ' LEU . 92.5 Cg_endo -80.08 -169.7 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.317 2.011 . . . . 0.0 112.468 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 66' ' ' PRO . 80.1 mt 40.41 95.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.102 0.953 . . . . 0.0 110.258 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.528 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 57.5 mp0 -89.53 -98.32 0.1 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.661 0.743 . . . . 0.0 109.635 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -171.45 84.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -155.06 149.38 26.11 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.732 -0.605 . . . . 0.0 109.692 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 40.04 60.28 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 109.974 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.463 ' ND1' ' N ' ' A' ' 73' ' ' HIS . 63.5 t-80 -154.75 163.06 40.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.642 -0.661 . . . . 0.0 109.84 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.463 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 46.2 p-80 -154.43 159.02 40.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 109.744 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.475 ' OXT' ' CG ' ' A' ' 74' ' ' HIS . 51.6 p-80 . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.156 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -107.84 178.24 4.58 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.604 0.716 . . . . 0.0 109.572 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.82 -159.87 19.09 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -132.67 134.86 45.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.538 -0.978 . . . . 0.0 109.682 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 5' ' ' VAL . 6.8 p -82.55 105.48 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.93 -36.42 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.7 t -150.36 144.57 25.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.936 -1.102 . . . . 0.0 109.857 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.447 ' CZ ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -125.14 -68.53 0.84 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.178 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.8 mt 57.93 109.46 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.975 0.893 . . . . 0.0 109.662 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.79 -23.3 27.27 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.904 0.859 . . . . 0.0 108.76 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -40.43 90.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.368 -0.833 . . . . 0.0 109.681 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 14' ' ' TYR . 99.5 mttt -97.77 -3.27 39.33 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.095 -1.003 . . . . 0.0 108.549 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? 52.19 9.35 0.09 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.478 -0.764 . . . . 0.0 110.464 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.443 ' H ' ' C ' ' A' ' 12' ' ' LYS . 58.1 m-85 -132.25 148.17 52.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -163.3 -159.83 10.91 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -139.09 155.53 47.84 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.3 -1.118 . . . . 0.0 109.547 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.69 135.07 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -101.11 118.57 37.25 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.861 0.838 . . . . 0.0 109.768 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.75 156.66 53.36 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.535 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 48.1 p-10 -67.27 -27.62 67.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.516 -0.99 . . . . 0.0 109.549 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.535 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 33.1 p-10 -89.41 9.01 27.89 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.518 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.34 12.51 67.34 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -95.66 114.69 26.47 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.006 -1.291 . . . . 0.0 109.917 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 41.4 t -78.75 147.75 33.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.605 -0.684 . . . . 0.0 109.672 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -131.99 141.68 49.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.425 -0.797 . . . . 0.0 109.835 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -76.41 144.15 40.19 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.629 0.728 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 28' ' ' HIS . 6.1 tt -114.16 122.28 46.32 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.792 0.806 . . . . 0.0 109.304 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.626 ' N ' HD23 ' A' ' 27' ' ' LEU . 7.6 p-80 -139.16 160.51 39.62 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.535 -0.728 . . . . 0.0 109.543 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -85.96 -10.82 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.869 0.842 . . . . 0.0 109.082 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.3 m -67.19 -11.72 58.12 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.384 -0.823 . . . . 0.0 109.37 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -108.38 -23.29 11.95 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.245 -0.909 . . . . 0.0 109.629 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.63 128.33 36.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.871 -1.143 . . . . 0.0 109.884 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.5 mt -63.53 -40.46 97.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 35' ' ' LYS . 64.3 t0 -132.03 129.57 40.24 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.909 0.861 . . . . 0.0 109.563 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 72.9 mmtt -63.92 -36.29 83.46 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.804 0.812 . . . . 0.0 109.28 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -62.61 -35.95 81.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.46 -0.775 . . . . 0.0 110.168 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.48 -6.16 2.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.948 -179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -63.41 -36.54 84.08 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.973 -1.079 . . . . 0.0 109.621 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.08 -7.1 81.37 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -95.59 0.05 52.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.179 -1.189 . . . . 0.0 108.723 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CZ ' ' A' ' 8' ' ' TYR . 83.8 mt -69.39 158.68 34.63 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.4 -0.812 . . . . 0.0 109.795 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 5' ' ' VAL . 7.8 p -122.89 138.29 53.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.735 0.779 . . . . 0.0 109.745 -179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -107.29 129.98 54.82 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.568 0.699 . . . . 0.0 110.108 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.94 25.21 46.08 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.8 m -140.29 173.29 11.66 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.03 -1.277 . . . . 0.0 110.387 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 78.8 mtm -78.3 144.68 35.88 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.879 0.847 . . . . 0.0 111.157 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.74 164.93 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -116.65 129.56 56.22 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -148.51 163.08 38.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.447 -0.783 . . . . 0.0 109.391 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' OD2' ' HB3' ' A' ' 62' ' ' ALA . 20.3 m-20 -104.59 111.37 65.2 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 121.39 -0.819 . . . . 0.0 109.469 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -49.35 137.93 30.7 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.309 2.006 . . . . 0.0 112.597 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.4 m -152.73 133.05 7.51 Favored Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.094 -1.004 . . . . 0.0 109.449 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.67 164.88 33.72 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.514 2.143 . . . . 0.0 112.748 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.655 HG21 ' HB2' ' A' ' 59' ' ' ALA . 0.7 OUTLIER -172.38 149.74 2.14 Favored Pre-proline 0 C--N 1.298 -1.633 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.713 179.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -47.6 -31.85 14.91 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 122.541 2.161 . . . . 0.0 111.642 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -77.99 2.57 17.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.369 -0.832 . . . . 0.0 109.3 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.87 -88.17 0.46 Allowed Glycine 0 N--CA 1.5 2.953 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.7 mt -130.02 149.26 51.82 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.357 -1.084 . . . . 0.0 109.616 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.655 ' HB2' HG21 ' A' ' 54' ' ' THR . . . -137.21 144.93 43.09 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 121.091 -1.006 . . . . 0.0 110.237 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.83 99.1 8.87 Favored 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 124.994 2.331 . . . . 0.0 111.264 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.304 43.2 tptt -82.24 143.36 31.41 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 111.555 -2.566 . . . . 0.0 113.1 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB3' ' OD2' ' A' ' 50' ' ' ASP . . . 42.14 66.79 0.67 Allowed 'General case' 0 N--CA 1.506 2.359 0 CA-C-O 122.369 1.08 . . . . 0.0 110.005 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 96.0 mt -75.05 137.82 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.425 -0.797 . . . . 0.0 109.175 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.2 t -123.8 147.91 47.15 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.48 -0.763 . . . . 0.0 110.071 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -124.99 79.72 64.79 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 67' ' ' LEU . 88.3 Cg_endo -81.63 -12.01 11.35 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.763 2.309 . . . . 0.0 111.579 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' C ' ' O ' ' A' ' 66' ' ' PRO . 17.5 mt 33.67 -151.47 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.913 0.863 . . . . 0.0 111.199 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.453 ' CD ' ' N ' ' A' ' 68' ' ' GLU . 2.1 pm0 -164.15 26.27 0.07 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.635 ' ND1' ' N ' ' A' ' 70' ' ' HIS . 25.7 p80 -61.39 -46.8 88.64 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.332 -0.855 . . . . 0.0 109.522 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.635 ' N ' ' ND1' ' A' ' 69' ' ' HIS . 97.4 m-70 -151.96 143.64 23.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.21 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -87.72 3.8 46.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.194 -0.941 . . . . 0.0 108.865 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.455 ' C ' ' H ' ' A' ' 74' ' ' HIS . 78.9 m80 -75.52 146.8 40.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.256 -0.902 . . . . 0.0 110.544 -179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 73' ' ' HIS . 59.8 t-80 53.3 10.17 0.18 Allowed 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.775 0.798 . . . . 0.0 109.203 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.455 ' H ' ' C ' ' A' ' 72' ' ' HIS . 86.1 t60 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.907 179.768 . . . . . . . . 1 1 . 1 stop_ save_